[{"title":"Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet","googleId":"-ZTd39R3XYUJ","googleLink":"https://www.nature.com/articles/s41375-018-0077-1","googleCitationCount":220,"googleAuthor":"T Barbui","doi":"10.1038/s41375-018-0077-1","elsevierAuthor":"Barbui T.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"165","altmetricAuthors":["Tiziano Barbui","Ayalew Tefferi","Alessandro M. Vannucchi","Francesco Passamonti","Richard T. Silver","Ronald Hoffman","Srdan Verstovsek","Ruben Mesa","Jean-Jacques Kiladjian","Rȕdiger Hehlmann","Andreas Reiter","Francisco Cervantes","Claire Harrison","Mary Frances Mc Mullin","Hans Carl Hasselbalch","Steffen Koschmieder","Monia Marchetti","Andrea Bacigalupo","Guido Finazzi","Nicolaus Kroeger","Martin Griesshammer","Gunnar Birgegard","Giovanni Barosi"],"twitterCount":11,"altmetricId":33896885,"statusesArray":["973744277095403520","973653155526430722","973478162192576513","973400891553472512","973318460309671937","973304692125192192","973275302372749313","973260642521112576","973260333279145984","970368902944514049","970366348407820288","970028154227224576"]},{"title":"Clinical use of lentiviral vectors","googleId":"shCSJgq8hB4J","googleLink":"https://www.nature.com/articles/s41375-018-0106-0","googleCitationCount":208,"googleAuthor":"MC Milone","doi":"10.1038/s41375-018-0106-0","elsevierAuthor":"Milone M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"143","altmetricAuthors":["Michael C. Milone","Una O’Doherty"],"twitterCount":12,"altmetricId":34712698,"statusesArray":["1300647275618881536","1285227441284358147","989872799694163969","985638760598585344","985467775568130048","979181460367163393","979092046144208897","977486858623078401","977140613916196864","977125125358260225","977116356452724736","977114824932057088","976796907291820033"]},{"title":"Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","googleId":"16Xpo2xAuEkJ","googleLink":"https://www.nature.com/articles/leu201729","googleCitationCount":289,"googleAuthor":"L Sanoja-Flores","doi":"10.1038/leu.2017.29","elsevierAuthor":"Flores-Montero J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"211","altmetricAuthors":["J Flores-Montero","L Sanoja-Flores","B Paiva","N Puig","O García-Sánchez","S Böttcher","V H J van der Velden","J-J Pérez-Morán","M-B Vidriales","R García-Sanz","C Jimenez","M González","J Martínez-López","A Corral-Mateos","G-E Grigore","R Fluxá","R Pontes","J Caetano","L Sedek","M-C del Cañizo","J Bladé","J-J Lahuerta","C Aguilar","A Bárez","A García-Mateo","J Labrador","P Leoz","C Aguilera-Sanz","J San-Miguel","M-V Mateos","B Durie","J J M van Dongen","A Orfao"],"twitterCount":20,"altmetricId":15608496,"statusesArray":["1351951397869203456","1337040409936207875","1336797346336747521","851518199644524544","851470740197183488","843290245340827650","842624104083656704","842401469370380290","842370367859511297","827747019502465024","823722390735745024","823719302733905920","823683966339162112","823608063324135424","823551582348443648","823299213823975424","823279486745608193","823169599684231173","822587948583493634","822575008509730817","822544689765224450","822533559474946050","822423105213726720"]},{"title":"The MLL recombinome of acute leukemias in 2017","googleId":"fYCNSZy--fAJ","googleLink":"https://www.nature.com/articles/leu2017213","googleCitationCount":253,"googleAuthor":"","doi":"10.1038/leu.2017.213","elsevierAuthor":"Meyer C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"182","altmetricAuthors":["C Meyer","T Burmeister","D Gröger","G Tsaur","L Fechina","A Renneville","R Sutton","N C Venn","M Emerenciano","M S Pombo-de-Oliveira","C Barbieri Blunck","B Almeida Lopes","J Zuna","J Trka","P Ballerini","H Lapillonne","M De Braekeleer","G Cazzaniga","L Corral Abascal","V H J van der Velden","E Delabesse","T S Park","S H Oh","M L M Silva","T Lund-Aho","V Juvonen","A S Moore","O Heidenreich","J Vormoor","E Zerkalenkova","Y Olshanskaya","C Bueno","P Menendez","A Teigler-Schlegel","U zur Stadt","J Lentes","G Göhring","A Kustanovich","O Aleinikova","B W Schäfer","S Kubetzko","H O Madsen","B Gruhn","X Duarte","P Gameiro","E Lippert","A Bidet","J M Cayuela","E Clappier","C N Alonso","C M Zwaan","M M van den Heuvel-Eibrink","S Izraeli","L Trakhtenbrot","P Archer","J Hancock","A Möricke","J Alten","M Schrappe","M Stanulla","S Strehl","A Attarbaschi","M Dworzak","O A Haas","R Panzer-Grümayer","L Sedék","T Szczepański","A Caye","L Suarez","H Cavé","R Marschalek"],"twitterCount":3,"altmetricId":21853312,"statusesArray":["887097911653261312","885579917685137408","885536805877108740"]},{"title":"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity","googleId":"0E8gAvVur34J","googleLink":"https://www.nature.com/articles/leu2017226","googleCitationCount":227,"googleAuthor":"E Liu","doi":"10.1038/leu.2017.226","elsevierAuthor":"Liu E.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"172","altmetricAuthors":["E Liu","Y Tong","G Dotti","H Shaim","B Savoldo","M Mukherjee","J Orange","X Wan","X Lu","A Reynolds","M Gagea","P Banerjee","R Cai","M H Bdaiwi","R Basar","M Muftuoglu","L Li","D Marin","W Wierda","M Keating","R Champlin","E Shpall","K Rezvani"],"twitterCount":47,"altmetricId":22242396,"statusesArray":["1138154825462439938","1138151012202668033","1079318333781090304","1079224156988817409","1065512987077701632","1043223847661527041","1043217507253796864","1043175147711197184","1040700210220085248","1040680211925422087","1035988453945683970","1034874058150690821","994779687896395778","994643417065025536","965898422136995841","965897793998028800","962237888946626560","962131978546954240","962103774738309121","962058320667230208","962042752320995329","939806612646256640","939804755030958080","939783444602683398","939758542462046208","939739357178720257","939728394060566528","939672506985742336","939592443590213632","939583601997438976","939575585759563778","939543986645192704","939527364140306432","939527160007667714","939520270322188288","939519985172365312","939507564466921472","939507428076351488","939506795017637889","939505531651272705","897842591806390272","894548732724862976","892722237886926848","892715669724291073","892582632550146050","892560997608636416","892467658809114625","892431942603468800","892416854270103554","892411189384417283","892403705210785793","889493830483030016","889485639116349444","889484099248939009","889449144343040000","889277479898275840","889266043960668160","888338930478837760","888194272809365505"]},{"title":"Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study","googleId":"6-l1jBUbW8oJ","googleLink":"https://www.nature.com/articles/leu201763","googleCitationCount":180,"googleAuthor":"JP Radich","doi":"10.1038/leu.2017.63","elsevierAuthor":"Hochhaus A.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"136","altmetricAuthors":["A Hochhaus","T Masszi","F J Giles","J P Radich","D M Ross","M T Gómez Casares","A Hellmann","J Stentoft","E Conneally","V García-Gutiérrez","N Gattermann","W Wiktor-Jedrzejczak","P D le Coutre","B Martino","S Saussele","H D Menssen","W Deng","N Krunic","V Bedoucha","G Saglio"],"twitterCount":17,"altmetricId":16619031,"statusesArray":["946121711145095174","939496177782927365","939496010585341952","939488667437060096","939479677604909056","939479448897933313","939478578055536640","884553294307262464","884551916730146816","884545014050820096","844635211182882817","844608664006742016","844604650653466628","834993756067741696","834435732815101952","834434722726019072","834434689691684865","834422539422224384","834362842732232704","834362607536574466","834361795263492098"]},{"title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","googleId":"rac7vI3jRP8J","googleLink":"https://www.nature.com/articles/leu2017259","googleCitationCount":163,"googleAuthor":"B Kumar","doi":"10.1038/leu.2017.259","elsevierAuthor":"Kumar B.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"101","altmetricAuthors":["B Kumar","M Garcia","L Weng","X Jung","J L Murakami","X Hu","T McDonald","A Lin","A R Kumar","D L DiGiusto","A S Stein","V A Pullarkat","S K Hui","N Carlesso","Y-H Kuo","R Bhatia","G Marcucci","C-C Chen"],"twitterCount":5,"altmetricId":24027614,"statusesArray":["1026390260987686912","979215766871408642","901321510731866116","901299429554216964","898528929140494336"]},{"title":"Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia","googleId":"UH4XEdR2ECEJ","googleLink":"https://www.nature.com/articles/leu2017265","googleCitationCount":161,"googleAuthor":"","doi":"10.1038/leu.2017.265","elsevierAuthor":"Toft N.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"114","altmetricAuthors":["N Toft","H Birgens","J Abrahamsson","L Griškevičius","H Hallböök","M Heyman","T W Klausen","ÓG Jónsson","K Palk","K Pruunsild","P Quist-Paulsen","G Vaitkeviciene","K Vettenranta","A Åsberg","T L Frandsen","H V Marquart","H O Madsen","U Norén-Nyström","K Schmiegelow"],"twitterCount":1,"altmetricId":24421614,"statusesArray":["902063187268444160"]},{"title":"Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond","googleId":"ZLqK5NJ8WuQJ","googleLink":"https://www.nature.com/articles/leu2017329","googleCitationCount":153,"googleAuthor":"SK Kumar","doi":"10.1038/leu.2017.329","elsevierAuthor":"Lv M.","publicationName":"Oncology Reports","elsevierCoverDate":"2021-03-01","elsevierCoverDisplayDate":"March 2021","elsevierCitationCount":"0","altmetricAuthors":["C S Chim","S K Kumar","R Z Orlowski","G Cook","P G Richardson","M A Gertz","S Giralt","M V Mateos","X Leleu","K C Anderson"],"twitterCount":15,"altmetricId":31820274,"statusesArray":["1054639041646333953","1054238117484527616","1052512381106970626","1052314918664503296","1052072178236166145","1050704254674063361","1050683633588146177","1050498311952711680","1050453415858503681","1050430341746438144","1050428554020818944","1050419677011292161","1050418900918292481","1050418299266367489","965637894479073280"]},{"title":"Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL","googleId":"wNUNmh3X8jwJ","googleLink":"https://www.nature.com/articles/leu2017175","googleCitationCount":156,"googleAuthor":"P Hillmen","doi":"10.1038/leu.2017.175","elsevierAuthor":"Brown J.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"118","altmetricAuthors":["J R Brown","P Hillmen","S O’Brien","J C Barrientos","N M Reddy","S E Coutre","C S Tam","S P Mulligan","U Jaeger","P M Barr","R R Furman","T J Kipps","F Cymbalista","P Thornton","F Caligaris-Cappio","J Delgado","M Montillo","S DeVos","C Moreno","J M Pagel","T Munir","J A Burger","D Chung","J Lin","L Gau","B Chang","G Cole","E Hsu","D F James","J C Byrd"],"twitterCount":8,"altmetricId":21488111,"statusesArray":["890681761671282688","890429994090057728","890386574017519616","890377674404671491","890268454359584769","890243565338509313","881912491441344513","881823490424307718"]},{"title":"Isocitrate dehydrogenase mutations in myeloid malignancies","googleId":"1VedVQXGK8UJ","googleLink":"https://www.nature.com/articles/leu2016275?source=content_type%3Areact%7Cfirst_level_url%3Aarticle%7Csection%3Amain_content%7Cbutton%3Abody_link","googleCitationCount":207,"googleAuthor":"AT Fathi","doi":"10.1038/leu.2016.275","elsevierAuthor":"Medeiros B.C.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"149","altmetricAuthors":["B C Medeiros","A T Fathi","C D DiNardo","D A Pollyea","S M Chan","R Swords"],"twitterCount":2,"altmetricId":12583248,"statusesArray":["925480620125540353","826794622852722692"]},{"title":"Gemtuzumab ozogamicin in acute myeloid leukemia","googleId":"_oMrOL1VctMJ","googleLink":"https://www.nature.com/articles/leu2017187","googleCitationCount":135,"googleAuthor":"RP Gale","doi":"10.1038/leu.2017.187","elsevierAuthor":"Godwin C.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"100","altmetricAuthors":["C D Godwin","R P Gale","R B Walter"],"twitterCount":5,"altmetricId":21130248,"statusesArray":["954097645248589824","943506268366483456","943481073979322374","913723468201553920","875888762705850369"]},{"title":"A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis","googleId":"1byBNqdPS1YJ","googleLink":"https://www.nature.com/articles/leu2017169","googleCitationCount":134,"googleAuthor":"F Passamonti","doi":"10.1038/leu.2017.169","elsevierAuthor":"Passamonti F.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"105","altmetricAuthors":["F Passamonti","T Giorgino","B Mora","P Guglielmelli","E Rumi","M Maffioli","A Rambaldi","M Caramella","R Komrokji","J Gotlib","J J Kiladjian","F Cervantes","T Devos","F Palandri","V De Stefano","M Ruggeri","R T Silver","G Benevolo","F Albano","D Caramazza","M Merli","D Pietra","R Casalone","G Rotunno","T Barbui","M Cazzola","A M Vannucchi"],"twitterCount":2,"altmetricId":20759789,"statusesArray":["905702866001682433","870330391910957056"]},{"title":"An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies","googleId":"4jKGtvRL1gwJ","googleLink":"https://www.nature.com/articles/s41375-018-0065-5","googleCitationCount":114,"googleAuthor":"","doi":"10.1038/s41375-018-0065-5","elsevierAuthor":"Cooper M.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"92","altmetricAuthors":["Matthew L Cooper","Jaebok Choi","Karl Staser","Julie K Ritchey","Jessica M Devenport","Kayla Eckardt","Michael P Rettig","Bing Wang","Linda G Eissenberg","Armin Ghobadi","Leah N Gehrs","Julie L Prior","Samuel Achilefu","Christopher A Miller","Catrina C Fronick","Julie O’Neal","Feng Gao","David M Weinstock","Alejandro Gutierrez","Robert S Fulton","John F DiPersio"],"twitterCount":12,"altmetricId":33770250,"statusesArray":["1116452683823501313","1062358407984889857","1034951549250928640","978470884884209668","978470749982801920","978470200189206528","978469863503966209","978469643835736064","973327789481803776","971689066923282432","971377039327531014","969029616898748418","968949228067217408","968896434186711042","968895968103059457","968830655416107008"]},{"title":"Trends in overall survival and costs of multiple myeloma, 2000–2014","googleId":"yD5wCsAD9-gJ","googleLink":"https://www.nature.com/articles/leu2016380","googleCitationCount":180,"googleAuthor":"R Fonseca","doi":"10.1038/leu.2016.380","elsevierAuthor":"Fonseca R.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"143","altmetricAuthors":["R Fonseca","S Abouzaid","M Bonafede","Q Cai","K Parikh","L Cosler","P Richardson"],"twitterCount":23,"altmetricId":15021805,"statusesArray":["1271800433401630722","1271450613767962626","1271436141665927168","994574436304064512","994537317649080326","975766425452326912","913722478098305024","905508720255389696","905405037916053504","905395984368205824","905395449787383808","905383222816645120","902546171234799617","879765402980667392","879764348691984384","879145717041967104","878993844733444096","878698641791361027","878656287688491009","878656215768760320","878127893083279360","878088529972264960","877904290638987264","866661225295466496","865697334918877185","865691801973379072","864825768555294720","864825399422980096","863428246137962496","863375834039582720","863254599246983168","863090496599502848","863089829772500993","863085926116986886","863084567359574018","817170960516345856","817047061287804928","817014411881775105","817012783132868608","812620582546067456"]},{"title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","googleId":"tTvgj7ym_1EJ","googleLink":"https://www.nature.com/articles/s41375-018-0067-3","googleCitationCount":88,"googleAuthor":"N Amodio","doi":"10.1038/s41375-018-0067-3","elsevierAuthor":"Amodio N.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"76","altmetricAuthors":["Nicola Amodio","Maria Angelica Stamato","Giada Juli","Eugenio Morelli","Mariateresa Fulciniti","Martina Manzoni","Elisa Taiana","Luca Agnelli","Maria Eugenia Gallo Cantafio","Enrica Romeo","Lavinia Raimondi","Daniele Caracciolo","Valeria Zuccalà","Marco Rossi","Antonino Neri","Nikhil C. Munshi","Pierosandro Tagliaferri","Pierfrancesco Tassone"],"twitterCount":3,"altmetricId":34432379,"statusesArray":["1021831262993043456","1021827282342694912","974809970792333312"]},{"title":"Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia","googleId":"Uza33I0dn2wJ","googleLink":"https://www.nature.com/articles/s41375-018-0210-1","googleCitationCount":112,"googleAuthor":"PL Zinzani","doi":"10.1038/s41375-018-0210-1","elsevierAuthor":"Kreitman R.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"81","altmetricAuthors":["Robert J. Kreitman","Claire Dearden","Pier Luigi Zinzani","Julio Delgado","Lionel Karlin","Tadeusz Robak","Douglas E. Gladstone","Philipp le Coutre","Sascha Dietrich","Mirjana Gotic","Loree Larratt","Fritz Offner","Gary Schiller","Ronan Swords","Larry Bacon","Monica Bocchia","Krimo Bouabdallah","Dimitri A. Breems","Agostino Cortelezzi","Shira Dinner","Michael Doubek","Bjorn Tore Gjertsen","Marco Gobbi","Andrzej Hellmann","Stephane Lepretre","Frederic Maloisel","Farhad Ravandi","Philippe Rousselot","Mathias Rummel","Tanya Siddiqi","Tamar Tadmor","Xavier Troussard","Cecilia Arana Yi","Giuseppe Saglio","Gail J. Roboz","Kemal Balic","Nathan Standifer","Peng He","Shannon Marshall","Wyndham Wilson","Ira Pastan","Nai-Shun Yao","Francis Giles"],"twitterCount":12,"altmetricId":46456588,"statusesArray":["1055014340670251008","1054706552593047558","1054693183672774657","1054692211022065665","1054692007212396544","1043153321777872896","1040581233338707968","1040471371753693185","1040356755878957057","1040354083478097922","1040353625707618304","1040344663444602880","1028939103058976768"]},{"title":"GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis","googleId":"ZH5e7cgRruEJ","googleLink":"https://www.nature.com/articles/s41375-018-0107-z","googleCitationCount":96,"googleAuthor":"P Guglielmelli","doi":"10.1038/s41375-018-0107-z","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"72","altmetricAuthors":["Ayalew Tefferi","Paola Guglielmelli","Maura Nicolosi","Francesco Mannelli","Mythri Mudireddy","Niccolo Bartalucci","Christy M. Finke","Terra L. Lasho","Curtis A. Hanson","Rhett P. Ketterling","Kebede H. Begna","Naseema Gangat","Animesh Pardanani","Alessandro M. Vannucchi"],"twitterCount":28,"altmetricId":39320270,"statusesArray":["1000759518689746944","998479669249880065","998457579947941888","998451131402588160","998286949109649409","998183292863164416","998153104829898752","998024392335478784","997853186462535682","997789143638953984","997772961934467073","997738250444988416","997719675088850944","997664126586572800","997646445409955840","997644699635716111","997637643486756864","997626420703711232","997624085340393472","997620897119899648","997609978545475584","997581956052332544","997526702451392512","997519595073425409","997519076804169728","997514023032840192","997511384891052033","997491568545357824","997490565896908801","989353216323268609"]},{"title":"Fully human CD19-specific chimeric antigen receptors for T-cell therapy","googleId":"02aIA7ONIiUJ","googleLink":"https://www.nature.com/articles/leu201757","googleCitationCount":123,"googleAuthor":"AI Salter","doi":"10.1038/leu.2017.57","elsevierAuthor":"Sommermeyer D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"85","altmetricAuthors":["D Sommermeyer","T Hill","S M Shamah","A I Salter","Y Chen","K M Mohler","S R Riddell"],"twitterCount":9,"altmetricId":16659139,"statusesArray":["925362155754545152","924670632691945475","847547066524061697","847272280564445184","847145584087777280","847101294947000325","840003495730147328","839863404034576384","834552903683678208","834496316856217600"]},{"title":"Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer","googleId":"vfS4kT3ZIioJ","googleLink":"https://www.nature.com/articles/s41375-018-0117-x","googleCitationCount":76,"googleAuthor":"B Wingelhofer","doi":"10.1038/s41375-018-0117-x","elsevierAuthor":"Wingelhofer B.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"57","altmetricAuthors":["Bettina Wingelhofer","Heidi A. Neubauer","Peter Valent","Xiaonan Han","Stefan N. Constantinescu","Patrick T. Gunning","Mathias Müller","Richard Moriggl"],"twitterCount":3,"altmetricId":34929366,"statusesArray":["1178699563961667585","1131159909871915010","979116952936501248"]},{"title":"ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation","googleId":"ouly619J3acJ","googleLink":"https://www.nature.com/articles/s41375-017-0007-7","googleCitationCount":81,"googleAuthor":"D Rossi","doi":"10.1038/s41375-017-0007-7","elsevierAuthor":"Malcikova J.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"58","altmetricAuthors":["J. Malcikova","E. Tausch","D. Rossi","L. A. Sutton","T. Soussi","T. Zenz","A. P. Kater","C. U. Niemann","D. Gonzalez","F. Davi","M. Gonzalez Diaz","C. Moreno","G. Gaidano","K. Stamatopoulos","R. Rosenquist","S. Stilgenbauer","P. Ghia","S. Pospisilova"],"twitterCount":18,"altmetricId":33018266,"statusesArray":["963062022723244033","962934153573519360","962922491474825216","962459635650359299","962429017008812032","962386970780618753","962363976624504832","962329617834086400","962319367261360128","962301473978798081","962286087195578368","962274270670966785","962262771185475584","962254956119117824","962246652491915264","962242935440969729","962242597694689280","962240833427779584"]},{"title":"Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial","googleId":"Wx5A0T5izigJ","googleLink":"https://www.nature.com/articles/leu2017211","googleCitationCount":105,"googleAuthor":"EK Mai","doi":"10.1038/leu.2017.211","elsevierAuthor":"Goldschmidt H.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"70","altmetricAuthors":["H Goldschmidt","H M Lokhorst","E K Mai","B van der Holt","I W Blau","S Zweegman","K C Weisel","E Vellenga","M Pfreundschuh","M J Kersten","C Scheid","S Croockewit","R Raymakers","D Hose","A Potamianou","A Jauch","J Hillengass","M Stevens-Kroef","M S Raab","A Broijl","H W Lindemann","G M J Bos","P Brossart","M van Marwijk Kooy","P Ypma","U Duehrsen","R M Schaafsma","U Bertsch","T Hielscher","Le Jarari","H J Salwender","P Sonneveld"],"twitterCount":9,"altmetricId":23398967,"statusesArray":["1105036717906628608","1086993956146167809","1070336012575039488","986669322021023751","986582742858117120","986437097467924486","895899497406091264","895302595304189952","895285310065606656","893323688724107264","893214901593710592"]},{"title":"Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study","googleId":"TxmKYa5oldwJ","googleLink":"https://www.nature.com/articles/leu2017138","googleCitationCount":146,"googleAuthor":"SK Kumar","doi":"10.1038/leu.2017.138","elsevierAuthor":"Kumar S.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"115","altmetricAuthors":["S K Kumar","M A Dimopoulos","E Kastritis","E Terpos","H Nahi","H Goldschmidt","J Hillengass","X Leleu","M Beksac","M Alsina","A Oriol","M Cavo","E M Ocio","M V Mateos","E K O'Donnell","R Vij","H M Lokhorst","N W C J van de Donk","C Min","T Mark","I Turesson","M Hansson","H Ludwig","S Jagannath","M Delforge","C Kyriakou","P Hari","U Mellqvist","S Z Usmani","D Dytfeld","A Z Badros","P Moreau","K Kim","P R Otero","J H Lee","C Shustik","D Waller","W J Chng","S Ozaki","J-J Lee","J de la Rubia","H S Eom","L Rosinol","J J Lahuerta","A Sureda","J S Kim","B G M Durie"],"twitterCount":5,"altmetricId":21150829,"statusesArray":["938363042781433856","877010155585642503","876786656241516545","876570127885578242","876530235189186561","876379271786352640"]},{"title":"High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients","googleId":"NiKtceOKkjUJ","googleLink":"https://www.nature.com/articles/leu2017145","googleCitationCount":105,"googleAuthor":"","doi":"10.1038/leu.2017.145","elsevierAuthor":"Tat T.","publicationName":"Oncotarget","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"2018","elsevierCitationCount":"1","altmetricAuthors":["J Pan","J F Yang","B P Deng","X J Zhao","X Zhang","Y H Lin","Y N Wu","Z L Deng","Y L Zhang","S H Liu","T Wu","P H Lu","D P Lu","A H Chang","C R Tong"],"twitterCount":6,"altmetricId":20176852,"statusesArray":["946013616712699904","865061305337753601","864807749263269890","864391411768209412","864357805309829120","864335109956132864","864305663517876229"]},{"title":"A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo","googleId":"_27yPjJvyJgJ","googleLink":"https://www.nature.com/articles/leu2016388","googleCitationCount":146,"googleAuthor":"","doi":"10.1038/leu.2016.388","elsevierAuthor":"Yang Y.","publicationName":"Journal of Hematology and Oncology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0","altmetricAuthors":["S Hipp","Y-T Tai","D Blanset","P Deegen","J Wahl","O Thomas","B Rattel","P J Adam","K C Anderson","M Friedrich"],"twitterCount":19,"altmetricId":15228079,"statusesArray":["833905476840497152","830932953047896064","829817111983882240","829812664763285504","822123083498565633","822086191138873344","821829439696805888","821763837393326084","820745153388445702","820320011952726016","820264902434652160","819899586408054785","819843512644403201","818696984823406592","818691556710330368","818685856349179904","816700177989763072","816690800402825216","816678642730356738","816646619106078720"]},{"title":"Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL","googleId":"_u5KtvgJqG0J","googleLink":"https://www.nature.com/articles/leu201741","googleCitationCount":108,"googleAuthor":"T Mueller","doi":"10.1038/leu.2017.41","elsevierAuthor":"Duell J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"81","altmetricAuthors":["J Duell","M Dittrich","T Bedke","T Mueller","F Eisele","A Rosenwald","L Rasche","E Hartmann","T Dandekar","H Einsele","M S Topp"],"twitterCount":14,"altmetricId":16797715,"statusesArray":["939560446041952256","929562236078776320","929343510066626560","928924445221314560","928918746760085504","923570834244902914","877396745881346048","877113971165286401","877090256394342400","877085685500583936","836136083171737600","836091089186664449","836065498240425984","836062898854195202","836054596539854850"]},{"title":"Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes","googleId":"2qe9yaKAYBkJ","googleLink":"https://www.nature.com/articles/s41375-018-0070-8","googleCitationCount":73,"googleAuthor":"G Garcia-Manero","doi":"10.1038/s41375-018-0070-8","elsevierAuthor":"Daver N.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"58","altmetricAuthors":["Naval Daver","Prajwal Boddu","Guillermo Garcia-Manero","Shalini Singh Yadav","Padmanee Sharma","James Allison","Hagop Kantarjian"],"twitterCount":4,"altmetricId":34427499,"statusesArray":["1107705195117465600","1008721625024483328","979214824499429376","974752384974016512"]},{"title":"Biological and clinical consequences of NPM1 mutations in AML","googleId":"YJZ4C9KKa48J","googleLink":"https://www.nature.com/articles/leu201730","googleCitationCount":101,"googleAuthor":"SM Chan","doi":"10.1038/leu.2017.30","elsevierAuthor":"Heath E.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"68","altmetricAuthors":["E M Heath","S M Chan","M D Minden","T Murphy","L I Shlush","A D Schimmer"],"twitterCount":2,"altmetricId":18694815,"statusesArray":["1353056204667281409","851377827853348865"]},{"title":"The emerging roles of tumor-derived exosomes in hematological malignancies","googleId":"x7NCGvPGgg8J","googleLink":"https://www.nature.com/articles/leu201791","googleCitationCount":105,"googleAuthor":"","doi":"10.1038/leu.2017.91","elsevierAuthor":"Boyiadzis M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"87","altmetricAuthors":["M Boyiadzis","T L Whiteside"],"twitterCount":1,"altmetricId":20898848,"statusesArray":["872599950475046912"]},{"title":"CAR T-cells targeting FLT3 have potent activity against FLT3− ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib","googleId":"u0N5EBUwCVEJ","googleLink":"https://www.nature.com/articles/s41375-018-0009-0","googleCitationCount":73,"googleAuthor":"","doi":"10.1038/s41375-018-0009-0","elsevierAuthor":"Jetani H.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"53","altmetricAuthors":["Hardikkumar Jetani","Irene Garcia-Cadenas","Thomas Nerreter","Simone Thomas","Julian Rydzek","Javier Briones Meijide","Halvard Bonig","Wolfgang Herr","Jordi Sierra","Hermann Einsele","Michael Hudecek"],"twitterCount":44,"altmetricId":32778144,"statusesArray":["1080933034835230721","1080885256994123776","1080883510720778240","1080882603778035712","1080881859674947585","1073486377361252352","994799315058118656","994637707656794112","994637624198467584","994625184345874432","994499531583754240","994467127322120192","977818321721675777","976465168438874114","976461320177504257","976355313191440384","976349944989831168","976342267874107392","976279450345025537","976260662010793984","976243999945015296","976241191862890498","976211196813733889","976201259165339649","976195726828072960","976193657639456768","976189372621049856","976185356746940418","976184365414744065","976171575492964352","976160559874953216","976158718826921984","976156005125025794","976155625540456448","976155367657877506","976155223046656000","976153893724934148","976153684148129792","965244811921018881","961805374188797952","961454731607662592","961291777587150848","961264099391877120","961201547832119299","961188816152391680","961188101606592512","961179013124382720"]},{"title":"Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia","googleId":"PgRtTBgaW0kJ","googleLink":"https://www.nature.com/articles/leu2016360","googleCitationCount":136,"googleAuthor":"","doi":"10.1038/leu.2016.360","elsevierAuthor":"Ilander M.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"101","altmetricAuthors":["M Ilander","U Olsson-Strömberg","H Schlums","J Guilhot","O Brück","H Lähteenmäki","T Kasanen","P Koskenvesa","S Söderlund","M Höglund","B Markevärn","A Själander","K Lotfi","A Dreimane","A Lübking","E Holm","M Björeman","S Lehmann","L Stenke","L Ohm","T Gedde-Dahl","W Majeed","H Ehrencrona","S Koskela","S Saussele","F-X Mahon","K Porkka","H Hjorth-Hansen","Y T Bryceson","J Richter","S Mustjoki"],"twitterCount":4,"altmetricId":14208559,"statusesArray":["867333462944043009","867320095915352065","860495139713818625","804268093220462592"]},{"title":"Pharmacologic inhibition of STAT5 in acute myeloid leukemia","googleId":"0UBuiV13zGEJ","googleLink":"https://www.nature.com/articles/s41375-017-0005-9","googleCitationCount":69,"googleAuthor":"B Wingelhofer","doi":"10.1038/s41375-017-0005-9","elsevierAuthor":"Wingelhofer B.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"56","altmetricAuthors":["Bettina Wingelhofer","Barbara Maurer","Elizabeth C. Heyes","Abbarna A. Cumaraswamy","Angelika Berger-Becvar","Elvin D. de Araujo","Anna Orlova","Patricia Freund","Frank Ruge","Jisung Park","Gary Tin","Siawash Ahmar","Charles-Hugues Lardeau","Irina Sadovnik","Dávid Bajusz","György Miklós Keserű","Florian Grebien","Stefan Kubicek","Peter Valent","Patrick T. Gunning","Richard Moriggl"],"twitterCount":4,"altmetricId":33510306,"statusesArray":["1308038064510578691","966649781161529344","966639350783016960","966610343270273024"]},{"title":"Measurable residual disease testing in acute myeloid leukaemia","googleId":"1aEsTh9jhpwJ","googleLink":"https://www.nature.com/articles/leu2017113","googleCitationCount":140,"googleAuthor":"CS Hourigan","doi":"10.1038/leu.2017.113","elsevierAuthor":"Hourigan C.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"104","altmetricAuthors":["C S Hourigan","R P Gale","N J Gormley","G J Ossenkoppele","R B Walter"],"twitterCount":9,"altmetricId":18585147,"statusesArray":["1250088337903357952","1250088022311350277","890356687961509889","888176634230038528","884550982952075266","884544699087847425","882831890855714819","860984614579580928","855519119814340609","855423086182752256","850809773108973568","850301178831405061"]},{"title":"Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients","googleId":"LiRo5eMVyD8J","googleLink":"https://www.nature.com/articles/leu2017179","googleCitationCount":93,"googleAuthor":"AL Sherborne","doi":"10.1038/leu.2017.179","elsevierAuthor":"Shah V.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"60","altmetricAuthors":["V Shah","A L Sherborne","B A Walker","D C Johnson","E M Boyle","S Ellis","D B Begum","P Z Proszek","J R Jones","C Pawlyn","S Savola","M W Jenner","M T Drayson","R G Owen","R S Houlston","D A Cairns","W M Gregory","G Cook","F E Davies","G H Jackson","G J Morgan","M F Kaiser"],"twitterCount":28,"altmetricId":20863908,"statusesArray":["1088560650454880256","951315597253636096","951152677303414784","951145452132593665","951130359281999872","951117804220141569","951110979521339392","951028559430193152","929096264599441409","928912035131396096","928879530160328704","928873257637482496","928872442243747840","928869692609126401","928825175453372416","894581692224110592","894574632703078400","894519568231780352","894516517605441537","894501561606557696","894499221541453824","887709150326788096","887708642987868160","887656629776375809","875340870261723136","875096018345447424","874795608489504769","874778608568553472","874678103901171712","874603165949276160","874544514064670720","874543274819768321","874267024742133760","872962479818760195","872263356316606464"]},{"title":"Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors","googleId":"QmkS2KUBA7cJ","googleLink":"https://www.nature.com/articles/leu2016180","googleCitationCount":127,"googleAuthor":"","doi":"10.1038/leu.2016.180","elsevierAuthor":"Monjezi R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"83","altmetricAuthors":["R Monjezi","C Miskey","T Gogishvili","M Schleef","M Schmeer","H Einsele","Z Ivics","M Hudecek"],"twitterCount":12,"altmetricId":9186200,"statusesArray":["765858924230737920","765851014058610688","763721983590883328","763721841718530048","763707918420217856","763702745496973312","763692314124398593","763690616710696960","763689950789328896","762519730464796672","749577514683629568","749316278175752192","749245092578418689"]},{"title":"Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML …","googleId":"pFn6oKCi4nUJ","googleLink":"https://www.nature.com/articles/leu2017253","googleCitationCount":141,"googleAuthor":"M Lauseker","doi":"10.1038/leu.2017.253","elsevierAuthor":"Hehlmann R.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"94","altmetricAuthors":["R Hehlmann","M Lauseker","S Saußele","M Pfirrmann","S Krause","H J Kolb","A Neubauer","D K Hossfeld","C Nerl","A Gratwohl","G M Baerlocher","D Heim","T H Brümmendorf","A Fabarius","C Haferlach","B Schlegelberger","M C Müller","S Jeromin","U Proetel","K Kohlbrenner","A Voskanyan","S Rinaldetti","W Seifarth","B Spieß","L Balleisen","M C Goebeler","M Hänel","A Ho","J Dengler","C Falge","L Kanz","S Kremers","A Burchert","M Kneba","F Stegelmann","C A Köhne","H W Lindemann","C F Waller","M Pfreundschuh","K Spiekermann","W E Berdel","L Müller","M Edinger","J Mayer","D W Beelen","M Bentz","H Link","B Hertenstein","R Fuchs","M Wernli","F Schlegel","R Schlag","M de Wit","L Trümper","H Hebart","M Hahn","J Thomalla","C Scheid","P Schafhausen","W Verbeek","M J Eckart","W Gassmann","A Pezzutto","M Schenk","P Brossart","T Geer","S Bildat","E Schäfer","A Hochhaus","J Hasford"],"twitterCount":1,"altmetricId":24506876,"statusesArray":["1273742149641797632"]},{"title":"Targeting Bcl-2 for the treatment of multiple myeloma","googleId":"iEhnGQPMAtYJ","googleLink":"https://www.nature.com/articles/s41375-018-0223-9","googleCitationCount":51,"googleAuthor":"P Moreau","doi":"10.1038/s41375-018-0223-9","elsevierAuthor":"Touzeau C.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"43","altmetricAuthors":["Cyrille Touzeau","Paulo Maciag","Martine Amiot","Philippe Moreau"],"twitterCount":8,"altmetricId":46068972,"statusesArray":["1032407204555620352","1031858432687702017","1026937800908779520","1026937495047598080","1026464728745500681","1026457010475155457","1026454279874387968","1026452840246472704","1026059962533928961","1026051215065460736"]},{"title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","googleId":"dF9EdfNcJU4J","googleLink":"https://www.nature.com/articles/leu2017251","googleCitationCount":82,"googleAuthor":"K Karube","doi":"10.1038/leu.2017.251","elsevierAuthor":"Karube K.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"56","altmetricAuthors":["K Karube","A Enjuanes","I Dlouhy","P Jares","D Martin-Garcia","F Nadeu","G R Ordóñez","J Rovira","G Clot","C Royo","A Navarro","B Gonzalez-Farre","A Vaghefi","G Castellano","C Rubio-Perez","D Tamborero","J Briones","A Salar","J M Sancho","S Mercadal","E Gonzalez-Barca","L Escoda","H Miyoshi","K Ohshima","K Miyawaki","K Kato","K Akashi","A Mozos","L Colomo","M Alcoceba","A Valera","A Carrió","D Costa","N Lopez-Bigas","R Schmitz","L M Staudt","I Salaverria","A López-Guillermo","E Campo"],"twitterCount":11,"altmetricId":23820637,"statusesArray":["1094189195688640512","978854420103532545","978618254741696513","978613770019917825","917316707173072896","901028420385112064","899342401394921472","897498139195617281","897491806165712896","897402752648728576","897398304392327168","897248150930563073"]},{"title":"Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia","googleId":"tQA1TTnumf8J","googleLink":"https://www.nature.com/articles/leu201732","googleCitationCount":93,"googleAuthor":"SM Fernandes","doi":"10.1038/leu.2017.32","elsevierAuthor":"Deng J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"67","altmetricAuthors":["J Deng","E Isik","S M Fernandes","J R Brown","A Letai","M S Davids"],"twitterCount":12,"altmetricId":16464756,"statusesArray":["834548199109038081","834479163880898560","833111471617871872","832724837667835904","832400782922285057","832336284609835008","832335717992976384","832258396556554241","832243493137416192","832240417160654852","832235819343581185","832229303861514242","832224766257827840"]},{"title":"Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1","googleId":"DWP4S1xzxCEJ","googleLink":"https://www.nature.com/articles/leu2017243","googleCitationCount":81,"googleAuthor":"DM Moujalled","doi":"10.1038/leu.2017.243","elsevierAuthor":"Teh T.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"66","altmetricAuthors":["T-C Teh","N-Y Nguyen","D M Moujalled","D Segal","G Pomilio","S Rijal","A Jabbour","K Cummins","K Lackovic","P Blombery","E Thompson","P G Ekert","G Lessene","S P Glaser","D C S Huang","A W Roberts","M A Guthridge","A H Wei"],"twitterCount":1,"altmetricId":28206722,"statusesArray":["925656183364612096"]},{"title":"Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD …","googleId":"mk7FKtmjpBEJ","googleLink":"https://www.nature.com/articles/leu2017304","googleCitationCount":79,"googleAuthor":"JA Burger","doi":"10.1038/leu.2017.304","elsevierAuthor":"Kondo K.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"51","altmetricAuthors":["K Kondo","H Shaim","P A Thompson","J A Burger","M Keating","Z Estrov","D Harris","E Kim","A Ferrajoli","M Daher","R Basar","M Muftuoglu","N Imahashi","A Alsuliman","C Sobieski","E Gokdemir","W Wierda","N Jain","E Liu","E J Shpall","K Rezvani"],"twitterCount":22,"altmetricId":26996358,"statusesArray":["919882937629208576","918861176989249536","918715430537117696","918690838137380864","918683464618016768","918622033281417217","918592140283916288","918556807072641024","918526310674239488","918516582829060097","918512757703610370","918511978343272449","918504600973578240","918498227552317441","918493878881325058","918493094328324098","918491269290106880","918491140134973440","918489983471587328","918487046670336001","918484153116475392","915519390379999232"]},{"title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","googleId":"POxuqSJlRoYJ","googleLink":"https://www.nature.com/articles/s41375-018-0037-9","googleCitationCount":77,"googleAuthor":"N Bolli","doi":"10.1038/s41375-018-0037-9","elsevierAuthor":"Bolli N.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"50","altmetricAuthors":["Niccolo Bolli","Giulia Biancon","Matahi Moarii","Silvia Gimondi","Yilong Li","Chiara de Philippis","Francesco Maura","Vijitha Sathiaseelan","Yu-Tzu Tai","Laura Mudie","Sarah O’Meara","Keiran Raine","Jon W. Teague","Adam P. Butler","Cristiana Carniti","Moritz Gerstung","Tina Bagratuni","Efstathios Kastritis","Meletios Dimopoulos","Paolo Corradini","Kenneth C. Anderson","Philippe Moreau","Stephane Minvielle","Peter J. Campbell","Elli Papaemmanuil","Herve Avet-Loiseau","Nikhil C. Munshi"],"twitterCount":10,"altmetricId":42326327,"statusesArray":["1139546047905034240","1072239296151740416","1029940864439799808","1020688637946744833","1020684830974017537","1001064979322298370","1001026475343208448","1001003035248783360","999608922750140416","999603122681991168","998877357791309824"]},{"title":"BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells","googleId":"XU0iQpgTMuAJ","googleLink":"https://www.nature.com/articles/leu2017207","googleCitationCount":78,"googleAuthor":"Y Qian","doi":"10.1038/leu.2017.207","elsevierAuthor":"Sun B.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"62","altmetricAuthors":["B Sun","W Fiskus","Y Qian","K Rajapakshe","K Raina","K G Coleman","A P Crew","A Shen","D T Saenz","C P Mill","A J Nowak","N Jain","L Zhang","M Wang","J D Khoury","C Coarfa","C M Crews","K N Bhalla"],"twitterCount":5,"altmetricId":21474198,"statusesArray":["881850317448638464","881710911454666752","881473886663127040","881472680830152705","881461236604575744"]},{"title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","googleId":"1CmVkqJucmEJ","googleLink":"https://www.nature.com/articles/leu201716","googleCitationCount":112,"googleAuthor":"","doi":"10.1038/leu.2017.16","elsevierAuthor":"Neuenhahn M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"81","altmetricAuthors":["M Neuenhahn","J Albrecht","M Odendahl","F Schlott","G Dössinger","M Schiemann","S Lakshmipathi","K Martin","D Bunjes","S Harsdorf","E M Weissinger","H Menzel","M Verbeek","L Uharek","N Kröger","E Wagner","G Kobbe","T Schroeder","M Schmitt","G Held","W Herr","L Germeroth","H Bonig","T Tonn","H Einsele","D H Busch","G U Grigoleit"],"twitterCount":9,"altmetricId":15577438,"statusesArray":["923134318746017794","915583034191175681","915581174361284608","836111541934030849","836065483098996736","836062866369310720","836054867693223937","823506869255806976","821920167324221440"]},{"title":"Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis","googleId":"G_C_HGhOOYoJ","googleLink":"https://www.nature.com/articles/s41375-018-0047-7","googleCitationCount":61,"googleAuthor":"M Jäger","doi":"10.1038/s41375-018-0047-7","elsevierAuthor":"Arends C.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"46","altmetricAuthors":["Christopher Maximilian Arends","Joel Galan-Sousa","Kaja Hoyer","Willy Chan","Marten Jäger","Kenichi Yoshida","Ricarda Seemann","Daniel Noerenberg","Nils Waldhueter","Helga Fleischer-Notter","Friederike Christen","Clemens A. Schmitt","Bernd Dörken","Uwe Pelzer","Marianne Sinn","Tomasz Zemojtel","Seishi Ogawa","Sven Märdian","Adrian Schreiber","Annegret Kunitz","Ulrike Krüger","Lars Bullinger","Elena Mylonas","Mareike Frick","Frederik Damm"],"twitterCount":8,"altmetricId":33789715,"statusesArray":["1005099033017421824","971932368176021504","971766838978891776","971756598539546625","971755505780776961","969541466866397184","969528591150125056","969006072454352896"]},{"title":"The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases","googleId":"Fngo7HOx_kIJ","googleLink":"https://www.nature.com/articles/leu2016263","googleCitationCount":111,"googleAuthor":"","doi":"10.1038/leu.2016.263","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"75","altmetricAuthors":["A Stengel","W Kern","T Haferlach","M Meggendorfer","A Fasan","C Haferlach"],"twitterCount":8,"altmetricId":12623656,"statusesArray":["789013073692680192","788948572234539008","788826096087302144","788769283027312640","788762026965397504","788752970082947072","788751743760736257","788750804693856257"]},{"title":"Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia","googleId":"NJTZVi1EyX8J","googleLink":"https://www.nature.com/articles/s41375-018-0034-z","googleCitationCount":71,"googleAuthor":"D Goerlich","doi":"10.1038/s41375-018-0034-z","elsevierAuthor":"Rothenberg-Thurley M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"57","altmetricAuthors":["Maja Rothenberg-Thurley","Susanne Amler","Dennis Goerlich","Thomas Köhnke","Nikola P. Konstandin","Stephanie Schneider","Maria C. Sauerland","Tobias Herold","Max Hubmann","Bianka Ksienzyk","Evelyn Zellmeier","Stefan K. Bohlander","Marion Subklewe","Andreas Faldum","Wolfgang Hiddemann","Jan Braess","Karsten Spiekermann","Klaus H. Metzeler"],"twitterCount":7,"altmetricId":33557427,"statusesArray":["1040146591678644224","979377319751180288","979370895557971973","970351766956101632","970270843766038528","970226959023312896","967451588846534656","966869512682463232","966866643279335425"]},{"title":"PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma","googleId":"YWts1y6hHcYJ","googleLink":"https://www.nature.com/articles/leu2017103","googleCitationCount":85,"googleAuthor":"","doi":"10.1038/leu.2017.103","elsevierAuthor":"Atsaves V.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"73","altmetricAuthors":["V Atsaves","N Tsesmetzis","D Chioureas","L Kis","V Leventaki","E Drakos","T Panaretakis","D Grander","L J Medeiros","K H Young","G Z Rassidakis"],"twitterCount":13,"altmetricId":19197195,"statusesArray":["855828258465751049","855522277395374080","855351399013531649","855226899827523584","855063325306048514","855057297323806721","855049566609166337","855046441605120000","855031273319833602","855023846419820544","855006737832828928","855001564154478592","854994047831752704"]},{"title":"Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","googleId":"wtDaD9MB1b0J","googleLink":"https://www.nature.com/articles/s41375-018-0104-2","googleCitationCount":59,"googleAuthor":"W Chen","doi":"10.1038/s41375-018-0104-2","elsevierAuthor":"Hu Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"47","altmetricAuthors":["Yi Hu","Jianhong Lin","Hua Fang","Jing Fang","Chen Li","Wei Chen","Shuang Liu","Sarah Ondrejka","Zihua Gong","Frederic Reu","Jaroslaw Maciejewski","Qing Yi","Jian-Jun Zhao"],"twitterCount":4,"altmetricId":34707768,"statusesArray":["1038251293200904192","984198150712770560","976764711667621889","976763934693715973"]},{"title":"Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care","googleId":"YGnustR0lnUJ","googleLink":"https://www.nature.com/articles/s41375-018-0257-z","googleCitationCount":46,"googleAuthor":"H Döhner","doi":"10.1038/s41375-018-0257-z","elsevierAuthor":"Döhner H.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"34","altmetricAuthors":["Hartmut Döhner","Anna Dolnik","Lin Tang","John F. Seymour","Mark D. Minden","Richard M. Stone","Teresa Bernal del Castillo","Haifa Kathrin Al-Ali","Valeria Santini","Paresh Vyas","C. L. Beach","Kyle J. MacBeth","Barry S. Skikne","Steve Songer","Nora Tu","Lars Bullinger","Hervé Dombret"],"twitterCount":7,"altmetricId":49179965,"statusesArray":["1075958323277688833","1074451124625788928","1074445556271996929","1074393570843521024","1052658140540481537","1051675589562822657","1051600228791570432","1047491153451307008"]},{"title":"Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)","googleId":"mS_OIxSdM5kJ","googleLink":"https://www.nature.com/articles/s41375-018-0142-9","googleCitationCount":54,"googleAuthor":"E Terpos","doi":"10.1038/s41375-018-0142-9","elsevierAuthor":"Larocca A.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"40","altmetricAuthors":["Alessandra Larocca","Sandra Maria Dold","Sonja Zweegman","Evangelos Terpos","Ralph Wäsch","Mattia D’Agostino","Sophia Scheubeck","Hartmut Goldschmidt","Francesca Gay","Michele Cavo","Heinz Ludwig","Christian Straka","Sara Bringhen","Holger W. Auner","Jo Caers","Martin Gramatzki","Massimo Offidani","Meletios A. Dimopoulos","Hermann Einsele","Mario Boccadoro","Pieter Sonneveld","Monika Engelhardt"],"twitterCount":9,"altmetricId":39277473,"statusesArray":["1056034179199098880","1046806950204211207","1031152566242107392","1009859367594807301","1007176180666191872","1006857813946257408","1006846243396640769","1005558978770857984","989134415308603393"]},{"title":"Multiple myeloma clonal evolution in homogeneously treated patients","googleId":"7FvecPOtNscJ","googleLink":"https://www.nature.com/articles/s41375-018-0153-6","googleCitationCount":47,"googleAuthor":"N Bolli","doi":"10.1038/s41375-018-0153-6","elsevierAuthor":"Corre J.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"36","altmetricAuthors":["Jill Corre","Alice Cleynen","Sébastien Robiou du Pont","Laure Buisson","Niccolo Bolli","Michel Attal","Nikhil Munshi","Hervé Avet-Loiseau"],"twitterCount":4,"altmetricId":43903505,"statusesArray":["1009845753362157568","1009340464913371136","1008715055192596482","1007213293927202816"]},{"title":"Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients","googleId":"lkrT_8z2t-IJ","googleLink":"https://www.nature.com/articles/s41375-018-0018-z","googleCitationCount":60,"googleAuthor":"M Nicolosi","doi":"10.1038/s41375-018-0018-z","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"46","altmetricAuthors":["Ayalew Tefferi","Maura Nicolosi","Mythri Mudireddy","Terra L. Lasho","Naseema Gangat","Kebede H. Begna","Curtis A. Hanson","Rhett P. Ketterling","Animesh Pardanani"],"twitterCount":3,"altmetricId":32711491,"statusesArray":["967372816860393472","961814604996227072","960693073465479168"]},{"title":"Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia","googleId":"blwLQnQDGUAJ","googleLink":"https://www.nature.com/articles/s41375-018-0075-3","googleCitationCount":55,"googleAuthor":"KH Chen","doi":"10.1038/s41375-018-0075-3","elsevierAuthor":"Petrov J.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"38","altmetricAuthors":["Jessica C. Petrov","Masayuki Wada","Kevin G. Pinz","Lulu E. Yan","Kevin H. Chen","Xiao Shuai","Hua Liu","Xi Chen","Lai-Han Leung","Huda Salman","Nabil Hagag","Fang Liu","Xun Jiang","Yupo Ma"],"twitterCount":8,"altmetricId":33681547,"statusesArray":["1113039528388935681","1010225903274790913","983347611754225666","968587461910847499","968480108712521730","968127156772630528","968126607692099584","968095264874446848","968050426108096512"]},{"title":"Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent …","googleId":"maTROr3-LMkJ","googleLink":"https://www.nature.com/articles/leu2017120","googleCitationCount":74,"googleAuthor":"A Dispenzieri","doi":"10.1038/leu.2017.120","elsevierAuthor":"Dispenzieri A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"54","altmetricAuthors":["A Dispenzieri","C Tong","B LaPlant","M Q Lacy","K Laumann","D Dingli","Y Zhou","M J Federspiel","M A Gertz","S Hayman","F Buadi","M O'Connor","V J Lowe","K-W Peng","S J Russell"],"twitterCount":15,"altmetricId":19591352,"statusesArray":["1147417536717176832","942003559385706496","865492543324041217","859858606061236225","857743907031056386","857706076736806913","857616586424934402","857594033174188033","857581348998926338","857564293016977408","857563677276467206","857363949116948481","857363011245309952","857269865278779392","857236000350887937","857216804426358784","857204948269969408"]},{"title":"Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012","googleId":"752LsznI8xIJ","googleLink":"https://www.nature.com/articles/s41375-018-0071-7","googleCitationCount":53,"googleAuthor":"JP Bourquin","doi":"10.1038/s41375-018-0071-7","elsevierAuthor":"Rasche M.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"35","altmetricAuthors":["Mareike Rasche","Martin Zimmermann","Lisa Borschel","Jean-Pierre Bourquin","Michael Dworzak","Thomas Klingebiel","Thomas Lehrnbecher","Ursula Creutzig","Jan-Henning Klusmann","Dirk Reinhardt"],"twitterCount":3,"altmetricId":49589574,"statusesArray":["1152965722802401281","1056022754560901123","1050829781313445888"]},{"title":"Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo","googleId":"B1sFaO91TC4J","googleLink":"https://www.nature.com/articles/leu201746","googleCitationCount":75,"googleAuthor":"S Pusch","doi":"10.1038/leu.2017.46","elsevierAuthor":"Chaturvedi A.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"57","altmetricAuthors":["A Chaturvedi","L Herbst","S Pusch","L Klett","R Goparaju","D Stichel","S Kaulfuss","O Panknin","K Zimmermann","L Toschi","R Neuhaus","A Haegebarth","H Rehwinkel","H Hess-Stumpp","M Bauser","T Bochtler","E A Struys","A Sharma","A Bakkali","R Geffers","M M Araujo-Cruz","F Thol","R Gabdoulline","A Ganser","A D Ho","A von Deimling","K Rippe","M Heuser","A Krämer"],"twitterCount":9,"altmetricId":16007565,"statusesArray":["923163369074442241","837002729256075265","837001742575353856","836964833975287808","836939185063886849","836938470945878016","836938328372985857","827940091129643008","826782808555266051","826602242396536834"]},{"title":"PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells","googleId":"a2DWdnioVJoJ","googleLink":"https://www.nature.com/articles/s41375-017-0008-6","googleCitationCount":52,"googleAuthor":"W Zheng","doi":"10.1038/s41375-017-0008-6","elsevierAuthor":"Zheng W.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"38","altmetricAuthors":["Wenting Zheng","Carol E. O’Hear","Rajshekhar Alli","Jacob H. Basham","Hossam A. Abdelsamed","Lance E. Palmer","Lindsay L. Jones","Ben Youngblood","Terrence L. Geiger"],"twitterCount":2,"altmetricId":70355634,"statusesArray":["1106859801601101824","968442608933466113"]},{"title":"Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary …","googleId":"L2H1CXccSmkJ","googleLink":"https://www.nature.com/articles/leu2016393","googleCitationCount":92,"googleAuthor":"Y Qian","doi":"10.1038/leu.2016.393","elsevierAuthor":"Saenz D.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"85","altmetricAuthors":["D T Saenz","W Fiskus","Y Qian","T Manshouri","K Rajapakshe","K Raina","K G Coleman","A P Crew","A Shen","C P Mill","B Sun","P Qiu","T M Kadia","N Pemmaraju","C DiNardo","M-S Kim","A J Nowak","C Coarfa","C M Crews","S Verstovsek","K N Bhalla"],"twitterCount":7,"altmetricId":15249914,"statusesArray":["913124081159024641","829486257168404480","826365442071465985","818456825880334337","818219232676745216","818141534054916096","817928432420089856","817034691958177792"]},{"title":"European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias","googleId":"RpziixaBx1oJ","googleLink":"https://www.nature.com/articles/s41375-018-0209-7","googleCitationCount":48,"googleAuthor":"M Gavriatopoulou","doi":"10.1038/s41375-018-0209-7","elsevierAuthor":"Gavriatopoulou M.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"27","altmetricAuthors":["Maria Gavriatopoulou","Pellegrino Musto","Jo Caers","Giampaolo Merlini","Efstathios Kastritis","Niels van de Donk","Francesca Gay","Ute Hegenbart","Roman Hajek","Sonja Zweegman","Benedetto Bruno","Christian Straka","Meletios A. Dimopoulos","Hermann Einsele","Mario Boccadoro","Pieter Sonneveld","Monika Engelhardt","Evangelos Terpos"],"twitterCount":31,"altmetricId":45512935,"statusesArray":["1120647359363465216","1056028994812862465","1056026563429298176","1043932754319167488","1043547707636441089","1043516334498304001","1043429918087045121","1043398455366901760","1043190087587119109","1043185159036698624","1038900182568640512","1038866383310794752","1038852774631534592","1038760618596216832","1038544039132442624","1038017549332406273","1038010081336483840","1038009258283950080","1035734627866931200","1029686152658399232","1029084587077627904","1029072228971962374","1029003469812850688","1028988250684305411","1028983647297327104","1028952055338156032","1028951201688309760","1028946673823666178","1028945508520407040","1028938476157390849","1024613255677988864","1022589254688489479","1022586599736045570","1022586563249819648","1022466566791688192","1022106462653308928","1022075758791942144"]},{"title":"Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts","googleId":"3q3PlEbENkcJ","googleLink":"https://www.nature.com/articles/s41375-018-0019-y","googleCitationCount":57,"googleAuthor":"","doi":"10.1038/s41375-018-0019-y","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"44","altmetricAuthors":["Ayalew Tefferi","Mythri Mudireddy","Francesco Mannelli","Kebede H. Begna","Mrinal M. Patnaik","Curtis A. Hanson","Rhett P. Ketterling","Naseema Gangat","Meera Yogarajah","Valerio De Stefano","Francesco Passamonti","Vittorio Rosti","Maria Chiara Finazzi","Alessandro Rambaldi","Alberto Bosi","Paola Guglielmelli","Animesh Pardanani","Alessandro M. Vannucchi"],"twitterCount":2,"altmetricId":32711492,"statusesArray":["961816315764723712","960693075311030274"]},{"title":"Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor","googleId":"S_G0ZkXyREsJ","googleLink":"https://www.nature.com/articles/leu20178","googleCitationCount":87,"googleAuthor":"KH Chen","doi":"10.1038/leu.2017.8","elsevierAuthor":"Chen K.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"69","altmetricAuthors":["K H Chen","M Wada","K G Pinz","H Liu","K-W Lin","A Jares","A E Firor","X Shuai","H Salman","M Golightly","F Lan","L Senzel","E L Leung","X Jiang","Y Ma"],"twitterCount":6,"altmetricId":15490109,"statusesArray":["821845093669867520","821837756074721281","821700956677148672","820319978201092096","820269865353232384","820269151906168833","820263643128401920"]},{"title":"A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)","googleId":"xiEgkjbCzvYJ","googleLink":"https://www.nature.com/articles/leu2016176","googleCitationCount":89,"googleAuthor":"A Palumbo","doi":"10.1038/leu.2016.176","elsevierAuthor":"Hájek R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"70","altmetricAuthors":["R Hájek","T Masszi","M T Petrucci","A Palumbo","L Rosiñol","A Nagler","K L Yong","A Oriol","J Minarik","L Pour","M A Dimopoulos","V Maisnar","D Rossi","H Kasparu","J Van Droogenbroeck","D B Yehuda","I Hardan","M Jenner","M Calbecka","M Dávid","J de la Rubia","J Drach","Z Gasztonyi","S Górnik","X Leleu","M Munder","M Offidani","N Zojer","K Rajangam","Y-L Chang","J F San-Miguel","H Ludwig"],"twitterCount":9,"altmetricId":9049319,"statusesArray":["903197946979782656","865599278185578496","857315138109616130","819122220156891137","816620198228819968","755722230441672704","755707712667656193","747082860788596736","747041405906804737","747033934173773825"]},{"title":"Antigen receptor stereotypy in chronic lymphocytic leukemia","googleId":"tHiHxW-zsO0J","googleLink":"https://www.nature.com/articles/leu2016322","googleCitationCount":90,"googleAuthor":"A Agathangelidis","doi":"10.1038/leu.2016.322","elsevierAuthor":"Stamatopoulos K.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"53","altmetricAuthors":["K Stamatopoulos","A Agathangelidis","R Rosenquist","P Ghia"],"twitterCount":3,"altmetricId":13481352,"statusesArray":["826994499989696513","826814980943147010","796620954508070912"]},{"title":"Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with response-adapted therapy","googleId":"X9dM4cqwchAJ","googleLink":"https://www.nature.com/articles/leu2016234","googleCitationCount":88,"googleAuthor":"","doi":"10.1038/leu.2016.234","elsevierAuthor":"Pui C.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"65","altmetricAuthors":["C-H Pui","D Pei","S C Raimondi","E Coustan-Smith","S Jeha","C Cheng","W P Bowman","J T Sandlund","R C Ribeiro","J E Rubnitz","H Inaba","T A Gruber","W H Leung","J J Yang","J R Downing","W E Evans","M V Relling","D Campana"],"twitterCount":1,"altmetricId":10842748,"statusesArray":["769120414123425792"]},{"title":"Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and-independent pathways","googleId":"HccgAgseW6AJ","googleLink":"https://www.nature.com/articles/leu2017116","googleCitationCount":65,"googleAuthor":"J Lou","doi":"10.1038/leu.2017.116","elsevierAuthor":"Vafadar A.","publicationName":"Current Pharmaceutical Design","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"42","altmetricAuthors":["Y Lyu","J Lou","Y Yang","J Feng","Y Hao","S Huang","L Yin","J Xu","D Huang","B Ma","D Zou","Y Wang","Y Zhang","B Zhang","P Chen","K Yu","E W-F Lam","X Wang","Q Liu","J Yan","B Jin"],"twitterCount":3,"altmetricId":18793324,"statusesArray":["942074607057518593","852528082619555840","852487917767282689"]},{"title":"Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network","googleId":"2mkRmQCRZgQJ","googleLink":"https://www.nature.com/articles/s41375-018-0040-1","googleCitationCount":58,"googleAuthor":"M Delforge","doi":"10.1038/s41375-018-0040-1","elsevierAuthor":"Ludwig H.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28","altmetricAuthors":["Heinz Ludwig","Michel Delforge","Thierry Facon","Hermann Einsele","Francesca Gay","Philippe Moreau","Hervé Avet-Loiseau","Mario Boccadoro","Roman Hajek","Mohamad Mohty","Michele Cavo","Meletios A Dimopoulos","Jesús F San-Miguel","Evangelos Terpos","Sonja Zweegman","Laurent Garderet","María-Victoria Mateos","Gordon Cook","Xavier Leleu","Hartmut Goldschmidt","Graham Jackson","Martin Kaiser","Katja Weisel","Niels W. C. J. van de Donk","Anders Waage","Meral Beksac","Ulf H. Mellqvist","Monika Engelhardt","Jo Caers","Christoph Driessen","Joan Bladé","Pieter Sonneveld"],"twitterCount":45,"altmetricId":40586532,"statusesArray":["1021927619271557120","1021858440610816001","1021828485772455936","1021827732362211330","1021802190908940288","1000515732738859009","996824698410254336","996814435980374016","996676115950391296","996628150665687040","996615525731061765","996032307793281024","995965192608468992","993939772312838144","993401929891016704","993391809022881792","993227136382259200","993216073599213569","993108944779464704","993060620625940480","993046140873527296","993023180532080640","992911125741232129","992901701538648064","992890717356818433","992873355056467968","992872139698171906","992847483838631937","992842953637933057","992837716248326144","992814113557446656","992810494733045760","992793753491472390","992771595470098433","992766583608049665","992765081602723840","992759206167105538","992754620228349952","992743696100659200","992708121247338496","992705543319023616","992692519539560448","992682735834664961","992680203536265216","992679611359289344","992344782830616578","991681827956899840"]},{"title":"Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial","googleId":"rhIkFsDSBAEJ","googleLink":"https://www.nature.com/articles/s41375-018-0129-6","googleCitationCount":45,"googleAuthor":"RF Schlenk","doi":"10.1038/s41375-018-0129-6","elsevierAuthor":"Estey E.","publicationName":"American Journal of Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"68","altmetricAuthors":["Peter Paschka","Richard F Schlenk","Daniela Weber","Axel Benner","Lars Bullinger","Michael Heuser","Verena I Gaidzik","Felicitas Thol","Mridul Agrawal","Veronica Teleanu","Michael Lübbert","Walter Fiedler","Markus Radsak","Jürgen Krauter","Heinz-A. Horst","Richard Greil","Karin Mayer","Andrea Kündgen","Uwe Martens","Gerhard Heil","Helmut R Salih","Bernd Hertenstein","Carsten Schwänen","Gerald Wulf","Elisabeth Lange","Michael Pfreundschuh","Mark Ringhoffer","Michael Girschikofsky","Thomas Heinicke","Doris Kraemer","Gudrun Göhring","Arnold Ganser","Konstanze Döhner","Hartmut Döhner"],"twitterCount":3,"altmetricId":37875423,"statusesArray":["1216024194825191425","1215862230773850112","986315092076593152"]},{"title":"Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site","googleId":"7MYtf4GsAkgJ","googleLink":"https://www.nature.com/articles/leu2017245","googleCitationCount":62,"googleAuthor":"E Hadzijusufovic","doi":"10.1038/leu.2017.245","elsevierAuthor":"Hadzijusufovic E.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"45","altmetricAuthors":["E Hadzijusufovic","K Albrecht-Schgoer","K Huber","G Hoermann","F Grebien","G Eisenwort","W Schgoer","S Herndlhofer","C Kaun","M Theurl","W R Sperr","U Rix","I Sadovnik","B Jilma","G H Schernthaner","J Wojta","D Wolf","G Superti-Furga","R Kirchmair","P Valent"],"twitterCount":4,"altmetricId":23351232,"statusesArray":["938374747372453888","892804725741162496","892723970314784772","892474609559367680"]},{"title":"Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma","googleId":"L4hQQcDTKMIJ","googleLink":"https://www.nature.com/articles/s41375-018-0044-x","googleCitationCount":44,"googleAuthor":"F Shirazi","doi":"10.1038/s41375-018-0044-x","elsevierAuthor":"Zhang X.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"38","altmetricAuthors":["Xiaohui Zhang","Hans C. Lee","Fazal Shirazi","Veerabhadran Baladandayuthapani","Heather Lin","Isere Kuiatse","Hua Wang","Richard J. Jones","Zuzana Berkova","Ram Kumar Singh","Jing Lu","Yimin Qian","Kanak Raina","Kevin G. Coleman","Craig M. Crews","Bingzong Li","Huihan Wang","Yared Hailemichael","Sheeba K. Thomas","Zhiqiang Wang","R. Eric Davis","Robert Z. Orlowski"],"twitterCount":4,"altmetricId":34954600,"statusesArray":["980400766094598144","980209946859130880","979479370564698112","979021303632904192"]},{"title":"Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen","googleId":"0rOjXWm410kJ","googleLink":"https://www.nature.com/articles/leu2016373","googleCitationCount":81,"googleAuthor":"S Rafiq","doi":"10.1038/leu.2016.373","elsevierAuthor":"Rafiq S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"51","altmetricAuthors":["S Rafiq","T J Purdon","A F Daniyan","M Koneru","T Dao","C Liu","D A Scheinberg","R J Brentjens"],"twitterCount":15,"altmetricId":15260100,"statusesArray":["1026404886395674624","1026364202263273473","1026299505895911424","1026258858144980992","1026212932407836673","1026183932696514560","1026181116066246656","821322272002560000","821322236686544896","821223408029630464","821140554679521280","820552661393084416","820531003722792962","820320073973989378","820311717343326209","820311523805528066","820266296445116418","818689261142675456","817280412569333760"]},{"title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations","googleId":"1WSD9NJzelYJ","googleLink":"https://www.nature.com/articles/leu2017125","googleCitationCount":62,"googleAuthor":"","doi":"10.1038/leu.2017.125","elsevierAuthor":"Rosenquist R.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"49","altmetricAuthors":["R Rosenquist","P Ghia","A Hadzidimitriou","L-A Sutton","A Agathangelidis","P Baliakas","N Darzentas","V Giudicelli","M-P Lefranc","A W Langerak","C Belessi","F Davi","K Stamatopoulos"],"twitterCount":2,"altmetricId":19573828,"statusesArray":["857209424871645184","857035358038618112"]},{"title":"Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma","googleId":"N0nX6-jHSvoJ","googleLink":"https://www.nature.com/articles/leu2017212","googleCitationCount":57,"googleAuthor":"L Rasche","doi":"10.1038/leu.2017.212","elsevierAuthor":"Besse A.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"47","altmetricAuthors":["A Besse","S C Stolze","L Rasche","N Weinhold","G J Morgan","M Kraus","J Bader","H S Overkleeft","L Besse","C Driessen"],"twitterCount":19,"altmetricId":21544950,"statusesArray":["1221229008630603778","1221228888573063168","1025214205429989376","1025189324307013632","1025151552305152000","1025118334378037251","1025084875835990016","1025080341512511489","1025056118668775429","1025055923704881156","894899473792487426","893025031759986688","892925208964849665","892842119529996288","892825204379992064","892803229708279808","892788334598270976","883589936846430208","883498000059858944","883370031270121473","882933429641203712"]},{"title":"Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial","googleId":"Ljf-iq7nQ0UJ","googleLink":"https://www.nature.com/articles/s41375-018-0179-9","googleCitationCount":41,"googleAuthor":"I Glauche","doi":"10.1038/s41375-018-0179-9","elsevierAuthor":"Suttorp M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28","altmetricAuthors":["Meinolf Suttorp","Philipp Schulze","Ingmar Glauche","Gudrun Göhring","Nils von Neuhoff","Markus Metzler","Petr Sedlacek","Eveline S. J. M. de Bont","Adriana Balduzzi","Birgitte Lausen","Olga Aleinikova","Sabina Sufliarska","Günter Henze","Gabriele Strauss","Angelika Eggert","Bernhard Kremens","Andreas H. Groll","Frank Berthold","Christoph Klein","Ute Groß-Wieltsch","Karl Walter Sykora","Arndt Borkhardt","Andreas E. Kulozik","Martin Schrappe","Christina Nowasz","Manuela Krumbholz","Josephine T. Tauer","Alexander Claviez","Jochen Harbott","Hans H. Kreipe","Brigitte Schlegelberger","Christian Thiede"],"twitterCount":0,"altmetricId":78832253,"statusesArray":[]},{"title":"Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling","googleId":"i_s-EG6Gh4kJ","googleLink":"https://www.nature.com/articles/leu2017252","googleCitationCount":58,"googleAuthor":"B Yadav","doi":"10.1038/leu.2017.252","elsevierAuthor":"Andersson E.I.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"42","altmetricAuthors":["E I Andersson","S Pützer","B Yadav","O Dufva","S Khan","L He","L Sellner","A Schrader","G Crispatzu","M Oleś","H Zhang","S Adnan-Awad","S Lagström","D Bellanger","J P Mpindi","S Eldfors","T Pemovska","P Pietarinen","A Lauhio","K Tomska","C Cuesta-Mateos","E Faber","S Koschmieder","T H Brümmendorf","S Kytölä","E-R Savolainen","T Siitonen","P Ellonen","O Kallioniemi","K Wennerberg","W Ding","M-H Stern","W Huber","S Anders","J Tang","T Aittokallio","T Zenz","M Herling","S Mustjoki"],"twitterCount":7,"altmetricId":23915761,"statusesArray":["905496211507085318","905460840379412480","901037848383688706","898331120286130177","898275997228777473","898092348160266240","897982280450187264","897850161656975361","897848426414489602"]},{"title":"CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells","googleId":"KwDSqspuWEcJ","googleLink":"https://www.nature.com/articles/s41375-018-0285-8","googleCitationCount":37,"googleAuthor":"","doi":"10.1038/s41375-018-0285-8","elsevierAuthor":"Alcantara M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"26","altmetricAuthors":["Marion Alcantara","Melania Tesio","Carl H. June","Roch Houot"],"twitterCount":99,"altmetricId":49653239,"statusesArray":["1138913983690354689","1138236606383398912","1137601971064623104","1137235353482321920","1137216519119802369","1137206972485292033","1136413912562249730","1136394443534360577","1136340990300549122","1136330029908938753","1136329072840269824","1136325070077476864","1092500177598984199","1067226183425826818","1067211509271543808","1067208241363525632","1067115798492266497","1067009018093170688","1066720189054631936","1066688808341655553","1066660142110973953","1066633429645778944","1066620358592249856","1066568813682937856","1066466735438602241","1066441196833251328","1066436317746262017","1066435160407605248","1066431075096936449","1066428996038979589","1066422589940269056","1066419114804170754","1066382527718412289","1066380966283890689","1066374846479769600","1066365369298890752","1066361836138708994","1066357239835959296","1066357176514633728","1066355436666978304","1066351080001417217","1066329262695870464","1066326043244539905","1066319575569088512","1066316841876885504","1066298217132949504","1066297202623111168","1066264948173611008","1066263021289439232","1066257398162046976","1066254701010800640","1066208590145470464","1066193776580931584","1066189905011691520","1066188559508492288","1066174056418893824","1066171107927937024","1066169311465799680","1066158366874062850","1066157379597869056","1066141347407552514","1066140474073862144","1066135416426893312","1066132562245021696","1066121446370566145","1066117520468426752","1066115873243574273","1066114330129649664","1066111597595303936","1066099305084264453","1066098458652594176","1066091154549043201","1066086510418481152","1066085851619356672","1066083566239531008","1066080675101646859","1066074410262638593","1066072879886815232","1066070248166699009","1063544815978233858","1061769580895326210","1061538084628676608","1061371688334565376","1061364109294399489","1054603020711804928","1054382651405148160","1054381914528903168","1053479633360904192","1053247929853579264","1053235743189913600","1053172916991406080","1053112814171082752","1053076001457168384","1053061097492766720","1053050082252279811","1053048096060518400","1052828854115536896","1052134196511236096","1051929563217965056","1051706201464033280"]},{"title":"Management of patients with acute promyelocytic leukemia","googleId":"GSI90OSmthoJ","googleLink":"https://www.nature.com/articles/s41375-018-0139-4","googleCitationCount":41,"googleAuthor":"RF Schlenk","doi":"10.1038/s41375-018-0139-4","elsevierAuthor":"Kayser S.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"32","altmetricAuthors":["Sabine Kayser","Richard F. Schlenk","Uwe Platzbecker"],"twitterCount":3,"altmetricId":39160936,"statusesArray":["1091029557296185345","988887062135877638","988885289593659392"]},{"title":"Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML","googleId":"GMpguTd3JFIJ","googleLink":"https://www.nature.com/articles/leu2017206","googleCitationCount":54,"googleAuthor":"S Kaushik","doi":"10.1038/leu.2017.206","elsevierAuthor":"Kaushik S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"39","altmetricAuthors":["S Kaushik","F Liu","K J Veazey","G Gao","P Das","L F Neves","K Lin","Y Zhong","Y Lu","V Giuliani","M T Bedford","S D Nimer","M A Santos"],"twitterCount":3,"altmetricId":22204621,"statusesArray":["889560316958445568","888135584178483201","887763787956330496"]},{"title":"Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?","googleId":"P06IYrzKJq4J","googleLink":"https://www.nature.com/articles/s41375-018-0061-9","googleCitationCount":46,"googleAuthor":"K Vanderkerken","doi":"10.1038/s41375-018-0061-9","elsevierAuthor":"Xu S.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28","altmetricAuthors":["Song Xu","Kim De Veirman","Ann De Becker","Karin Vanderkerken","Ivan Van Riet"],"twitterCount":10,"altmetricId":33921042,"statusesArray":["1118459222818091009","1016286924334608384","1016252791906418688","987132747712839680","974332285443952640","974296175791702016","974255279431757824","971937221996662784","970347873035530241","970334329099505664"]},{"title":"Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts","googleId":"0jBLbWvTEQUJ","googleLink":"https://www.nature.com/articles/leu2016251","googleCitationCount":76,"googleAuthor":"A Mupo","doi":"10.1038/leu.2016.251","elsevierAuthor":"Mupo A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"60","altmetricAuthors":["A Mupo","M Seiler","V Sathiaseelan","A Pance","Y Yang","A A Agrawal","F Iorio","R Bautista","S Pacharne","K Tzelepis","N Manes","P Wright","E Papaemmanuil","D G Kent","P C Campbell","S Buonamici","N Bolli","G S Vassiliou"],"twitterCount":5,"altmetricId":11897229,"statusesArray":["903921485672275968","789171471813795848","777837230006079488","774209030285762561","774185669446938625","773877652348362752"]},{"title":"A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes","googleId":"MaGb_Il-pkoJ","googleLink":"https://www.nature.com/articles/leu2017192","googleCitationCount":55,"googleAuthor":"A Symeonidis","doi":"10.1038/leu.2017.192","elsevierAuthor":"Platzbecker U.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"45","altmetricAuthors":["U Platzbecker","A Symeonidis","E N Oliva","J S Goede","M Delforge","J Mayer","B Slama","S Badre","E Gasal","B Mehta","J Franklin"],"twitterCount":3,"altmetricId":21900470,"statusesArray":["905380088350261250","885858877421613056","885858172145106944"]},{"title":"Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma …","googleId":"S87N4L9r8L8J","googleLink":"https://www.nature.com/articles/s41375-018-0062-8","googleCitationCount":41,"googleAuthor":"Y Song","doi":"10.1038/s41375-018-0062-8","elsevierAuthor":"Bae J.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"35","altmetricAuthors":["Jooeun Bae","Teru Hideshima","Yu-Tzu Tai","Yan Song","Paul Richardson","Noopur Raje","Nikhil C. Munshi","Kenneth C. Anderson"],"twitterCount":5,"altmetricId":34432882,"statusesArray":["1128282698219261955","975621788746047488","975477052643082240","974816695801049088","969206510159986689"]},{"title":"Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia","googleId":"0tddOeSZ8a8J","googleLink":"https://www.nature.com/articles/leu2017291","googleCitationCount":52,"googleAuthor":"F Nadeu","doi":"10.1038/leu.2017.291","elsevierAuthor":"Nadeu F.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"40","altmetricAuthors":["F Nadeu","G Clot","J Delgado","D Martín-García","T Baumann","I Salaverria","S Beà","M Pinyol","P Jares","A Navarro","H Suárez-Cisneros","M Aymerich","M Rozman","N Villamor","D Colomer","M González","M Alcoceba","M J Terol","B Navarro","E Colado","ÁR Payer","X S Puente","C López-Otín","A López-Guillermo","A Enjuanes","E Campo"],"twitterCount":5,"altmetricId":26309870,"statusesArray":["979358006705098752","973785674133499910","973770793514541056","915092190883467264","910119081507983360"]},{"title":"Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of …","googleId":"0F0VPpETe0MJ","googleLink":"https://www.nature.com/articles/s41375-018-0068-2","googleCitationCount":43,"googleAuthor":"K Mrózek","doi":"10.1038/s41375-018-0068-2","elsevierAuthor":"Eisfeld A.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"34","altmetricAuthors":["Ann-Kathrin Eisfeld","Jessica Kohlschmidt","Krzysztof Mrózek","James S. Blachly","Christopher J. Walker","Deedra Nicolet","Shelley Orwick","Sophia E. Maharry","Andrew J. Carroll","Richard M. Stone","Albert de la Chapelle","Eunice S. Wang","Jonathan E. Kolitz","Bayard L. Powell","John C. Byrd","Clara D. Bloomfield"],"twitterCount":3,"altmetricId":33664046,"statusesArray":["1113033214539423744","977131464058814465","967864344846487553"]},{"title":"SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies","googleId":"dIKCZmy7d1cJ","googleLink":"https://www.nature.com/articles/s41375-018-0074-4","googleCitationCount":41,"googleAuthor":"J Davidsson","doi":"10.1038/s41375-018-0074-4","elsevierAuthor":"Davidsson J.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"32","altmetricAuthors":["Josef Davidsson","Andreas Puschmann","Ulf Tedgård","David Bryder","Lars Nilsson","Jörg Cammenga"],"twitterCount":3,"altmetricId":33664045,"statusesArray":["976784938933653504","976773230890401792","967864345978863623"]},{"title":"Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma","googleId":"5jxUFxEdg-MJ","googleLink":"https://www.nature.com/articles/leu2016366","googleCitationCount":71,"googleAuthor":"S Mithraprabhu","doi":"10.1038/leu.2016.366","elsevierAuthor":"Mithraprabhu S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"48","altmetricAuthors":["S Mithraprabhu","T Khong","M Ramachandran","A Chow","D Klarica","L Mai","S Walsh","D Broemeling","A Marziali","M Wiggin","J Hocking","A Kalff","B Durie","A Spencer"],"twitterCount":7,"altmetricId":15231509,"statusesArray":["819214543599665152","819198123109216257","819185850651054080","817995323834585088","816862538784718848","816728159672483841","816697201611022336"]},{"title":"A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS","googleId":"mquWwBHDZasJ","googleLink":"https://www.nature.com/articles/s41375-018-0118-9","googleCitationCount":44,"googleAuthor":"","doi":"10.1038/s41375-018-0118-9","elsevierAuthor":"Fenaux P.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"37","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma","googleId":"wR_lgzgUV8kJ","googleLink":"https://www.nature.com/articles/s41375-018-0043-y","googleCitationCount":45,"googleAuthor":"J Wang","doi":"10.1038/s41375-018-0043-y","elsevierAuthor":"Araf S.","publicationName":"Leukemia","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"1 June 2019","elsevierCitationCount":"0","altmetricAuthors":["Shamzah Araf","Jun Wang","Koorosh Korfi","Celine Pangault","Eleni Kotsiou","Ana Rio-Machin","Tahrima Rahim","James Heward","Andrew Clear","Sameena Iqbal","Jeff K. Davies","Peter Johnson","Maria Calaminici","Silvia Montoto","Rebecca Auer","Claude Chelala","John G. Gribben","Trevor A. Graham","Thierry Fest","Jude Fitzgibbon","Jessica Okosun"],"twitterCount":18,"altmetricId":32914469,"statusesArray":["1000749058141622273","1000639985492594688","999265391355596800","998843105129332736","970777071831126016","968815851221725186","964959423746707457","964594359495741440","964223918071517185","964150699130056706","964150563838550016","964143026569433088","964121002178424833","964106271568859136","964093085440503808","964088736605786112","962159871725518848","962156231233241088","961804891902693377"]},{"title":"Molecular remission as a therapeutic objective in acute promyelocytic leukemia","googleId":"lFIXu8IatEkJ","googleLink":"https://www.nature.com/articles/s41375-018-0219-5","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/s41375-018-0219-5","elsevierAuthor":"Cicconi L.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"26","altmetricAuthors":["Laura Cicconi","Pierre Fenaux","Hagop Kantarjian","Martin Tallman","Miguel A. Sanz","Francesco Lo-Coco"],"twitterCount":1,"altmetricId":45532046,"statusesArray":["1022214973307662337"]},{"title":"Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in …","googleId":"b_EphjSm3uwJ","googleLink":"https://www.nature.com/articles/leu201787","googleCitationCount":54,"googleAuthor":"DH Mak","doi":"10.1038/leu.2017.87","elsevierAuthor":"Zhou H.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"42","altmetricAuthors":["H Zhou","P Y Mak","H Mu","D H Mak","Z Zeng","J Cortes","Q Liu","M Andreeff","B Z Carter"],"twitterCount":2,"altmetricId":18040530,"statusesArray":["854255466683154432","844947578487816193"]},{"title":"CHIP, ICUS, CCUS and other four-letter words","googleId":"3LK7Xss9R2YJ","googleLink":"https://www.nature.com/articles/leu2017181","googleCitationCount":52,"googleAuthor":"","doi":"10.1038/leu.2017.181","elsevierAuthor":"Bejar R.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"36","altmetricAuthors":["R Bejar"],"twitterCount":8,"altmetricId":20918521,"statusesArray":["1326309079220936709","1326288846083006464","1326205271161638914","1326201816669937666","1326201782272462848","1301890221290684423","1248980327768502274","1215392176739360769","1133814304975802369","1044661625138147329","1042084673323773954","1014221037175738368","939215369985757185","939213071444316166","907948686667390976","872947155140571136"]},{"title":"RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia","googleId":"edjvsJPb33sJ","googleLink":"https://www.nature.com/articles/leu2017303","googleCitationCount":50,"googleAuthor":"","doi":"10.1038/leu.2017.303","elsevierAuthor":"Jerchel I.S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"33","altmetricAuthors":["I S Jerchel","A Q Hoogkamer","I M Ariës","E M P Steeghs","J M Boer","N J M Besselink","A Boeree","C van de Ven","H A de Groot-Kruseman","V de Haas","M A Horstmann","G Escherich","C M Zwaan","E Cuppen","M J Koudijs","R Pieters","M L den Boer"],"twitterCount":7,"altmetricId":26999040,"statusesArray":["925856654930927617","923241392335441920","923241335020236801","918720063410143232","918438795988660224","918421487870029826","915539771631353856"]},{"title":"Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category","googleId":"vjqLNWkvGuMJ","googleLink":"https://www.nature.com/articles/leu2016369","googleCitationCount":69,"googleAuthor":"E Muchtar","doi":"10.1038/leu.2016.369","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"55","altmetricAuthors":["E Muchtar","A Dispenzieri","S K Kumar","R P Ketterling","D Dingli","M Q Lacy","F K Buadi","S R Hayman","P Kapoor","N Leung","R Chakraborty","W Gonsalves","R Warsame","T V Kourelis","S Russell","J A Lust","Y Lin","R S Go","S Zeldenrust","R A Kyle","S V Rajkumar","M A Gertz"],"twitterCount":2,"altmetricId":15701032,"statusesArray":["882726756968484864","823534507890511872"]},{"title":"Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics","googleId":"avsG_PSYlFUJ","googleLink":"https://www.nature.com/articles/leu201736","googleCitationCount":56,"googleAuthor":"","doi":"10.1038/leu.2017.36","elsevierAuthor":"Reckel S.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"46","altmetricAuthors":["S Reckel","R Hamelin","S Georgeon","F Armand","Q Jolliet","D Chiappe","M Moniatte","O Hantschel"],"twitterCount":1,"altmetricId":15875240,"statusesArray":["846266253765435392"]},{"title":"Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial","googleId":"ZP0b6E0AMx8J","googleLink":"https://www.nature.com/articles/leu2017234","googleCitationCount":50,"googleAuthor":"TI George","doi":"10.1038/leu.2017.234","elsevierAuthor":"DeAngelo D.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"38","altmetricAuthors":["D J DeAngelo","T I George","A Linder","C Langford","C Perkins","J Ma","P Westervelt","J D Merker","C Berube","S Coutre","M Liedtke","B Medeiros","D Sternberg","C Dutreix","P-A Ruffie","C Corless","T J Graubert","J Gotlib"],"twitterCount":1,"altmetricId":22304768,"statusesArray":["902791690616000512"]},{"title":"Genomic determinants of chronic myelomonocytic leukemia","googleId":"4L3Kg1ANI4IJ","googleLink":"https://www.nature.com/articles/leu2017164","googleCitationCount":51,"googleAuthor":"S Thota","doi":"10.1038/leu.2017.164","elsevierAuthor":"Patel B.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"41","altmetricAuthors":["B J Patel","B Przychodzen","S Thota","T Radivoyevitch","V Visconte","T Kuzmanovic","M Clemente","C Hirsch","A Morawski","R Souaid","C Saygin","A Nazha","B Demarest","T LaFramboise","H Sakaguchi","S Kojima","H E Carraway","S Ogawa","H Makishima","M A Sekeres","J P Maciejewski"],"twitterCount":5,"altmetricId":20709522,"statusesArray":["943860114922004482","880771095648980992","870741732438282241","869883600438607872","869707795637161984"]},{"title":"Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS","googleId":"UAyIyhkh9xMJ","googleLink":"https://www.nature.com/articles/s41375-018-0140-y","googleCitationCount":37,"googleAuthor":"J Abdi","doi":"10.1038/s41375-018-0140-y","elsevierAuthor":"Rastgoo N.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"26","altmetricAuthors":["Nasrin Rastgoo","Maryam Pourabdollah","Jahangir Abdi","Donna Reece","Hong Chang"],"twitterCount":2,"altmetricId":41044057,"statusesArray":["1026579719972638721","1026573635170050050"]},{"title":"Differentiation stage of myeloma plasma cells: biological and clinical significance","googleId":"pTpWhdlIMzgJ","googleLink":"https://www.nature.com/articles/leu2016211","googleCitationCount":67,"googleAuthor":"","doi":"10.1038/leu.2016.211","elsevierAuthor":"Paiva B.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"39","altmetricAuthors":["B Paiva","N Puig","M T Cedena","B G de Jong","Y Ruiz","I Rapado","J Martinez-Lopez","L Cordon","D Alignani","J A Delgado","M C van Zelm","J J M Van Dongen","M Pascual","X Agirre","F Prosper","J I Martín-Subero","M-B Vidriales","N C Gutierrez","M T Hernandez","A Oriol","M A Echeveste","Y Gonzalez","S K Johnson","J Epstein","B Barlogie","G J Morgan","A Orfao","J Blade","M V Mateos","J J Lahuerta","J F San-Miguel"],"twitterCount":8,"altmetricId":10250821,"statusesArray":["903997203701579777","903953542393638913","903937692454592512","834546835272454145","779369084777402368","779127774002970628","778563440101117953","760905807416397825"]},{"title":"High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells","googleId":"qfnaKNz1dacJ","googleLink":"https://www.nature.com/articles/leu201781","googleCitationCount":49,"googleAuthor":"P Sujobert","doi":"10.1038/leu.2017.81","elsevierAuthor":"Poulain L.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"31","altmetricAuthors":["L Poulain","P Sujobert","F Zylbersztejn","S Barreau","L Stuani","M Lambert","T L Palama","V Chesnais","R Birsen","F Vergez","T Farge","C Chenevier-Gobeaux","M Fraisse","F Bouillaud","C Debeissat","O Herault","C Récher","C Lacombe","M Fontenay","P Mayeux","T T Maciel","J-C Portais","J-E Sarry","J Tamburini","D Bouscary","N Chapuis"],"twitterCount":1,"altmetricId":17304508,"statusesArray":["843962904235905025"]},{"title":"A compound chimeric antigen receptor strategy for targeting multiple myeloma","googleId":"jjEIYYOt7n8J","googleLink":"https://www.nature.com/articles/leu2017302","googleCitationCount":47,"googleAuthor":"KH Chen","doi":"10.1038/leu.2017.302","elsevierAuthor":"Chen K.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"40","altmetricAuthors":["K H Chen","M Wada","K G Pinz","H Liu","X Shuai","X Chen","L E Yan","J C Petrov","H Salman","L Senzel","E L H Leung","X Jiang","Y Ma"],"twitterCount":16,"altmetricId":26697745,"statusesArray":["972236879709040641","972215476947431424","916382617955692544","916156537432936448","915979125583728642","915978483884548096","915925647868022784","915871866304286720","915868335388205056","915866401688059906","914850116699344896","914848996614688769","913411335257391105","913409837802901504","913392030205784065","913389151814246401","913387829702541314"]},{"title":"A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers","googleId":"VDy5AquqUy8J","googleLink":"https://www.nature.com/articles/leu201759","googleCitationCount":51,"googleAuthor":"G Tatsumi","doi":"10.1038/leu.2017.59","elsevierAuthor":"Sugino N.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"42","altmetricAuthors":["N Sugino","M Kawahara","G Tatsumi","A Kanai","H Matsui","R Yamamoto","Y Nagai","S Fujii","Y Shimazu","M Hishizawa","T Inaba","A Andoh","T Suzuki","A Takaori-Kondo"],"twitterCount":1,"altmetricId":16794845,"statusesArray":["836006727342489602"]},{"title":"Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy","googleId":"bY0r451pUjAJ","googleLink":"https://www.nature.com/articles/leu2016282","googleCitationCount":65,"googleAuthor":"GL Uy","doi":"10.1038/leu.2016.282","elsevierAuthor":"Uy G.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"49","altmetricAuthors":["G L Uy","E J Duncavage","G S Chang","M A Jacoby","C A Miller","J Shao","S Heath","K Elliott","T Reineck","R S Fulton","C C Fronick","M O'Laughlin","L Ganel","C N Abboud","A F Cashen","J F DiPersio","R K Wilson","D C Link","J S Welch","T J Ley","T A Graubert","P Westervelt","M J Walter"],"twitterCount":6,"altmetricId":13075015,"statusesArray":["801414920726155265","801402530760683520","801400912875061248","791619760459026432","791618598200565760","791617059943776256","791616755668021248","791616237411368960"]},{"title":"High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)","googleId":"BXi5Iei7L5IJ","googleLink":"https://www.nature.com/articles/leu2016334","googleCitationCount":66,"googleAuthor":"B Kasenda","doi":"10.1038/leu.2016.334","elsevierAuthor":"Fritsch K.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"52","altmetricAuthors":["K Fritsch","B Kasenda","E Schorb","P Hau","J Bloehdorn","R Möhle","S Löw","M Binder","J Atta","U Keller","H-H Wolf","S W Krause","G Heß","R Naumann","S Sasse","C Hirt","M Lamprecht","U Martens","A Morgner","J Panse","N Frickhofen","A Röth","C Hader","M Deckert","H Fricker","G Ihorst","J Finke","G Illerhaus"],"twitterCount":15,"altmetricId":13903876,"statusesArray":["1245968626663948288","919510930320437248","919477591093981184","801883810518286336","801691271207223297","801486464450232321","801385776680308736","801349678893768705","801332728331374592","801313103069769728","801309451957530624","801301130928095232","801300592954081280","801293124005986304","801271780895760384","801232334758383616"]},{"title":"Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients","googleId":"9-wYQWhg7fgJ","googleLink":"https://www.nature.com/articles/s41375-018-0027-y","googleCitationCount":40,"googleAuthor":"TML Andersson","doi":"10.1038/s41375-018-0027-y","elsevierAuthor":"Landtblom A.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"29","altmetricAuthors":["Anna Ravn Landtblom","Hannah Bower","Therese M.-L. Andersson","Paul W. Dickman","Jan Samuelsson","Magnus Björkholm","Sigurdur Yngvi Kristinsson","Malin Hultcrantz"],"twitterCount":2,"altmetricId":34360010,"statusesArray":["1050830094338543618","974206163666354176"]},{"title":"Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms","googleId":"NNbYoGPFxD0J","googleLink":"https://www.nature.com/articles/s41375-018-0103-3","googleCitationCount":37,"googleAuthor":"AJ Cornish","doi":"10.1038/s41375-018-0103-3","elsevierAuthor":"Hoang P.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"30","altmetricAuthors":["Phuc H. Hoang","Sara E. Dobbins","Alex J. Cornish","Daniel Chubb","Philip J. Law","Martin Kaiser","Richard S. Houlston"],"twitterCount":26,"altmetricId":34774572,"statusesArray":["1140720619027345410","1140698929790693377","1140688711434133504","1140686841038790657","1140686825704632321","1139529186454851586","1009587823073288192","1005498135504973824","1001554273245769729","991992827704987649","991992014773325825","991959476352770048","991515953145040896","991496824551890946","991487664917565441","991481768447545345","990360480379260930","990358973890138113","990275875307442177","989205087212965888","987393352508243969","985872757119438848","985794712853471233","985489279236239360","985474555278852097","985465767150870528","984795232997867520","984788902895603712","983333789790326784","983330944575852544","983327940422365187","983315571306614784","983315240787103744","983300387200434177","979002736229408768","977950416557223936","977658703448100870","977470997237587968","977447627787825152","977317204252352512","977305786958401536"]},{"title":"Monoclonal antibody therapy in multiple myeloma","googleId":"joFSCV2pD5UJ","googleLink":"https://www.nature.com/articles/leu201760","googleCitationCount":49,"googleAuthor":"","doi":"10.1038/leu.2017.60","elsevierAuthor":"Touzeau C.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"38","altmetricAuthors":["C Touzeau","P Moreau","C Dumontet"],"twitterCount":1,"altmetricId":17288413,"statusesArray":["840935960670064640"]},{"title":"Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug …","googleId":"x5AJwQS6eg4J","googleLink":"https://www.nature.com/articles/s41375-018-0154-5","googleCitationCount":32,"googleAuthor":"R Katayama","doi":"10.1038/s41375-018-0154-5","elsevierAuthor":"Sakamoto K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"25","altmetricAuthors":["Kana Sakamoto","Ryohei Katayama","Reimi Asaka","Seiji Sakata","Satoko Baba","Hideki Nakasone","Sumie Koike","Naoko Tsuyama","Akito Dobashi","Makoto Sasaki","Ryo Ichinohasama","Emi Takakuwa","Rie Yamazaki","Jun Takizawa","Takahiro Maeda","Miwako Narita","Koji Izutsu","Yoshinobu Kanda","Koichi Ohshima","Kengo Takeuchi"],"twitterCount":5,"altmetricId":42982029,"statusesArray":["1078394193238577152","1078318849429303297","1002170290414252032","1001984835387379712","1001789794463055872"]},{"title":"Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines","googleId":"E9WXnszC5voJ","googleLink":"https://www.nature.com/articles/leu2017345","googleCitationCount":45,"googleAuthor":"M Petljak","doi":"10.1038/leu.2017.345","elsevierAuthor":"Maura F.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"28","altmetricAuthors":["F Maura","M Petljak","M Lionetti","I Cifola","W Liang","E Pinatel","L B Alexandrov","A Fullam","I Martincorena","K J Dawson","N Angelopoulos","M K Samur","R Szalat","J Zamora","P Tarpey","H Davies","P Corradini","K C Anderson","S Minvielle","A Neri","H Avet-Loiseau","J Keats","P J Campbell","N C Munshi","N Bolli"],"twitterCount":4,"altmetricId":30112424,"statusesArray":["1108912181033226242","1108707335868813314","939525062423482368","938757373715390464","938729695964667904"]},{"title":"The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy","googleId":"NFry1hj5gXcJ","googleLink":"https://www.nature.com/articles/leu2017214","googleCitationCount":48,"googleAuthor":"MO Holmström","doi":"10.1038/leu.2017.214","elsevierAuthor":"Holmström M.O.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"41","altmetricAuthors":["M O Holmström","E Martinenaite","S M Ahmad","Ö Met","C Friese","L Kjær","C H Riley","P thor Straten","I M Svane","H C Hasselbalch","M H Andersen"],"twitterCount":2,"altmetricId":21577429,"statusesArray":["885504914373267457","885456310942216192"]},{"title":"Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia","googleId":"6AW4KSG6wb8J","googleLink":"https://www.nature.com/articles/s41375-018-0127-8","googleCitationCount":35,"googleAuthor":"S Demeyer","doi":"10.1038/s41375-018-0127-8","elsevierAuthor":"De Bie J.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"26","altmetricAuthors":["Jolien De Bie","Sofie Demeyer","Llucia Alberti-Servera","Ellen Geerdens","Heidi Segers","Michaël Broux","Kim De Keersmaecker","Lucienne Michaux","Peter Vandenberghe","Thierry Voet","Nancy Boeckx","Anne Uyttebroeck","Jan Cools"],"twitterCount":11,"altmetricId":37986059,"statusesArray":["994883266942504961","994609201493110785","994559905754501120","994524908393656321","991663137748340736","991629711368376320","991609309602729989","991455248051978241","991379210966102016","991376906208661504","986556445540806657"]},{"title":"Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study","googleId":"QTBbiyuWUK8J","googleLink":"https://www.nature.com/articles/s41375-018-0094-0","googleCitationCount":41,"googleAuthor":"","doi":"10.1038/s41375-018-0094-0","elsevierAuthor":"Sun W.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"27","altmetricAuthors":["Weili Sun","Jemily Malvar","Richard Sposto","Anupam Verma","Jennifer J. Wilkes","Robyn Dennis","Kenneth Heym","Theodore W. Laetsch","Melissa Widener","Susan R Rheingold","Javier Oesterheld","Nobuko Hijiya","Maria Luisa Sulis","Van Huynh","Andrew E. Place","Henrique Bittencourt","Raymond Hutchinson","Yoav Messinger","Bill Chang","Yousif Matloub","David S. Ziegler","Rebecca Gardner","Todd Cooper","Francesco Ceppi","Michelle Hermiston","Luciano Dalla-Pozza","Kirk R. Schultz","Paul Gaynon","Alan S. Wayne","James A. Whitlock"],"twitterCount":7,"altmetricId":40866266,"statusesArray":["1061505134914650112","1061483945030832128","1061474152308187142","1061417198479126528","1061364616821858305","1061364479680757767","994512639828086784"]},{"title":"Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients","googleId":"_hWDz3ECduYJ","googleLink":"https://www.nature.com/articles/leu2016324","googleCitationCount":62,"googleAuthor":"S Vosberg","doi":"10.1038/leu.2016.324","elsevierAuthor":"Von Der Heide E.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"45","altmetricAuthors":["E K von der Heide","M Neumann","S Vosberg","A R James","M P Schroeder","J Ortiz-Tanchez","K Isaakidis","C Schlee","M Luther","K Jöhrens","I Anagnostopoulos","L H Mochmann","D Nowak","W K Hofmann","P A Greif","C D Baldus"],"twitterCount":2,"altmetricId":13686786,"statusesArray":["863031852856201216","798870788342501376"]},{"title":"Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth","googleId":"V5fv7olL2iAJ","googleLink":"https://www.nature.com/articles/leu2017152","googleCitationCount":50,"googleAuthor":"J Delgado-Calle","doi":"10.1038/leu.2017.152","elsevierAuthor":"Delgado-Calle J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"40","altmetricAuthors":["J Delgado-Calle","J Anderson","M D Cregor","K W Condon","S A Kuhstoss","L I Plotkin","T Bellido","G D Roodman"],"twitterCount":3,"altmetricId":20406714,"statusesArray":["942048899048656896","868362265283768320","866971259803795456"]},{"title":"PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies","googleId":"Tt_8Vkm-xYAJ","googleLink":"https://www.nature.com/articles/leu2016254?amp%3Bcode=7a1e93ec-9600-4e8a-aafb-bebc9c92fa5b","googleCitationCount":62,"googleAuthor":"PF Thall","doi":"10.1038/leu.2016.254","elsevierAuthor":"Qazilbash M.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"46","altmetricAuthors":["M H Qazilbash","E Wieder","P F Thall","X Wang","R Rios","S Lu","S Kanodia","K E Ruisaard","S A Giralt","E H Estey","J Cortes","K V Komanduri","K Clise-Dwyer","G Alatrash","Q Ma","R E Champlin","J J Molldrem"],"twitterCount":21,"altmetricId":12144039,"statusesArray":["833115317786259456","833044408962576384","806258785102811136","806255207298387968","789493784987987968","789467920049070080","789455918815510528","789435401337536512","789434055070588928","789429779896336384","785230553976934400","784451381944090624","784401894487785472","784398336308629504","784395656534392832","784392890600427520","782632555770183681","781161220732809218","780429592234496000","780428141982523394","780198985944268800","780156703903887360","780155825335758848","780155544392695808","780055399269445632","779474973781929984","779076291848830976","779060671128346624"]},{"title":"Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?","googleId":"sPpVzQk2yWYJ","googleLink":"https://www.nature.com/articles/s41375-018-0051-y","googleCitationCount":38,"googleAuthor":"MW Drazer","doi":"10.1038/s41375-018-0051-y","elsevierAuthor":"Tawana K.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"24","altmetricAuthors":["Kiran Tawana","Michael W. Drazer","Jane E. Churpek"],"twitterCount":4,"altmetricId":33708196,"statusesArray":["986411492517040129","968462783460364288","968275659943501825","968274911310569472"]},{"title":"Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML","googleId":"9BJHBokyLyUJ","googleLink":"https://www.nature.com/articles/s41375-018-0175-0","googleCitationCount":30,"googleAuthor":"O Dufva","doi":"10.1038/s41375-018-0175-0","elsevierAuthor":"Brück O.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"24","altmetricAuthors":["Oscar Brück","Sami Blom","Olli Dufva","Riku Turkki","Himanshu Chheda","Antonio Ribeiro","Panu Kovanen","Tero Aittokallio","Perttu Koskenvesa","Olli Kallioniemi","Kimmo Porkka","Teijo Pellinen","Satu Mustjoki"],"twitterCount":4,"altmetricId":43937360,"statusesArray":["1014474243915042816","1013608207128907778","1010846896770781185","1009627546932031488"]},{"title":"Selective inhibition of leukemia-associated SHP2 E69K mutant by the allosteric SHP2 inhibitor SHP099","googleId":"I_j9HPz5gvEJ","googleLink":"https://www.nature.com/articles/s41375-018-0020-5","googleCitationCount":35,"googleAuthor":"X Sun","doi":"10.1038/s41375-018-0020-5","elsevierAuthor":"Sun X.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"28","altmetricAuthors":["X Sun","Y Ren","S Gunawan","P Teng","Z Chen","HR Lawrence","J Cai","NJ Lawrence","J Wu"],"twitterCount":1,"altmetricId":32848409,"statusesArray":["961621060398600192"]},{"title":"Subtype-specific patterns of molecular mutations in acute myeloid leukemia","googleId":"EilTcQyeuHUJ","googleLink":"https://www.nature.com/articles/leu2016163","googleCitationCount":62,"googleAuthor":"D Rose","doi":"10.1038/leu.2016.163","elsevierAuthor":"Rose D.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"33","altmetricAuthors":["D Rose","T Haferlach","S Schnittger","K Perglerová","W Kern","C Haferlach"],"twitterCount":5,"altmetricId":8654072,"statusesArray":["750683976688242688","741634995861606402","741593366056472576","741571502022135808","741423293954199552"]},{"title":"Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia","googleId":"Fr3DIruozz0J","googleLink":"https://www.nature.com/articles/leu2017257","googleCitationCount":44,"googleAuthor":"C Krupka","doi":"10.1038/leu.2017.257","elsevierAuthor":"Reiter K.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"33","altmetricAuthors":["K Reiter","H Polzer","C Krupka","A Maiser","B Vick","M Rothenberg-Thurley","K H Metzeler","D Dörfel","H R Salih","G Jung","E Nößner","I Jeremias","W Hiddemann","H Leonhardt","K Spiekermann","M Subklewe","P A Greif"],"twitterCount":2,"altmetricId":25161948,"statusesArray":["907914278216146944","907913792473899008"]},{"title":"Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms","googleId":"Fpu_99cEDJYJ","googleLink":"https://www.nature.com/articles/leu2016262","googleCitationCount":61,"googleAuthor":"M Ruella","doi":"10.1038/leu.2016.262","elsevierAuthor":"Ruella M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"49","altmetricAuthors":["M Ruella","S S Kenderian","O Shestova","M Klichinsky","J J Melenhorst","M A Wasik","S F Lacey","C H June","S Gill"],"twitterCount":26,"altmetricId":12617517,"statusesArray":["1273519245499011073","1273348923415949312","915214184744390656","915070489378349057","792418492209168384","792413258934136832","792410409353351168","792409901880385536","791159276702236672","789489632324964352","789325397011763201","789324760744198145","789272380619325440","789243076715896833","789205940134289408","789099932204601344","789092474069352448","789088175683735552","789084973030449152","789084389158236160","789082320510808064","789080560442413057","789080477193768961","788435258794442754","788399510112247808","788339135920693249","786982979298025472"]},{"title":"Therapeutic targeting of CK2 in acute and chronic leukemias","googleId":"IQJJ9mGSrPAJ","googleLink":"https://www.nature.com/articles/leu2017301","googleCitationCount":47,"googleAuthor":"M Ruzzene","doi":"10.1038/leu.2017.301","elsevierAuthor":"Daneshmanesh A.","publicationName":"PLoS ONE","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial","googleId":"d7iNQmJCxlcJ","googleLink":"https://www.nature.com/articles/leu201735","googleCitationCount":47,"googleAuthor":"A Oriol","doi":"10.1038/leu.2017.35","elsevierAuthor":"Rosiñol L.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"30","altmetricAuthors":["L Rosiñol","A Oriol","A I Teruel","A L de la Guía","MaJ Blanchard","J de la Rubia","M Granell","MaA Sampol","L Palomera","Y González","MaA Etxebeste","R Martínez-Martínez","M T Hernández","F de Arriba","A Alegre","MaT Cibeira","MaV Mateos","J Martínez-López","J J Lahuerta","J San Miguel","J Bladé"],"twitterCount":4,"altmetricId":15793308,"statusesArray":["913752897602637824","839884046800822272","824687162813743107","824256775113228288"]},{"title":"Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria","googleId":"J8h1nOatuWoJ","googleLink":"https://www.nature.com/articles/s41375-018-0060-x","googleCitationCount":36,"googleAuthor":"E Muchtar","doi":"10.1038/s41375-018-0060-x","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"33","altmetricAuthors":["Eli Muchtar","Angela Dispenzieri","Nelson Leung","Martha Q. Lacy","Francis K. Buadi","David Dingli","Martha Grogan","Suzanne R. Hayman","Prashant Kapoor","Yi Lisa Hwa","Amie Fonder","Miriam Hobbs","Rajshekhar Chakraborty","Wilson Gonsalves","Taxiarchis V. Kourelis","Rahma Warsame","Stephen Russell","John A. Lust","Yi Lin","Ronald S. Go","Steven Zeldenrust","Robert A. Kyle","S. Vincent Rajkumar","Shaji K. Kumar","Morie A. Gertz"],"twitterCount":13,"altmetricId":33553755,"statusesArray":["1056022721904033792","1050830625358405633","984927067597934598","984885335166304256","984837110191583232","984829065310941185","981177391698628608","981176245542060032","978961149138911232","978939927357480960","978935740489875456","978001889521520640","966838830446891008"]},{"title":"Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib","googleId":"bJdo7g5cNZ8J","googleLink":"https://www.nature.com/articles/leu2016368","googleCitationCount":60,"googleAuthor":"J Yu","doi":"10.1038/leu.2016.368","elsevierAuthor":"Yu J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"43","altmetricAuthors":["J Yu","L Chen","B Cui","Christina Wu","M Y Choi","Y Chen","L Zhang","L Z Rassenti","G F Widhopf II","T J Kipps"],"twitterCount":2,"altmetricId":14649744,"statusesArray":["807918700623962112","807848673468149760"]},{"title":"Treatment and outcome of 2904 CML patients from the EUTOS population-based registry","googleId":"BxkvzDlHk10J","googleLink":"https://www.nature.com/articles/leu2016246","googleCitationCount":61,"googleAuthor":"","doi":"10.1038/leu.2016.246","elsevierAuthor":"Hoffmann V.S.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"43","altmetricAuthors":["V S Hoffmann","M Baccarani","J Hasford","F Castagnetti","F Di Raimondo","L F Casado","A Turkina","D Zackova","G Ossenkoppele","A Zaritskey","M Höglund","B Simonsson","K Indrak","Z Sninska","T Sacha","R Clark","A Bogdanovic","A Hellmann","L Griskevicius","G Schubert-Fritschle","D Sertic","J Guilhot","S Lejniece","I Zupan","S Burgstaller","P Koskenvesa","H Everaus","P Costeas","D Lindoerfer","G Rosti","S Saussele","A Hochhaus","R Hehlmann"],"twitterCount":2,"altmetricId":10913764,"statusesArray":["849032943821574144","770934455385063424"]},{"title":"U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions","googleId":"ZQ9OMrqpKkUJ","googleLink":"https://www.nature.com/articles/s41375-018-0078-0","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/s41375-018-0078-0","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"33","altmetricAuthors":["Ayalew Tefferi","Christy M. Finke","Terra L. Lasho","Curtis A. Hanson","Rhett P. Ketterling","Naseema Gangat","Animesh Pardanani"],"twitterCount":2,"altmetricId":33748422,"statusesArray":["979733353854390273","968628577418858496"]},{"title":"The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression","googleId":"ebd9jxndC_EJ","googleLink":"https://www.nature.com/articles/leu201782","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2017.82","elsevierAuthor":"Abraham M.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"43","altmetricAuthors":["M Abraham","S Klein","B Bulvik","H Wald","I D Weiss","D Olam","L Weiss","K Beider","O Eizenberg","O Wald","E Galun","A Avigdor","O Benjamini","A Nagler","Y Pereg","S Tavor","A Peled"],"twitterCount":0,"altmetricId":17341803,"statusesArray":[]},{"title":"JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","googleId":"wpkzaXpOTJEJ","googleLink":"https://www.nature.com/articles/leu2017136","googleCitationCount":59,"googleAuthor":"","doi":"10.1038/leu.2017.136","elsevierAuthor":"Meyer L.K.","publicationName":"PLoS ONE","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"1 June 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation","googleId":"Lwxhu4C-pLoJ","googleLink":"https://www.nature.com/articles/leu2017137","googleCitationCount":45,"googleAuthor":"","doi":"10.1038/leu.2017.137","elsevierAuthor":"Timrott K.","publicationName":"PLoS ONE","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"0","altmetricAuthors":["N Stickel","K Hanke","D Marschner","G Prinz","M Köhler","W Melchinger","D Pfeifer","A Schmitt-Graeff","T Brummer","A Heine","P Brossart","D Wolf","N von Bubnoff","J Finke","J Duyster","J Ferrara","U Salzer","R Zeiser"],"twitterCount":2,"altmetricId":20030091,"statusesArray":["942261593303158784","862495116518277120","862454481115430912"]},{"title":"HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia","googleId":"ncEFb_eQmyMJ","googleLink":"https://www.nature.com/articles/leu2016222","googleCitationCount":59,"googleAuthor":"A Kumar","doi":"10.1038/leu.2016.222","elsevierAuthor":"Kontro M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"37","altmetricAuthors":["M Kontro","A Kumar","M M Majumder","S Eldfors","A Parsons","T Pemovska","J Saarela","B Yadav","D Malani","Y Fløisand","M Höglund","K Remes","B T Gjertsen","O Kallioniemi","K Wennerberg","C A Heckman","K Porkka"],"twitterCount":4,"altmetricId":10351960,"statusesArray":["773535917554274304","773514601577209856","773509953596239872","762989550889164802"]},{"title":"Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure","googleId":"X5oYm32fWIUJ","googleLink":"https://www.nature.com/articles/leu201723","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2017.23","elsevierAuthor":"Wattad M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"38","altmetricAuthors":["M Wattad","D Weber","K Döhner","J Krauter","V I Gaidzik","P Paschka","M Heuser","F Thol","T Kindler","M Lübbert","H R Salih","A Kündgen","H-A Horst","P Brossart","K Götze","D Nachbaur","C-H Köhne","M Ringhoffer","G Wulf","G Held","H Salwender","A Benner","A Ganser","H Döhner","R F Schlenk"],"twitterCount":2,"altmetricId":16797734,"statusesArray":["836065333525913600","836055333994909696"]},{"title":"Chromothripsis in acute myeloid leukemia: biological features and impact on survival","googleId":"04Rgq_CSo84J","googleLink":"https://www.nature.com/articles/s41375-018-0035-y","googleCitationCount":35,"googleAuthor":"G Marconi","doi":"10.1038/s41375-018-0035-y","elsevierAuthor":"Fontana M.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28","altmetricAuthors":["Maria Chiara Fontana","Giovanni Marconi","Jelena D. Milosevic Feenstra","Eugenio Fonzi","Cristina Papayannidis","Andrea Ghelli Luserna di Rorá","Antonella Padella","Vincenza Solli","Eugenia Franchini","Emanuela Ottaviani","Anna Ferrari","Carmen Baldazzi","Nicoletta Testoni","Ilaria Iacobucci","Simona Soverini","Torsten Haferlach","Viviana Guadagnuolo","Lukas Semerad","Michael Doubek","Michael Steurer","Zdenek Racil","Stefania Paolini","Marco Manfrini","Michele Cavo","Giorgia Simonetti","Robert Kralovics","Giovanni Martinelli"],"twitterCount":5,"altmetricId":33557421,"statusesArray":["1122589208638566400","1118582934586437632","1118558370741415936","968042131590909952","967429671930413056","967187213560832000","966866557845598210"]},{"title":"Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome","googleId":"f9XQ7lwSTYQJ","googleLink":"https://www.nature.com/articles/leu2017142","googleCitationCount":46,"googleAuthor":"M Walsh","doi":"10.1038/leu.2017.142","elsevierAuthor":"Schwartz J.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"32","altmetricAuthors":["J R Schwartz","S Wang","J Ma","T Lamprecht","M Walsh","G Song","S C Raimondi","G Wu","M F Walsh","R B McGee","C Kesserwan","K E Nichols","B E Cauff","R C Ribeiro","M Wlodarski","J M Klco"],"twitterCount":5,"altmetricId":36826181,"statusesArray":["1113054896855683073","1112919382034968576","1112787513725341696","1112775647057805312","1112775532108804098"]},{"title":"Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma","googleId":"5kW_2oV9em8J","googleLink":"https://www.nature.com/articles/leu2017273","googleCitationCount":49,"googleAuthor":"M Fujisawa","doi":"10.1038/leu.2017.273","elsevierAuthor":"Fujisawa M.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"31","altmetricAuthors":["M Fujisawa","M Sakata-Yanagimoto","S Nishizawa","D Komori","P Gershon","M Kiryu","S Tanzima","K Fukumoto","T Enami","M Muratani","K Yoshida","S Ogawa","K Matsue","N Nakamura","K Takeuchi","K Izutsu","K Fujimoto","T Teshima","H Miyoshi","P Gaulard","K Ohshima","S Chiba"],"twitterCount":4,"altmetricId":24237582,"statusesArray":["979225702753955840","901997902200954881","901997377527173120","900470133445021696"]},{"title":"Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment—the involvement …","googleId":"XqKIxg-rINYJ","googleLink":"https://www.nature.com/articles/s41375-018-0087-z","googleCitationCount":31,"googleAuthor":"A Abdel-Latif","doi":"10.1038/s41375-018-0087-z","elsevierAuthor":"Ratajczak M.Z.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"26","altmetricAuthors":["Mariusz Z Ratajczak","Mateusz Adamiak","Monika Plonka","Ahmed Abdel-Latif","Janina Ratajczak"],"twitterCount":0,"altmetricId":72879371,"statusesArray":[]},{"title":"Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia","googleId":"-opwynA7KEoJ","googleLink":"https://www.nature.com/articles/leu201739","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2017.39","elsevierAuthor":"Rossig C.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"36","altmetricAuthors":["C Rossig","M Pule","B Altvater","S Saiagh","G Wright","S Ghorashian","L Clifton-Hadley","K Champion","Z Sattar","B Popova","A Hackshaw","P Smith","T Roberts","E Biagi","B Dreno","R Rousseau","S Kailayangiri","M Ahlmann","R Hough","B Kremens","M G Sauer","P Veys","N Goulden","M Cummins","P J Amrolia"],"twitterCount":4,"altmetricId":15989789,"statusesArray":["890975529930829824","869269281090961410","840136410837405696","826442805417488384"]},{"title":"Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma","googleId":"fchLZxC8K2sJ","googleLink":"https://www.nature.com/articles/leu2016175","googleCitationCount":57,"googleAuthor":"Q Gong","doi":"10.1038/leu.2016.175","elsevierAuthor":"Bouska A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"45","altmetricAuthors":["A Bouska","W Zhang","Q Gong","J Iqbal","A Scuto","J Vose","M Ludvigsen","K Fu","D D Weisenburger","T C Greiner","R D Gascoyne","A Rosenwald","G Ott","E Campo","L M Rimsza","J Delabie","E S Jaffe","R M Braziel","J M Connors","C-I Wu","L M Staudt","F D‘Amore","T W McKeithan","W C Chan"],"twitterCount":3,"altmetricId":9518407,"statusesArray":["751890458159165440","751817980216958984","751453496419856384"]},{"title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","googleId":"A4K6I3pXYFoJ","googleLink":"https://www.nature.com/articles/leu201711","googleCitationCount":58,"googleAuthor":"NS Saba","doi":"10.1038/leu.2017.11","elsevierAuthor":"Herndon T.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"44","altmetricAuthors":["T M Herndon","S-S Chen","N S Saba","J Valdez","C Emson","M Gatmaitan","X Tian","T E Hughes","C Sun","D C Arthur","M Stetler-Stevenson","C M Yuan","C U Niemann","G E Marti","G Aue","S Soto","M Z H Farooqui","S E M Herman","N Chiorazzi","A Wiestner"],"twitterCount":1,"altmetricId":20871695,"statusesArray":["872410408661000192"]},{"title":"High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the …","googleId":"SMyJKZVsgqoJ","googleLink":"https://www.nature.com/articles/leu2017170","googleCitationCount":41,"googleAuthor":"B Kasenda","doi":"10.1038/leu.2017.170","elsevierAuthor":"Kasenda B.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"31","altmetricAuthors":["B Kasenda","G Ihorst","R Schroers","A Korfel","I Schmidt-Wolf","G Egerer","L von Baumgarten","A Röth","J Bloehdorn","R Möhle","M Binder","U Keller","M Lamprecht","M Pfreundschuh","E Valk","H Fricker","E Schorb","K Fritsch","J Finke","G Illerhaus"],"twitterCount":4,"altmetricId":20757092,"statusesArray":["941986563549999104","875853100715831298","870716138723958784","870288692987838464"]},{"title":"Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia","googleId":"-vNVWaCtpxEJ","googleLink":"https://www.nature.com/articles/leu2017300","googleCitationCount":40,"googleAuthor":"","doi":"10.1038/leu.2017.300","elsevierAuthor":"Fujita S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"31","altmetricAuthors":["S Fujita","D Honma","N Adachi","K Araki","E Takamatsu","T Katsumoto","K Yamagata","K Akashi","K Aoyama","A Iwama","I Kitabayashi"],"twitterCount":4,"altmetricId":26661095,"statusesArray":["915961854366769152","915565417774571522","914198620697776129","914184348806598656"]},{"title":"The AP-1-BATF and-BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma","googleId":"Uop7IapGtcoJ","googleLink":"https://www.nature.com/articles/s41375-018-0045-9","googleCitationCount":30,"googleAuthor":"","doi":"10.1038/s41375-018-0045-9","elsevierAuthor":"Schleussner N.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"23","altmetricAuthors":["Nikolai Schleussner","Olaf Merkel","Mariantonia Costanza","Huan-Chang Liang","Franziska Hummel","Chiara Romagnani","Pawel Durek","Ioannis Anagnostopoulos","Michael Hummel","Korinna Jöhrens","Antonia Niedobitek","Patrick R. Griffin","Roberto Piva","Henrike L. Sczakiel","Wilhelm Woessmann","Christine Damm-Welk","Christian Hinze","Dagmar Stoiber","Bernd Gillissen","Suzanne D. Turner","Eva Kaergel","Linda von Hoff","Michael Grau","Georg Lenz","Bernd Dörken","Claus Scheidereit","Lukas Kenner","Martin Janz","Stephan Mathas"],"twitterCount":3,"altmetricId":34982588,"statusesArray":["1128550384388255744","983809487533461504","979298491905142785"]},{"title":"HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications","googleId":"RvXyGNhrHNsJ","googleLink":"https://www.nature.com/articles/leu2017144","googleCitationCount":41,"googleAuthor":"","doi":"10.1038/leu.2017.144","elsevierAuthor":"Iwasa M.","publicationName":"Oncotarget","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"1 March 2019","elsevierCitationCount":"4","altmetricAuthors":["T Harada","H Ohguchi","Y Grondin","S Kikuchi","M Sagawa","Y-T Tai","R Mazitschek","T Hideshima","K C Anderson"],"twitterCount":4,"altmetricId":20071420,"statusesArray":["864145863169454081","864136603362627586","864106703943610369","864105586970902528","863018344344977411"]},{"title":"Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial","googleId":"Kj4xvF0JLvEJ","googleLink":"https://www.nature.com/articles/leu2016219","googleCitationCount":55,"googleAuthor":"DI Marks","doi":"10.1038/leu.2016.219","elsevierAuthor":"Patel B.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"45","altmetricAuthors":["B Patel","A A Kirkwood","A Dey","D I Marks","A K McMillan","T F Menne","L Micklewright","P Patrick","S Purnell","C J Rowntree","P Smith","A K Fielding"],"twitterCount":5,"altmetricId":10251675,"statusesArray":["761516826622889984","761515642763771905","761037172380082176","761029280646111232","760921182845734912"]},{"title":"ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition","googleId":"ShK0eIkpNucJ","googleLink":"https://www.nature.com/articles/leu201745","googleCitationCount":44,"googleAuthor":"J Yang","doi":"10.1038/leu.2017.45","elsevierAuthor":"Ju H.Q.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"29","altmetricAuthors":["H-Q Ju","G Zhan","A Huang","Y Sun","S Wen","J Yang","W-h Lu","R-h Xu","J Li","Y Li","G Garcia-Manero","P Huang","Y Hu"],"twitterCount":1,"altmetricId":16462986,"statusesArray":["923567660872351744"]},{"title":"Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis","googleId":"QjtkqMPK7N4J","googleLink":"https://www.nature.com/articles/s41375-018-0058-4","googleCitationCount":30,"googleAuthor":"MJ Oberley","doi":"10.1038/s41375-018-0058-4","elsevierAuthor":"Maruffi M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"20","altmetricAuthors":["Maria Maruffi","Richard Sposto","Matthew J Oberley","Lynn Kysh","Etan Orgel"],"twitterCount":17,"altmetricId":33745384,"statusesArray":["1116879214911938560","1116876292367048704","1116870425450110976","1116835743056441346","1116834237502689281","1116801547680268289","1116750315406143490","1116739198168567808","1116717897156452352","1116524465368764416","1116507074102300672","1116506672304779264","1116505725830717441","1116505055924867072","976588277066088449","976171521365352449","970025677826162688","968986615493230592","968881476983914497"]},{"title":"Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells","googleId":"RZAFevOBqOEJ","googleLink":"https://www.nature.com/articles/s41375-018-0264-0","googleCitationCount":27,"googleAuthor":"DM Ross","doi":"10.1038/s41375-018-0264-0","elsevierAuthor":"Ross D.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"21","altmetricAuthors":["David M. Ross","Ilaria S. Pagani","Naranie Shanmuganathan","Chung H. Kok","John F. Seymour","Anthony K. Mills","Robin J. Filshie","Christopher K. Arthur","Phuong Dang","Verity A. Saunders","Jodi Braley","Agnes S. Yong","David T. Yeung","Deborah L. White","Andrew P. Grigg","Anthony P. Schwarer","Susan Branford","Timothy P. Hughes"],"twitterCount":5,"altmetricId":49652518,"statusesArray":["1072205054696964098","1071976804372660225","1054477376376238080","1054477263369134081","1051412891952447496"]},{"title":"Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open …","googleId":"d_M7QjTKo24J","googleLink":"https://www.nature.com/articles/s41375-018-0023-2","googleCitationCount":35,"googleAuthor":"W Jurczak","doi":"10.1038/s41375-018-0023-2","elsevierAuthor":"Rule S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"25","altmetricAuthors":["S Rule","W Jurczak","M Jerkeman","C Rusconi","M Trneny","F Offner","D Caballero","C Joao","M Witzens-Harig","G Hess","I Bence-Bruckler","S-G Cho","C Thieblemont","W Zhou","T Henninger","J Goldberg","J Vermeulen","M Dreyling"],"twitterCount":1,"altmetricId":54919490,"statusesArray":["977851474838405120"]},{"title":"SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells","googleId":"Gvkbp0pKTUcJ","googleLink":"https://www.nature.com/articles/s41375-018-0152-7","googleCitationCount":29,"googleAuthor":"T Tebaldi","doi":"10.1038/s41375-018-0152-7","elsevierAuthor":"Liang Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"20","altmetricAuthors":["Yang Liang","Toma Tebaldi","Kai Rejeski","Poorval Joshi","Giovanni Stefani","Ashley Taylor","Yuanbin Song","Radovan Vasic","Jamie Maziarz","Kunthavai Balasubramanian","Anastasia Ardasheva","Alicia Ding","Alessandro Quattrone","Stephanie Halene"],"twitterCount":6,"altmetricId":43147384,"statusesArray":["1025069493372899329","1006221686289690629","1005547654741360641","1003215787908198401","1002861878715080707","1002691725784223744"]},{"title":"Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV mut and IgHV unmut …","googleId":"DKsXJpIF3SMJ","googleLink":"https://www.nature.com/articles/leu2017177","googleCitationCount":40,"googleAuthor":"R Alsolami","doi":"10.1038/leu.2017.177","elsevierAuthor":"Burns A.","publicationName":"Leukemia","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":["A Burns","R Alsolami","J Becq","B Stamatopoulos","A Timbs","D Bruce","P Robbe","D Vavoulis","R Clifford","M Cabes","H Dreau","J Taylor","S J L Knight","R Mansson","D Bentley","R Beekman","J I Martín-Subero","E Campo","R S Houlston","K E Ridout","A Schuh"],"twitterCount":4,"altmetricId":20863899,"statusesArray":["1080787870871244802","872543486435667968","872528363482632192","872398748416184320","872397632966144000","872262961028530176"]},{"title":"Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)","googleId":"Rid0bTfzZZ0J","googleLink":"https://www.nature.com/articles/leu2017242","googleCitationCount":41,"googleAuthor":"N Kröger","doi":"10.1038/leu.2017.242","elsevierAuthor":"Bug G.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"27","altmetricAuthors":["G Bug","A Burchert","E-M Wagner","N Kröger","T Berg","S Güller","S K Metzelder","A Wolf","S Hünecke","P Bader","J Schetelig","H Serve","O G Ottmann"],"twitterCount":1,"altmetricId":22947183,"statusesArray":["903648666514317313"]},{"title":"Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the …","googleId":"bS4gL8VLFgkJ","googleLink":"https://www.nature.com/articles/leu2016186","googleCitationCount":56,"googleAuthor":"D Joshua","doi":"10.1038/leu.2016.186","elsevierAuthor":"Moreau P.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"38","altmetricAuthors":["P Moreau","D Joshua","W-J Chng","A Palumbo","H Goldschmidt","R Hájek","T Facon","H Ludwig","L Pour","R Niesvizky","A Oriol","L Rosiñol","A Suvorov","G Gaidano","T Pika","K Weisel","V Goranova-Marinova","H H Gillenwater","N Mohamed","S Aggarwal","S Feng","M A Dimopoulos"],"twitterCount":4,"altmetricId":9226633,"statusesArray":["1266373528485429248","903212971169632256","762303841786142720","761711332982923264","750047222788653056"]},{"title":"Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR","googleId":"4EycgOxstmwJ","googleLink":"https://www.nature.com/articles/leu2016390","googleCitationCount":56,"googleAuthor":"WJ Chng","doi":"10.1038/leu.2016.390","elsevierAuthor":"Chng W.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"37","altmetricAuthors":["W-J Chng","H Goldschmidt","M A Dimopoulos","P Moreau","D Joshua","A Palumbo","T Facon","H Ludwig","L Pour","R Niesvizky","A Oriol","L Rosiñol","A Suvorov","G Gaidano","T Pika","K Weisel","V Goranova-Marinova","H H Gillenwater","N Mohamed","S Feng","S Aggarwal","R Hájek"],"twitterCount":11,"altmetricId":15228137,"statusesArray":["921031505316646913","828227895474716672","817471020110139392","817154880687185920","817107960887463938","817044587449614336","817012453007650816","816698054552260609","816678630055149569","816649001600749568","816647877837672448"]},{"title":"miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding","googleId":"w-RR7LmQ2uUJ","googleLink":"https://www.nature.com/articles/s41375-018-0015-2","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/s41375-018-0015-2","elsevierAuthor":"Peng D.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"30","altmetricAuthors":["Danyue Peng","Huifang Wang","Lei Li","Xiao Ma","Ying Chen","Hao Zhou","Yi Luo","Yin Xiao","Lingbo Liu"],"twitterCount":4,"altmetricId":32808663,"statusesArray":["1195678854855053312","1107895069896527873","961703711776104448","961416821785223169"]},{"title":"Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma","googleId":"jN2emo8K7FEJ","googleLink":"https://www.nature.com/articles/leu2017322","googleCitationCount":41,"googleAuthor":"DS Das","doi":"10.1038/leu.2017.322","elsevierAuthor":"Ray A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"29","altmetricAuthors":["A Ray","D S Das","Y Song","T Hideshima","Y-T Tai","D Chauhan","K C Anderson"],"twitterCount":1,"altmetricId":28487279,"statusesArray":["930066894371151873"]},{"title":"KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells","googleId":"KBdVFfHV-XgJ","googleLink":"https://www.nature.com/articles/leu2016145","googleCitationCount":52,"googleAuthor":"","doi":"10.1038/leu.2016.145","elsevierAuthor":"Etchin J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"35","altmetricAuthors":["J Etchin","A Berezovskaya","A S Conway","I A Galinsky","R M Stone","E Baloglu","W Senapedis","Y Landesman","M Kauffman","S Shacham","J C Y Wang","A T Look"],"twitterCount":8,"altmetricId":8208754,"statusesArray":["737279419811692546","737268779600609280","737267012586639360","737237504198381568","736168957485420545","736162614665940992","735587366270705664","735342895952203778"]},{"title":"KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival","googleId":"rqkt12wmYz0J","googleLink":"https://www.nature.com/articles/leu2017141","googleCitationCount":40,"googleAuthor":"","doi":"10.1038/leu.2017.141","elsevierAuthor":"Ohguchi H.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"29","altmetricAuthors":["H Ohguchi","T Harada","M Sagawa","S Kikuchi","Y-T Tai","P G Richardson","T Hideshima","K C Anderson"],"twitterCount":1,"altmetricId":20071250,"statusesArray":["863017165296877568"]},{"title":"Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib","googleId":"B8zAhrFPvqgJ","googleLink":"https://www.nature.com/articles/leu2016308","googleCitationCount":53,"googleAuthor":"K Shide","doi":"10.1038/leu.2016.308","elsevierAuthor":"Shide K.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"40","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs","googleId":"lTloFMPYffoJ","googleLink":"https://www.nature.com/articles/leu2017163","googleCitationCount":39,"googleAuthor":"AR Pyzer","doi":"10.1038/leu.2017.163","elsevierAuthor":"Pyzer A.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"36","altmetricAuthors":["A R Pyzer","D Stroopinsky","J Rosenblatt","E Anastasiadou","H Rajabi","A Washington","A Tagde","J-H Chu","M Coll","A L Jiao","L T Tsai","D E Tenen","L Cole","K Palmer","A Ephraim","R K Leaf","M Nahas","A Apel","M Bar-Natan","S Jain","M McMasters","L Mendez","J Arnason","B A Raby","F Slack","D Kufe","D Avigan"],"twitterCount":10,"altmetricId":20723555,"statusesArray":["1343573415266033664","1343367126745149442","1343366528897601536","1029117311297499136","938982398599065600","897511224757407744","870285466616168448","870026894212771840","870024990401232897","869969011798298628","869886951574216704","869877223418978304"]},{"title":"Natural history of t (11; 14) multiple myeloma","googleId":"o5yR_dJs8bcJ","googleLink":"https://www.nature.com/articles/leu2017204","googleCitationCount":40,"googleAuthor":"A Lakshman","doi":"10.1038/leu.2017.204","elsevierAuthor":"Lakshman A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"32","altmetricAuthors":["A Lakshman","M Alhaj Moustafa","S V Rajkumar","A Dispenzieri","M A Gertz","F K Buadi","M Q Lacy","D Dingli","A L Fonder","S R Hayman","M A Hobbs","W I Gonsalves","Y L Hwa","P Kapoor","N Leung","R S Go","Y Lin","T V Kourelis","J A Lust","S J Russell","S R Zeldenrust","R A Kyle","S K Kumar"],"twitterCount":28,"altmetricId":21369072,"statusesArray":["1206196213466501120","1206019895336603648","1206005020807725056","1105089568708153344","1067830068028821505","1067829309233135616","998628662277795848","997897177694339072","975083065012703232","925404203828301824","924240189568028673","923928397537038336","915307806324133889","914053532449476608","913991199979134976","913003217600024577","912855932715114497","912844671285710848","912812770181226497","912638580140466177","888602124271181824","881918668732608512","881721596142120960","880938393982476289","880916397634846720","880833347928416256","880811000706080769","880778294219747328","880775849657606146","880775427580723200","880366874722156544","879667441147809797"]},{"title":"Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants","googleId":"8J1TWjCQ6AQJ","googleLink":"https://www.nature.com/articles/leu2017199","googleCitationCount":39,"googleAuthor":"","doi":"10.1038/leu.2017.199","elsevierAuthor":"Wang Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"25","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"JAM-A as a prognostic factor and new therapeutic target in multiple myeloma","googleId":"fIGij7VQ6hMJ","googleLink":"https://www.nature.com/articles/leu2017287","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.287","elsevierAuthor":"Solimando A.G.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"25","altmetricAuthors":["A G Solimando","A Brandl","K Mattenheimer","C Graf","M Ritz","A Ruckdeschel","T Stühmer","Z Mokhtari","M Rudelius","J Dotterweich","M Bittrich","V Desantis","R Ebert","P Trerotoli","M A Frassanito","A Rosenwald","A Vacca","H Einsele","F Jakob","A Beilhack"],"twitterCount":10,"altmetricId":27910466,"statusesArray":["926096082538340352","926036334204129280","925978524363706368","925846379322163201","925802424744497154","925776967869304833","925773185433337858","923207725319933952","923196809954119683","923172311313690624","923138845167706113"]},{"title":"p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status","googleId":"OSa2LjRajjUJ","googleLink":"https://www.nature.com/articles/leu2016350","googleCitationCount":51,"googleAuthor":"A Qutub","doi":"10.1038/leu.2016.350","elsevierAuthor":"Quintás-Cardama A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"39","altmetricAuthors":["A Quintás-Cardama","C Hu","A Qutub","Y H Qiu","X Zhang","S M Post","N Zhang","K Coombes","S M Kornblau"],"twitterCount":12,"altmetricId":14425454,"statusesArray":["822156319192911872","821907205813215232","821825854787485697","821757918995431425","821711646963838977","821709477326049281","821701589467545602","821701425835151360","805845854280151042","805568803987980289","805192108038557700","805179784015716352"]},{"title":"MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences","googleId":"veXXdmUF3VYJ","googleLink":"https://www.nature.com/articles/s41375-018-0033-0","googleCitationCount":36,"googleAuthor":"I Cifola","doi":"10.1038/s41375-018-0033-0","elsevierAuthor":"L’Abbate A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0","altmetricAuthors":["Alberto L′Abbate","Doron Tolomeo","Ingrid Cifola","Marco Severgnini","Antonella Turchiano","Bartolomeo Augello","Gabriella Squeo","Pietro D′Addabbo","Debora Traversa","Giulia Daniele","Angelo Lonoce","Mariella Pafundi","Massimo Carella","Orazio Palumbo","Anna Dolnik","Dominique Muehlematter","Jacqueline Schoumans","Nadine Van Roy","Gianluca De Bellis","Giovanni Martinelli","Giuseppe Merla","Lars Bullinger","Claudia Haferlach","Clelia Tiziana Storlazzi"],"twitterCount":2,"altmetricId":33496217,"statusesArray":["988902875295289344","966480171300737025"]},{"title":"Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma","googleId":"9VJa6btXU4AJ","googleLink":"https://www.nature.com/articles/leu2017334","googleCitationCount":35,"googleAuthor":"M Fulciniti","doi":"10.1038/leu.2017.334","elsevierAuthor":"Gullà A.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"23","altmetricAuthors":["A Gullà","T Hideshima","G Bianchi","M Fulciniti","M Kemal Samur","J Qi","Y-T Tai","T Harada","E Morelli","N Amodio","R Carrasco","P Tagliaferri","N C Munshi","P Tassone","K C Anderson"],"twitterCount":12,"altmetricId":29320727,"statusesArray":["936088699334471680","934694871922806784","934596852170735616","934512020485009409","933691785234276352","933690425667477505","933687107020783622","933678709806194688","933674808486739968","933662710939631616","933655211087941632","933654614049808384"]},{"title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","googleId":"0EWSdOY1CP0J","googleLink":"https://www.nature.com/articles/leu201744","googleCitationCount":42,"googleAuthor":"","doi":"10.1038/leu.2017.44","elsevierAuthor":"Kobayashi S.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"24","altmetricAuthors":["S Kobayashi","A Kobayashi","Y Osawa","S Nagao","K Takano","Y Okada","N Tachi","M Teramoto","T Kawamura","T Horiuchi","S Kato","T Maekawa","T Yamamura","J Watanabe","Y Harada","H Harada","K Sato","F Kimura"],"twitterCount":1,"altmetricId":16374904,"statusesArray":["831439621233926145"]},{"title":"Targeting acute myeloid leukemia by drug-induced c-MYB degradation","googleId":"1g3o_iOw60IJ","googleLink":"https://www.nature.com/articles/leu2017317","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.317","elsevierAuthor":"Walf-Vorderwülbecke V.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"30","altmetricAuthors":["V Walf-Vorderwülbecke","K Pearce","T Brooks","M Hubank","M M van den Heuvel-Eibrink","C M Zwaan","S Adams","D Edwards","J Bartram","S Samarasinghe","P Ancliff","A Khwaja","N Goulden","G Williams","J de Boer","O Williams"],"twitterCount":4,"altmetricId":28319154,"statusesArray":["1187618904111140864","992427722474512386","926222177573228544","926209850270474242"]},{"title":"Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors","googleId":"6Pd3PW9b7yAJ","googleLink":"https://www.nature.com/articles/leu2016391","googleCitationCount":49,"googleAuthor":"GR Friberg","doi":"10.1038/leu.2016.391","elsevierAuthor":"Aldoss I.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"35","altmetricAuthors":["I Aldoss","R C Bargou","D Nagorsen","G R Friberg","P A Baeuerle","S J Forman"],"twitterCount":4,"altmetricId":16797736,"statusesArray":["851376849066348544","836091092034531329","836065302198640640","836055541050933248"]},{"title":"The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma","googleId":"4i0lOdqssukJ","googleLink":"https://www.nature.com/articles/leu2016296","googleCitationCount":48,"googleAuthor":"JT Powers","doi":"10.1038/leu.2016.296","elsevierAuthor":"Manier S.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"36","altmetricAuthors":["S Manier","J T Powers","A Sacco","S V Glavey","D Huynh","M R Reagan","K Z Salem","M Moschetta","J Shi","Y Mishima","C Roche-Lestienne","X Leleu","A M Roccaro","G Q Daley","I M Ghobrial"],"twitterCount":7,"altmetricId":13684224,"statusesArray":["822922908674748416","822904482002599936","822833837071798272","822807212447801345","798864904790757376","798856913173655552","798847838620884992"]},{"title":"Dysregulated iron metabolism in polycythemia vera: etiology and consequences","googleId":"WBd4gcpzjPIJ","googleLink":"https://www.nature.com/articles/s41375-018-0207-9","googleCitationCount":25,"googleAuthor":"J Varkonyi","doi":"10.1038/s41375-018-0207-9","elsevierAuthor":"Ginzburg Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"22","altmetricAuthors":["Yelena Z. Ginzburg","Maria Feola","Eran Zimran","Judit Varkonyi","Tomas Ganz","Ronald Hoffman"],"twitterCount":6,"altmetricId":46456571,"statusesArray":["1298914619713617920","1224037360679247880","1120810135884943360","1071871008372678656","1050829284523331584","1028938745129648129"]},{"title":"Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease","googleId":"epahABuYVAYJ","googleLink":"https://www.nature.com/articles/s41375-018-0123-z","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/s41375-018-0123-z","elsevierAuthor":"Choi J.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"23","altmetricAuthors":["Jaebok Choi","Matthew L. Cooper","Karl Staser","Kidist Ashami","Kiran R. Vij","Bing Wang","Lynne Marsala","Jessica Niswonger","Julie Ritchey","Bader Alahmari","Samuel Achilefu","Ikuo Tsunoda","Mark A. Schroeder","John F. DiPersio"],"twitterCount":19,"altmetricId":39158191,"statusesArray":["1064597526760824832","1061366588698435585","993628876927590401","993607548413644806","993593222567026689","992006525463027712","991962265799856128","991776213000769536","991751463629029376","991724108860837888","991719452881379329","991718939242778625","991716757772619782","991714971414343681","991703092834914310","991697430046486528","991696422943776773","991681193421701120","991669721325072384","991669315727515655","991668666109452288","990060681893482496"]},{"title":"BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells","googleId":"Qh46B9bvwrkJ","googleLink":"https://www.nature.com/articles/leu2016260","googleCitationCount":49,"googleAuthor":"K Rajapakshe","doi":"10.1038/leu.2016.260","elsevierAuthor":"Saenz D.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"41","altmetricAuthors":["D T Saenz","W Fiskus","T Manshouri","K Rajapakshe","S Krieger","B Sun","C P Mill","C DiNardo","N Pemmaraju","T Kadia","S Parmar","S Sharma","C Coarfa","P Qiu","S Verstovsek","K N Bhalla"],"twitterCount":6,"altmetricId":12322790,"statusesArray":["903923970117746688","794165147585507328","790656813427548161","788540125307215872","788539675501748224","788539041113214976","783331326124523521","782202556609097728","781851463521804288"]},{"title":"Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML","googleId":"715ndTxlVzUJ","googleLink":"https://www.nature.com/articles/leu20179","googleCitationCount":48,"googleAuthor":"","doi":"10.1038/leu.2017.9","elsevierAuthor":"Schütz C.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"2","altmetricAuthors":["C Schütz","S Inselmann","S Sausslele","C T Dietz","M C Müller","E Eigendorff","C A Brendel","S K Metzelder","T H Brümmendorf","C Waller","J Dengler","M E Goebeler","R Herbst","G Freunek","S Hanzel","T Illmer","Y Wang","T Lange","F Finkernagel","R Hehlmann","M Huber","A Neubauer","A Hochhaus","J Guilhot","F Xavier Mahon","M Pfirrmann","A Burchert"],"twitterCount":7,"altmetricId":16004164,"statusesArray":["827283089999196160","827236924930793476","827227978920841216","827108563751419904","827105743757258753","827092564671156224","827088421063516160"]},{"title":"miR-194-5p/BCLAF1 deregulation in AML tumorigenesis","googleId":"LVMdaA17uOwJ","googleLink":"https://www.nature.com/articles/leu201764","googleCitationCount":38,"googleAuthor":"G Lania","doi":"10.1038/leu.2017.64","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia","googleId":"_XM4wX_EKdEJ","googleLink":"https://www.nature.com/articles/leu2016327","googleCitationCount":48,"googleAuthor":"","doi":"10.1038/leu.2016.327","elsevierAuthor":"Dafflon C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"40","altmetricAuthors":["C Dafflon","V J Craig","H Méreau","J Gräsel","B Schacher Engstler","G Hoffman","F Nigsch","S Gaulis","L Barys","M Ito","J Aguadé-Gorgorió","B Bornhauser","J-P Bourquin","A Proske","C Stork-Fux","M Murakami","W R Sellers","F Hofmann","J Schwaller","R Tiedt"],"twitterCount":1,"altmetricId":13796332,"statusesArray":["799637410346835972"]},{"title":"The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders","googleId":"RWmQDOpjHcwJ","googleLink":"https://www.nature.com/articles/leu2017139","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.139","elsevierAuthor":"Maslah N.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"25","altmetricAuthors":["N Maslah","B Cassinat","E Verger","J-J Kiladjian","L Velazquez"],"twitterCount":6,"altmetricId":20008366,"statusesArray":["906862173623930881","899814963631534080","899656349457559556","895600452859027456","894542110547955713","893054625632354304","892857375480217600","862281840463196160"]},{"title":"Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia","googleId":"6HiTGZcKTDIJ","googleLink":"https://www.nature.com/articles/leu2016309","googleCitationCount":48,"googleAuthor":"RK Hills","doi":"10.1038/leu.2016.309","elsevierAuthor":"Khan N.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"43","altmetricAuthors":["N Khan","R K Hills","P Virgo","S Couzens","N Clark","A Gilkes","P Richardson","S Knapper","D Grimwade","N H Russell","A K Burnett","S D Freeman"],"twitterCount":2,"altmetricId":19904435,"statusesArray":["907930410696540160","860921094068482048"]},{"title":"The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling","googleId":"vH86fOENQzAJ","googleLink":"https://www.nature.com/articles/leu2017225","googleCitationCount":36,"googleAuthor":"S Vereecke","doi":"10.1038/leu.2017.225","elsevierAuthor":"Girardi T.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"24","altmetricAuthors":["T Girardi","S Vereecke","S O Sulima","Y Khan","L Fancello","J W Briggs","C Schwab","J Op de Beeck","J Verbeeck","J Royaert","E Geerdens","C Vicente","S Bornschein","C J Harrison","J P Meijerink","J Cools","J D Dinman","K R Kampen","K De Keersmaecker"],"twitterCount":3,"altmetricId":22691581,"statusesArray":["1094272697213820928","1094231829660356608","890526217245409281","890524550777065473"]},{"title":"Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression","googleId":"_4qadwh8XTAJ","googleLink":"https://www.nature.com/articles/s41375-018-0013-4","googleCitationCount":29,"googleAuthor":"CF de Larrea","doi":"10.1038/s41375-018-0013-4","elsevierAuthor":"De Larrea C.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"22","altmetricAuthors":["Carlos Fernández de Larrea","Ignacio Isola","Arturo Pereira","Ma Teresa Cibeira","Laura Magnano","Natalia Tovar","Luis-Gerardo Rodríguez-Lobato","Xavier Calvo","Juan I. Aróstegui","Tania Díaz","Ester Lozano","María Rozman","Jordi Yagüe","Joan Bladé","Laura Rosiñol"],"twitterCount":10,"altmetricId":32710986,"statusesArray":["1113041520934809601","966757872796225536","966738885798641664","961541963215491073","961243182955679745","960953192451371009","960952827467231233","960946931072614400","960860307718537217","960853887572787200","960689398567223297"]},{"title":"Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation","googleId":"yZoVNJXabOMJ","googleLink":"https://www.nature.com/articles/leu2016310","googleCitationCount":48,"googleAuthor":"E van den Berg","doi":"10.1038/leu.2016.310","elsevierAuthor":"Berger G.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"28","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia","googleId":"yxf9ObciBrsJ","googleLink":"https://www.nature.com/articles/leu2017200","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/leu.2017.200","elsevierAuthor":"Gaidzik V.I.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"28","altmetricAuthors":["V I Gaidzik","D Weber","P Paschka","A Kaumanns","S Krieger","A Corbacioglu","J Krönke","S Kapp-Schwoerer","D Krämer","H-A Horst","I Schmidt-Wolf","G Held","A Kündgen","M Ringhoffer","K Götze","T Kindler","W Fiedler","M Wattad","R F Schlenk","L Bullinger","V Teleanu","B Schlegelberger","F Thol","M Heuser","A Ganser","H Döhner","K Döhner"],"twitterCount":6,"altmetricId":21320060,"statusesArray":["879001273994887168","878701797896048640","878697716934733824","878694945133137920","878689823669854208","878554198912016384"]},{"title":"Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias","googleId":"KDkv4e-NBRUJ","googleLink":"https://www.nature.com/articles/leu2016166","googleCitationCount":48,"googleAuthor":"M Sanchez-Martin","doi":"10.1038/leu.2016.166","elsevierAuthor":"Wang K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"31","altmetricAuthors":["K Wang","M Sanchez-Martin","X Wang","K M Knapp","R Koche","L Vu","M K Nahas","J He","M Hadler","E M Stein","M S Tallman","A L Donahue","G M Frampton","D Lipson","S Roels","P J Stephens","E M Sanford","T Brennan","G A Otto","R Yelensky","V A Miller","M G Kharas","R L Levine","A Ferrando","S A Armstrong","A V Krivtsov"],"twitterCount":6,"altmetricId":8709097,"statusesArray":["915928262546780161","915920791308505088","819326431809376256","816673025986793472","752690750308122624","749385454588293120","749288814581997568","742393403372097536"]},{"title":"Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T cells","googleId":"L66_B5BbDtgJ","googleLink":"https://www.nature.com/articles/leu2017249","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/leu.2017.249","elsevierAuthor":"Lai Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"30","altmetricAuthors":["Y Lai","J Weng","X Wei","L Qin","P Lai","R Zhao","Z Jiang","B Li","S Lin","S Wang","Q Wu","Z Tang","P Liu","D Pei","Y Yao","X Du","P Li"],"twitterCount":0,"altmetricId":49726584,"statusesArray":[]},{"title":"Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic …","googleId":"HIkt2m2epSgJ","googleLink":"https://www.nature.com/articles/leu2017276","googleCitationCount":35,"googleAuthor":"S Demeyer","doi":"10.1038/leu.2017.276","elsevierAuthor":"Degryse S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0","altmetricAuthors":["S Degryse","C E de Bock","S Demeyer","I Govaerts","S Bornschein","D Verbeke","K Jacobs","S Binos","D A Skerrett-Byrne","H C Murray","N M Verrills","P Van Vlierberghe","J Cools","M D Dun"],"twitterCount":6,"altmetricId":24707516,"statusesArray":["1099798044688691200","908991396102549504","907916261018959872","907888183408435201","907823215182995456","905318357775384576","904307855154712576"]},{"title":"Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains","googleId":"dvke3iL1IlkJ","googleLink":"https://www.nature.com/articles/leu2017286","googleCitationCount":34,"googleAuthor":"S Sidana","doi":"10.1038/leu.2017.286","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"35","altmetricAuthors":["S Sidana","N Tandon","A Dispenzieri","M A Gertz","F K Buadi","M Q Lacy","D Dingli","A L Fonder","S R Hayman","M A Hobbs","W I Gonsalves","Y L Hwa","P Kapoor","R A Kyle","N Leung","R S Go","J A Lust","S J Russell","S R Zeldenrust","S V Rajkumar","S K Kumar"],"twitterCount":10,"altmetricId":26303257,"statusesArray":["1198788641688035328","978710410667884544","978422468867104768","978420992736337920","914212707762688003","911739445749088257","911696675403714560","911048341588463616","911024254904356864","911018046386573312","910991451584126976","910961890850955264","910088607578316800"]},{"title":"Targeting MYC in multiple myeloma","googleId":"-yqAubH9bzAJ","googleLink":"https://www.nature.com/articles/s41375-018-0036-x","googleCitationCount":35,"googleAuthor":"KK Jovanović","doi":"10.1038/s41375-018-0036-x","elsevierAuthor":"Jovanović K.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"21","altmetricAuthors":["K. K. Jovanović","C. Roche-Lestienne","I. M. Ghobrial","T. Facon","B. Quesnel","S. Manier"],"twitterCount":3,"altmetricId":33929809,"statusesArray":["970451677697409024","970447727258726401","968167262434754560"]},{"title":"Preleukemia: one name, many meanings","googleId":"EVhCupysSYAJ","googleLink":"https://www.nature.com/articles/leu2016364","googleCitationCount":46,"googleAuthor":"","doi":"10.1038/leu.2016.364","elsevierAuthor":"Koeffler H.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"30","altmetricAuthors":["H P Koeffler","G Leong"],"twitterCount":3,"altmetricId":14342811,"statusesArray":["820793997614575617","820339793011699712","804783845048356864"]},{"title":"Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on …","googleId":"Q3b-5sBgr-sJ","googleLink":"https://www.nature.com/articles/leu201733","googleCitationCount":40,"googleAuthor":"AM Zeidan","doi":"10.1038/leu.2017.33","elsevierAuthor":"Zeidan A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"29","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components","googleId":"oOno2Ws9yuIJ","googleLink":"https://www.nature.com/articles/leu201790","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.90","elsevierAuthor":"Pozzo F.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"25","altmetricAuthors":["F Pozzo","T Bittolo","E Vendramini","R Bomben","P Bulian","F M Rossi","A Zucchetto","E Tissino","M Degan","G D’Arena","F Di Raimondo","F Zaja","G Pozzato","D Rossi","G Gaidano","G Del Poeta","V Gattei","M Dal Bo"],"twitterCount":5,"altmetricId":18040954,"statusesArray":["925983469611692032","925975161492393984","846535958090727424","846319716301983745","844953691627020289"]},{"title":"A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26. 13 and 12q23. 1","googleId":"AormZh75kFUJ","googleLink":"https://www.nature.com/articles/leu2016271","googleCitationCount":47,"googleAuthor":"J Vijayakrishnan","doi":"10.1038/leu.2016.271","elsevierAuthor":"Vijayakrishnan J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"41","altmetricAuthors":["J Vijayakrishnan","R Kumar","M Y R Henrion","A V Moorman","P S Rachakonda","I Hosen","M I da Silva Filho","A Holroyd","S E Dobbins","R Koehler","H Thomsen","J A Irving","J M Allan","T Lightfoot","E Roman","S E Kinsey","E Sheridan","P D Thompson","P Hoffmann","M M Nöthen","S Heilmann-Heimbach","K H Jöckel","M Greaves","C J Harrison","C R Bartram","M Schrappe","M Stanulla","K Hemminki","R S Houlston"],"twitterCount":9,"altmetricId":12529437,"statusesArray":["943144457528053761","939796991919390720","798972044759224320","798944558369357824","798865857870864384","798840519849672705","798830580783685632","791779193310674950","791663316334555137","791619980886478848","785410044972105728"]},{"title":"Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)","googleId":"DB473EzXuV8J","googleLink":"https://www.nature.com/articles/leu2016160","googleCitationCount":48,"googleAuthor":"QY Sun","doi":"10.1038/leu.2016.160","elsevierAuthor":"Sun Q.Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"37","altmetricAuthors":["Q-Y Sun","L-W Ding","K-T Tan","W Chien","A Mayakonda","D-C Lin","X-Y Loh","J-F Xiao","M Meggendorfer","T Alpermann","M Garg","S-L Lim","V Madan","N Hattori","Y Nagata","S Miyano","A E J Yeoh","H-A Hou","Y-Y Jiang","S Takao","L-Z Liu","S-Z Tan","M Lill","M Hayashi","A Kinoshita","H M Kantarjian","S M Kornblau","S Ogawa","T Haferlach","H Yang","H P Koeffler"],"twitterCount":5,"altmetricId":8595419,"statusesArray":["816957332131291136","751782210550632448","751724622169509888","740725581193617408","740685013356843008"]},{"title":"Proteomic characterization of human multiple myeloma bone marrow extracellular matrix","googleId":"6hwMtyJtGgcJ","googleLink":"https://www.nature.com/articles/leu2017102","googleCitationCount":37,"googleAuthor":"SV Glavey","doi":"10.1038/leu.2017.102","elsevierAuthor":"Glavey S.V.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"31","altmetricAuthors":["S V Glavey","A Naba","S Manier","K Clauser","S Tahri","J Park","M R Reagan","M Moschetta","Y Mishima","M Gambella","A Rocci","A Sacco","M E O'Dwyer","J M Asara","A Palumbo","A M Roccaro","R O Hynes","I M Ghobrial"],"twitterCount":9,"altmetricId":18455052,"statusesArray":["938383032985190400","938366188643479552","874456496377147392","863305373868060672","862839289025089536","861992800711307264","860820211699769345","855103499142606848","854321116525064196","849963262812844032","849010105286885376","848884041193586689","848862696317571072"]},{"title":"PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia","googleId":"Gb1pLdK55JIJ","googleLink":"https://www.nature.com/articles/leu2016328","googleCitationCount":46,"googleAuthor":"","doi":"10.1038/leu.2016.328","elsevierAuthor":"Goltz D.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"35","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL","googleId":"01hJJDno0m0J","googleLink":"https://www.nature.com/articles/leu2016375","googleCitationCount":45,"googleAuthor":"SK Tasian","doi":"10.1038/leu.2016.375","elsevierAuthor":"Tasian S.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"37","altmetricAuthors":["S K Tasian","C Hurtz","G B Wertheim","N G Bailey","M S Lim","R C Harvey","I-M Chen","C L Willman","R Astles","A Zebrowski","S C Reshmi","M M Li","N V Frey","S M Luger","M Carroll","A E Perl"],"twitterCount":2,"altmetricId":15461320,"statusesArray":["820023463888953348","819988383606964225"]},{"title":"Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma","googleId":"pXqNcceq_A8J","googleLink":"https://www.nature.com/articles/s41375-018-0038-8","googleCitationCount":33,"googleAuthor":"A Krishnan","doi":"10.1038/s41375-018-0038-8","elsevierAuthor":"Krishnan A.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"16","altmetricAuthors":["Amrita Krishnan","Prashant Kapoor","Joycelynne M. Palmer","Ni-Chun Tsai","Shaji Kumar","Sagar Lonial","Myo Htut","Chatchada Karanes","Nitya Nathwani","Michael Rosenzweig","Firoozeh Sahebi","George Somlo","Lupe Duarte","James F. Sanchez","Daniel Auclair","Stephen J. Forman","Jesus G. Berdeja"],"twitterCount":8,"altmetricId":33818209,"statusesArray":["976090101959753728","975869896260235264","975866541412462592","975866500966961153","975849881335205888","970451675726209024","970447413684199424","969233459947495426"]},{"title":"Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time","googleId":"E6rMp9UwK54J","googleLink":"https://www.nature.com/articles/leu2017331","googleCitationCount":32,"googleAuthor":"SK Kumar","doi":"10.1038/leu.2017.331","elsevierAuthor":"Kumar S.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"21","altmetricAuthors":["S K Kumar","A Dispenzieri","R Fraser","F Mingwei","G Akpek","R Cornell","M Kharfan-Dabaja","C Freytes","S Hashmi","G Hildebrandt","L Holmberg","R Kyle","H Lazarus","C Lee","J Mikhael","T Nishihori","J Tay","S Usmani","D Vesole","R Vij","B Wirk","A Krishnan","C Gasparetto","T Mark","Y Nieto","P Hari","A D'Souza"],"twitterCount":25,"altmetricId":29094575,"statusesArray":["949235646400516096","945509275748663296","945494180717125634","945414354719203330","945411426721689600","944969021140688896","944924957414449152","944924873096384513","944920427020931072","944871506550644736","944786340541009920","944767873234472960","944767603406499840","944683190924562432","944655893198667776","944616084107341825","944615572838510598","944588788885524487","944588423003820032","944580304328642560","944575658956640256","944568276251578368","944272064101404672","944271156357582848","944261147095683074","944245152989810688","944223265194741760","931881744705339394","931873778593918977"]},{"title":"Consequences of mutant TET2 on clonality and subclonal hierarchy","googleId":"3Xq9NSgpbUgJ","googleLink":"https://www.nature.com/articles/s41375-018-0150-9","googleCitationCount":24,"googleAuthor":"A Nazha","doi":"10.1038/s41375-018-0150-9","elsevierAuthor":"Hirsch C.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"18","altmetricAuthors":["Cassandra M. Hirsch","Aziz Nazha","Kassy Kneen","Mohamed E. Abazeed","Manja Meggendorfer","Bartlomiej P. Przychodzen","Niroshan Nadarajah","Vera Adema","Yasunobu Nagata","Abhinav Goyal","Hassan Awada","Mohammad Fahad Asad","Valeria Visconte","Yihong Guan","Mikkael A. Sekeres","Ryszard Olinski","Babal Kant Jha","Thomas LaFramboise","Tomas Radivoyevitch","Torsten Haferlach","Jaroslaw P. Maciejewski"],"twitterCount":3,"altmetricId":42934065,"statusesArray":["1001914356177821702","1001592992082219008","1001556563650228224"]},{"title":"A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence","googleId":"wWzJsNohsSMJ","googleLink":"https://www.nature.com/articles/leu2016300","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2016.300","elsevierAuthor":"Chowdhury O.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":["A Tefferi","H K Al-Ali","G Barosi","T Devos","H Gisslinger","Q Jiang","J-J Kiladjian","R Mesa","F Passamonti","V Ribrag","G Schiller","A M Vannucchi","D Zhou","D Reiser","J Zhong","R P Gale"],"twitterCount":12,"altmetricId":12973858,"statusesArray":["842197653161185280","841470520461778944","840994736357924866","840588728548614144","840576169003081729","830049712149504000","829764411837513728","829740328815058945","829715996105703425","829715632023334912","792414531792277504","790720504952786945"]},{"title":"A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with⩽ 30% blasts","googleId":"l1PTZ61EgAMJ","googleLink":"https://www.nature.com/articles/leu2017159","googleCitationCount":36,"googleAuthor":"G Garcia-Manero","doi":"10.1038/leu.2017.159","elsevierAuthor":"Garcia-Manero G.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"29","altmetricAuthors":["G Garcia-Manero","M A Sekeres","M Egyed","M Breccia","C Graux","J D Cavenagh","H Salman","A Illes","P Fenaux","D J DeAngelo","R Stauder","K Yee","N Zhu","J-H Lee","D Valcarcel","A MacWhannell","Z Borbenyi","L Gazi","S Acharyya","S Ide","M Marker","O G Ottmann"],"twitterCount":2,"altmetricId":20857062,"statusesArray":["873351716338642945","872268576186654720","872137886937874432"]},{"title":"Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease","googleId":"0TlQkZCkXZsJ","googleLink":"https://www.nature.com/articles/s41375-018-0151-8","googleCitationCount":30,"googleAuthor":"","doi":"10.1038/s41375-018-0151-8","elsevierAuthor":"Kim Y.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"25","altmetricAuthors":["YongHwan Kim","Hye Jin Jin","Jinbeom Heo","Hyein Ju","Hye-Yeon Lee","Sujin Kim","Seungun Lee","Jisun Lim","Sang Young Jeong","JiHye Kwon","Miyeon Kim","Soo Jin Choi","Wonil Oh","Yoon Sun Yang","Hyun Ho Hwang","Hwan Yeul Yu","Chae-Min Ryu","Hong Bae Jeon","Dong-Myung Shin"],"twitterCount":9,"altmetricId":42483866,"statusesArray":["1139642874243538945","1139551332996567040","1000855445047840768","1000796591056449537","1000766984894730241","1000762331029299200","1000055052051009537","999681643349622787","999608926898307072"]},{"title":"GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML","googleId":"MwR0L2syRmMJ","googleLink":"https://www.nature.com/articles/s41375-018-0134-9","googleCitationCount":27,"googleAuthor":"AF Al Seraihi","doi":"10.1038/s41375-018-0134-9","elsevierAuthor":"Al Seraihi A.F.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"21","altmetricAuthors":["Ahad F. Al Seraihi","Ana Rio-Machin","Kiran Tawana","Csaba Bödör","Jun Wang","Ai Nagano","James A. Heward","Sameena Iqbal","Steven Best","Nicholas Lea","Donal McLornan","Emilia J. Kozyra","Marcin W. Wlodarski","Charlotte M. Niemeyer","Hamish Scott","Chris Hahn","Alicia Ellison","Hemanth Tummala","Shirleny Romualdo Cardoso","Tom Vulliamy","Inderjeet Dokal","Tom Butler","Matthew Smith","Jamie Cavenagh","Jude Fitzgibbon"],"twitterCount":5,"altmetricId":41151366,"statusesArray":["1216794595847262208","1008982936492957696","1008815208872267776","1008809278206038018","995275031423971328"]},{"title":"The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia","googleId":"7c0NOG-XeesJ","googleLink":"https://www.nature.com/articles/leu201786","googleCitationCount":35,"googleAuthor":"K Mrózek","doi":"10.1038/leu.2017.86","elsevierAuthor":"Eisfeld A.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"26","altmetricAuthors":["A-K Eisfeld","K Mrózek","J Kohlschmidt","D Nicolet","S Orwick","C J Walker","K W Kroll","J S Blachly","A J Carroll","J E Kolitz","B L Powell","E S Wang","R M Stone","A de la Chapelle","J C Byrd","C D Bloomfield"],"twitterCount":1,"altmetricId":17857279,"statusesArray":["844915494041911296"]},{"title":"Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials","googleId":"HG8In44iGiYJ","googleLink":"https://www.nature.com/articles/s41375-018-0163-4","googleCitationCount":23,"googleAuthor":"A Richter","doi":"10.1038/s41375-018-0163-4","elsevierAuthor":"Heaney J.L.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"13","altmetricAuthors":["Jennifer L. J. Heaney","John P. Campbell","Gulnaz Iqbal","David Cairns","Alex Richter","J. Anthony Child","Walter Gregory","Graham Jackson","Martin Kaiser","Roger Owen","Faith Davies","Gareth Morgan","Janet Dunn","Mark T. Drayson"],"twitterCount":9,"altmetricId":44114653,"statusesArray":["1093573646252093440","1093565100789764096","1046837151093014529","1014055502043639808","1013969585614319616","1013841803412410368","1013839980358090752","1013829659115573248","1011269571209236481","1011224095164379137"]},{"title":"Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT …","googleId":"idgsXTWlQ1oJ","googleLink":"https://www.nature.com/articles/leu2016382","googleCitationCount":43,"googleAuthor":"VM Patel","doi":"10.1038/leu.2016.382","elsevierAuthor":"Patel V.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"37","altmetricAuthors":["V M Patel","K Balakrishnan","M Douglas","T Tibbitts","E Y Xu","J L Kutok","M Ayers","A Sarkar","R Guerrieri","W G Wierda","S O'Brien","N Jain","H M Stern","V Gandhi"],"twitterCount":9,"altmetricId":15576887,"statusesArray":["829345900183044099","829297944104931329","829294595242602497","829293794789036032","829291940290056192","822036233173860352","821956538541686784","821905017095548932","821903481011249152"]},{"title":"Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio","googleId":"T21e9BDKrN4J","googleLink":"https://www.nature.com/articles/leu2016183","googleCitationCount":45,"googleAuthor":"J Versluis","doi":"10.1038/leu.2016.183","elsevierAuthor":"Versluis J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"35","altmetricAuthors":["J Versluis","F E M in ‘t Hout","R Devillier","W L J van Putten","M G Manz","M -C Vekemans","M -C Legdeur","J R Passweg","J Maertens","J Kuball","B J Biemond","P J M Valk","B A van der Reijden","G Meloni","H C Schouten","E Vellenga","T Pabst","R Willemze","B Löwenberg","G Ossenkoppele","F Baron","G Huls","J J Cornelissen"],"twitterCount":5,"altmetricId":9049324,"statusesArray":["877899439012159488","793562063520104448","754427673846308864","747040494434168832","747034205771661312"]},{"title":"Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 …","googleId":"V1FeboTSKgwJ","googleLink":"https://www.nature.com/articles/leu2017230","googleCitationCount":34,"googleAuthor":"","doi":"10.1038/leu.2017.230","elsevierAuthor":"Kubesova B.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"21","altmetricAuthors":["B Kubesova","S Pavlova","J Malcikova","J Kabathova","L Radova","N Tom","B Tichy","K Plevova","B Kantorova","K Fiedorova","M Slavikova","V Bystry","J Kissova","B Gisslinger","H Gisslinger","M Penka","J Mayer","R Kralovics","S Pospisilova","M Doubek"],"twitterCount":6,"altmetricId":24506136,"statusesArray":["1222491660631846914","1222212588261396480","1222166065351995392","1222165114666663936","1222129958312648705","1221997328602746880"]},{"title":"TanCAR T cells targeting CD19 and CD133 efficiently eliminate MLL leukemic cells","googleId":"Mopzuds15NEJ","googleLink":"https://www.nature.com/articles/s41375-018-0212-z","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-018-0212-z","elsevierAuthor":"Li D.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"20","altmetricAuthors":["Dan Li","Yutian Hu","Zhen Jin","You Zhai","Yuting Tan","Yan Sun","Shouhai Zhu","Chunjun Zhao","Bing Chen","Jiang Zhu","Zhu Chen","Saijuan Chen","Junmin Li","Han Liu"],"twitterCount":1,"altmetricId":46123863,"statusesArray":["1026471359633940480"]},{"title":"Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia","googleId":"aeb3ElAqvBkJ","googleLink":"https://www.nature.com/articles/leu201710","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2017.10","elsevierAuthor":"Ruefli-Brasse A.","publicationName":"Biochemical Journal","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"35","altmetricAuthors":["S Peirs","V Frismantas","F Matthijssens","W Van Loocke","T Pieters","N Vandamme","B Lintermans","M P Dobay","G Berx","B Poppe","S Goossens","B C Bornhauser","J-P Bourquin","P Van Vlierberghe"],"twitterCount":9,"altmetricId":15381147,"statusesArray":["829961394124644353","829945993751838720","829784074474622977","829752005518295040","829706041600385026","829697866352373760","819493013663707136","819263177460486147","819105809271558144"]},{"title":"Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis","googleId":"VSs1oR_ebQcJ","googleLink":"https://www.nature.com/articles/leu2016381","googleCitationCount":44,"googleAuthor":"V Montefusco","doi":"10.1038/leu.2016.381","elsevierAuthor":"Gay F.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"30","altmetricAuthors":["F Gay","S Oliva","M T Petrucci","V Montefusco","C Conticello","P Musto","L Catalano","A Evangelista","S Spada","P Campbell","R Ria","M Salvini","M Offidani","A M Carella","P Omedé","A M Liberati","R Troia","A M Cafro","A Malfitano","A P Falcone","T Caravita","F Patriarca","A Nagler","A Spencer","R Hajek","A Palumbo","M Boccadoro"],"twitterCount":10,"altmetricId":15100886,"statusesArray":["900668392373460992","892853924939444224","827696214703558660","817600729892339713","817416900951048193","817415835505618944","817404659967164418","817379080047919106","817375173493960709","813778462632775680"]},{"title":"HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma","googleId":"dTf635YU9GsJ","googleLink":"https://www.nature.com/articles/leu2017299","googleCitationCount":30,"googleAuthor":"WG Wang","doi":"10.1038/leu.2017.299","elsevierAuthor":"Jia Y.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"24","altmetricAuthors":["Y J Jia","Z B Liu","W G Wang","C B Sun","P Wei","Y L Yang","M J You","B H Yu","X Q Li","X Y Zhou"],"twitterCount":4,"altmetricId":28949002,"statusesArray":["930835150623064064","930834919474868224","930798312340389890","930754289827381249"]},{"title":"Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells","googleId":"0Ov9Luswc3sJ","googleLink":"https://www.nature.com/articles/leu2017133","googleCitationCount":35,"googleAuthor":"MK Hasan","doi":"10.1038/leu.2017.133","elsevierAuthor":"Caras I.W.","publicationName":"Stem Cells Translational Medicine","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0","altmetricAuthors":["M K Hasan","J Yu","L Chen","Bing Cui","G F Widhopf II","L Rassenti","Z Shen","S P Briggs","T J Kipps"],"twitterCount":4,"altmetricId":20087431,"statusesArray":["942731360417882112","941993822673887233","863370790540120064","863174553136234496"]},{"title":"Decreased spermatogonial quantity in prepubertal boys with leukaemia treated with alkylating agents","googleId":"gf7fdJYQS_MJ","googleLink":"https://www.nature.com/articles/leu201776","googleCitationCount":37,"googleAuthor":"I Masliukaite","doi":"10.1038/leu.2017.76","elsevierAuthor":"Poganitsch-Korhonen M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"24","altmetricAuthors":["M Poganitsch-Korhonen","I Masliukaite","M Nurmio","P Lähteenmäki","M van Wely","A M M van Pelt","K Jahnukainen","J-B Stukenborg"],"twitterCount":1,"altmetricId":17187379,"statusesArray":["840101073700319232"]},{"title":"Ninety-minute daratumumab infusion is safe in multiple myeloma","googleId":"Rkl2lSJnIlgJ","googleLink":"https://www.nature.com/articles/s41375-018-0120-2","googleCitationCount":31,"googleAuthor":"","doi":"10.1038/s41375-018-0120-2","elsevierAuthor":"Barr H.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"24","altmetricAuthors":["Hallie Barr","Jessica Dempsey","Allyson Waller","Ying Huang","Nita Williams","Nidhi Sharma","Don M. Benson","Ashley E. Rosko","Yvonne A. Efebera","Craig C. Hofmeister"],"twitterCount":18,"altmetricId":35058248,"statusesArray":["989873571768958976","988732283808092160","988660180266106881","988556393400754177","988532826176917504","988486995910582272","988481851059826689","988474609514287104","988364576273006594","988302854380249088","988268444331200513","988189446486061056","988163666460794880","988163572210569217","988163017668988928","988086499227811842","988085431563575296","980008118078844929"]},{"title":"C/EBPα deregulation as a paradigm for leukemogenesis","googleId":"PByNMbGKL_sJ","googleLink":"https://www.nature.com/articles/leu2017229","googleCitationCount":32,"googleAuthor":"JA Pulikkan","doi":"10.1038/leu.2017.229","elsevierAuthor":"Pulikkan J.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"23","altmetricAuthors":["J A Pulikkan","D G Tenen","G Behre"],"twitterCount":3,"altmetricId":23289606,"statusesArray":["901784560077119491","892023587275776000","891798088058376192"]},{"title":"Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells","googleId":"mXwjI0Fm-t8J","googleLink":"https://www.nature.com/articles/s41375-018-0122-0","googleCitationCount":22,"googleAuthor":"K Bujko","doi":"10.1038/s41375-018-0122-0","elsevierAuthor":"Adamiak M.","publicationName":"Leukemia","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"1 April 2019","elsevierCitationCount":"0","altmetricAuthors":["Mateusz Adamiak","Kamila Bujko","Monika Cymer","Monika Plonka","Talita Glaser","Magda Kucia","Janina Ratajczak","Henning Ulrich","Ahmed Abdel-Latif","Mariusz Z. Ratajczak"],"twitterCount":4,"altmetricId":40824338,"statusesArray":["993915914373423104","993863101463367681","993754728147320833","993584753902174208"]},{"title":"Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion","googleId":"l_2AShPQpaAJ","googleLink":"https://www.nature.com/articles/s41375-018-0131-z","googleCitationCount":23,"googleAuthor":"","doi":"10.1038/s41375-018-0131-z","elsevierAuthor":"Heaton W.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"21","altmetricAuthors":["William L. Heaton","Anna V. Senina","Anthony D. Pomicter","Mohamed E. Salama","Phillip M. Clair","Dongqing Yan","Russell N. Bell","Jeremy M. Gililland","Josef T. Prchal","Thomas O’Hare","Michael W. Deininger"],"twitterCount":1,"altmetricId":40823307,"statusesArray":["993572153181294597"]},{"title":"Novel targets in the treatment of chronic graft-versus-host disease","googleId":"0ye7l4JUSVsJ","googleLink":"https://www.nature.com/articles/leu2016367","googleCitationCount":42,"googleAuthor":"","doi":"10.1038/leu.2016.367","elsevierAuthor":"Im A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"32","altmetricAuthors":["A Im","F T Hakim","S Z Pavletic"],"twitterCount":5,"altmetricId":14756810,"statusesArray":["849032827953917954","828303345030828033","828286645753544705","828258636069732352","828228406017941504","809245047182852096","809228698880708608"]},{"title":"Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD","googleId":"YHI7O9PMeUMJ","googleLink":"https://www.nature.com/articles/leu201780","googleCitationCount":34,"googleAuthor":"Q Zhang","doi":"10.1038/leu.2017.80","elsevierAuthor":"Yuan T.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"26","altmetricAuthors":["T Yuan","Y Yang","J Chen","W Li","W Li","Q Zhang","Y Mi","R S Goswami","J Q You","D Lin","M D Qian","S Calin","Y Liang","R N Miranda","G A Calin","X Zhou","L Ma","P A Zweidler-McKay","B Liu","A P Weng","L J Medeiros","Y Zhang","M J You"],"twitterCount":1,"altmetricId":17824053,"statusesArray":["843703781959327744"]},{"title":"Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes","googleId":"xBZTodsgvTkJ","googleLink":"https://www.nature.com/articles/leu2017266","googleCitationCount":31,"googleAuthor":"A Nazha","doi":"10.1038/leu.2017.266","elsevierAuthor":"Nazha A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"26","altmetricAuthors":["A Nazha","K Al-Issa","B K Hamilton","T Radivoyevitch","A T Gerds","S Mukherjee","V Adema","A Zarzour","N Abuhadra","B J Patel","C M Hirsch","A Advani","B Przychodzen","H E Carraway","J P Maciejewski","M A Sekeres"],"twitterCount":6,"altmetricId":24021024,"statusesArray":["1056122013918605312","1056121018794868736","939159891385733120","902518593602117633","902517987571322882","898849806939955205","898689406504099844"]},{"title":"RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma","googleId":"F_mFY61she4J","googleLink":"https://www.nature.com/articles/leu201754","googleCitationCount":34,"googleAuthor":"YL Lin","doi":"10.1038/leu.2017.54","elsevierAuthor":"Viziteu E.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"26","altmetricAuthors":["E Viziteu","B Klein","J Basbous","Y-L Lin","C Hirtz","C Gourzones","L Tiers","A Bruyer","L Vincent","C Grandmougin","A Seckinger","H Goldschmidt","A Constantinou","P Pasero","D Hose","J Moreaux"],"twitterCount":2,"altmetricId":16348576,"statusesArray":["837581388899561472","831504522153320449","830900890857009154"]},{"title":"Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: A Phase IIa Study","googleId":"1vPl6E1br_wJ","googleLink":"https://www.nature.com/articles/leu20175","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2017.5","elsevierAuthor":"Ludwig H.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"39","altmetricAuthors":["H Ludwig","K Weisel","M T Petrucci","X Leleu","A M Cafro","L Garderet","C Leitgeb","R Foa","R Greil","I Yakoub-Agha","D Zboralski","S Vauléon","T Dümmler","D Beyer","A Kruschinski","K Riecke","M Baumann","M Engelhardt"],"twitterCount":4,"altmetricId":16172518,"statusesArray":["830025020458012673","828634726705590274","828616596323172354","828605421724254208"]},{"title":"Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503 …","googleId":"fANCLm6Ul2wJ","googleLink":"https://www.nature.com/articles/leu2016252","googleCitationCount":42,"googleAuthor":"G Uy","doi":"10.1038/leu.2016.252","elsevierAuthor":"Blum W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"36","altmetricAuthors":["W Blum","B L Sanford","R Klisovic","D J DeAngelo","G Uy","B L Powell","W Stock","M R Baer","J E Kolitz","E S Wang","E Hoke","K Mrózek","J Kohlschmidt","C D Bloomfield","S Geyer","G Marcucci","R M Stone","R A Larson"],"twitterCount":27,"altmetricId":11983900,"statusesArray":["787711345311514624","787455990925037568","787410398953734144","787404453435416576","787325294919180288","787244628210753536","787089572828024834","787078575291768832","787046294741192704","787012235239366656","786990341287137280","786931815781113856","786928746200641536","786927572399644672","786917260816478210","786826912651939841","786789859780288512","786788408664334340","786745104392335360","786744190197727232","786743477614747648","786742530952065024","786741684243750912","786741323193847808","786618833599623170","775878985095884800","775859581293588480","775855233725530112","775848260330074112"]},{"title":"Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations","googleId":"cyD_5jBTsqoJ","googleLink":"https://www.nature.com/articles/leu2016283","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2016.283","elsevierAuthor":"Marchetti M.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"28","altmetricAuthors":["M Marchetti","G Barosi","F Cervantes","G Birgegård","M Griesshammer","C Harrison","R Hehlmann","J-J Kiladjian","N Kröger","M F McMullin","F Passamonti","A Vannucchi","T Barbui"],"twitterCount":10,"altmetricId":12736242,"statusesArray":["855817818562080769","854992560913342464","802109480741781504","801807662069534720","801778802296848384","801777395036463104","801768079352938496","788613534875807744","788602287539232768","788563406085251072","788470783681163264"]},{"title":"APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL","googleId":"wNe6yIlrD7oJ","googleLink":"https://www.nature.com/articles/leu201775","googleCitationCount":35,"googleAuthor":"Z Li","doi":"10.1038/leu.2017.75","elsevierAuthor":"Li Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"27","altmetricAuthors":["Z Li","B J Abraham","A Berezovskaya","N Farah","Y Liu","T Leon","A Fielding","S H Tan","T Sanda","A S Weintraub","B Li","S Shen","J Zhang","M R Mansour","R A Young","A T Look"],"twitterCount":15,"altmetricId":17084706,"statusesArray":["898148908676898817","864570338776150016","850429021850611713","847895089619795968","841401113987420162","841377248389283840","841376291723051012","840700610005651456","840609304549838848","840549251671310337","840548156173611008","839501743398535173","839372167615770625","839305308216291329","839231401501282304","839221283594321921","839166631888764928","839161445367574528","839160761041764352"]},{"title":"NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis","googleId":"qYvv4k1MXi4J","googleLink":"https://www.nature.com/articles/leu2016267","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2016.267","elsevierAuthor":"Struski S.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"33","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma","googleId":"buc92JKwa9cJ","googleLink":"https://www.nature.com/articles/leu2017197","googleCitationCount":31,"googleAuthor":"A Laganà","doi":"10.1038/leu.2017.197","elsevierAuthor":"Laganà A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"20","altmetricAuthors":["A Laganà","D Perumal","D Melnekoff","B Readhead","B A Kidd","V Leshchenko","P-Y Kuo","J Keats","M DeRome","J Yesil","D Auclair","S Lonial","A Chari","H J Cho","B Barlogie","S Jagannath","J T Dudley","S Parekh"],"twitterCount":21,"altmetricId":21320291,"statusesArray":["917424540992659456","917419774128291840","890938747621179392","883001101305483265","880267348854353921","880245489995829248","880236040782479360","880226939591675905","880226618953826308","879562895184539648","879546758375903232","879501506218799104","879500857770999808","879433620469035008","879382471686709248","879342722485768194","879323360529981442","878701789956145152","878697685133516800","878694878028419072","878690877002199043","878576827513556997","878556575350235136"]},{"title":"Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells","googleId":"yUwguSxkF8UJ","googleLink":"https://www.nature.com/articles/leu2016349","googleCitationCount":43,"googleAuthor":"F Yan","doi":"10.1038/leu.2016.349","elsevierAuthor":"Yan F.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"37","altmetricAuthors":["F Yan","N Shen","J X Pang","Y W Zhang","E Y Rao","A M Bode","A Al-Kali","D E Zhang","M R Litzow","B Li","S J Liu"],"twitterCount":2,"altmetricId":14190770,"statusesArray":["1353357479409815557","804034257966473217"]},{"title":"Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell …","googleId":"LZYCgl4YwmoJ","googleLink":"https://www.nature.com/articles/s41375-017-0004-x","googleCitationCount":24,"googleAuthor":"ZM Li","doi":"10.1038/s41375-017-0004-x","elsevierAuthor":"Nairismägi M.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"20","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia","googleId":"TCdgIx3uGqAJ","googleLink":"https://www.nature.com/articles/leu2016365","googleCitationCount":41,"googleAuthor":"C Frech","doi":"10.1038/leu.2016.365","elsevierAuthor":"Vesely C.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"30","altmetricAuthors":["C Vesely","C Frech","C Eckert","G Cario","A Mecklenbräuker","U zur Stadt","K Nebral","F Kraler","S Fischer","A Attarbaschi","M Schuster","C Bock","H Cavé","A von Stackelberg","M Schrappe","M A Horstmann","G Mann","O A Haas","R Panzer-Grümayer"],"twitterCount":1,"altmetricId":20846441,"statusesArray":["882726028153696260"]},{"title":"The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation","googleId":"KLlAG4TrvewJ","googleLink":"https://www.nature.com/articles/leu201770","googleCitationCount":31,"googleAuthor":"F Li","doi":"10.1038/leu.2017.70","elsevierAuthor":"Ha V.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"17","altmetricAuthors":["V L Ha","A Luong","F Li","D Casero","J Malvar","Y M Kim","R Bhatia","G M Crooks","C Parekh"],"twitterCount":2,"altmetricId":16901865,"statusesArray":["837283243254820865","837012127642693633"]},{"title":"A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia","googleId":"V4E-Wh-uLZcJ","googleLink":"https://www.nature.com/articles/leu2017186","googleCitationCount":32,"googleAuthor":"M Lunghi","doi":"10.1038/leu.2017.186","elsevierAuthor":"Santini V.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"20","altmetricAuthors":["V Santini","B Allione","G Zini","D Gioia","M Lunghi","A Poloni","D Cilloni","A Sanna","E Masiera","M Ceccarelli","O Abdel-Wahab","A Terenzi","E Angelucci","C Finelli","F Onida","A Pelizzari","D Ferrero","G Saglio","M Figueroa","A Levis"],"twitterCount":1,"altmetricId":23351607,"statusesArray":["895503046767194112"]},{"title":"Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration","googleId":"rHuOyzFFTUkJ","googleLink":"https://www.nature.com/articles/s41375-018-0012-5","googleCitationCount":24,"googleAuthor":"N Eissa","doi":"10.1038/s41375-018-0012-5","elsevierAuthor":"Ali A.Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"17","altmetricAuthors":["Ahmed Y. Ali","Xun Wu","Nour Eissa","Sen Hou","Jean-Eric Ghia","Thomas T. Murooka","Versha Banerji","James B. Johnston","Francis Lin","Spencer B. Gibson","Aaron J. Marshall"],"twitterCount":5,"altmetricId":32791709,"statusesArray":["1091710231799828480","961782784783241218","961359998302306304","961305915176767489","961260722394161152"]},{"title":"Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes","googleId":"0Euk653ZsCgJ","googleLink":"https://www.nature.com/articles/leu2017196","googleCitationCount":30,"googleAuthor":"P Venugopal","doi":"10.1038/leu.2017.196","elsevierAuthor":"Chong C.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"24","altmetricAuthors":["C-E Chong","P Venugopal","P H Stokes","Y K Lee","P J Brautigan","D T O Yeung","M Babic","G A Engler","S W Lane","M Klingler-Hoffmann","J M Matthews","R J D'Andrea","A L Brown","C N Hahn","H S Scott"],"twitterCount":5,"altmetricId":21320619,"statusesArray":["930682986038775808","930676660873113601","883137480941199360","880162277206499328","878560225476857856"]},{"title":"Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia","googleId":"-lia0OLjLzgJ","googleLink":"https://www.nature.com/articles/leu2017171","googleCitationCount":31,"googleAuthor":"M Mingay","doi":"10.1038/leu.2017.171","elsevierAuthor":"Mingay M.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"25","altmetricAuthors":["M Mingay","A Chaturvedi","M Bilenky","Q Cao","L Jackson","T Hui","M Moksa","A Heravi-Moussavi","R K Humphries","M Heuser","M Hirst"],"twitterCount":12,"altmetricId":20781639,"statusesArray":["898692714568536064","886344307401256960","886268847463948289","885944218551595008","885873553962188802","885757447629029376","884544997583867905","881118323638812672","870776771632918529","870709156063227905","870709150921105408","870704120033705984","870704044578267136","870703631909011457"]},{"title":"Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response","googleId":"l_9Pqrt2g9YJ","googleLink":"https://www.nature.com/articles/leu2017130","googleCitationCount":31,"googleAuthor":"","doi":"10.1038/leu.2017.130","elsevierAuthor":"Long J.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"24","altmetricAuthors":["J Long","W Y Fang","L Chang","W H Gao","Y Shen","M Y Jia","Y X Zhang","Y Wang","H B Dou","W J Zhang","J Zhu","A B Liang","J M Li","Jiong Hu"],"twitterCount":3,"altmetricId":19851239,"statusesArray":["941991320683286529","938512360284844032","938511787670024194","860135483300433921"]},{"title":"Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia","googleId":"U-JbLbTzVmYJ","googleLink":"https://www.nature.com/articles/s41375-018-0097-x","googleCitationCount":29,"googleAuthor":"MA Burns","doi":"10.1038/s41375-018-0097-x","elsevierAuthor":"Burns M.A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"23","altmetricAuthors":["Melissa A. Burns","Zi Wei Liao","Natsuko Yamagata","Gayle P. Pouliot","Kristen E. Stevenson","Donna S. Neuberg","Aaron R. Thorner","Matthew Ducar","Emily A. Silverman","Stephen P. Hunger","Mignon L. Loh","Stuart S. Winter","Kimberly P. Dunsmore","Brent Wood","Meenakshi Devidas","Marian H. Harris","Lewis B. Silverman","Stephen E. Sallan","Alejandro Gutierrez"],"twitterCount":3,"altmetricId":37386799,"statusesArray":["985646815990104064","985491041582104577","985464515004317696"]},{"title":"Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis","googleId":"_7zT0YOmDFEJ","googleLink":"https://www.nature.com/articles/leu2016345","googleCitationCount":39,"googleAuthor":"R Gabdoulline","doi":"10.1038/leu.2016.345","elsevierAuthor":"Thol F.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"31","altmetricAuthors":["F Thol","S Klesse","L Köhler","R Gabdoulline","A Kloos","A Liebich","M Wichmann","A Chaturvedi","J Fabisch","V I Gaidzik","P Paschka","L Bullinger","G Bug","H Serve","G Göhring","B Schlegelberger","M Lübbert","H Kirchner","M Wattad","D Kraemer","B Hertenstein","G Heil","W Fiedler","J Krauter","R F Schlenk","K Döhner","H Döhner","A Ganser","M Heuser"],"twitterCount":1,"altmetricId":14051891,"statusesArray":["802156404681228289"]},{"title":"RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia","googleId":"O12VQffCL2wJ","googleLink":"https://www.nature.com/articles/s41375-018-0102-4","googleCitationCount":21,"googleAuthor":"S Rudat","doi":"10.1038/s41375-018-0102-4","elsevierAuthor":"Rudat S.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"16","altmetricAuthors":["S. Rudat","A. Pfaus","Y. Y. Cheng","J. Holtmann","J. M. Ellegast","C. Bühler","D. Di Marcantonio","E. Martinez","S. Göllner","C. Wickenhauser","C. Müller-Tidow","C. Lutz","L. Bullinger","M. D. Milsom","S. M. Sykes","S. Fröhling","C. Scholl"],"twitterCount":5,"altmetricId":37394588,"statusesArray":["1300397803286540290","985874596271415296","985874429233152000","985548414891905024","985476598206906370"]},{"title":"Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms","googleId":"5Ww4ACGwCfsJ","googleLink":"https://www.nature.com/articles/s41375-018-0294-7","googleCitationCount":20,"googleAuthor":"K Bujko","doi":"10.1038/s41375-018-0294-7","elsevierAuthor":"Ratajczak M.Z.","publicationName":"Leukemia","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"1 April 2019","elsevierCitationCount":"0","altmetricAuthors":["Mariusz Z. Ratajczak","Kamila Bujko","Aaron Mack","Magda Kucia","Janina Ratajczak"],"twitterCount":7,"altmetricId":50487321,"statusesArray":["1073436236323393536","1062807750684672000","1059307049060851712","1059294659380359168","1059180339002781698","1059108024588079105","1057595053890187265"]},{"title":"Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma","googleId":"hxeZ-QfFlb0J","googleLink":"https://www.nature.com/articles/leu2016325","googleCitationCount":38,"googleAuthor":"","doi":"10.1038/leu.2016.325","elsevierAuthor":"Qin Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"36","altmetricAuthors":["Y Qin","S Zhang","S Deng","G An","X Qin","F Li","Y Xu","M Hao","Y Yang","W Zhou","H Chang","L Qiu"],"twitterCount":9,"altmetricId":15390214,"statusesArray":["822090328819822592","822084956218335232","819307220282277889","819279993129799681","819255067543040000","819227631765757952","819217251488276481","819212472473317378","819212021359001600"]},{"title":"Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis","googleId":"kGgBBjzqZ58J","googleLink":"https://www.nature.com/articles/leu201761","googleCitationCount":32,"googleAuthor":"JA Cutler","doi":"10.1038/leu.2017.61","elsevierAuthor":"Cutler J.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"23","altmetricAuthors":["J A Cutler","R Tahir","S K Sreenivasamurthy","C Mitchell","S Renuse","R S Nirujogi","A H Patil","M Heydarian","X Wong","X Wu","T-C Huang","M-S Kim","K L Reddy","A Pandey"],"twitterCount":0,"altmetricId":21398493,"statusesArray":[]},{"title":"Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling","googleId":"UFd6elPHV0EJ","googleLink":"https://www.nature.com/articles/leu201748","googleCitationCount":33,"googleAuthor":"M Wang","doi":"10.1038/leu.2017.48","elsevierAuthor":"Wang M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"26","altmetricAuthors":["M Wang","J Lindberg","D Klevebring","C Nilsson","A S Mer","M Rantalainen","S Lehmann","H Grönberg"],"twitterCount":3,"altmetricId":16265187,"statusesArray":["1092548190434250752","853053654504525824","829722068128198657"]},{"title":"Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International …","googleId":"pFeMgYawOJ4J","googleLink":"https://www.nature.com/articles/leu201788","googleCitationCount":32,"googleAuthor":"MG Della Porta","doi":"10.1038/leu.2017.88","elsevierAuthor":"Della Porta M.G.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"19","altmetricAuthors":["M G Della Porta","C H Jackson","E P Alessandrino","M Rossi","A Bacigalupo","M T van Lint","M Bernardi","B Allione","A Bosi","S Guidi","V Santini","L Malcovati","M Ubezio","C Milanesi","E Todisco","M T Voso","P Musto","F Onida","A P Iori","R Cerretti","G Grillo","A Molteni","P Pioltelli","L Borin","E Angelucci","E Oldani","S Sica","C Pascutto","V Ferretti","A Santoro","F Bonifazi","M Cazzola","A Rambaldi"],"twitterCount":12,"altmetricId":18694868,"statusesArray":["950669509840527360","950619855182553088","950598169842323456","950580797693669376","933592755447713793","932694170522865664","932678165071319040","930402833307877387","855393294959992832","855161727801073664","855105558227161090","855105060866600960","851378534476115968"]},{"title":"Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression","googleId":"brxdkDjOQN8J","googleLink":"https://www.nature.com/articles/leu2016205","googleCitationCount":40,"googleAuthor":"WI Gonsalves","doi":"10.1038/leu.2016.205","elsevierAuthor":"Gonsalves W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"29","altmetricAuthors":["W I Gonsalves","S V Rajkumar","A Dispenzieri","D Dingli","M M Timm","W G Morice","M Q Lacy","F K Buadi","R S Go","N Leung","P Kapoor","S R Hayman","J A Lust","S J Russell","S R Zeldenrust","L Hwa","T V Kourelis","R A Kyle","M A Gertz","S K Kumar"],"twitterCount":1,"altmetricId":10093258,"statusesArray":["758648996055298048"]},{"title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","googleId":"UeNkR69nxEoJ","googleLink":"https://www.nature.com/articles/s41375-018-0082-4","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/s41375-018-0082-4","elsevierAuthor":"Pillonel V.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"19","altmetricAuthors":["V. Pillonel","D. Juskevicius","C. K. Y. Ng","A. Bodmer","A. Zettl","D. Jucker","S. Dirnhofer","A. Tzankov"],"twitterCount":2,"altmetricId":33789631,"statusesArray":["1067960291135234049","1061365493968371712","969005094879551488"]},{"title":"The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment","googleId":"ZA-mzV7gVf4J","googleLink":"https://www.nature.com/articles/leu2016179","googleCitationCount":41,"googleAuthor":"LN Eadie","doi":"10.1038/leu.2016.179","elsevierAuthor":"Eadie L.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"29","altmetricAuthors":["L N Eadie","P Dang","V A Saunders","D T Yeung","M P Osborn","A P Grigg","T P Hughes","D L White"],"twitterCount":1,"altmetricId":9737418,"statusesArray":["758551994097205248"]},{"title":"Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis","googleId":"n_W6PE9QUlIJ","googleLink":"https://www.nature.com/articles/leu2016229","googleCitationCount":39,"googleAuthor":"","doi":"10.1038/leu.2016.229","elsevierAuthor":"Landau H.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"38","altmetricAuthors":["H Landau","M Smith","C Landry","J F Chou","S M Devlin","H Hassoun","C Bello","S Giralt","R L Comenzo"],"twitterCount":12,"altmetricId":10709706,"statusesArray":["778855067508154368","778832725281218560","769931533650161664","769927261927514112","769120382544547840","767162416908165120","767045671262228481","766947524531916800","766838922848641024","766835253897945088","766794228957585408","766792734015361025"]},{"title":"A predictive model for risk of early grade≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial","googleId":"uqh2zPaCt-MJ","googleLink":"https://www.nature.com/articles/s41375-018-0133-x","googleCitationCount":21,"googleAuthor":"MA Dimopoulos","doi":"10.1038/s41375-018-0133-x","elsevierAuthor":"Dumontet C.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"13","altmetricAuthors":["Charles Dumontet","Cyrille Hulin","Meletios A. Dimopoulos","Andrew Belch","Angela Dispenzieri","Heinz Ludwig","Philippe Rodon","Jan Van Droogenbroeck","Lugui Qiu","Michele Cavo","Ann Van de Velde","Juan José Lahuerta","Olivier Allangba","Jae Hoon Lee","Eileen Boyle","Aurore Perrot","Philippe Moreau","Salomon Manier","Michel Attal","Murielle Roussel","Mohamad Mohty","Jean Yves Mary","Alexandre Civet","Bruno Costa","Antoine Tinel","Yann Gaston-Mathé","Thierry Facon"],"twitterCount":3,"altmetricId":42490227,"statusesArray":["1019205076253052928","1000356828449050625","999639506730061824"]},{"title":"Health-related quality of life in lower-risk MDS patients compared with age-and sex-matched reference populations: a European LeukemiaNet study","googleId":"MsO-TCqsSpQJ","googleLink":"https://www.nature.com/articles/s41375-018-0089-x","googleCitationCount":24,"googleAuthor":"G Yu","doi":"10.1038/s41375-018-0089-x","elsevierAuthor":"Stauder R.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"21","altmetricAuthors":["Reinhard Stauder","Ge Yu","Karin A. Koinig","Tim Bagguley","Pierre Fenaux","Argiris Symeonidis","Guillermo Sanz","Jaroslav Cermak","Moshe Mittelman","Eva Hellström-Lindberg","Saskia Langemeijer","Mette Skov Holm","Krzysztof Mądry","Luca Malcovati","Aurelia Tatic","Ulrich Germing","Aleksandar Savic","Corine van Marrewijk","Agnès Guerci-Bresler","Elisa Luño","Jackie Droste","Fabio Efficace","Alex Smith","David Bowen","Theo de Witte"],"twitterCount":4,"altmetricId":34004899,"statusesArray":["978090158258966528","977851479699505152","977849072852742144","971067028273430529"]},{"title":"Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma","googleId":"jlYXy2i-tv0J","googleLink":"https://www.nature.com/articles/leu201758","googleCitationCount":34,"googleAuthor":"J Martinez-Lopez","doi":"10.1038/leu.2017.58","elsevierAuthor":"Martinez-Lopez J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"23","altmetricAuthors":["J Martinez-Lopez","B Sanchez-Vega","S Barrio","I Cuenca","Y Ruiz-Heredia","R Alonso","I Rapado","C Marin","M-T Cedena","B Paiva","N Puig","M-V Mateos","R Ayala","M-T Hernández","C Jimenez","L Rosiñol","R Martínez","A-I Teruel","N Gutiérrez","M-L Martin-Ramos","A Oriol","J Bargay","J Bladé","J San-Miguel","R Garcia-Sanz","J-J Lahuerta"],"twitterCount":2,"altmetricId":22730390,"statusesArray":["928607109041836032","926173377877946369","926063849312223232"]},{"title":"Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group","googleId":"BrkIEYCNUlgJ","googleLink":"https://www.nature.com/articles/leu2017246","googleCitationCount":31,"googleAuthor":"","doi":"10.1038/leu.2017.246","elsevierAuthor":"Hoechstetter M.A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"18","altmetricAuthors":["M A Hoechstetter","R Busch","B Eichhorst","A Bühler","D Winkler","M J Eckart","U Vehling-Kaiser","H Schimke","U Jäger","H J Hurtz","G Hopfinger","F Hartmann","H Fuss","W Abenhardt","I Blau","W Freier","L Müller","M Goebeler","C M Wendtner","J Bahlo","K Fischer","M Bentz","B Emmerich","H Döhner","M Hallek","S Stilgenbauer"],"twitterCount":5,"altmetricId":23870684,"statusesArray":["899130070530445312","897973341767688192","897820201730793472","897817240246132736","897551772222242816"]},{"title":"Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche","googleId":"_vuaMVAZ1tIJ","googleLink":"https://www.nature.com/articles/s41375-018-0161-6","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/s41375-018-0161-6","elsevierAuthor":"Tsukamoto S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"15","altmetricAuthors":["Shokichi Tsukamoto","Marianne B. Løvendorf","Jihye Park","Karma Z. Salem","Michaela R. Reagan","Salomon Manier","Oksana Zavidij","Mahshid Rahmat","Daisy Huynh","Satoshi Takagi","Yawara Kawano","Katsutoshi Kokubun","Charlotte Albæk Thrue","Kenichi Nagano","Andreas Petri","Aldo M. Roccaro","Marzia Capelletti","Roland Baron","Sakari Kauppinen","Irene M. Ghobrial"],"twitterCount":5,"altmetricId":44311751,"statusesArray":["1013812615804530689","1013771829368979458","1013769262714851328","1012871760713277441","1012763923873976320"]},{"title":"Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia","googleId":"4bjJMbBpaOQJ","googleLink":"https://www.nature.com/articles/leu2016307","googleCitationCount":38,"googleAuthor":"T Smith","doi":"10.1038/leu.2016.307","elsevierAuthor":"Stamatopoulos B.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"25","altmetricAuthors":["B Stamatopoulos","A Timbs","D Bruce","T Smith","R Clifford","P Robbe","A Burns","D V Vavoulis","L Lopez","P Antoniou","J Mason","H Dreau","A Schuh"],"twitterCount":2,"altmetricId":13338425,"statusesArray":["811522544369012736","808579715590189056","794530018676195328"]},{"title":"A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies","googleId":"azaE1hRelTkJ","googleLink":"https://www.nature.com/articles/s41375-018-0083-3","googleCitationCount":22,"googleAuthor":"P Sheridan","doi":"10.1038/s41375-018-0083-3","elsevierAuthor":"Inoue D.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"18","altmetricAuthors":["Daichi Inoue","Takeshi Fujino","Paul Sheridan","Yao-zhong Zhang","Reina Nagase","Sayuri Horikawa","Zaomin Li","Hirotaka Matsui","Akinori Kanai","Makoto Saika","Rui Yamaguchi","Hiroko Kozuka-Hata","Kimihito Cojin Kawabata","Akihiko Yokoyama","Susumu Goyama","Toshiya Inaba","Seiya Imoto","Satoru Miyano","Mingjiang Xu","Feng-Chun Yang","Masaaki Oyama","Toshio Kitamura"],"twitterCount":1,"altmetricId":34660665,"statusesArray":["976362819250618369"]},{"title":"Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies","googleId":"QcSwHocSjWQJ","googleLink":"https://www.nature.com/articles/s41375-018-0132-y","googleCitationCount":22,"googleAuthor":"CB Peterson","doi":"10.1038/s41375-018-0132-y","elsevierAuthor":"Thompson P.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"13","altmetricAuthors":["Philip A. Thompson","Christine B. Peterson","Paolo Strati","Jeff Jorgensen","Michael J. Keating","Susan M. O’Brien","Alessandra Ferrajoli","Jan A. Burger","Zeev Estrov","Nitin Jain","Tapan M. Kadia","Gautam Borthakur","Courtney D. DiNardo","Naval Daver","Elias Jabbour","William G. Wierda"],"twitterCount":4,"altmetricId":37866574,"statusesArray":["1063609977355538432","1063545951309242369","1061365020183982080","986298735956189184"]},{"title":"An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma","googleId":"wS2IVF_fNqcJ","googleLink":"https://www.nature.com/articles/leu2017203","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/leu.2017.203","elsevierAuthor":"Lollies A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"22","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genomic profiling of acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis","googleId":"0nNlQsgmNOwJ","googleLink":"https://www.nature.com/articles/leu201755","googleCitationCount":30,"googleAuthor":"T Kolb","doi":"10.1038/leu.2017.55","elsevierAuthor":"Ratnaparkhe M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"20","altmetricAuthors":["M Ratnaparkhe","M Hlevnjak","T Kolb","A Jauch","K K Maass","F Devens","A Rode","V Hovestadt","A Korshunov","A Pastorczak","W Mlynarski","S Sungalee","J Korbel","J Hoell","U Fischer","T Milde","C Kramm","M Nathrath","K Chrzanowska","E Tausch","M Takagi","T Taga","S Constantini","J Loeffen","J Meijerink","S Zielen","G Gohring","B Schlegelberger","E Maass","R Siebert","J Kunz","A E Kulozik","B Worst","D T Jones","S M Pfister","M Zapatka","P Lichter","A Ernst"],"twitterCount":5,"altmetricId":20916860,"statusesArray":["1049030605088931841","979026138621235205","921389263786250240","915675663016882176","915609823911272448"]},{"title":"PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment","googleId":"zMjWHLzRdeIJ","googleLink":"https://www.nature.com/articles/leu2017110","googleCitationCount":30,"googleAuthor":"D Jones","doi":"10.1038/leu.2017.110","elsevierAuthor":"Jones D.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"24","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy","googleId":"NkTmpxU8yzIJ","googleLink":"https://www.nature.com/articles/leu2017272","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.272","elsevierAuthor":"Kelly K.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"19","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation","googleId":"aFc97QinIRwJ","googleLink":"https://www.nature.com/articles/leu2017202","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/leu.2017.202","elsevierAuthor":"Yabe T.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"22","altmetricAuthors":["T Yabe","F Azuma","K Kashiwase","K Matsumoto","T Orihara","H Yabe","S Kato","K Kato","S Kai","T Mori","S Morishima","M Satake","M Takanashi","K Nakajima","Y Morishima"],"twitterCount":15,"altmetricId":21387885,"statusesArray":["1105089570104856576","955422224424546304","955197372610564101","938735435832061955","926042140223967232","925308576565997568","889423515555942400","885835184615981057","885834333092806657","885834262418784256","880986886852022273","880752824883318784","880681318593560576","880681243142221825","880354931475075072","880182364307165184","880003294185246720"]},{"title":"Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma","googleId":"OjbhSVeXuwUJ","googleLink":"https://www.nature.com/articles/leu2017173","googleCitationCount":29,"googleAuthor":"CC Hofmeister","doi":"10.1038/leu.2017.173","elsevierAuthor":"Richardson P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0","altmetricAuthors":["P G Richardson","C C Hofmeister","N S Raje","D S Siegel","S Lonial","J Laubach","Y A Efebera","D H Vesole","A K Nooka","J Rosenblatt","D Doss","M H Zaki","A Bensmaine","J Herring","Y Li","L Watkins","M S Chen","K C Anderson"],"twitterCount":2,"altmetricId":21335514,"statusesArray":["942064136673996800","878966005652959233"]},{"title":"The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia","googleId":"9msnqEkssPAJ","googleLink":"https://www.nature.com/articles/leu2016214","googleCitationCount":38,"googleAuthor":"","doi":"10.1038/leu.2016.214","elsevierAuthor":"Qorraj M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"27","altmetricAuthors":["M Qorraj","H Bruns","M Böttcher","L Weigand","D Saul","A Mackensen","R Jitschin","D Mougiakakos"],"twitterCount":0,"altmetricId":11010491,"statusesArray":[]},{"title":"Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies","googleId":"8p177PIBAHwJ","googleLink":"https://www.nature.com/articles/s41375-018-0197-7","googleCitationCount":19,"googleAuthor":"T Bagratuni","doi":"10.1038/s41375-018-0197-7","elsevierAuthor":"Bagratuni T.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"13","altmetricAuthors":["Tina Bagratuni","Ioannis Ntanasis-Stathopoulos","Maria Gavriatopoulou","Nefeli Mavrianou-Koutsoukou","Christine Liacos","Dimitrios Patseas","Nikolaos Kanellias","Magdalini Migkou","Dimitrios C. Ziogas","Evangelos Eleutherakis-Papaiakovou","Maria Roussou","Despina Fotiou","Evangelos Terpos","Efstathios Kastritis","Meletios A. Dimopoulos"],"twitterCount":5,"altmetricId":45577431,"statusesArray":["1074565762424168448","1074422439327748096","1074401346004996096","1074394484455165952","1022526965054550017"]},{"title":"Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation","googleId":"_nUEac3LK6sJ","googleLink":"https://www.nature.com/articles/leu2016288","googleCitationCount":36,"googleAuthor":"J Kanda","doi":"10.1038/leu.2016.288","elsevierAuthor":"Kanda J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"30","altmetricAuthors":["J Kanda","Y Morishima","S Terakura","A Wake","N Uchida","S Takahashi","Y Ono","Y Onishi","H Kanamori","N Aotsuka","Y Ozawa","H Ogawa","T Sakura","K Ohashi","T Ichinohe","K Kato","Y Atsuta","T Teshima","M Murata"],"twitterCount":14,"altmetricId":12685581,"statusesArray":["803425937954054144","801496948905799684","801466759329026049","801451051371073538","801451043448090624","801449708833144832","801428355128184832","801296402890555392","801296290663530496","791240753322352640","788563246579986432","788558666517667840","788490198132850688","788470803377512448","788470628508635141","788074905342472193"]},{"title":"Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia","googleId":"0MPDJeRp50oJ","googleLink":"https://www.nature.com/articles/s41375-018-0110-4","googleCitationCount":20,"googleAuthor":"AEJ Yeoh","doi":"10.1038/s41375-018-0110-4","elsevierAuthor":"Ngoc P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"16","altmetricAuthors":["Phuong Cao Thi Ngoc","Shi Hao Tan","Tze King Tan","Min Min Chan","Zhenhua Li","Allen. E. J. Yeoh","Daniel G Tenen","Takaomi Sanda"],"twitterCount":5,"altmetricId":35724408,"statusesArray":["985630595953836037","985467771151511552","981844643200552960","981842455241912320","981841130181529600"]},{"title":"CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D","googleId":"9dUtsjY681sJ","googleLink":"https://www.nature.com/articles/leu2016378","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2016.378","elsevierAuthor":"Bruns H.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"27","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Flow-cytometric vs.-morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)","googleId":"AbNAcJdVx5wJ","googleLink":"https://www.nature.com/articles/s41375-018-0039-7","googleCitationCount":25,"googleAuthor":"S Gupta","doi":"10.1038/s41375-018-0039-7","elsevierAuthor":"Gupta S.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"18","altmetricAuthors":["Sumit Gupta","Meenakshi Devidas","Mignon L. Loh","Elizabeth A. Raetz","Si Chen","Cindy Wang","Patrick Brown","Andrew J. Carroll","Nyla A. Heerema","Julie M. Gastier-Foster","Kimberly P. Dunsmore","Eric C. Larsen","Kelly W. Maloney","Leonard A. Mattano","Stuart S. Winter","Naomi J. Winick","William L. Carroll","Stephen P. Hunger","Michael J. Borowitz","Brent L. Wood"],"twitterCount":6,"altmetricId":33603183,"statusesArray":["1113018744727461894","974070405374726145","973964810877591552","973963320284901376","973951250633916416","967465459283931136","967187215423098881"]},{"title":"We skip to work: alternative splicing in normal and malignant myelopoiesis","googleId":"odYmgPzS0RcJ","googleLink":"https://www.nature.com/articles/s41375-018-0021-4","googleCitationCount":20,"googleAuthor":"JEJ Rasko","doi":"10.1038/s41375-018-0021-4","elsevierAuthor":"Wong A.C.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"17","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Dnmt3a regulates T-cell development and suppresses T-ALL transformation","googleId":"nGkpQJ6_PP8J","googleLink":"https://www.nature.com/articles/leu201789","googleCitationCount":30,"googleAuthor":"AC Kramer","doi":"10.1038/leu.2017.89","elsevierAuthor":"Kramer A.C.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"17","altmetricAuthors":["A C Kramer","A Kothari","W C Wilson","H Celik","J Nikitas","C Mallaney","E L Ostrander","E Eultgen","A Martens","M C Valentine","A L Young","T E Druley","M E Figueroa","B Zhang","G A Challen"],"twitterCount":1,"altmetricId":18494733,"statusesArray":["849401243915124737"]},{"title":"Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells","googleId":"8bVNcCx_eYMJ","googleLink":"https://www.nature.com/articles/leu2017132","googleCitationCount":29,"googleAuthor":"J Yu","doi":"10.1038/leu.2017.132","elsevierAuthor":"Yu J.","publicationName":"Methods in Molecular Biology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation","googleId":"XHuuw7k6F2MJ","googleLink":"https://www.nature.com/articles/s41375-018-0073-5","googleCitationCount":20,"googleAuthor":"A Hnízda","doi":"10.1038/s41375-018-0073-5","elsevierAuthor":"Hnízda A.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"18","altmetricAuthors":["Aleš Hnízda","Milan Fábry","Takaya Moriyama","Petr Pachl","Michael Kugler","Vítězslav Brinsa","David B. Ascher","William L. Carroll","Petr Novák","Markéta Žaliová","Jan Trka","Pavlína Řezáčová","Jun J. Yang","Václav Veverka"],"twitterCount":4,"altmetricId":33679565,"statusesArray":["981815515508301824","981814985453129729","981814750676946945","981784771805184001","968055750428975106","968034862618873856","968033607045603328"]},{"title":"An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia","googleId":"IfgvpewfIAoJ","googleLink":"https://www.nature.com/articles/leu2016194","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/leu.2016.194","elsevierAuthor":"Koerner S.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"25","altmetricAuthors":["S P Koerner","M C André","J S Leibold","P C Kousis","A Kübler","M Pal","S P Haen","H-J Bühring","L Grosse-Hovest","G Jung","H R Salih"],"twitterCount":5,"altmetricId":9928670,"statusesArray":["759832545919901696","759828553424855040","756354606515359745","756244021194858496","756183340777082880"]},{"title":"Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome","googleId":"lU-rIrE7xdYJ","googleLink":"https://www.nature.com/articles/leu2016168","googleCitationCount":36,"googleAuthor":"C Wang","doi":"10.1038/leu.2016.168","elsevierAuthor":"Wang C.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"30","altmetricAuthors":["C Wang","X-F Huang","Q-Q Cai","X-X Cao","M-H Duan","H Cai","D-B Zhou","J Li"],"twitterCount":10,"altmetricId":8709105,"statusesArray":["826847882082996228","826808285688950787","826797254224719872","752625189460910080","751838855528058880","751814907805442048","751779735231954946","746749562702815233","743228864076218371","742404539089838080","742393483785293825"]},{"title":"The JAK2 V617F mutation is a target for specific T cells in the JAK2 V617F-positive myeloproliferative neoplasms","googleId":"WyVrcmcySv8J","googleLink":"https://www.nature.com/articles/leu2016290","googleCitationCount":36,"googleAuthor":"MO Holmström","doi":"10.1038/leu.2016.290","elsevierAuthor":"Holmström M.O.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"29","altmetricAuthors":["M O Holmström","M D Hjortsø","S M Ahmad","Ö Met","E Martinenaite","C Riley","P Straten","I M Svane","H C Hasselbalch","M H Andersen"],"twitterCount":0,"altmetricId":18282708,"statusesArray":[]},{"title":"Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia","googleId":"SGnTVgh1th0J","googleLink":"https://www.nature.com/articles/leu2016377","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2016.377","elsevierAuthor":"Fisher D.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"30","altmetricAuthors":["D A C Fisher","O Malkova","E K Engle","C A Miner","M C Fulbright","G K Behbehani","T B Collins","S Bandyopadhyay","A Zhou","G P Nolan","S T Oh"],"twitterCount":11,"altmetricId":16327185,"statusesArray":["1044381564086423554","1044361632095383553","1044306061816188928","1044302545869463553","1044300209617080321","1044299711124054020","905421350151565312","830952616272211968","830571506455498752","830557636298997760","830431458263171073","830388215278403584"]},{"title":"MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells","googleId":"_VHZ9kMD8GsJ","googleLink":"https://www.nature.com/articles/leu2017336","googleCitationCount":26,"googleAuthor":"C Botta","doi":"10.1038/leu.2017.336","elsevierAuthor":"Botta C.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"21","altmetricAuthors":["C Botta","M Cucè","M R Pitari","D Caracciolo","A Gullà","E Morelli","C Riillo","L Biamonte","M E Gallo Cantafio","R Prabhala","C Mignogna","A Di Vito","E Altomare","N Amodio","M T Di Martino","P Correale","M Rossi","A Giordano","N C Munshi","P Tagliaferri","P Tassone"],"twitterCount":9,"altmetricId":29275275,"statusesArray":["1108699535344168962","937334216160718848","937231465292509184","937016027245883392","934925485963743232","934890294243360768","934874400381210624","933378435035967489","933296523873361920"]},{"title":"Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade …","googleId":"JmVJTY-05ooJ","googleLink":"https://www.nature.com/articles/leu2017165","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.165","elsevierAuthor":"Halpern A.B.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"23","altmetricAuthors":["A B Halpern","M Othus","E M Huebner","S A Buckley","E L Pogosova-Agadjanyan","K F Orlowski","B L Scott","P S Becker","P C Hendrie","T L Chen","M-E M Percival","E H Estey","D L Stirewalt","R B Walter"],"twitterCount":1,"altmetricId":20729588,"statusesArray":["869923008663625728"]},{"title":"Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm","googleId":"kchrZVlrOZEJ","googleLink":"https://www.nature.com/articles/leu2017101","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/leu.2017.101","elsevierAuthor":"Suzuki K.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"21","altmetricAuthors":["K Suzuki","Y Suzuki","A Hama","H Muramatsu","M Nakatochi","M Gunji","D Ichikawa","M Hamada","R Taniguchi","S Kataoka","N Murakami","D Kojima","Y Sekiya","E Nishikawa","N Kawashima","A Narita","N Nishio","Y Nakazawa","H Iwafuchi","K-i Watanabe","Y Takahashi","M Ito","S Kojima","S Kato","Y Okuno"],"twitterCount":12,"altmetricId":18177245,"statusesArray":["1208082616869629952","1208082579993305088","1208078831715672064","1208062208934068224","950779046568382466","950778125884981248","950764161457410049","877156663437828096","847638357156929536","847114242406805504","847114028786708480","846884125780803584","846772513354891264","846559017010909184","846514449989165057"]},{"title":"Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma","googleId":"NJXZcXwHViQJ","googleLink":"https://www.nature.com/articles/leu2016355","googleCitationCount":37,"googleAuthor":"KT Siu","doi":"10.1038/leu.2016.355","elsevierAuthor":"Siu K.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"31","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia","googleId":"mFpliuTaPpcJ","googleLink":"https://www.nature.com/articles/leu2016359","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2016.359","elsevierAuthor":"Young E.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"24","altmetricAuthors":["E Young","D Noerenberg","L Mansouri","V Ljungström","M Frick","L-A Sutton","S J Blakemore","J Galan-Sousa","K Plevova","P Baliakas","D Rossi","R Clifford","D Roos-Weil","V Navrkalova","B Dörken","C A Schmitt","K E Smedby","G Juliusson","B Giacopelli","J S Blachly","C Belessi","P Panagiotidis","N Chiorazzi","F Davi","A W Langerak","D Oscier","A Schuh","G Gaidano","P Ghia","W Xu","L Fan","O A Bernard","F Nguyen-Khac","L Rassenti","J Li","T J Kipps","K Stamatopoulos","S Pospisilova","T Zenz","C C Oakes","J C Strefford","R Rosenquist","F Damm"],"twitterCount":9,"altmetricId":14131218,"statusesArray":["884469876181659649","884431389151576064","884402166852706304","883775374689042432","883088778289655813","805675730772357120","803303467750195201","803248217865539584","803225311278223361"]},{"title":"Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical …","googleId":"OnBqDND8ApUJ","googleLink":"https://www.nature.com/articles/leu2016172","googleCitationCount":35,"googleAuthor":"S Barrio","doi":"10.1038/leu.2016.172","elsevierAuthor":"Barrio S.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"23","altmetricAuthors":["S Barrio","T D Shanafelt","J Ojha","K G Chaffee","C Secreto","K M Kortüm","S Pathangey","D L Van-Dyke","S L Slager","R Fonseca","N E Kay","E Braggio"],"twitterCount":1,"altmetricId":24776418,"statusesArray":["904854861610491904"]},{"title":"Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858","googleId":"6n-nZDXVFCIJ","googleLink":"https://www.nature.com/articles/leu201721","googleCitationCount":33,"googleAuthor":"EA Eksioglu","doi":"10.1038/leu.2017.21","elsevierAuthor":"Eksioglu E.A.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"29","altmetricAuthors":["E A Eksioglu","X Chen","K-H Heider","B Rueter","K L McGraw","A A Basiorka","M Wei","A Burnette","P Cheng","J Lancet","R Komrokji","J Djeu","A List","S Wei"],"twitterCount":1,"altmetricId":27910192,"statusesArray":["923136918216433664"]},{"title":"Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1","googleId":"cHdzy6NTKqAJ","googleLink":"https://www.nature.com/articles/leu2016198","googleCitationCount":35,"googleAuthor":"A Abdelbaset-Ismail","doi":"10.1038/leu.2016.198","elsevierAuthor":"Abdelbaset-Ismail A.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"30","altmetricAuthors":["A Abdelbaset-Ismail","S Borkowska-Rzeszotek","E Kubis","K Bujko","K Brzeźniakiewicz-Janus","L Bolkun","J Kloczko","M Moniuszko","G W Basak","W Wiktor-Jedrzejczak","M Z Ratajczak"],"twitterCount":4,"altmetricId":10105213,"statusesArray":["903937664885415936","762435704785805312","760625094125170688","758780378542768129"]},{"title":"Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials","googleId":"IplMGZg7d20J","googleLink":"https://www.nature.com/articles/leu2017320","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2017.320","elsevierAuthor":"Arana P.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"16","altmetricAuthors":["P Arana","B Paiva","M-T Cedena","N Puig","L Cordon","M-B Vidriales","N C Gutierrez","F Chiodi","L Burgos","L-L Anglada","J Martinez-Lopez","M-T Hernandez","A-I Teruel","M Gironella","M-A Echeveste","L Rosiñol","R Martinez","A Oriol","J De la Rubia","A Orfao","J Blade","J-J Lahuerta","M-V Mateos","J-F San Miguel"],"twitterCount":14,"altmetricId":28420653,"statusesArray":["981444630607728642","929325241997905920","929181297813213184","927931761258106883","927895916622868481","927895606328258560","927546943747837953","927343508972859397","927263649764401154","927203864926924800","926811954190041090","926807551974375426","926783794178166785","926781107864977409","926753280629211136"]},{"title":"Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia","googleId":"MNwlm_gyTU8J","googleLink":"https://www.nature.com/articles/leu2017313","googleCitationCount":25,"googleAuthor":"L Lhermitte","doi":"10.1038/leu.2017.313","elsevierAuthor":"Lhermitte L.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"22","altmetricAuthors":["L Lhermitte","E Mejstrikova","A J van der Sluijs-Gelling","G E Grigore","L Sedek","A E Bras","G Gaipa","E Sobral da Costa","M Novakova","E Sonneveld","C Buracchi","T de Sá Bacelar","J G te Marvelde","A Trinquand","V Asnafi","T Szczepanski","S Matarraz","A Lopez","B Vidriales","J Bulsa","O Hrusak","T Kalina","Q Lecrevisse","M Martin Ayuso","M Brüggemann","J Verde","P Fernandez","L Burgos","B Paiva","C E Pedreira","J J M van Dongen","A Orfao","V H J van der Velden"],"twitterCount":3,"altmetricId":34337204,"statusesArray":["1030075528257183746","998906608439656448","981443663367671808","925685054805893120"]},{"title":"High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG","googleId":"8GLLt9vJMBYJ","googleLink":"https://www.nature.com/articles/leu2017283","googleCitationCount":24,"googleAuthor":"","doi":"10.1038/leu.2017.283","elsevierAuthor":"Sakura T.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"13","altmetricAuthors":["T Sakura","F Hayakawa","I Sugiura","T Murayama","K Imai","N Usui","S Fujisawa","T Yamauchi","T Yujiri","K Kakihana","Y Ito","H Kanamori","Y Ueda","Y Miyata","M Kurokawa","N Asou","K Ohnishi","S Ohtake","Y Kobayashi","K Matsuo","H Kiyoi","Y Miyazaki","T Naoe"],"twitterCount":15,"altmetricId":25442139,"statusesArray":["974440866931793920","974263963461484544","974175342851186689","974097785107767297","974043856579825664","971511982569398272","971443510422335489","971402414661120002","971394442534858752","971392026141839360","933097272006492160","932975755239202817","910845420456292353","910676739000606721","910510612047728640","909018574710173697"]},{"title":"Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia","googleId":"jAZUVhcgE40J","googleLink":"https://www.nature.com/articles/leu201722","googleCitationCount":33,"googleAuthor":"RF Schlenk","doi":"10.1038/leu.2017.22","elsevierAuthor":"Schlenk R.F.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"27","altmetricAuthors":["R F Schlenk","P Frech","D Weber","P Brossart","H-A Horst","D Kraemer","G Held","M Ringhoffer","A Burchardt","G Kobbe","K Götze","D Nachbaur","T Fischer","M Lübbert","H R Salih","H Salwender","G Wulf","E Koller","M Wattad","W Fiedler","S Kremers","H Kirchen","B Hertenstein","P Paschka","V I Gaidzik","V Teleanu","M Heuser","F Thol","K Döhner","J Krauter","A Ganser","H Döhner"],"twitterCount":2,"altmetricId":16144815,"statusesArray":["828303812586729472","828228134751330304"]},{"title":"Novel evidence that the mannan-binding lectin pathway of complement activation plays a pivotal role in triggering mobilization of hematopoietic stem …","googleId":"zUF4HFYhpuMJ","googleLink":"https://www.nature.com/articles/leu2016278","googleCitationCount":33,"googleAuthor":"A Abdelbaset-Ismail","doi":"10.1038/leu.2016.278","elsevierAuthor":"Adamiak M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"30","altmetricAuthors":["M Adamiak","A Abdelbaset-Ismail","M Suszynska","A Abdel-Latif","J Ratajczak","M Z Ratajczak"],"twitterCount":0,"altmetricId":36827672,"statusesArray":[]},{"title":"Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children","googleId":"r-bwmJ9A-HsJ","googleLink":"https://www.nature.com/articles/leu2016274","googleCitationCount":36,"googleAuthor":"K Yoshida","doi":"10.1038/leu.2016.274","elsevierAuthor":"Kato M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"21","altmetricAuthors":["M Kato","S Ishimaru","M Seki","K Yoshida","Y Shiraishi","K Chiba","N Kakiuchi","Y Sato","H Ueno","H Tanaka","T Inukai","D Tomizawa","D Hasegawa","T Osumi","Y Arakawa","T Aoki","M Okuya","K Kaizu","K Kato","Y Taneyama","H Goto","T Taki","M Takagi","M Sanada","K Koh","J Takita","S Miyano","S Ogawa","A Ohara","M Tsuchida","A Manabe"],"twitterCount":10,"altmetricId":12472060,"statusesArray":["819413494265036801","819093841907249152","818734008079028225","818054542151430145","817375090237018112","816773647893286912","816695330334834688","816015960624676864","815735301402263552","815550224592605185","815525332258144256","804833971775291392","791273922054488064","791271917491585024","784080914745815040"]},{"title":"Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma","googleId":"xcXTTiGogE8J","googleLink":"https://www.nature.com/articles/s41375-018-0116-y","googleCitationCount":20,"googleAuthor":"M Fulciniti","doi":"10.1038/s41375-018-0116-y","elsevierAuthor":"Samur M.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"18","altmetricAuthors":["Mehmet Kemal Samur","Stephane Minvielle","Annamaria Gulla","Mariateresa Fulciniti","Alice Cleynen","Anil Aktas Samur","Raphael Szalat","Masood Shammas","Florence Magrangeas","Yu-Tzu Tai","Daniel Auclair","Jonathan Keats","Paul Richardson","Michel Attal","Philippe Moreau","Kenneth C. Anderson","Giovanni Parmigiani","Hervé Avet-Loiseau","Nikhil C. Munshi"],"twitterCount":5,"altmetricId":41148803,"statusesArray":["1021017018684731397","996020229091274757","995788733227118594","995731984973484032","995252561958453248"]},{"title":"HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells","googleId":"OpfRCLWpc8sJ","googleLink":"https://www.nature.com/articles/leu2017106","googleCitationCount":27,"googleAuthor":"","doi":"10.1038/leu.2017.106","elsevierAuthor":"Germini D.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"18","altmetricAuthors":["D Germini","T Tsfasman","M Klibi","R El-Amine","A Pichugin","O V Iarovaia","C Bilhou-Nabera","F Subra","Y Bou Saada","A Sukhanova","D Boutboul","M Raphaël","J Wiels","S V Razin","S Bury-Moné","E Oksenhendler","M Lipinski","Y S Vassetzky"],"twitterCount":2,"altmetricId":18388671,"statusesArray":["848233483482693633","848231011372507137"]},{"title":"Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t (8; 21)(q22; q22) acute myeloid leukemia","googleId":"MAVTbMaESOIJ","googleLink":"https://www.nature.com/articles/leu2016332","googleCitationCount":32,"googleAuthor":"","doi":"10.1038/leu.2016.332","elsevierAuthor":"Eisfeld A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"24","altmetricAuthors":["A-K Eisfeld","J Kohlschmidt","S Schwind","D Nicolet","J S Blachly","S Orwick","C Shah","M Bainazar","K W Kroll","C J Walker","A J Carroll","B L Powell","R M Stone","J E Kolitz","M R Baer","A de la Chapelle","K Mrózek","J C Byrd","C D Bloomfield"],"twitterCount":1,"altmetricId":14541784,"statusesArray":["807249206612230144"]},{"title":"Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del (5q) MDS","googleId":"zGvtW1wgToAJ","googleLink":"https://www.nature.com/articles/leu2017326","googleCitationCount":23,"googleAuthor":"Y Mei","doi":"10.1038/leu.2017.326","elsevierAuthor":"Mei Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"21","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20 …","googleId":"E0gmcaM_Wx4J","googleLink":"https://repub.eur.nl/pub/111318/","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.216","elsevierAuthor":"Garrido Castro P.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"22","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide","googleId":"ZZJVEQDa-ZgJ","googleLink":"https://www.nature.com/articles/leu201792","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.92","elsevierAuthor":"Kayser S.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"20","altmetricAuthors":["S Kayser","J Krzykalla","M A Elliott","K Norsworthy","P Gonzales","R K Hills","M R Baer","Z Ráčil","J Mayer","J Novak","P Žák","T Szotkowski","D Grimwade","N H Russell","R B Walter","E H Estey","J Westermann","M Görner","A Benner","A Krämer","B D Smith","A K Burnett","C Thiede","C Röllig","A D Ho","G Ehninger","R F Schlenk","M S Tallman","M J Levis","U Platzbecker"],"twitterCount":1,"altmetricId":20917080,"statusesArray":["926115397346234368","926114880444354562"]},{"title":"Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes","googleId":"CWzP4BMzNFsJ","googleLink":"https://www.nature.com/articles/leu201728","googleCitationCount":32,"googleAuthor":"AK Johnson","doi":"10.1038/leu.2017.28","elsevierAuthor":"Guidugli L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"23","altmetricAuthors":["L Guidugli","A K Johnson","G Alkorta-Aranburu","V Nelakuditi","K Arndt","J E Churpek","L A Godley","D Townsley","N S Young","C Fitzpatrick","D del Gaudio","S Das","Z Li"],"twitterCount":1,"altmetricId":15652119,"statusesArray":["822970702395387906"]},{"title":"The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9","googleId":"aqrCT7sGwmcJ","googleLink":"https://www.nature.com/articles/leu2016240","googleCitationCount":33,"googleAuthor":"J Peterson","doi":"10.1038/leu.2016.240","elsevierAuthor":"Fisher J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"22","altmetricAuthors":["J B Fisher","J Peterson","M Reimer","C Stelloh","K Pulakanti","Z J Gerbec","A M Abel","J M Strouse","C Strouse","M McNulty","S Malarkannan","J D Crispino","S Milanovich","S Rao"],"twitterCount":4,"altmetricId":10815433,"statusesArray":["844227166791450625","784811964002340864","783512062123180032","772213886313439232","768821414094700544","768756534926991360"]},{"title":"Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma","googleId":"Urej8tstUa8J","googleLink":"https://www.nature.com/articles/leu2016187","googleCitationCount":32,"googleAuthor":"KL Eales","doi":"10.1038/leu.2016.187","elsevierAuthor":"McNee G.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"23","altmetricAuthors":["G McNee","K L Eales","W Wei","D S Williams","A Barkhuizen","D B Bartlett","S Essex","S Anandram","A Filer","P A H Moss","G Pratt","S Basu","C C Davies","D A Tennant"],"twitterCount":19,"altmetricId":9583271,"statusesArray":["862740383935209473","758295998175346688","756093933965508608","756082879663378432","753676197813489664","753123016373112834","753122820826234880","752878667072729088","752859670222508032","752832108872146944","752820070225616897","752810323438997505","752810268275552256","752809764917096448","752672333081501696","752671360770576384","752567386260246529","752526430026817536","752522248745938945","752517873000677376","752515588916862976"]},{"title":"Driver mutations' effect in secondary myelofibrosis: an international multicenter study based on 781 patients","googleId":"aXRk9gSx4x8J","googleLink":"https://www.nature.com/articles/leu2016351","googleCitationCount":34,"googleAuthor":"F Passamonti","doi":"10.1038/leu.2016.351","elsevierAuthor":"Passamonti F.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"29","altmetricAuthors":["F Passamonti","B Mora","T Giorgino","P Guglielmelli","M Cazzola","M Maffioli","A Rambaldi","M Caramella","R Komrokji","J Gotlib","J J Kiladjian","F Cervantes","T Devos","F Palandri","V De Stefano","M Ruggeri","R Silver","G Benevolo","F Albano","D Caramazza","E Rumi","M Merli","D Pietra","R Casalone","T Barbui","L Pieri","A M Vannucchi"],"twitterCount":1,"altmetricId":15240085,"statusesArray":["816890144397684736"]},{"title":"Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing","googleId":"2-kyzwQD9V4J","googleLink":"https://www.nature.com/articles/s41375-017-0002-z","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/s41375-017-0002-z","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"13","altmetricAuthors":["Anna Stengel","Niroshan Nadarajah","Torsten Haferlach","Frank Dicker","Wolfgang Kern","Manja Meggendorfer","Claudia Haferlach"],"twitterCount":1,"altmetricId":33708192,"statusesArray":["968274905493114880"]},{"title":"Identification of a novel PML-RARG fusion in acute promyelocytic leukemia","googleId":"5a8K93nbJMUJ","googleLink":"https://www.nature.com/articles/leu2017167","googleCitationCount":26,"googleAuthor":"CS Ki","doi":"10.1038/leu.2017.167","elsevierAuthor":"Ha J.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"17","altmetricAuthors":["J-S Ha","Y R Do","C-S Ki","C Lee","D-H Kim","W Lee","N-H Ryoo","D-S Jeon"],"twitterCount":1,"altmetricId":20709514,"statusesArray":["869707566015819779"]},{"title":"Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study","googleId":"BKubYiqhVDAJ","googleLink":"https://www.nature.com/articles/s41375-018-0146-5","googleCitationCount":18,"googleAuthor":"S Stilgenbauer","doi":"10.1038/s41375-018-0146-5","elsevierAuthor":"Stilgenbauer S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"13","altmetricAuthors":["Stephan Stilgenbauer","Veronique Leblond","Robin Foà","Sebastian Böttcher","Osman Ilhan","Wolfgang Knauf","Eva Mikuskova","Christoph Renner","Eugen Tausch","Dariusz Woszczyk","Ekaterina Gresko","Linda Lundberg","Tom Moore","Thea Morris","Susan Robson","Francesc Bosch"],"twitterCount":1,"altmetricId":64532613,"statusesArray":["996561978020646913"]},{"title":"Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study","googleId":"0bxYFgbGQG8J","googleLink":"https://www.nature.com/articles/s41375-018-0024-1","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-018-0024-1","elsevierAuthor":"Bringhen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"22","altmetricAuthors":["Sara Bringhen","Roberto Mina","Anna Maria Cafro","Anna Marina Liberati","Stefano Spada","Angelo Belotti","Gianluca Gaidano","Francesca Patriarca","Rossella Troia","Renato Fanin","Lorenzo De Paoli","Giuseppe Rossi","Alessandra Lombardo","Paola Bertazzoni","Antonio Palumbo","Pieter Sonneveld","Mario Boccadoro"],"twitterCount":3,"altmetricId":45309527,"statusesArray":["1048032910257868800","1046868956458508289","1046867348186050560"]},{"title":"Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation","googleId":"623UmfoGHn8J","googleLink":"https://www.nature.com/articles/s41375-018-0014-3","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/s41375-018-0014-3","elsevierAuthor":"Correnti C.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"20","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children","googleId":"83lgBOB8HHoJ","googleLink":"https://www.nature.com/articles/leu2016321","googleCitationCount":32,"googleAuthor":"","doi":"10.1038/leu.2016.321","elsevierAuthor":"Zvyagin I.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"21","altmetricAuthors":["I V Zvyagin","I Z Mamedov","O V Tatarinova","E A Komech","E E Kurnikova","E V Boyakova","V Brilliantova","L N Shelikhova","D N Balashov","M Shugay","A L Sycheva","S A Kasatskaya","Y B Lebedev","A A Maschan","M A Maschan","D M Chudakov"],"twitterCount":4,"altmetricId":13420644,"statusesArray":["800500280823607296","795985075821223937","795894854169587713","795764312258256896"]},{"title":"Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results","googleId":"kvYHSV2ZNLsJ","googleLink":"https://www.nature.com/articles/leu2017247","googleCitationCount":25,"googleAuthor":"TP Hughes","doi":"10.1038/leu.2017.247","elsevierAuthor":"Hughes T.P.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"24","altmetricAuthors":["T P Hughes","B Leber","F Cervantes","N Spector","R Pasquini","N C D Clementino","A P Schwarer","P E Dorlhiac-Llacer","F-X Mahon","D Rea","A Guerci-Bresler","S Kamel-Reid","I Bendit","S Acharya","T Glynos","D Dalal","S Branford","J H Lipton"],"twitterCount":2,"altmetricId":23394504,"statusesArray":["911063371826343936","903935326535561217"]},{"title":"UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response","googleId":"DxfeyClYs3EJ","googleLink":"https://www.nature.com/articles/s41375-018-0141-x","googleCitationCount":19,"googleAuthor":"GL Zhang","doi":"10.1038/s41375-018-0141-x","elsevierAuthor":"Huiting L.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"14","altmetricAuthors":["LN Huiting","Y Samaha","GL Zhang","JE Roderick","B Li","NM Anderson","YW Wang","L Wang","FJF Laroche","JW Choi","CT Liu","MA Kelliher","H Feng"],"twitterCount":6,"altmetricId":39388858,"statusesArray":["1012324408331923456","1012324235115544577","995223345200320513","995218103255564288","993483221764640770","991766228627836929","991765737898377217","990572578224988160"]},{"title":"A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells","googleId":"MtaHXAa2Kk4J","googleLink":"https://www.nature.com/articles/leu2017135","googleCitationCount":26,"googleAuthor":"DS Das","doi":"10.1038/leu.2017.135","elsevierAuthor":"Ray A.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"22","altmetricAuthors":["A Ray","D S Das","Y Song","V Macri","P Richardson","C L Brooks","D Chauhan","K C Anderson"],"twitterCount":2,"altmetricId":20041174,"statusesArray":["942261591034044418","862656039984005121"]},{"title":"Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1","googleId":"2rhOGPSF5oIJ","googleLink":"https://www.nature.com/articles/leu2017100","googleCitationCount":26,"googleAuthor":"A Cosson","doi":"10.1038/leu.2017.100","elsevierAuthor":"Cosson A.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"15","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress","googleId":"RfCV9nI7Nz8J","googleLink":"https://www.nature.com/articles/leu2017231","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2017.231","elsevierAuthor":"Masciarelli S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"17","altmetricAuthors":["S Masciarelli","E Capuano","T Ottone","M Divona","S De Panfilis","C Banella","N I Noguera","A Picardi","G Fontemaggi","G Blandino","F Lo-Coco","F Fazi"],"twitterCount":3,"altmetricId":23460090,"statusesArray":["1080783046373269505","894762541884129280","893945743047770112","893774415560929284"]},{"title":"A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis","googleId":"Hf6BUGFknx4J","googleLink":"https://www.nature.com/articles/leu2016215","googleCitationCount":33,"googleAuthor":"","doi":"10.1038/leu.2016.215","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"22","altmetricAuthors":["S Verstovsek","M Talpaz","E Ritchie","M Wadleigh","O Odenike","C Jamieson","B Stein","T Uno","R A Mesa"],"twitterCount":1,"altmetricId":10527898,"statusesArray":["765385812368175105"]},{"title":"YAP and TAZ are dispensable for physiological and malignant haematopoiesis","googleId":"qAzY02BmBcAJ","googleLink":"https://www.nature.com/articles/s41375-018-0111-3","googleCitationCount":19,"googleAuthor":"E Donato","doi":"10.1038/s41375-018-0111-3","elsevierAuthor":"Donato E.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"13","altmetricAuthors":["Elisa Donato","Francesca Biagioni","Andrea Bisso","Marieta Caganova","Bruno Amati","Stefano Campaner"],"twitterCount":2,"altmetricId":37387620,"statusesArray":["985467778013446144","985465763006791682"]},{"title":"RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC","googleId":"WOFVE2fHtekJ","googleLink":"https://www.nature.com/articles/leu201740","googleCitationCount":27,"googleAuthor":"V Selvarajan","doi":"10.1038/leu.2017.40","elsevierAuthor":"Selvarajan V.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"22","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment","googleId":"qVYAM_xwB0YJ","googleLink":"https://www.nature.com/articles/leu2016358","googleCitationCount":30,"googleAuthor":"MH Bashari","doi":"10.1038/leu.2016.358","elsevierAuthor":"Fan F.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"23","altmetricAuthors":["F Fan","M H Bashari","E Morelli","G Tonon","S Malvestiti","S Vallet","M Jarahian","A Seckinger","D Hose","L Bakiri","C Sun","Y Hu","C R Ball","H Glimm","M Sattler","H Goldschmidt","E F Wagner","P Tassone","D Jaeger","K Podar"],"twitterCount":1,"altmetricId":15454357,"statusesArray":["819910627250487299"]},{"title":"Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy","googleId":"7InKg1wJYZcJ","googleLink":"https://www.nature.com/articles/leu2017222","googleCitationCount":24,"googleAuthor":"GC Manyam","doi":"10.1038/leu.2017.222","elsevierAuthor":"Yao Z.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"17","altmetricAuthors":["Z Yao","L Deng","Z Y Xu-Monette","G C Manyam","P Jain","A Tzankov","C Visco","G Bhagat","J Wang","K Dybkaer","W Tam","E D Hsi","J H van Krieken","M Ponzoni","A J M Ferreri","M B Møller","J N Winter","M A Piris","L Fayad","Y Liu","Y Song","R Z Orlowski","H Kantarjian","L J Medeiros","Y Li","J Cortes","K H Young"],"twitterCount":1,"altmetricId":21806836,"statusesArray":["890654156112908288"]},{"title":"Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma","googleId":"W_gVsY609RcJ","googleLink":"https://www.nature.com/articles/leu2016243","googleCitationCount":32,"googleAuthor":"A Tzankov","doi":"10.1038/leu.2016.243","elsevierAuthor":"Xia Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"23","altmetricAuthors":["Y Xia","Z Y Xu-Monette","A Tzankov","X Li","G C Manyam","V Murty","G Bhagat","S Zhang","L Pasqualucci","C Visco","K Dybkaer","A Chiu","A Orazi","Y Zu","K L Richards","E D Hsi","W W L Choi","J H van Krieken","J Huh","M Ponzoni","A J M Ferreri","M B Møller","B M Parsons","J N Winter","M A Piris","J Westin","N Fowler","R N Miranda","C Y Ok","Y Li","J Li","L J Medeiros","K H Young"],"twitterCount":8,"altmetricId":10904142,"statusesArray":["834220628420984832","784134128748859393","783764166473646080","783748089395937280","783675620819468288","770751731919486978","770586423535611904","770563621977858048"]},{"title":"Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape","googleId":"-D83yZbvB5sJ","googleLink":"https://www.nature.com/articles/leu2017109","googleCitationCount":27,"googleAuthor":"P Silva","doi":"10.1038/leu.2017.109","elsevierAuthor":"Silva P.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"18","altmetricAuthors":["P Silva","M Neumann","M P Schroeder","S Vosberg","C Schlee","K Isaakidis","J Ortiz-Tanchez","L R Fransecky","T Hartung","S Türkmen","A Graf","S Krebs","H Blum","C Müller-Tidow","C Thiede","G Ehninger","H Serve","J Hecht","W E Berdel","P A Greif","C Röllig","C D Baldus"],"twitterCount":5,"altmetricId":18469340,"statusesArray":["890121652058587136","849320583800262656","849103300133867520","849068709775847425","849067620087332866"]},{"title":"RPL5 on 1p22. 1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response","googleId":"M6VhNzcjx3oJ","googleLink":"https://www.nature.com/articles/leu2016370","googleCitationCount":31,"googleAuthor":"L Fancello","doi":"10.1038/leu.2016.370","elsevierAuthor":"Hofman I.J.F.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"25","altmetricAuthors":["I J F Hofman","M van Duin","E De Bruyne","L Fancello","G Mulligan","E Geerdens","E Garelli","C Mancini","H Lemmens","M Delforge","P Vandenberghe","I Wlodarska","A Aspesi","L Michaux","K Vanderkerken","P Sonneveld","K De Keersmaecker"],"twitterCount":14,"altmetricId":14417390,"statusesArray":["821353782646706176","819450503880839168","819197332717797376","819182083780280323","817011034338848768","817005232110571520","809228437395296260","808682611027693568","808527714768580608","808514131229896704","808416976590766081","808412040784150528","805086676322111488","805035886844907520"]},{"title":"Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia","googleId":"iZmw7PSKfqQJ","googleLink":"https://www.nature.com/articles/leu2017147","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/leu.2017.147","elsevierAuthor":"Chen L.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"19","altmetricAuthors":["L Chen","H Mao","J Zhang","J Chu","S Devine","M A Caligiuri","J Yu"],"twitterCount":9,"altmetricId":20171513,"statusesArray":["1080885208407293953","1080883523698020353","1080882591027335168","1080881151613587456","873508741777285122","873192333826830336","873162234842796032","873160501517320193","864209887898861569"]},{"title":"Nucleotide excision repair is a potential therapeutic target in multiple myeloma","googleId":"41kgzfhurLoJ","googleLink":"https://www.nature.com/articles/leu2017182","googleCitationCount":26,"googleAuthor":"M Fulciniti","doi":"10.1038/leu.2017.182","elsevierAuthor":"Szalat R.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"20","altmetricAuthors":["R Szalat","M K Samur","M Fulciniti","M Lopez","P Nanjappa","A Cleynen","K Wen","S Kumar","T Perini","A S Calkins","E Reznichenko","D Chauhan","Y-T Tai","M A Shammas","K C Anderson","J-P Fermand","B Arnulf","H Avet-Loiseau","J-B Lazaro","N C Munshi"],"twitterCount":5,"altmetricId":20918728,"statusesArray":["882579919997292545","882547108418654212","874265964275261441","872979250399379456","872952891195236360"]},{"title":"Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22","googleId":"7qi6oSVvHIgJ","googleLink":"https://www.nature.com/articles/leu2016383","googleCitationCount":32,"googleAuthor":"B Gizdic","doi":"10.1038/leu.2016.383","elsevierAuthor":"Arruga F.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"26","altmetricAuthors":["F Arruga","B Gizdic","C Bologna","S Cignetto","R Buonincontri","S Serra","T Vaisitti","K Gizzi","N Vitale","G Garaffo","E Mereu","F Diop","F Neri","D Incarnato","M Coscia","J Allan","R Piva","S Oliviero","R R Furman","D Rossi","G Gaidano","S Deaglio"],"twitterCount":8,"altmetricId":15411866,"statusesArray":["823100462710788097","819669313200263169","819655959320690688","819640220559745024","819553166261940224","819543998889136128","819537181580660736","819529359723819009"]},{"title":"Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol","googleId":"siNTeCHANU8J","googleLink":"https://www.nature.com/articles/leu2016203","googleCitationCount":31,"googleAuthor":"BO Wolthers","doi":"10.1038/leu.2016.203","elsevierAuthor":"Wolthers B.O.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"24","altmetricAuthors":["B O Wolthers","T L Frandsen","J Abrahamsson","B K Albertsen","L R Helt","M Heyman","Ó G Jónsson","L T Kõrgvee","B Lund","R A Raja","K K Rasmussen","M Taskinen","M Tulstrup","G E Vaitkevičienė","R Yadav","R Gupta","K Schmiegelow"],"twitterCount":1,"altmetricId":10088402,"statusesArray":["758604928675815424"]},{"title":"Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML","googleId":"2MneLYdQ8uAJ","googleLink":"https://www.nature.com/articles/leu2017239","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.239","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"16","altmetricAuthors":["A Stengel","W Kern","M Meggendorfer","N Nadarajah","K Perglerovà","T Haferlach","C Haferlach"],"twitterCount":7,"altmetricId":22965846,"statusesArray":["893172361649848320","893157790331555841","893072374454640640","893067970045521920","893053037576687616","893052574177386496","890959770525544448"]},{"title":"Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements","googleId":"x2aohf2UpkgJ","googleLink":"https://www.nature.com/articles/leu2016362","googleCitationCount":30,"googleAuthor":"E Stalika","doi":"10.1038/leu.2016.362","elsevierAuthor":"Vardi A.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"22","altmetricAuthors":["A Vardi","E Vlachonikola","M Karypidou","E Stalika","V Bikos","K Gemenetzi","C Maramis","A Siorenta","A Anagnostopoulos","S Pospisilova","N Maglaveras","I Chouvarda","K Stamatopoulos","A Hadzidimitriou"],"twitterCount":3,"altmetricId":26689944,"statusesArray":["914475899428442114","913485046438350848","913343940941590529"]},{"title":"Why are hematopoietic stem cells so 'sexy'? On a search for developmental explanation","googleId":"6OTTW9OcTlcJ","googleLink":"https://www.nature.com/articles/leu2017148","googleCitationCount":24,"googleAuthor":"","doi":"10.1038/leu.2017.148","elsevierAuthor":"Ratajczak M.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"21","altmetricAuthors":["M Z Ratajczak"],"twitterCount":4,"altmetricId":20185266,"statusesArray":["892750449874542592","892709871749140480","866803410078765056","864439061448081408"]},{"title":"Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia","googleId":"OLXe6Il6vIgJ","googleLink":"https://www.nature.com/articles/leu2017281","googleCitationCount":21,"googleAuthor":"DC Lin","doi":"10.1038/leu.2017.281","elsevierAuthor":"Takao S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"17","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment","googleId":"7nmkfHpujHoJ","googleLink":"https://www.nature.com/articles/s41375-018-0144-7","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0144-7","elsevierAuthor":"Cheung L.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"13","altmetricAuthors":["Laurence C. Cheung","Jennifer Tickner","Anastasia M. Hughes","Patrycja Skut","Meegan Howlett","Bree Foley","Joyce Oommen","Julia E. Wells","Bo He","Sajla Singh","Grace-Alyssa Chua","Jette Ford","Charles G. Mullighan","Rishi S. Kotecha","Ursula R. Kees"],"twitterCount":7,"altmetricId":40872682,"statusesArray":["994634488255787014","994543443270553600","994541017285050369","994465035396132864","994393576803975168","994391831550013440","994001481643720705"]},{"title":"Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations","googleId":"2_j_N9l4rkcJ","googleLink":"https://www.nature.com/articles/leu2016326","googleCitationCount":29,"googleAuthor":"ML Loh","doi":"10.1038/leu.2016.326","elsevierAuthor":"Liu W.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"25","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Extracellular vesicles as potential biomarkers of acute graft-vs-host disease","googleId":"ZbWpsea36PIJ","googleLink":"https://www.nature.com/articles/leu2017277","googleCitationCount":21,"googleAuthor":"S Bruno","doi":"10.1038/leu.2017.277","elsevierAuthor":"Lia G.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"20","altmetricAuthors":["G Lia","L Brunello","S Bruno","A Carpanetto","P Omedè","M Festuccia","L Tosti","E Maffini","L Giaccone","M Arpinati","G Ciccone","M Boccadoro","A Evangelista","G Camussi","B Bruno"],"twitterCount":1,"altmetricId":24584640,"statusesArray":["903361759121203200"]},{"title":"Germline alterations in a consecutive series of acute myeloid leukemia","googleId":"X3TW4dAKZkIJ","googleLink":"https://www.nature.com/articles/s41375-018-0049-5","googleCitationCount":16,"googleAuthor":"E Pitkänen","doi":"10.1038/s41375-018-0049-5","elsevierAuthor":"Wartiovaara-Kautto U.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"7","altmetricAuthors":["Ulla Wartiovaara-Kautto","Elina A. M. Hirvonen","Esa Pitkänen","Caroline Heckman","Janna Saarela","Kaisa Kettunen","Kimmo Porkka","Outi Kilpivaara"],"twitterCount":6,"altmetricId":36114278,"statusesArray":["984685647863664640","984412458734555137","983626286735208450","983613719342141440","983610871564955648","983606761524482048","983600782195986433"]},{"title":"Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML","googleId":"S6ixjnN27iIJ","googleLink":"https://www.nature.com/articles/leu2016314","googleCitationCount":29,"googleAuthor":"D Malani","doi":"10.1038/leu.2016.314","elsevierAuthor":"Malani D.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"25","altmetricAuthors":["D Malani","A Murumägi","B Yadav","M Kontro","S Eldfors","A Kumar","R Karjalainen","M M Majumder","P Ojamies","T Pemovska","K Wennerberg","C Heckman","K Porkka","M Wolf","T Aittokallio","O Kallioniemi"],"twitterCount":10,"altmetricId":13545981,"statusesArray":["861069403340910593","861046587866271745","860966546218209281","860921769061953540","806482681030656000","806471939938250752","806470203173437440","806464273870245888","798103995671724032","797407419269836800"]},{"title":"Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants","googleId":"mzaCluWqCEMJ","googleLink":"https://www.nature.com/articles/leu2016342","googleCitationCount":31,"googleAuthor":"V Pastor","doi":"10.1038/leu.2016.342","elsevierAuthor":"Pastor V.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"19","altmetricAuthors":["V Pastor","S Hirabayashi","A Karow","J Wehrle","E J Kozyra","R Nienhold","G Ruzaike","D Lebrecht","A Yoshimi","M Niewisch","T Ripperger","G Göhring","I Baumann","S Schwarz","B Strahm","C Flotho","R C Skoda","C M Niemeyer","M W Wlodarski"],"twitterCount":1,"altmetricId":13992648,"statusesArray":["801801340905201666"]},{"title":"IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the …","googleId":"WNkiJdqsun4J","googleLink":"https://www.nature.com/articles/leu2016384","googleCitationCount":30,"googleAuthor":"J Krönke","doi":"10.1038/leu.2016.384","elsevierAuthor":"Krönke J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"23","altmetricAuthors":["J Krönke","F Kuchenbauer","M Kull","V Teleanu","L Bullinger","D Bunjes","A Greiner","S Kolmus","S Köpff","M Schreder","L-O Mügge","C Straka","M Engelhardt","H Döhner","H Einsele","F Bassermann","R Bargou","S Knop","C Langer"],"twitterCount":6,"altmetricId":15100929,"statusesArray":["921016293419077632","824294764681908224","817068825237745664","817053682873303042","817009007739236352","813780125720477696","813779584822886400"]},{"title":"Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation","googleId":"YIfvD0iElpQJ","googleLink":"https://www.nature.com/articles/leu2017256","googleCitationCount":20,"googleAuthor":"R Chakraborty","doi":"10.1038/leu.2017.256","elsevierAuthor":"Chakraborty R.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"15","altmetricAuthors":["R Chakraborty","E Muchtar","S K Kumar","F K Buadi","D Dingli","A Dispenzieri","S R Hayman","W J Hogan","P Kapoor","M Q Lacy","N Leung","R Warsame","T Kourelis","W Gonsalves","M A Gertz"],"twitterCount":5,"altmetricId":24574111,"statusesArray":["907826626251063297","907386214197743621","907293757472636929","903670653013938176","903271165300498434"]},{"title":"Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma","googleId":"g56ve7jPsp0J","googleLink":"https://www.nature.com/articles/leu2017193","googleCitationCount":23,"googleAuthor":"Q Wang","doi":"10.1038/leu.2017.193","elsevierAuthor":"Wang Q.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"18","altmetricAuthors":["Q Wang","Y Lu","R Li","Y Jiang","Y Zheng","J Qian","E Bi","C Zheng","J Hou","S Wang","Q Yi"],"twitterCount":2,"altmetricId":21221091,"statusesArray":["887390769526517760","877511439359123456"]},{"title":"Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant","googleId":"GhIGmv59LA0J","googleLink":"https://www.nature.com/articles/leu2016153","googleCitationCount":33,"googleAuthor":"A Hamasy","doi":"10.1038/leu.2016.153","elsevierAuthor":"Hamasy A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"22","altmetricAuthors":["A Hamasy","Q Wang","K E M Blomberg","D K Mohammad","L Yu","M Vihinen","A Berglöf","C I E Smith"],"twitterCount":0,"altmetricId":8647581,"statusesArray":[]},{"title":"Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia","googleId":"E9ReEkoahRQJ","googleLink":"https://www.nature.com/articles/s41375-018-0095-z","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/s41375-018-0095-z","elsevierAuthor":"Qin Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"14","altmetricAuthors":["Ya-Zhen Qin","Xiao-Jun Huang","Hong-Hu Zhu"],"twitterCount":1,"altmetricId":34344057,"statusesArray":["974047208801820673"]},{"title":"The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms","googleId":"HGHYMep5RNsJ","googleLink":"https://www.nature.com/articles/leu2017233","googleCitationCount":22,"googleAuthor":"H Zhan","doi":"10.1038/leu.2017.233","elsevierAuthor":"Zhan H.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"16","altmetricAuthors":["H Zhan","C H S Lin","Y Segal","K Kaushansky"],"twitterCount":1,"altmetricId":23501462,"statusesArray":["894700955484160007"]},{"title":"Alloreactivity: the Janus-face of hematopoietic stem cell transplantation","googleId":"iBJZnFmQGP8J","googleLink":"https://www.nature.com/articles/leu201779","googleCitationCount":24,"googleAuthor":"J Cornelissen","doi":"10.1038/leu.2017.79","elsevierAuthor":"Gratwohl A.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"12","altmetricAuthors":["A Gratwohl","A Sureda","J Cornelissen","J Apperley","P Dreger","R Duarte","H T Greinix","E Mc Grath","N Kroeger","F Lanza","A Nagler","J A Snowden","D Niederwieser","R Brand"],"twitterCount":13,"altmetricId":17398601,"statusesArray":["892972467068821505","854188150255751169","854186792978964480","854176578892423168","852786584139186180","852673126718722048","852625377881194498","852621194578866177","852463527617073152","852274580672700417","843522917262655488","842326254435078144","842301563091709952"]},{"title":"Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib","googleId":"7sse_0UWu3cJ","googleLink":"https://www.nature.com/articles/leu2016316","googleCitationCount":31,"googleAuthor":"W Thomas","doi":"10.1038/leu.2016.316","elsevierAuthor":"Kazianka L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"24","altmetricAuthors":["L Kazianka","C Drucker","C Skrabs","W Thomas","T Melchardt","S Struve","M Bergmann","P B Staber","E Porpaczy","C Einberger","M Heinz","A Hauswirth","M Raderer","I Pabinger","R Thalhammer","A Egle","C-M Wendtner","G Follows","G Hoermann","P Quehenberger","B Jilma","U Jaeger"],"twitterCount":7,"altmetricId":14540924,"statusesArray":["860396219520229377","806791252993720321","806582995587133440","806572297251389440","806565897133588480","806561682126499840","806543042459025408"]},{"title":"Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatments","googleId":"a7CWmycdl8QJ","googleLink":"https://www.nature.com/articles/s41375-018-0109-x","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/s41375-018-0109-x","elsevierAuthor":"Ghia P.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation","googleId":"4p1H9yWtDHYJ","googleLink":"https://www.nature.com/articles/leu2016280","googleCitationCount":29,"googleAuthor":"FL Nice","doi":"10.1038/leu.2016.280","elsevierAuthor":"Kollmann K.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"21","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia","googleId":"RgAGUA3nj2AJ","googleLink":"https://www.nature.com/articles/leu2016209","googleCitationCount":32,"googleAuthor":"SC Nunes","doi":"10.1038/leu.2016.209","elsevierAuthor":"Quotti Tubi L.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"27","altmetricAuthors":["L Quotti Tubi","S Canovas Nunes","A Brancalion","E Doriguzzi Breatta","S Manni","E Mandato","F Zaffino","P Macaccaro","M Carrino","K Gianesin","L Trentin","G Binotto","R Zambello","G Semenzato","C Gurrieri","F Piazza"],"twitterCount":2,"altmetricId":11010494,"statusesArray":["904001489785430017","774394525074726913"]},{"title":"Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia","googleId":"fK_BG-9svEsJ","googleLink":"https://www.nature.com/articles/leu2016279","googleCitationCount":28,"googleAuthor":"B Phipson","doi":"10.1038/leu.2016.279","elsevierAuthor":"Narayan N.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"22","altmetricAuthors":["N Narayan","L Morenos","B Phipson","S N Willis","G Brumatti","S Eggers","N Lalaoui","L M Brown","H J Kosasih","R C Bartolo","L Zhou","D Catchpoole","R Saffery","A Oshlack","G J Goodall","P G Ekert"],"twitterCount":1,"altmetricId":12970726,"statusesArray":["790695673939230720"]},{"title":"A decade of progress in myelodysplastic syndrome with chromosome 5q deletion","googleId":"YjZxDlUZp_IJ","googleLink":"https://www.nature.com/articles/s41375-018-0029-9","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/s41375-018-0029-9","elsevierAuthor":"List A.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"16","altmetricAuthors":["Alan List","Benjamin L. Ebert","Pierre Fenaux"],"twitterCount":2,"altmetricId":32696617,"statusesArray":["1118491054846566402","964459356837171201","960553452739817473"]},{"title":"NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome","googleId":"tFZq4tYJZLYJ","googleLink":"https://www.nature.com/articles/s41375-018-0147-4","googleCitationCount":15,"googleAuthor":"K Mrózek","doi":"10.1038/s41375-018-0147-4","elsevierAuthor":"Eisfeld A.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner","googleId":"wtFVkxwwOc0J","googleLink":"https://www.nature.com/articles/leu2017261","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.261","elsevierAuthor":"Peña-Martínez P.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"17","altmetricAuthors":["P Peña-Martínez","M Eriksson","R Ramakrishnan","M Chapellier","C Högberg","C Orsmark-Pietras","J Richter","A Andersson","T Fioretos","M Järås"],"twitterCount":1,"altmetricId":24070553,"statusesArray":["898871448881610752"]},{"title":"NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL","googleId":"G5vTJjye8q8J","googleLink":"https://www.nature.com/articles/leu2017294","googleCitationCount":19,"googleAuthor":"C Prieto","doi":"10.1038/leu.2017.294","elsevierAuthor":"Rauwolf K.K.","publicationName":"Cancer and Metastasis Reviews","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"0","altmetricAuthors":["C Prieto","B López-Millán","H Roca-Ho","R W Stam","D Romero-Moya","F J Rodríguez-Baena","A Sanjuan-Pla","V Ayllón","M Ramírez","M Bardini","P De Lorenzo","M G Valsecchi","M Stanulla","M Iglesias","P Ballerini","Á M Carcaboso","J Mora","F Locatelli","A Bertaina","L Padilla","Juan Carlos Rodríguez-Manzaneque","C Bueno","P Menéndez"],"twitterCount":2,"altmetricId":26865230,"statusesArray":["987282251389063169","914374335476969474"]},{"title":"Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy","googleId":"6vrOzy0UeAQJ","googleLink":"https://www.nature.com/articles/leu2017160","googleCitationCount":22,"googleAuthor":"M Swamy","doi":"10.1038/leu.2017.160","elsevierAuthor":"Grzes K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"18","altmetricAuthors":["K M Grzes","M Swamy","J L Hukelmann","E Emslie","L V Sinclair","D A Cantrell"],"twitterCount":2,"altmetricId":20652064,"statusesArray":["887956581882744833","868476919896981505"]},{"title":"Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile janus kinase inhibition","googleId":"M1DIPJMp9TwJ","googleLink":"https://www.nature.com/articles/leu201743","googleCitationCount":44,"googleAuthor":"E Leroy","doi":"10.1038/leu.2017.43","elsevierAuthor":"Leroy E.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"1","altmetricAuthors":["E Leroy","S N Constantinescu"],"twitterCount":4,"altmetricId":19812060,"statusesArray":["859853376099627009","859747293431554049","859743531052781568","859740824447442945"]},{"title":"In vitro and in vivo assessment of direct effects of simulated solar and galactic cosmic radiation on human hematopoietic stem/progenitor cells","googleId":"qIuKbw4ILrkJ","googleLink":"https://www.nature.com/articles/leu2016344","googleCitationCount":27,"googleAuthor":"G Almeida-Porada","doi":"10.1038/leu.2016.344","elsevierAuthor":"Rodman C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"15","altmetricAuthors":["C Rodman","G Almeida-Porada","S K George","J Moon","S Soker","T Pardee","M Beaty","P Guida","S P Sajuthi","C D Langefeld","S J Walker","P F Wilson","C D Porada"],"twitterCount":10,"altmetricId":14426371,"statusesArray":["1219890868888514561","1219471769305677826","848155573245890561","844837934347935744","844837726218170369","841665232808366081","839546171307732992","816086556943392768","805268095820529664","805210071710007296"]},{"title":"Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine","googleId":"t02AZ8-FWakJ","googleLink":"https://www.nature.com/articles/leu2017323","googleCitationCount":21,"googleAuthor":"RJ Molenaar","doi":"10.1038/leu.2017.323","elsevierAuthor":"Molenaar R.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"14","altmetricAuthors":["R J Molenaar","C Pleyer","T Radivoyevitch","S Sidana","A Godley","A S Advani","A T Gerds","H E Carraway","M Kalaycio","A Nazha","D J Adelstein","C Nasr","D Angelini","J P Maciejewski","N Majhail","M A Sekeres","S Mukherjee"],"twitterCount":24,"altmetricId":28518631,"statusesArray":["944783451600822272","944782766259937281","941338171744444416","941329050240471041","937919047114428421","937899354622345216","937811316110114826","937787798563647489","937787766103871488","937699595940802560","937699368722821120","937680592295968771","937655047713779712","937647506355302400","937644601220898816","937640007409459202","937628678955057152","937627772322639873","937624726884696071","937620074122289152","937597889445892096","928645368526573568","928644778782330880","928419167560019968","928279699352051712","927683690863452162"]},{"title":"Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","googleId":"PGV4jOe2frEJ","googleLink":"https://www.nature.com/articles/leu2016231","googleCitationCount":28,"googleAuthor":"Z Chen","doi":"10.1038/leu.2016.231","elsevierAuthor":"Chen Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"22","altmetricAuthors":["Z Chen","C Shao","W Wang","Z Zuo","X Mou","S J Hu","J A DiGiuseppe","Y Zu","L J Medeiros","S Hu"],"twitterCount":2,"altmetricId":10842750,"statusesArray":["771689997594271745","769120419668303872"]},{"title":"ANP32A regulates histone H3 acetylation and promotes leukemogenesis","googleId":"nCUhlh8I47QJ","googleLink":"https://www.nature.com/articles/s41375-018-0010-7","googleCitationCount":14,"googleAuthor":"B Lu","doi":"10.1038/s41375-018-0010-7","elsevierAuthor":"Yang X.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"5","altmetricAuthors":["Xuejing Yang","Bin Lu","Xueqin Sun","Cuijuan Han","Chunling Fu","Kailin Xu","Min Wang","Dengju Li","Zhichao Chen","Puneet Opal","Qiang Wen","John D. Crispino","Qian-fei Wang","Zan Huang"],"twitterCount":1,"altmetricId":33489415,"statusesArray":["966409764271017984"]},{"title":"Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients","googleId":"Q7oXnjvgUdMJ","googleLink":"https://www.nature.com/articles/leu2016195","googleCitationCount":31,"googleAuthor":"K El-Karoui","doi":"10.1038/leu.2016.195","elsevierAuthor":"Vignon M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"19","altmetricAuthors":["M Vignon","V Javaugue","M P Alexander","K El-Karoui","A Karras","D Roos-Weil","B Royer","B Asli","B Knebelmann","G Touchard","A Jaccard","B Arnulf","F Bridoux","N Leung","J P Fermand"],"twitterCount":1,"altmetricId":9932872,"statusesArray":["756251448698998784"]},{"title":"Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined …","googleId":"poHkoYGkyOcJ","googleLink":"https://www.nature.com/articles/leu2016385","googleCitationCount":29,"googleAuthor":"MJ Maurer","doi":"10.1038/leu.2016.385","elsevierAuthor":"Rossille D.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"26","altmetricAuthors":["D Rossille","I Azzaoui","A L Feldman","M J Maurer","G Labouré","M Parrens","C Pangault","T M Habermann","S M Ansell","B K Link","K Tarte","T E Witzig","T Lamy","S L Slager","M Roussel","N Milpied","J R Cerhan","T Fest"],"twitterCount":9,"altmetricId":15230846,"statusesArray":["824917389686956032","817106450224922629","817105489297346561","817033664106295296","816913701504765952","816727285826891776","816693866166419458","816690873249439744","816689390609113092"]},{"title":"First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells","googleId":"ZgRFs5tZN3YJ","googleLink":"https://www.nature.com/articles/s41375-018-0113-1","googleCitationCount":17,"googleAuthor":"M Hojjat-Farsangi","doi":"10.1038/s41375-018-0113-1","elsevierAuthor":"Hojjat-Farsangi M.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival","googleId":"yFSh17-2xzEJ","googleLink":"https://www.nature.com/articles/leu2016140","googleCitationCount":30,"googleAuthor":"E Muchtar","doi":"10.1038/leu.2016.140","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"21","altmetricAuthors":["E Muchtar","A Dispenzieri","S K Kumar","F K Buadi","M Q Lacy","S Zeldenrust","S R Hayman","N Leung","T V Kourelis","W Gonsalves","R Chakraborty","S Russell","D Dingli","J A Lust","Y Lin","P Kapoor","R Go","R A Kyle","S V Rajkumar","M A Gertz"],"twitterCount":9,"altmetricId":8156735,"statusesArray":["740218019599781890","740214478743076864","740213854282612736","740213493144555520","740059981274288128","735196659005718528","735082423126523905","735075915311374336","735071502538661888"]},{"title":"Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma","googleId":"DUBQFw2MrwYJ","googleLink":"https://www.nature.com/articles/leu2017327","googleCitationCount":20,"googleAuthor":"M D'Agostino","doi":"10.1038/leu.2017.327","elsevierAuthor":"Bringhen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"15","altmetricAuthors":["S Bringhen","M D'Agostino","L De Paoli","V Montefusco","A M Liberati","P Galieni","S Grammatico","V E Muccio","F Esma","C De Angelis","P Musto","S Ballanti","M Offidani","M T Petrucci","G Gaidano","P Corradini","A Palumbo","P Sonneveld","M Boccadoro"],"twitterCount":2,"altmetricId":30841393,"statusesArray":["944782251371515904","944598488846827521"]},{"title":"Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia","googleId":"jrTv5zzHJmgJ","googleLink":"https://www.nature.com/articles/leu2017240","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2017.240","elsevierAuthor":"Jawhar M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"15","altmetricAuthors":["M Jawhar","N Naumann","M Knut","J Score","M Ghazzawi","B Schneider","K-A Kreuzer","M Hallek","H G Drexler","J Chacko","L Wallis","A Fabarius","G Metzgeroth","W-K Hofmann","A Chase","W Tapper","A Reiter","N C P Cross"],"twitterCount":1,"altmetricId":22947189,"statusesArray":["890959773524525057"]},{"title":"Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia","googleId":"JejmyVRibicJ","googleLink":"https://www.nature.com/articles/s41375-018-0130-0","googleCitationCount":15,"googleAuthor":"S Iyer","doi":"10.1038/s41375-018-0130-0","elsevierAuthor":"Garcia E.G.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"11","altmetricAuthors":["Elaine G. Garcia","Sowmya Iyer","Sara P. Garcia","Siebe Loontiens","Ruslan I. Sadreyev","Frank Speleman","David M. Langenau"],"twitterCount":2,"altmetricId":40954898,"statusesArray":["994976668262559744","994617970772135936"]},{"title":"Structural basis of DUX4/IGH-driven transactivation","googleId":"1YzfHe4B9hwJ","googleLink":"https://www.nature.com/articles/s41375-018-0093-1","googleCitationCount":14,"googleAuthor":"J Huang","doi":"10.1038/s41375-018-0093-1","elsevierAuthor":"Schroeder M.P.","publicationName":"Scientific Reports","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"6","altmetricAuthors":["Xue Dong","Weina Zhang","Haiyan Wu","Jinyan Huang","Ming Zhang","Pengran Wang","Hao Zhang","Zhu Chen","Sai-Juan Chen","Guoyu Meng"],"twitterCount":7,"altmetricId":34823004,"statusesArray":["1105044891258810369","1104850252354502656","1104786932020719616","981883919111938048","980744976987541504","978164464695439360","977851488000122880"]},{"title":"The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia","googleId":"8l5hHC1jVG8J","googleLink":"https://www.nature.com/articles/leu2017194","googleCitationCount":20,"googleAuthor":"A Rio-Machin","doi":"10.1038/leu.2017.194","elsevierAuthor":"Rio-Machin A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"8","altmetricAuthors":["A Rio-Machin","G Gómez-López","J Muñoz","F Garcia-Martinez","A Maiques-Diaz","S Alvarez","R N Salgado","M Shrestha","R Torres-Ruiz","C Haferlach","M J Larráyoz","M J Calasanz","J Fitzgibbon","J C Cigudosa"],"twitterCount":5,"altmetricId":21290019,"statusesArray":["881086262911938560","878306948927631360","878284559468511232","878220339204939776","878206869801533440"]},{"title":"Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia","googleId":"eZ3x9mmFcFUJ","googleLink":"https://www.nature.com/articles/leu2017306","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.306","elsevierAuthor":"Topp M.S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"13","altmetricAuthors":["M S Topp","M Stelljes","G Zugmaier","P Barnette","L T Heffner","T Trippett","J Duell","R C Bargou","C Holland","J E Benjamin","M Klinger","M R Litzow"],"twitterCount":1,"altmetricId":27189742,"statusesArray":["1184358990202966016"]},{"title":"NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways","googleId":"vVr0MVM0BpEJ","googleLink":"https://www.nature.com/articles/leu2017296","googleCitationCount":18,"googleAuthor":"","doi":"10.1038/leu.2017.296","elsevierAuthor":"Benedetti D.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"10","altmetricAuthors":["D Benedetti","E Tissino","F Pozzo","T Bittolo","C Caldana","C Perini","D Martorelli","V Bravin","T D’Agaro","F M Rossi","R Bomben","E Santinelli","F Zaja","G Pozzato","A Chiarenza","F Di Raimondo","G Del Poeta","D Rossi","G Gaidano","M Dal Bo","V Gattei","A Zucchetto"],"twitterCount":2,"altmetricId":26451909,"statusesArray":["911356013940498433","911332580804489216"]},{"title":"Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy","googleId":"zWZYqOo1IL0J","googleLink":"https://www.nature.com/articles/leu2017321","googleCitationCount":18,"googleAuthor":"VK Patel","doi":"10.1038/leu.2017.321","elsevierAuthor":"Patel V.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"12","altmetricAuthors":["V K Patel","B Lamothe","M L Ayres","J Gay","J P Cheung","K Balakrishnan","C Ivan","J Morse","M Nelson","M J Keating","W G Wierda","J R Marszalek","V Gandhi"],"twitterCount":2,"altmetricId":28420649,"statusesArray":["926811989006888960","926781098381623296"]},{"title":"A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML","googleId":"A2i73F4gpEkJ","googleLink":"https://www.nature.com/articles/leu201784","googleCitationCount":24,"googleAuthor":"LM Kats","doi":"10.1038/leu.2017.84","elsevierAuthor":"Kats L.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"21","altmetricAuthors":["L M Kats","S J Vervoort","R Cole","A J Rogers","G P Gregory","E Vidacs","J Li","R Nagaraja","K E Yen","R W Johnstone"],"twitterCount":0,"altmetricId":17780775,"statusesArray":[]},{"title":"Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib","googleId":"4L5SovRQhh0J","googleLink":"https://www.nature.com/articles/leu2017264","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/leu.2017.264","elsevierAuthor":"Qiang W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"19","altmetricAuthors":["W Qiang","O Antelope","M S Zabriskie","A D Pomicter","N A Vellore","P Szankasi","D Rea","J M Cayuela","T W Kelley","M W Deininger","T O’Hare"],"twitterCount":0,"altmetricId":24021027,"statusesArray":[]},{"title":"The clonal origins of leukemic progression of myelodysplasia","googleId":"ygh7yvzlsxkJ","googleLink":"https://www.nature.com/articles/leu201717","googleCitationCount":24,"googleAuthor":"T Kim","doi":"10.1038/leu.2017.17","elsevierAuthor":"Kim T.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"20","altmetricAuthors":["T Kim","M S Tyndel","H J Kim","J-S Ahn","S H Choi","H J Park","Y-k Kim","D-H Yang","J-J Lee","S-H Jung","S Y Kim","Y H Min","J-W Cheong","S K Sohn","J H Moon","M Choi","M Lee","Z Zhang","D(D H) Kim"],"twitterCount":3,"altmetricId":24857051,"statusesArray":["905424455731744768","905420822151659521","905400732874092544"]},{"title":"Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia","googleId":"re9NbOH6MuIJ","googleLink":"https://www.nature.com/articles/s41375-018-0157-2","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0157-2","elsevierAuthor":"Ernst T.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis","googleId":"GdbyuFdI5W4J","googleLink":"https://www.nature.com/articles/leu2017318","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.318","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"17","altmetricAuthors":["A Tefferi","T L Lasho","C Finke","N Gangat","C A Hanson","R P Ketterling","A Pardanani"],"twitterCount":2,"altmetricId":28206676,"statusesArray":["932991369429188608","925684932625780736"]},{"title":"Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin","googleId":"UUZ8lnoP7PkJ","googleLink":"https://www.nature.com/articles/leu201738","googleCitationCount":24,"googleAuthor":"L Brunetti","doi":"10.1038/leu.2017.38","elsevierAuthor":"Brunetti L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"17","altmetricAuthors":["L Brunetti","V Di Battista","A Venanzi","G Schiavoni","M P Martelli","S Ascani","C Mecucci","E Tiacci","B Falini"],"twitterCount":5,"altmetricId":15774882,"statusesArray":["1008134270022569984","859105695374995456","858731316443058176","824136684887490561","824002527494598657"]},{"title":"Evidence-and consensus-based recommendations for phlebotomy in polycythemia vera","googleId":"b9Fpm8ee8mcJ","googleLink":"https://www.nature.com/articles/s41375-018-0199-5","googleCitationCount":13,"googleAuthor":"T Barbui","doi":"10.1038/s41375-018-0199-5","elsevierAuthor":"Barbui T.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"11","altmetricAuthors":["Tiziano Barbui","Francesco Passamonti","Patrizia Accorsi","Fabrizio Pane","Alessandro M. Vannucchi","Claudio Velati","Robert P. Gale","Sante Tura","Giovanni Barosi"],"twitterCount":9,"altmetricId":44245255,"statusesArray":["1056023835693088768","1044000117794254848","1043972442925019142","1014326110144753664","1014234802462117889","1014080282734071808","1014025304166338561","1013916742215716864","1012314934414213124"]},{"title":"Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era","googleId":"m5e9F2lIqIUJ","googleLink":"https://www.nature.com/articles/leu2017150","googleCitationCount":20,"googleAuthor":"L Falchi","doi":"10.1038/leu.2017.150","elsevierAuthor":"Falchi L.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"12","altmetricAuthors":["L Falchi","H M Kantarjian","S Verstovsek"],"twitterCount":2,"altmetricId":25065499,"statusesArray":["907903581747073024","906898238560751616"]},{"title":"Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?","googleId":"6BIwzWFti8YJ","googleLink":"https://www.nature.com/articles/s41375-018-0017-0","googleCitationCount":17,"googleAuthor":"C Pawlyn","doi":"10.1038/s41375-018-0017-0","elsevierAuthor":"Pawlyn C.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"13","altmetricAuthors":["Charlotte Pawlyn","Andrea Loehr","Cody Ashby","Ruslana Tytarenko","Shayu Deshpande","James Sun","Kyle Fedorchak","Tariq Mughal","Faith E. Davies","Brian A. Walker","Gareth J. Morgan"],"twitterCount":2,"altmetricId":33585839,"statusesArray":["1118491055962222592","968161420595597312","967045141079851008"]},{"title":"Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma","googleId":"gjUeLSduSlAJ","googleLink":"https://www.nature.com/articles/leu2016387","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/leu.2016.387","elsevierAuthor":"Da Silva Filho M.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"23","altmetricAuthors":["M I da Silva Filho","A Försti","N Weinhold","I Meziane","C Campo","S Huhn","J Nickel","P Hoffmann","M M Nöthen","K-H Jöckel","S Landi","J S Mitchell","D Johnson","G J Morgan","R Houlston","H Goldschmidt","A Jauch","P Milani","G Merlini","D Rowcieno","P Hawkins","U Hegenbart","G Palladini","A Wechalekar","S O Schönland","K Hemminki"],"twitterCount":9,"altmetricId":15133983,"statusesArray":["900301242018213890","885027884745850884","884928272404033538","884879978864627712","817025906908794880","817012490341126144","816698407049920512","816645361162780672","814923055109722112","814620027651575808","814619691918524416"]},{"title":"Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance","googleId":"Lx6I-kXDomwJ","googleLink":"https://www.nature.com/articles/s41375-018-0030-3","googleCitationCount":18,"googleAuthor":"A Lakshman","doi":"10.1038/s41375-018-0030-3","elsevierAuthor":"Lakshman A.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"10","altmetricAuthors":["Arjun Lakshman","Shilpa Paul","S. Vincent Rajkumar","Rhett P. Ketterling","Patricia T. Greipp","Angela Dispenzieri","Morie A Gertz","Francis K. Buadi","Martha Q. Lacy","David Dingli","Amie L. Fonder","Suzanne R. Hayman","Miriam A. Hobbs","Wilson I. Gonsalves","Yi Lisa Hwa","Prashant Kapoor","Nelson Leung","Ronald S. Go","Yi Lin","Taxiarchis V. Kourelis","Rahma Warsame","John A. Lust","Stephen J. Russell","Steven R. Zeldenrust","Robert A. Kyle","Shaji K. Kumar"],"twitterCount":34,"altmetricId":33147142,"statusesArray":["1002181535066415104","1002176709507059713","984856492883849217","984838125057986560","984829320261664773","966855514222219264","965064672788402176","964740532797825026","964205726875893761","963971996089495554","963961363805728769","963853005622796289","963842065212805122","963836901898752000","963834313468010498","963784476185767936","963773415470530561","963768635482345473","963751589944217602","963750064438030336","963644553260564483","963591781249032192","963588073765441536","963581275285151747","963564772372381696","963548342495203328","963529261746479110","963516718294425600","963499257348190208","963495789493399553","963433592247463936","963433513008680962","963411263224209408","963407408038064129","963399649234247680","963395521502236672","963395349757997057","963390202696884224","963318246488322048"]},{"title":"Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)","googleId":"cVmGjvAQ_Y8J","googleLink":"https://www.nature.com/articles/leu201747","googleCitationCount":24,"googleAuthor":"","doi":"10.1038/leu.2017.47","elsevierAuthor":"Chanan-Khan A.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"21","altmetricAuthors":["A Chanan-Khan","M Egyed","T Robak","F A Martinelli de Oliveira","M A Echeveste","S Dolan","P Desjardins","J Z Blonski","J Mei","N Golany","J Zhang","J G Gribben"],"twitterCount":11,"altmetricId":16544251,"statusesArray":["859712632667881473","834098200189480960","834074471665373186","834069480628158465","834063916951019520","833680486195159040","833680106585366529","833642646803451904","833373795108941824","833372906013020160","833371329541894144"]},{"title":"Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system","googleId":"IpfmI4eMIRoJ","googleLink":"https://www.nature.com/articles/leu2017328","googleCitationCount":18,"googleAuthor":"S Demeyer","doi":"10.1038/leu.2017.328","elsevierAuthor":"Bornschein S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"12","altmetricAuthors":["S Bornschein","S Demeyer","R Stirparo","O Gielen","C Vicente","E Geerdens","B Ghesquière","S Aerts","J Cools","C E de Bock"],"twitterCount":5,"altmetricId":29159233,"statusesArray":["978929745277501441","953889865917255680","953532256953528320","953333806735425541","953276435698987009","932665154176733185","932658686404775936","932563335022825473","932536952154341376"]},{"title":"E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271","googleId":"zbVf0B2XonYJ","googleLink":"https://www.nature.com/articles/leu2017123","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2017.123","elsevierAuthor":"Natoni A.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"13","altmetricAuthors":["A Natoni","T A G Smith","N Keane","C McEllistrim","C Connolly","A Jha","M Andrulis","E Ellert","M S Raab","S V Glavey","L Kirkham-McCarthy","S K Kumar","S C Locatelli-Hoops","I Oliva","W E Fogler","J L Magnani","M E O'Dwyer"],"twitterCount":13,"altmetricId":19580088,"statusesArray":["941988363401416704","866754973874348032","866754751144144896","858111631376699392","858024200317145089","857950166191669248","857946256844390402","857645206090502144","857574399440019456","857574399381315584","857306037992509440","857304848756346884","857229872959279104","857198854956961792","857188713687863297","857135030577049600"]},{"title":"Preclinical modeling of myelodysplastic syndromes","googleId":"BSVEkeM0yOoJ","googleLink":"https://www.nature.com/articles/leu2017172","googleCitationCount":20,"googleAuthor":"K Rouault-Pierre","doi":"10.1038/leu.2017.172","elsevierAuthor":"Rouault-Pierre K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"16","altmetricAuthors":["K Rouault-Pierre","S A Mian","M Goulard","A Abarrategi","A Di Tulio","A E Smith","A Mohamedali","S Best","A-M Nloga","A G Kulasekararaj","L Ades","C Chomienne","P Fenaux","C Dosquet","G J Mufti","D Bonnet"],"twitterCount":3,"altmetricId":32809195,"statusesArray":["968796964400791552","961524639305363456","961424502944022529"]},{"title":"Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia","googleId":"ZqXXmUFv35sJ","googleLink":"https://www.nature.com/articles/leu2016162","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2016.162","elsevierAuthor":"Ping N.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"21","altmetricAuthors":["N Ping","A Sun","Y Song","Q Wang","J Yin","W Cheng","Y Xu","L Wen","H Yao","L Ma","H Qiu","C Ruan","D Wu","S Chen"],"twitterCount":1,"altmetricId":9543215,"statusesArray":["753239328717885441"]},{"title":"Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin","googleId":"G6IXwFrfFokJ","googleLink":"https://www.nature.com/articles/s41375-018-0069-1","googleCitationCount":14,"googleAuthor":"VP Lavallée","doi":"10.1038/s41375-018-0069-1","elsevierAuthor":"Lavallée V.P.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"13","altmetricAuthors":["Vincent-Philippe Lavallée","Jalila Chagraoui","Tara MacRae","Miriam Marquis","Arnaud Bonnefoy","Jana Krosl","Sébastien Lemieux","Anne Marinier","Caroline Pabst","Georges-Étienne Rivard","Josée Hébert","Guy Sauvageau"],"twitterCount":1,"altmetricId":70360122,"statusesArray":["976126477426089986"]},{"title":"Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels","googleId":"b14f_C-CwnkJ","googleLink":"https://www.nature.com/articles/s41375-018-0211-0","googleCitationCount":13,"googleAuthor":"V Svobodova","doi":"10.1038/s41375-018-0211-0","elsevierAuthor":"Pavlasova G.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia","googleId":"ymZokqkbVw8J","googleLink":"https://www.nature.com/articles/leu2017339","googleCitationCount":17,"googleAuthor":"F He","doi":"10.1038/leu.2017.339","elsevierAuthor":"Bu J.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies","googleId":"BUlG66RHm80J","googleLink":"https://www.nature.com/articles/leu20174","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/leu.2017.4","elsevierAuthor":"Freund P.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"21","altmetricAuthors":["P Freund","M A Kerenyi","M Hager","T Wagner","B Wingelhofer","H T T Pham","M Elabd","X Han","P Valent","F Gouilleux","V Sexl","O H Krämer","B Groner","R Moriggl"],"twitterCount":2,"altmetricId":16552119,"statusesArray":["839447704652681216","833638368932139012","833584860161855488","833578514012057601"]},{"title":"HDAC1, 2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome …","googleId":"hhrTRFLRLzAJ","googleLink":"https://www.nature.com/articles/leu2017174","googleCitationCount":21,"googleAuthor":"DP Johnson","doi":"10.1038/leu.2017.174","elsevierAuthor":"Tharkar-Promod S.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"13","altmetricAuthors":["S Tharkar-Promod","D P Johnson","S E Bennett","E M Dennis","B G Banowsky","S S Jones","J R Shearstone","S N Quayle","C Min","M Jarpe","T Mosbruger","A D Pomicter","R R Miles","W Y Chen","K N Bhalla","P A Zweidler-McKay","D C Shrieve","M W Deininger","M B Chandrasekharan","S Bhaskara"],"twitterCount":4,"altmetricId":20933046,"statusesArray":["879808439022759937","873995525305008129","873932377332076545","873231965935124480"]},{"title":"Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases","googleId":"Ky7sU6U_nC8J","googleLink":"https://www.nature.com/articles/s41375-018-0143-8","googleCitationCount":15,"googleAuthor":"MM Patnaik","doi":"10.1038/s41375-018-0143-8","elsevierAuthor":"Patnaik M.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"13","altmetricAuthors":["Mrinal M. Patnaik","Ana A. Pierola","Rangit Vallapureddy","Fevzi F. Yalniz","Tapan M. Kadia","Elias J. Jabbour","Terra Lasho","Curtis A. Hanson","Rhett P. Ketterling","Hagop M. Kantarjian","Ayalew Tefferi","Guillermo Garcia-Manero"],"twitterCount":5,"altmetricId":39307835,"statusesArray":["1165457044985524226","1165412922144763904","1165404009429159936","1165396480489865216","989229279253811200"]},{"title":"Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing","googleId":"3evsD49CCSkJ","googleLink":"https://www.nature.com/articles/s41375-018-0115-z","googleCitationCount":16,"googleAuthor":"G Guo","doi":"10.1038/s41375-018-0115-z","elsevierAuthor":"Guo G.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"13","altmetricAuthors":["Guangwu Guo","Noopur S. Raje","Charles Seifer","Jake Kloeber","Randi Isenhart","Gavin Ha","Andrew J. Yee","Elizabeth K. O’Donnell","Yu-Tzu Tai","Paul G. Richardson","Giada Bianchi","Jacob P. Laubach","Diane Warren","Erica Gemme","Jordan Voisine","Julia Frede","Antonis Kokkalis","Huiyoung Yun","Valeriya Dimitrova","Tushara Vijaykumar","Matthew Meyerson","Nikhil C. Munshi","Kenneth C. Anderson","Birgit Knoechel","Jens G. Lohr"],"twitterCount":1,"altmetricId":41351056,"statusesArray":["996021457900703749"]},{"title":"Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche","googleId":"uWU7Wmhqi8IJ","googleLink":"https://www.nature.com/articles/leu2017117","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.117","elsevierAuthor":"De Rooij B.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"12","altmetricAuthors":["B de Rooij","R Polak","F Stalpers","R Pieters","M L den Boer"],"twitterCount":1,"altmetricId":19027864,"statusesArray":["854331018672844800"]},{"title":"A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target","googleId":"TopDOzrsppQJ","googleLink":"https://www.nature.com/articles/leu2017307","googleCitationCount":20,"googleAuthor":"F Yan","doi":"10.1038/leu.2017.307","elsevierAuthor":"Yan F.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"13","altmetricAuthors":["F Yan","N Shen","J X Pang","N Zhao","Y W Zhang","A M Bode","A Al-Kali","M R Litzow","B Li","S J Liu"],"twitterCount":1,"altmetricId":99041335,"statusesArray":["1355176711663607811"]},{"title":"Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita","googleId":"nZs625K5zSEJ","googleLink":"https://www.nature.com/articles/s41375-018-0125-x","googleCitationCount":13,"googleAuthor":"MW Wlodarski","doi":"10.1038/s41375-018-0125-x","elsevierAuthor":"Kirschner M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"12","altmetricAuthors":["Martin Kirschner","Angela Maurer","Marcin W. Wlodarski","Monica S. Ventura Ferreira","Anne-Sophie Bouillon","Insa Halfmeyer","Wolfgang Blau","Michael Kreuter","Martin Rosewich","Selim Corbacioglu","Joachim Beck","Michaela Schwarz","Jörg Bittenbring","Markus P. Radsak","Christian Matthias Wilk","Steffen Koschmieder","Matthias Begemann","Ingo Kurth","Mirle Schemionek","Tim H. Brümmendorf","Fabian Beier"],"twitterCount":3,"altmetricId":35123796,"statusesArray":["1252934068574044160","980897969850462211","980740614772813824"]},{"title":"A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells","googleId":"ByFSRBGqryMJ","googleLink":"https://www.nature.com/articles/leu2016352","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2016.352","elsevierAuthor":"Hasnat S.","publicationName":"International Journal of Molecular Sciences","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0","altmetricAuthors":["E J Cheadle","G Lipowska-Bhalla","S J Dovedi","E Fagnano","C Klein","J Honeychurch","T M Illidge"],"twitterCount":2,"altmetricId":15204778,"statusesArray":["823520263396618240","816219859239325697"]},{"title":"The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL","googleId":"EIME0zeoobEJ","googleLink":"https://www.nature.com/articles/leu201793","googleCitationCount":20,"googleAuthor":"AM Savino","doi":"10.1038/leu.2017.93","elsevierAuthor":"Savino A.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"14","altmetricAuthors":["A M Savino","J Sarno","L Trentin","M Vieri","G Fazio","M Bardini","C Bugarin","G Fossati","K L Davis","G Gaipa","S Izraeli","L H Meyer","G P Nolan","A Biondi","G Te Kronnie","C Palmi","G Cazzaniga"],"twitterCount":4,"altmetricId":18077112,"statusesArray":["926841134621642754","857302142515892225","857269290998710272","845330912875180033"]},{"title":"Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome","googleId":"NHuw9TLjRiEJ","googleLink":"https://www.nature.com/articles/leu2016268","googleCitationCount":24,"googleAuthor":"S Koide","doi":"10.1038/leu.2016.268","elsevierAuthor":"Hasegawa N.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"16","altmetricAuthors":["N Hasegawa","M Oshima","G Sashida","H Matsui","S Koide","A Saraya","C Wang","T Muto","K Takane","A Kaneda","K Shimoda","C Nakaseko","K Yokote","A Iwama"],"twitterCount":1,"altmetricId":12422214,"statusesArray":["783311350193754117"]},{"title":"JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia","googleId":"Vte9ySqSpq8J","googleLink":"https://www.nature.com/articles/leu2016329?report=reader","googleCitationCount":24,"googleAuthor":"E Martinez","doi":"10.1038/leu.2016.329","elsevierAuthor":"Zhou C.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"22","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm","googleId":"h4p7fdB-ae4J","googleLink":"https://www.nature.com/articles/leu20171","googleCitationCount":23,"googleAuthor":"H Yao","doi":"10.1038/leu.2017.1","elsevierAuthor":"Yao H.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"19","altmetricAuthors":["H Yao","Y Ma","Z Hong","L Zhao","S A Monaghan","M-C Hu","L J Huang"],"twitterCount":1,"altmetricId":27908970,"statusesArray":["923130783925075968"]},{"title":"Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis","googleId":"MABX6RCg7JMJ","googleLink":"https://www.nature.com/articles/leu201778","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/leu.2017.78","elsevierAuthor":"Mosoyan G.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"17","altmetricAuthors":["G Mosoyan","T Kraus","F Ye","K Eng","J D Crispino","R Hoffman","C Iancu-Rubin"],"twitterCount":6,"altmetricId":17321983,"statusesArray":["939870614197739520","938367809465106432","892329008922324992","847342939596402690","847222051781738496","846048191359270913","841453353192194048"]},{"title":"Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma","googleId":"_A5BOHBST8kJ","googleLink":"https://www.nature.com/articles/leu2016232","googleCitationCount":24,"googleAuthor":"MM Nietert","doi":"10.1038/leu.2016.232","elsevierAuthor":"Linke F.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"20","altmetricAuthors":["F Linke","M Harenberg","M M Nietert","S Zaunig","F von Bonin","A Arlt","M Szczepanowski","H A Weich","S Lutz","C Dullin","P Janovská","M Krafčíková","L Trantírek","P Ovesná","W Klapper","T Beissbarth","F Alves","V Bryja","L Trümper","J Wilting","D Kube"],"twitterCount":1,"altmetricId":10702294,"statusesArray":["766620958987653120"]},{"title":"Validation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patients","googleId":"jOhEJTx5UfIJ","googleLink":"https://www.nature.com/articles/s41375-018-0136-7","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/s41375-018-0136-7","elsevierAuthor":"Geelen I.G.P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"11","altmetricAuthors":["Inge G. P. Geelen","Fredrik Sandin","Noortje Thielen","Jeroen J. W. M. Janssen","Mels Hoogendoorn","Otto Visser","Jan J. Cornelissen","Martin Hoglund","Peter E. Westerweel"],"twitterCount":1,"altmetricId":38209675,"statusesArray":["986958832927629318"]},{"title":"Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial","googleId":"flOC6KFXFeUJ","googleLink":"https://www.nature.com/articles/leu2017111","googleCitationCount":20,"googleAuthor":"NJ Bahlis","doi":"10.1038/leu.2017.111","elsevierAuthor":"Bahlis N.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"13","altmetricAuthors":["N J Bahlis","A Corso","L-O Mugge","Z-X Shen","P Desjardins","A-M Stoppa","O Decaux","T de Revel","M Granell","G Marit","H Nahi","H Demuynck","S-Y Huang","S Basu","T H Guthrie","A Ervin-Haynes","J Marek","G Chen","T Facon"],"twitterCount":8,"altmetricId":18530447,"statusesArray":["862569289106239488","860890729924759552","859728657190965248","859727487244292097","852869060064923649","849729814911217665","849718505108799488","849630852762001408","849630828732829697"]},{"title":"Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy","googleId":"3kmgGxeTNDsJ","googleLink":"https://www.nature.com/articles/leu2016394","googleCitationCount":25,"googleAuthor":"G Cutrona","doi":"10.1038/leu.2016.394","elsevierAuthor":"Cutrona G.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"19","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia","googleId":"WOHlRvJBkvMJ","googleLink":"https://www.nature.com/articles/leu201725","googleCitationCount":22,"googleAuthor":"Y Okuno","doi":"10.1038/leu.2017.25","elsevierAuthor":"Yoshida N.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"18","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"AMKL chimeric transcription factors are potent inducers of leukemia","googleId":"7_3XCwxrr3oJ","googleLink":"https://www.nature.com/articles/leu201751","googleCitationCount":22,"googleAuthor":"P Vogel","doi":"10.1038/leu.2017.51","elsevierAuthor":"Dang J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"19","altmetricAuthors":["J Dang","S Nance","J Ma","J Cheng","M P Walsh","P Vogel","J Easton","G Song","M Rusch","A L Gedman","C Koss","J R Downing","T A Gruber"],"twitterCount":2,"altmetricId":16494085,"statusesArray":["923179606059859969","832741628884381697"]},{"title":"Genotoxic stresses promote clonal expansion of hematopoietic stem cells expressing mutant p53","googleId":"h5o9hyKBseIJ","googleLink":"https://www.nature.com/articles/leu2017325","googleCitationCount":18,"googleAuthor":"S Chen","doi":"10.1038/leu.2017.325","elsevierAuthor":"Chen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Erratum: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis","googleId":"AEc0qg7Wx1cJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609269/","googleCitationCount":25,"googleAuthor":"AM Vannucchi","doi":"10.1038/leu.2016.323","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"SHP2 is required for BCR-ABL1-induced hematologic neoplasia","googleId":"62NhdcaftMIJ","googleLink":"https://www.nature.com/articles/leu2017250","googleCitationCount":16,"googleAuthor":"S Gu","doi":"10.1038/leu.2017.250","elsevierAuthor":"Gu S.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"13","altmetricAuthors":["S Gu","A Sayad","G Chan","W Yang","Z Lu","C Virtanen","R A Van Etten","B G Neel"],"twitterCount":1,"altmetricId":23845944,"statusesArray":["897439764848291840"]},{"title":"AZA-MS: a novel multiparameter mass spectrometry method to determine the intracellular dynamics of azacitidine therapy in vivo","googleId":"5-CP_yOIzhEJ","googleLink":"https://www.nature.com/articles/leu2017340","googleCitationCount":15,"googleAuthor":"A Unnikrishnan","doi":"10.1038/leu.2017.340","elsevierAuthor":"Unnikrishnan A.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"15","altmetricAuthors":["A Unnikrishnan","A N Q Vo","R Pickford","M J Raftery","A C Nunez","A Verma","L B Hesson","J E Pimanda"],"twitterCount":13,"altmetricId":30682158,"statusesArray":["982444677243682816","968797448687767552","956405035319087104","954390875894964225","954348599466496000","954251746724937729","953727280978657281","953545634363015168","953377725544267781","953374483095568385","953351446338007040","953287097959534592","953237856129990657","953174045402349569","953173266285260800","943295384427814912"]},{"title":"Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors","googleId":"6Ksk-7yQRxkJ","googleLink":"https://www.nature.com/articles/leu2016182","googleCitationCount":24,"googleAuthor":"E Donato","doi":"10.1038/leu.2016.182","elsevierAuthor":"Donato E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"20","altmetricAuthors":["E Donato","O Croci","A Sabò","H Muller","M J Morelli","M Pelizzola","S Campaner"],"twitterCount":3,"altmetricId":9970527,"statusesArray":["827063401155268608","757711800775221248","757479290539683840"]},{"title":"Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression","googleId":"FXMdnplD0w8J","googleLink":"https://www.nature.com/articles/leu2016217","googleCitationCount":23,"googleAuthor":"GP Maiti","doi":"10.1038/leu.2016.217","elsevierAuthor":"Boysen J.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"20","altmetricAuthors":["J Boysen","M Nelson","G Magzoub","G P Maiti","S Sinha","M Goswami","S K Vesely","T D Shanafelt","N E Kay","A K Ghosh"],"twitterCount":2,"altmetricId":10258363,"statusesArray":["826821702730514433","761070949743546370"]},{"title":"Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms","googleId":"BqYQYXJIH9oJ","googleLink":"https://www.nature.com/articles/s41375-018-0135-8","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0135-8","elsevierAuthor":"Halpern A.B.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"12","altmetricAuthors":["Anna B. Halpern","Megan Othus","Emily M. Huebner","Bart L. Scott","Pamela S. Becker","Mary-Elizabeth M. Percival","Paul C. Hendrie","Kelda M. Gardner","Tara L. Chen","Sarah A. Buckley","Kaysey F. Orlowski","Asma Anwar","Frederick R. Appelbaum","Harry P. Erba","Elihu H. Estey","Roland B. Walter"],"twitterCount":3,"altmetricId":37875422,"statusesArray":["1063545393051574272","995417490795659266","995052470039609344","986315090851905536"]},{"title":"Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013","googleId":"H8_0TMwpNSoJ","googleLink":"https://www.nature.com/articles/leu201771","googleCitationCount":23,"googleAuthor":"","doi":"10.1038/leu.2017.71","elsevierAuthor":"Lehmann S.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"15","altmetricAuthors":["S Lehmann","S Deneberg","P Antunovic","Å Rangert-Derolf","H Garelius","V Lazarevic","K Myhr-Eriksson","L Möllgård","B Uggla","A Wahlin","L Wennström","M Höglund","G Juliusson"],"twitterCount":1,"altmetricId":17184504,"statusesArray":["840074140652462080"]},{"title":"Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV","googleId":"v8tHgKW0BisJ","googleLink":"https://www.nature.com/articles/s41375-018-0055-7","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/s41375-018-0055-7","elsevierAuthor":"Saussele S.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"11","altmetricAuthors":["Susanne Saussele","Rüdiger Hehlmann","Alice Fabarius","Sabine Jeromin","Ulrike Proetel","Sebastien Rinaldetti","Katharina Kohlbrenner","Hermann Einsele","Christiane Falge","Lothar Kanz","Andreas Neubauer","Michael Kneba","Frank Stegelmann","Michael Pfreundschuh","Cornelius F. Waller","Elisabeth Oppliger Leibundgut","Dominik Heim","Stefan W. Krause","Wolf-Karsten Hofmann","Joerg Hasford","Markus Pfirrmann","Martin C. Müller","Andreas Hochhaus","Michael Lauseker"],"twitterCount":0,"altmetricId":78844152,"statusesArray":[]},{"title":"The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20 …","googleId":"_pIrMQ3yddEJ","googleLink":"https://www.nature.com/articles/leu2017216","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.216","elsevierAuthor":"Garrido Castro P.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"22","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis","googleId":"IU48o4kmR2gJ","googleLink":"https://www.nature.com/articles/leu2017297","googleCitationCount":19,"googleAuthor":"JG Correa","doi":"10.1038/leu.2017.297","elsevierAuthor":"Hernández-Boluda J.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"13","altmetricAuthors":["J-C Hernández-Boluda","A Pereira","J-G Correa","A Alvarez-Larrán","F Ferrer-Marín","J-M Raya","J Martínez-López","M Pérez-Encinas","N Estrada","P Velez","M-L Fox","V García-Gutiérrez","A Payer","A Kerguelen","B Cuevas","M-A Durán","M-J Ramírez","M-T Gómez-Casares","M-I Mata-Vázquez","E Mora","C Martínez-Valverde","M Gómez","F Cervantes"],"twitterCount":6,"altmetricId":26445289,"statusesArray":["1082230533927645184","930048431946690565","930047632260653057","930045613688934400","912648634138791941","912646525699928064"]},{"title":"PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts","googleId":"__fu5Hq60V0J","googleLink":"https://www.nature.com/articles/s41375-018-0221-y","googleCitationCount":11,"googleAuthor":"","doi":"10.1038/s41375-018-0221-y","elsevierAuthor":"Marlein C.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"6","altmetricAuthors":["Christopher R. Marlein","Lyubov Zaitseva","Rachel E. Piddock","Livia Raso-Barnett","Michael A. Scott","Christopher J. Ingham","Angela Collins","Kristian M. Bowles","Stuart A. Rushworth"],"twitterCount":11,"altmetricId":45284743,"statusesArray":["1025285697933062144","1024330665205133318","1021327990242840576","1021285547543842816","1020396744515964930","1020388539761127426","1020388475814797313","1020363798220353536","1020363732541730818","1020315191718883328","1020298273352044544","1020297081590894594","1020292710714966016","1020273800691306496","1020273511393316864"]},{"title":"A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials","googleId":"KDYRUm4IpiQJ","googleLink":"https://www.nature.com/articles/leu2016303","googleCitationCount":24,"googleAuthor":"X Huang","doi":"10.1038/leu.2016.303","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0","altmetricAuthors":["G Montalban-Bravo","X Huang","E Jabbour","G Borthakur","C D DiNardo","N Pemmaraju","J Cortes","S Verstovsek","T Kadia","N Daver","W Wierda","Y Alvarado","M Konopleva","F Ravandi","Z Estrov","N Jain","A Alfonso","M Brandt","T Sneed","H-C Chen","H Yang","C Bueso-Ramos","S Pierce","E Estey","Z Bohannan","H M Kantarjian","G Garcia-Manero"],"twitterCount":30,"altmetricId":13232190,"statusesArray":["1349870380689858561","1349374991834480642","1329107781710962692","1230247764568805384","1230243206077480962","1203069018099322890","1194950538963509249","1149759146306281472","1125841543452090368","1091721938173607936","1068302576783933445","857259789159628800","856608198744264705","856607989561741312","855976601615560704","855574971434897409","855537493764079616","855513524965126144","855201934130761729","855176918441893888","855059548393963520","855045935935737856","855044673177571328","851422073872363520","845745624708395008","845682780629536768","845654281487355905","824629895867293699","824628042056208384","822678635454799872","820683309034389504","819594260857155584","819590564286988288","819590365061795840","819586985954308099","819586854630653953","819585643433132032","815270838375161856","813836300109365248","813834218484666368","812364110142799872","801555880076595207","801505455268761600","801452941337067520","801451496982323200","799036561711132673","799035954723950592","799035910008557568","799035788293980161","798999128277663744","798981610855137280","798979321067016192","794168803693240320","793578946608533504","793476205882343424","793475907109257217"]},{"title":"A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients","googleId":"_E6s1c9-nYgJ","googleLink":"https://www.nature.com/articles/leu2017210","googleCitationCount":18,"googleAuthor":"JAI Thoms","doi":"10.1038/leu.2017.210","elsevierAuthor":"Beck D.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"16","altmetricAuthors":["D Beck","J A I Thoms","C Palu","T Herold","A Shah","J Olivier","L Boelen","Y Huang","D Chacon","A Brown","M Babic","C Hahn","M Perugini","X Zhou","B J Huntly","A Schwarzer","J-H Klusmann","W E Berdel","B Wörmann","T Büchner","W Hiddemann","S K Bohlander","L B To","H S Scott","I D Lewis","R J D'Andrea","J W H Wong","J E Pimanda"],"twitterCount":3,"altmetricId":21524741,"statusesArray":["908016066735083520","907919285271584768","882547152450273281"]},{"title":"Pharmacogenomics and chemical library screens reveal a novel SCF SKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma","googleId":"aepABNtP7icJ","googleLink":"https://www.nature.com/articles/leu2016258","googleCitationCount":24,"googleAuthor":"E Malek","doi":"10.1038/leu.2016.258","elsevierAuthor":"Malek E.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"22","altmetricAuthors":["E Malek","M A Y Abdel-Malek","S Jagannathan","N Vad","R Karns","A G Jegga","A Broyl","M van Duin","P Sonneveld","F Cottini","K C Anderson","J J Driscoll"],"twitterCount":2,"altmetricId":12269906,"statusesArray":["785464907261108225","781270815023194112"]},{"title":"The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation","googleId":"aLRWOGz0CboJ","googleLink":"https://www.nature.com/articles/s41375-018-0185-y","googleCitationCount":11,"googleAuthor":"JA Fein","doi":"10.1038/s41375-018-0185-y","elsevierAuthor":"Fein J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"7","altmetricAuthors":["Joshua A. Fein","Avichai Shimoni","Myriam Labopin","Noga Shem-Tov","Ronit Yerushalmi","Hila Magen","Nadav Furie","Eli Kopel","Ivetta Danylesko","Arnon Nagler","Roni Shouval"],"twitterCount":21,"altmetricId":44200393,"statusesArray":["1014609558961115136","1013177440624095233","1012613262352019456","1012586132964552705","1012519643280441344","1012495846691176448","1012437919095812097","1012420638743650309","1012418598139256833","1012409026884358151","1012352007212941314","1012350431262052352","1012348842489106434","1012345489830875136","1012262231558574080","1012205233462824960","1012152527327055872","1012032940023435265","1011992671844352000","1011988303879528449","1011968027405848578"]},{"title":"Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia","googleId":"CMu6lhFWkZgJ","googleLink":"https://www.nature.com/articles/leu2017282","googleCitationCount":18,"googleAuthor":"SJ Vervoort","doi":"10.1038/leu.2017.282","elsevierAuthor":"Waibel M.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"12","altmetricAuthors":["M Waibel","S J Vervoort","I Y Kong","S Heinzel","K M Ramsbottom","B P Martin","E D Hawkins","R W Johnstone"],"twitterCount":3,"altmetricId":25320269,"statusesArray":["909036028127670272","909018568804548608","908996163558268928"]},{"title":"A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone","googleId":"VA8RxIpsKuwJ","googleLink":"https://www.nature.com/articles/s41375-018-0121-1","googleCitationCount":13,"googleAuthor":"MM Patnaik","doi":"10.1038/s41375-018-0121-1","elsevierAuthor":"Patnaik M.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"12","altmetricAuthors":["Mrinal M. Patnaik","Rangit Vallapureddy","Terra L. Lasho","Katherine P. Hoversten","Christy M. Finke","Rhett P. Ketterling","Curtis A. Hanson","Naseema Gangat","Ayalew Tefferi","Animesh Pardanani"],"twitterCount":23,"altmetricId":53610268,"statusesArray":["1275941945282617347","1275938275430027264","1275931471140712448","1275922927045705728","1275823376632856577","1275822871332499458","1164706442693115904","1164685877995560965","1164589125800005632","1164574615957454848","1164558729754349569","1164558107252535298","1164544786402930689","1164488627130265601","1164485820046303232","1164442509235257346","1164405216671703040","1164400853798871040","1164368174441254912","1164364914695299072","1164356064827117568","1164355117497425920","1164344495279943682","1164338605705302016"]},{"title":"Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the …","googleId":"uXWPNnk4LTcJ","googleLink":"https://www.nature.com/articles/leu2017128","googleCitationCount":21,"googleAuthor":"M Van der Meulen","doi":"10.1038/leu.2017.128","elsevierAuthor":"Van Der Meulen M.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"14","altmetricAuthors":["M van der Meulen","A G Dinmohamed","O Visser","J K Doorduijn","J E C Bromberg"],"twitterCount":1,"altmetricId":19735658,"statusesArray":["877052071182204928","861808005611966464","858587170952683520"]},{"title":"Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition","googleId":"z0yCbk8iwG0J","googleLink":"https://www.nature.com/articles/leu2017129","googleCitationCount":17,"googleAuthor":"R Thijssen","doi":"10.1038/leu.2017.129","elsevierAuthor":"Slinger E.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia","googleId":"FEu4pFjcvbcJ","googleLink":"https://www.nature.com/articles/leu2016202","googleCitationCount":24,"googleAuthor":"S Eldfors","doi":"10.1038/leu.2016.202","elsevierAuthor":"Eldfors S.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"16","altmetricAuthors":["S Eldfors","H Kuusanmäki","M Kontro","M M Majumder","A Parsons","H Edgren","T Pemovska","O Kallioniemi","K Wennerberg","N Gökbuget","T Burmeister","K Porkka","C A Heckman"],"twitterCount":5,"altmetricId":11010492,"statusesArray":["774473274227032065","774140128948162560","773858336940982273","773845610906595334","772490478121914368"]},{"title":"Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia","googleId":"oZ96OdPnXxQJ","googleLink":"https://www.nature.com/articles/leu201724","googleCitationCount":22,"googleAuthor":"SE Karol","doi":"10.1038/leu.2017.24","elsevierAuthor":"Karol S.E.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma","googleId":"GOZ7oGisAZgJ","googleLink":"https://www.nature.com/articles/leu201794","googleCitationCount":21,"googleAuthor":"A Dzikiewicz-Krawczyk","doi":"10.1038/leu.2017.94","elsevierAuthor":"Dzikiewicz-Krawczyk A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"16","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Copy-number analysis identified new prognostic marker in acute myeloid leukemia","googleId":"Ac6lWJRXDDAJ","googleLink":"https://www.nature.com/articles/leu2016265","googleCitationCount":22,"googleAuthor":"N Pottier","doi":"10.1038/leu.2016.265","elsevierAuthor":"Nibourel O.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"19","altmetricAuthors":["O Nibourel","S Guihard","C Roumier","N Pottier","C Terre","A Paquet","P Peyrouze","S Geffroy","S Quentin","A Alberdi","R B Abdelali","A Renneville","C Demay","K Celli-Lebras","P Barbry","B Quesnel","S Castaigne","H Dombret","J Soulier","C Preudhomme","M H Cheok"],"twitterCount":1,"altmetricId":22732626,"statusesArray":["925328922996363264"]},{"title":"Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis","googleId":"anbixTwdY-8J","googleLink":"https://www.nature.com/articles/leu2017330","googleCitationCount":16,"googleAuthor":"AW Roberts","doi":"10.1038/leu.2017.330","elsevierAuthor":"Pardanani A.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"MLL is essential for NUP98-HOXA9-induced leukemia","googleId":"rJIhGIfuLlQJ","googleLink":"https://www.nature.com/articles/leu201762","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2017.62","elsevierAuthor":"Shima Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"16","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia","googleId":"3ef960by7m8J","googleLink":"https://www.nature.com/articles/leu2017342","googleCitationCount":16,"googleAuthor":"AG Sanarico","doi":"10.1038/leu.2017.342","elsevierAuthor":"Sanarico A.G.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"12","altmetricAuthors":["A G Sanarico","C Ronchini","A Croce","E M Memmi","U A Cammarata","A De Antoni","S Lavorgna","M Divona","L Giacò","G E M Melloni","A Brendolan","G Simonetti","G Martinelli","P Mancuso","F Bertolini","F Lo Coco","G Melino","P G Pelicci","F Bernassola"],"twitterCount":3,"altmetricId":31492003,"statusesArray":["1041089172134612997","1040720048711761920","951021435220381699"]},{"title":"S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells","googleId":"9Un8KA5-jR8J","googleLink":"https://www.nature.com/articles/leu2017275","googleCitationCount":17,"googleAuthor":"M Ibrahim","doi":"10.1038/leu.2017.275","elsevierAuthor":"Vrzalikova K.","publicationName":"Leukemia","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"1 August 2019","elsevierCitationCount":"0","altmetricAuthors":["K Vrzalikova","M Ibrahim","M Vockerodt","T Perry","S Margielewska","L Lupino","E Nagy","E Soilleux","D Liebelt","R Hollows","A Last","G Reynolds","M Abdullah","H Curley","M Care","D Krappmann","R Tooze","J Allegood","S Spiegel","W Wei","C B J Woodman","P G Murray"],"twitterCount":4,"altmetricId":24984780,"statusesArray":["924228265954361344","923886927786512384","921254259479535616","906340902343340032"]},{"title":"Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial","googleId":"N556-ZjSmfgJ","googleLink":"https://www.nature.com/articles/leu2016298","googleCitationCount":23,"googleAuthor":"MJJ Rose-Zerilli","doi":"10.1038/leu.2016.298","elsevierAuthor":"Larrayoz M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"16","altmetricAuthors":["M Larrayoz","M J J Rose-Zerilli","L Kadalayil","H Parker","S Blakemore","J Forster","Z Davis","A J Steele","A Collins","M Else","D Catovsky","D G Oscier","J C Strefford"],"twitterCount":1,"altmetricId":13007734,"statusesArray":["826822023380873216"]},{"title":"Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms","googleId":"zMjJhD_eXEgJ","googleLink":"https://www.nature.com/articles/leu2017190","googleCitationCount":16,"googleAuthor":"A Chase","doi":"10.1038/leu.2017.190","elsevierAuthor":"Rinke J.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"10","altmetricAuthors":["J Rinke","J P Müller","M F Blaess","A Chase","M Meggendorfer","V Schäfer","N Winkelmann","C Haferlach","N C P Cross","A Hochhaus","T Ernst"],"twitterCount":3,"altmetricId":21195086,"statusesArray":["877533857242767361","877194594894655489","877131817052131333"]},{"title":"TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome","googleId":"gZehssIxDBUJ","googleLink":"https://www.nature.com/articles/leu2017176","googleCitationCount":17,"googleAuthor":"P Villarese","doi":"10.1038/leu.2017.176","elsevierAuthor":"Villarese P.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"14","altmetricAuthors":["P Villarese","C Lours","A Trinquand","S Le Noir","M Belhocine","L Lhermitte","A Cieslak","M Tesio","A Petit","M LeLorch","S Spicuglia","N Ifrah","H Dombret","A W Langerak","N Boissel","E Macintyre","V Asnafi"],"twitterCount":2,"altmetricId":20918724,"statusesArray":["873119436797911041","872952732306550784"]},{"title":"Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents","googleId":"1sFGbdEO1GUJ","googleLink":"https://www.nature.com/articles/s41375-018-0098-9","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/s41375-018-0098-9","elsevierAuthor":"Avet-Loiseau H.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse","googleId":"kNWGjpAZyhQJ","googleLink":"https://www.nature.com/articles/leu2017285","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.285","elsevierAuthor":"Boddu P.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"16","altmetricAuthors":["P Boddu","J Jorgensen","H Kantarjian","G Borthakur","T Kadia","N Daver","Y Alvarado","N Pemmaraju","P Bose","K Naqvi","M Yilmaz","S Pierce","M Brandt","C D DiNardo","E J Jabbour","M Konopleva","G Garcia-Manero","J Cortes","F Ravandi"],"twitterCount":5,"altmetricId":26387393,"statusesArray":["946012516773187585","945841672621092865","945833171349798912","945822248002375681","937017403439017988"]},{"title":"Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia","googleId":"Jk4UWJMNpGAJ","googleLink":"https://www.nature.com/articles/leu2016392","googleCitationCount":21,"googleAuthor":"WS Liau","doi":"10.1038/leu.2016.392","elsevierAuthor":"Liau W.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"16","altmetricAuthors":["W S Liau","S H Tan","P C T Ngoc","C Q Wang","V Tergaonkar","H Feng","Z Gong","M Osato","A T Look","T Sanda"],"twitterCount":2,"altmetricId":15218260,"statusesArray":["818187396042936320","818077351678504962","816479345669767169"]},{"title":"The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response","googleId":"lgsJ_pSjy8sJ","googleLink":"https://www.nature.com/articles/s41375-018-0022-3","googleCitationCount":14,"googleAuthor":"S Sidana","doi":"10.1038/s41375-018-0022-3","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"12","altmetricAuthors":["Surbhi Sidana","Nidhi Tandon","Angela Dispenzieri","Morie A. Gertz","S. Vincent Rajkumar","Shaji K. Kumar"],"twitterCount":10,"altmetricId":33266595,"statusesArray":["988108327161769984","977578446741221376","977526717727244288","977526197209853952","964744100497903616","964587678980362241","964357020705988609","964331927284211712","964326273156833280","964325024265134084"]},{"title":"Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma","googleId":"jAssFoqdYIYJ","googleLink":"https://www.nature.com/articles/leu201783","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.83","elsevierAuthor":"Einsele H.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"16","altmetricAuthors":["H Einsele","S Knop","M Vogel","J Müller","M Kropff","B Metzner","C Langer","H Sayer","W Jung","H A Dürk","H Salwender","H Wandt","F Bassermann","M Gramatzki","W Rösler","H-H Wolf","W Brugger","M Engelhardt","T Fischer","P Liebisch","C Straka"],"twitterCount":8,"altmetricId":17409376,"statusesArray":["868806143514214400","862979864479092737","862839656240566273","844174257269723136","842979731230281728","842469339282432000","842393118272065536","842375272125075457"]},{"title":"Loss of p300 accelerates MDS-associated leukemogenesis","googleId":"LHLX7pfA0pEJ","googleLink":"https://www.nature.com/articles/leu2016347","googleCitationCount":23,"googleAuthor":"T Asai","doi":"10.1038/leu.2016.347","elsevierAuthor":"Cheng G.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"16","altmetricAuthors":["G Cheng","F Liu","T Asai","F Lai","N Man","H Xu","S Chen","S Greenblatt","P-J Hamard","K Ando","X Chen","L Wang","C Martinez","M Tadi","L Wang","M Xu","F-C Yang","R Shiekhattar","S D Nimer"],"twitterCount":1,"altmetricId":18175872,"statusesArray":["854700893278806016"]},{"title":"Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia","googleId":"6_R9sMoHu1AJ","googleLink":"https://www.nature.com/articles/leu2017157","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.157","elsevierAuthor":"Tesio M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients","googleId":"RTTtyEs8JxQJ","googleLink":"https://www.nature.com/articles/s41375-018-0028-x","googleCitationCount":16,"googleAuthor":"M Nicolosi","doi":"10.1038/s41375-018-0028-x","elsevierAuthor":"Nicolosi M.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia","googleId":"hkFaHOewjd8J","googleLink":"https://www.nature.com/articles/leu2017151","googleCitationCount":16,"googleAuthor":"E Bernson","doi":"10.1038/leu.2017.151","elsevierAuthor":"Bernson E.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"10","altmetricAuthors":["E Bernson","A Hallner","F E Sander","O Wilsson","O Werlenius","A Rydström","R Kiffin","M Brune","R Foà","J Aurelius","A Martner","K Hellstrand","F B Thorén"],"twitterCount":10,"altmetricId":20404906,"statusesArray":["943437097519730688","882672861340725248","876227173492903937","870281513790787584","867280566722449409","867131473509453827","867110423807406080","866978290678063104","866971747848904704","866959191428272128"]},{"title":"Targeting nucleolin for better survival in diffuse large B-cell lymphoma","googleId":"b3fMuxhAAzUJ","googleLink":"https://www.nature.com/articles/leu2017215","googleCitationCount":16,"googleAuthor":"R Mathur","doi":"10.1038/leu.2017.215","elsevierAuthor":"Jain N.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"11","altmetricAuthors":["N Jain","H Zhu","T Khashab","Q Ye","B George","R Mathur","R K Singh","Z Berkova","J F Wise","F K Braun","X Wang","K Patel","Z Y Xu-Monette","J Courty","K H Young","L Sehgal","F Samaniego"],"twitterCount":3,"altmetricId":21723109,"statusesArray":["888115370606735360","884734068390277121","884431038776266757"]},{"title":"Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient","googleId":"ASPDdP7AWeMJ","googleLink":"https://www.nature.com/articles/leu2017104","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.104","elsevierAuthor":"Herold S.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"14","altmetricAuthors":["S Herold","M Kuhn","M v Bonin","T Stange","U Platzbecker","J Radke","T Lange","K Sockel","K Gutsche","J Schetelig","C Röllig","C Schuster","I Roeder","A Dahl","B Mohr","H Serve","C Brandts","G Ehninger","M Bornhäuser","C Thiede"],"twitterCount":1,"altmetricId":21534923,"statusesArray":["882729040620253184"]},{"title":"Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes","googleId":"N3wKl_9S0foJ","googleLink":"https://www.nature.com/articles/s41375-018-0112-2","googleCitationCount":14,"googleAuthor":"S Abdelhamed","doi":"10.1038/s41375-018-0112-2","elsevierAuthor":"Hosseini M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"11","altmetricAuthors":["Mona M. Hosseini","Stephen E. Kurtz","Sherif Abdelhamed","Shawn Mahmood","Monika A. Davare","Andy Kaempf","Johannes Elferich","Jason E. McDermott","Tao Liu","Samuel H. Payne","Ujwal Shinde","Karin D. Rodland","Motomi Mori","Brian J. Druker","Jack W. Singer","Anupriya Agarwal"],"twitterCount":1,"altmetricId":44273177,"statusesArray":["1012539370593832960"]},{"title":"Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute …","googleId":"tys_6wM1degJ","googleLink":"https://www.nature.com/articles/leu2016341","googleCitationCount":21,"googleAuthor":"C Cerella","doi":"10.1038/leu.2016.341","elsevierAuthor":"Cerella C.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14","altmetricAuthors":["C Cerella","A Gaigneaux","A Mazumder","J-Y Lee","E Saland","F Radogna","T Farge","F Vergez","C Récher","J-E Sarry","K-W Kim","H Y Shin","M Dicato","M Diederich"],"twitterCount":4,"altmetricId":13960359,"statusesArray":["802048743113682944","801994598465859584","801806444043599872","801672060640428032"]},{"title":"Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells","googleId":"3l_YxCN02kEJ","googleLink":"https://www.nature.com/articles/s41375-018-0032-1","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0032-1","elsevierAuthor":"Casado P.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"11","altmetricAuthors":["Pedro Casado","Edmund H. Wilkes","Farideh Miraki-Moud","Marym Mohammad Hadi","Ana Rio-Machin","Vinothini Rajeeve","Rebecca Pike","Sameena Iqbal","Santiago Marfa","Nicholas Lea","Steven Best","John Gribben","Jude Fitzgibbon","Pedro R. Cutillas"],"twitterCount":5,"altmetricId":35872313,"statusesArray":["1084847970749726720","983194773895888897","983030713090949120","982991628615864320","982979077752610816","982956212936368129","982925518876979202"]},{"title":"Proposed diagnostic criteria and classification of basophilic leukemias and related disorders","googleId":"xHZDl_mvQpIJ","googleLink":"https://www.nature.com/articles/leu201715","googleCitationCount":21,"googleAuthor":"K Hartmann","doi":"10.1038/leu.2017.15","elsevierAuthor":"Valent P.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"13","altmetricAuthors":["P Valent","K Sotlar","K Blatt","K Hartmann","A Reiter","I Sadovnik","W R Sperr","P Bettelheim","C Akin","K Bauer","T I George","E Hadzijusufovic","D Wolf","J Gotlib","F-X Mahon","D D Metcalfe","H-P Horny","M Arock"],"twitterCount":2,"altmetricId":15590924,"statusesArray":["851376930372947969","822121260507340802"]},{"title":"Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach","googleId":"EyA5InbjMqAJ","googleLink":"https://www.nature.com/articles/leu201749","googleCitationCount":20,"googleAuthor":"A Coppe","doi":"10.1038/leu.2017.49","elsevierAuthor":"Coppe A.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"15","altmetricAuthors":["A Coppe","E I Andersson","A Binatti","V R Gasparini","S Bortoluzzi","M Clemente","M Herling","J Maciejewski","S Mustjoki","S Bortoluzzi"],"twitterCount":2,"altmetricId":16208718,"statusesArray":["830003972014534656","829086203781795841"]},{"title":"Histone deacetylase inhibitors interrupt HSP90• RASGRP1 and HSP90• CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells","googleId":"BhSQDpQf0IUJ","googleLink":"https://www.nature.com/articles/leu2016357","googleCitationCount":19,"googleAuthor":"H Ding","doi":"10.1038/leu.2016.357","elsevierAuthor":"Ding H.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis","googleId":"adAotowuBp0J","googleLink":"https://www.nature.com/articles/s41375-018-0085-1","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0085-1","elsevierAuthor":"Verbiest T.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"8","altmetricAuthors":["Tom Verbiest","Rosemary Finnon","Natalie Brown","Lourdes Cruz-Garcia","Paul Finnon","Grainne O’Brien","Eleanor Ross","Simon Bouffler","Cheryl L. Scudamore","Christophe Badie"],"twitterCount":2,"altmetricId":34147295,"statusesArray":["972160710582161408","972152605207158784"]},{"title":"Kinase domain activation through gene rearrangement in multiple myeloma","googleId":"NBh0NIG-I8UJ","googleLink":"https://www.nature.com/articles/s41375-018-0108-y","googleCitationCount":11,"googleAuthor":"GJ Morgan","doi":"10.1038/s41375-018-0108-y","elsevierAuthor":"Morgan G.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"6","altmetricAuthors":["Gareth J Morgan","Jie He","Ruslana Tytarenko","Purvi Patel","Owen W Stephens","Shan Zhong","Shayu Deshpande","Michael Bauer","Niels Weinhold","Carolina Schinke","Leo Rasche","Mark Bailey","Siraj Ali","Jeff Ross","Vincent A Miller","Phillip Stephens","Sharmilan Thanendrarajan","Maurizio Zangari","Frits van Rhee","Tariq Mughal","Faith E Davies","Brian A Walker"],"twitterCount":1,"altmetricId":37052965,"statusesArray":["984885249183281157"]},{"title":"NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia","googleId":"1LM5OH8PDucJ","googleLink":"https://www.nature.com/articles/s41375-018-0245-3","googleCitationCount":8,"googleAuthor":"M Tulstrup","doi":"10.1038/s41375-018-0245-3","elsevierAuthor":"Tulstrup M.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"6","altmetricAuthors":["Morten Tulstrup","Marie Grosjean","Stine Nygaard Nielsen","Kathrine Grell","Benjamin Ole Wolthers","Peder Skov Wegener","Olafur Gisli Jonsson","Bendik Lund","Arja Harila-Saari","Jonas Abrahamsson","Goda Vaitkeviciene","Kaie Pruunsild","Nina Toft","Mette Holm","Erik Hulegårdh","Sigurd Liestøl","Laimonas Griskevicius","Mari Punab","Jinhua Wang","William L. Carroll","Zeyu Zhang","Marlene D. Dalgaard","Ramneek Gupta","Jacob Nersting","Kjeld Schmiegelow"],"twitterCount":3,"altmetricId":48062039,"statusesArray":["1164214634015944704","1039892348044496897","1039144852699508736"]},{"title":"Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms","googleId":"UzrfNvcFoY4J","googleLink":"https://www.nature.com/articles/s41375-018-0190-1","googleCitationCount":12,"googleAuthor":"T Osumi","doi":"10.1038/s41375-018-0190-1","elsevierAuthor":"Tsujimoto S.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"7","altmetricAuthors":["Shinichi Tsujimoto","Tomoo Osumi","Meri Uchiyama","Ryota Shirai","Takaya Moriyama","Rina Nishii","Yuji Yamada","Ko Kudo","Masahiro Sekiguchi","Yuki Arakawa","Masanori Yoshida","Toru Uchiyama","Kiminori Terui","Shuichi Ito","Katsuyoshi Koh","Junko Takita","Etsuro Ito","Daisuke Tomizawa","Atsushi Manabe","Nobutaka Kiyokawa","Jun J. Yang","Motohiro Kato"],"twitterCount":1,"altmetricId":44391779,"statusesArray":["1013699560831504387"]},{"title":"Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway","googleId":"bLp_rJyYonoJ","googleLink":"https://www.nature.com/articles/leu2016287","googleCitationCount":24,"googleAuthor":"J Xin","doi":"10.1038/leu.2016.287","elsevierAuthor":"Xin J.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"17","altmetricAuthors":["J Xin","D You","P Breslin","J Li","J Zhang","W Wei","J Cannova","A Volk","R Gutierrez","Y Xiao","A Ni","G Ng","R Schmidt","Z Xia","J Pan","H Chen","M M Patel","P C Kuo","S Nand","A R Kini","J Zhang","J Chen","J Zhu","J Zhang"],"twitterCount":0,"altmetricId":23066513,"statusesArray":[]},{"title":"A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma","googleId":"tEMlLl81BLAJ","googleLink":"https://www.nature.com/articles/leu2016239","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2016.239","elsevierAuthor":"Bonsignore L.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"17","altmetricAuthors":["L Bonsignore","K Passelli","C Pelzer","M Perroud","A Konrad","M Thurau","M Stürzl","L Dai","J Trillo-Tinoco","L Del Valle","Z Qin","M Thome"],"twitterCount":2,"altmetricId":10729551,"statusesArray":["767178702941663233","767151251536486400"]},{"title":"Heavy+ light chain monitoring correlates with clinical outcome in multiple myeloma patients","googleId":"MZodUHfd5ecJ","googleLink":"https://www.nature.com/articles/leu2017209","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.209","elsevierAuthor":"Michallet M.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"12","altmetricAuthors":["M Michallet","C Chapuis-Cellier","T Dejoie","C Lombard","H Caillon","M Sobh","P Moreau","M Attal","H Avet-Loiseau"],"twitterCount":8,"altmetricId":21478916,"statusesArray":["891401341662265344","888602028397797376","883836769128644608","883258943174316032","881918169731915776","881719537774866432","881623503019155456","881618482214821888"]},{"title":"Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin","googleId":"lRLslndOmEwJ","googleLink":"https://www.nature.com/articles/leu2016165","googleCitationCount":20,"googleAuthor":"MN Cruickshank","doi":"10.1038/leu.2016.165","elsevierAuthor":"Cruickshank M.N.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"11","altmetricAuthors":["M N Cruickshank","J Ford","L C Cheung","J Heng","S Singh","J Wells","T W Failes","G M Arndt","N Smithers","R K Prinjha","D Anderson","K W Carter","A M Gout","T Lassmann","J O'Reilly","C H Cole","R S Kotecha","U R Kees"],"twitterCount":2,"altmetricId":9970523,"statusesArray":["816855392747716608","759011052654768128"]},{"title":"Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing","googleId":"QDhtY-CxCYQJ","googleLink":"https://www.nature.com/articles/leu2017270","googleCitationCount":14,"googleAuthor":"A Zamò","doi":"10.1038/leu.2017.270","elsevierAuthor":"Zamò A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"14","altmetricAuthors":["A Zamò","J Pischimarov","M Schlesner","P Rosenstiel","R Bomben","H Horn","T Grieb","T Nedeva","C López","A Haake","J Richter","L Trümper","C Lawerenz","W Klapper","P Möller","M Hummel","D Lenze","M Szczepanowski","L Flossbach","M Schreder","V Gattei","G Ott","R Siebert","A Rosenwald","E Leich"],"twitterCount":4,"altmetricId":24157242,"statusesArray":["900080044059525120","899996023916908544","899934317987610626","899790069745070080"]},{"title":"Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2","googleId":"cu9JEjN93CEJ","googleLink":"https://www.nature.com/articles/leu2017298","googleCitationCount":14,"googleAuthor":"M Faisal","doi":"10.1038/leu.2017.298","elsevierAuthor":"Bartels S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"10","altmetricAuthors":["S Bartels","M Faisal","G Büsche","J Schlue","H Kreipe","U Lehmann"],"twitterCount":2,"altmetricId":26445288,"statusesArray":["911355933497884672","911332654225723394"]},{"title":"Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden","googleId":"QX3YrabFOJIJ","googleLink":"https://www.nature.com/articles/leu2016312","googleCitationCount":20,"googleAuthor":"V Lazarevic","doi":"10.1038/leu.2016.312","elsevierAuthor":"Juliusson G.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"10","altmetricAuthors":["G Juliusson","J Abrahamsson","V Lazarevic","P Antunovic","Å Derolf","H Garelius","S Lehmann","K Myhr-Eriksson","L Möllgård","B Uggla","A Wahlin","L Wennström","M Höglund"],"twitterCount":0,"altmetricId":22723712,"statusesArray":[]},{"title":"FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome","googleId":"qEdITKXg5tQJ","googleLink":"https://www.nature.com/articles/s41375-018-0124-y","googleCitationCount":9,"googleAuthor":"T Hu","doi":"10.1038/s41375-018-0124-y","elsevierAuthor":"Hu T.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions","googleId":"kd1gCx3KtMsJ","googleLink":"https://www.nature.com/articles/leu2016395","googleCitationCount":18,"googleAuthor":"SE Dunn","doi":"10.1038/leu.2016.395","elsevierAuthor":"Li Y.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"12","altmetricAuthors":["Y-J Li","L Sun","Y Shi","G Wang","X Wang","S E Dunn","C Iorio","R A Screaton","D E Spaner"],"twitterCount":1,"altmetricId":15410851,"statusesArray":["819514552123527168"]},{"title":"Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality","googleId":"EP9oKOwTUW4J","googleLink":"https://www.nature.com/articles/leu2017260","googleCitationCount":14,"googleAuthor":"K Durkin","doi":"10.1038/leu.2017.260","elsevierAuthor":"Artesi M.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"9","altmetricAuthors":["M Artesi","A Marçais","K Durkin","N Rosewick","V Hahaut","F Suarez","A Trinquand","L Lhermitte","V Asnafi","V Avettand-Fenoel","A Burny","M Georges","O Hermine","A Van den Broeke"],"twitterCount":7,"altmetricId":23907861,"statusesArray":["1019268950029369345","1019243035157192704","906824702198415360","906510472819724289","905706068931698688","905500744329166852","905436579916902400","905383169888804864","897800713786597376"]},{"title":"Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes","googleId":"cf7Wf1IyNyUJ","googleLink":"https://www.nature.com/articles/leu2017122","googleCitationCount":16,"googleAuthor":"MV Mateos","doi":"10.1038/leu.2017.122","elsevierAuthor":"Tangen J.","publicationName":"BMC Cancer","elsevierCoverDate":"2018-08-08","elsevierCoverDisplayDate":"8 August 2018","elsevierCitationCount":"3","altmetricAuthors":["P Hari","M-V Mateos","R Abonour","S Knop","W Bensinger","H Ludwig","K Song","R Hajek","P Moreau","D S Siegel","S Feng","M Obreja","S K Aggarwal","K Iskander","H Goldschmidt"],"twitterCount":12,"altmetricId":19639099,"statusesArray":["942018669902745600","858879817596510208","858872398195642368","858826577106407427","858822763355799552","858819761744080896","858785439926321153","858781037689790464","858270805326794753","858019926434603008","857976494987063296","857975886192291840","857580106822189057"]},{"title":"Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms","googleId":"9FbxpyV-77sJ","googleLink":"https://www.nature.com/articles/leu2016295","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2016.295","elsevierAuthor":"Visconte V.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"15","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression","googleId":"ZYmA2NsQufkJ","googleLink":"https://www.nature.com/articles/leu201774","googleCitationCount":15,"googleAuthor":"H Gazon","doi":"10.1038/leu.2017.74","elsevierAuthor":"Terol M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"11","altmetricAuthors":["M Terol","H Gazon","I Lemasson","M Duc-Dodon","B Barbeau","R Césaire","J-M Mesnard","J-M Péloponèse Jr"],"twitterCount":2,"altmetricId":18060828,"statusesArray":["923134057713565697","845209870001307648"]},{"title":"Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia","googleId":"J89g_lgodsAJ","googleLink":"https://www.nature.com/articles/leu2017140","googleCitationCount":16,"googleAuthor":"I Wilson","doi":"10.1038/leu.2017.140","elsevierAuthor":"Abarrategi A.","publicationName":"Journal of Experimental Medicine","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"36","altmetricAuthors":["A Elder","S Bomken","I Wilson","H J Blair","S Cockell","F Ponthan","K Dormon","D Pal","O Heidenreich","J Vormoor"],"twitterCount":3,"altmetricId":20200292,"statusesArray":["865239500603215875","865060641052250112","864624326116597760"]},{"title":"Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab","googleId":"jOdOsVrhpJoJ","googleLink":"https://www.nature.com/articles/s41375-018-0100-6","googleCitationCount":10,"googleAuthor":"TD Shanafelt","doi":"10.1038/s41375-018-0100-6","elsevierAuthor":"Gentile M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t (6; 7)(p21; q34)/TRB@-PIM1 rearrangement","googleId":"7hm6e1bgN4wJ","googleLink":"https://www.nature.com/articles/s41375-018-0031-2","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0031-2","elsevierAuthor":"La Starza R.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Utx loss causes myeloid transformation","googleId":"XrVFVEBtZ30J","googleLink":"https://www.nature.com/articles/s41375-018-0011-6","googleCitationCount":8,"googleAuthor":"L Xu","doi":"10.1038/s41375-018-0011-6","elsevierAuthor":"Zheng L.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"6","altmetricAuthors":["Liting Zheng","Longyong Xu","Qing Xu","Lu Yu","Danfeng Zhao","Pu Chen","Wei Wang","Yiqin Wang","Gang Han","Charlie Degui Chen"],"twitterCount":3,"altmetricId":32859148,"statusesArray":["968468898306695168","962404555613929473","961650909414608897"]},{"title":"Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis","googleId":"6mcdxZd9TFAJ","googleLink":"https://www.nature.com/articles/s41375-018-0042-z","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0042-z","elsevierAuthor":"Suárez-González J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"7","altmetricAuthors":["Julia Suárez-González","Carolina Martínez-Laperche","Nerea Martínez","Gabriela Rodríguez-Macías","Mi Kwon","Pascual Balsalobre","Diego Carbonell","María Chicano","David Serrano","Juan Carlos Triviño","Miguel Ángel Piris","Jorge Gayoso","José Luis Díez-Martín","Ismael Buño"],"twitterCount":2,"altmetricId":32916196,"statusesArray":["962019636672806913","961941480003825664","961809034406801409"]},{"title":"Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences","googleId":"p9uhacAg_QEJ","googleLink":"https://www.nature.com/articles/leu2016277","googleCitationCount":21,"googleAuthor":"B Scheijen","doi":"10.1038/leu.2016.277","elsevierAuthor":"Waanders E.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"15","altmetricAuthors":["E Waanders","B Scheijen","M C J Jongmans","H Venselaar","S V van Reijmersdal","A H A van Dijk","A Pastorczak","R D A Weren","C E van der Schoot","M van de Vorst","E Sonneveld","N Hoogerbrugge","V H J van der Velden","B Gruhn","P M Hoogerbrugge","J J M van Dongen","A Geurts van Kessel","F N van Leeuwen","R P Kuiper"],"twitterCount":6,"altmetricId":12711533,"statusesArray":["858948828594139136","801808697047584768","801808497411293184","801799861159002112","801799033610268672","788358987527909376","788357516568715264"]},{"title":"Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease","googleId":"A3j95k-mKTUJ","googleLink":"https://www.nature.com/articles/leu2016281","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2016.281","elsevierAuthor":"Rubio M.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"18","altmetricAuthors":["M-T Rubio","M Bouillié","N Bouazza","T Coman","H Trebeden-Nègre","A Gomez","F Suarez","D Sibon","A Brignier","E Paubelle","S Nguyen-Khoc","M Cavazzana","O Lantz","M Mohty","S Urien","O Hermine"],"twitterCount":5,"altmetricId":12736297,"statusesArray":["804301497475485696","804300016546435072","788563334266167296","788558696477491200","788471089735270401"]},{"title":"Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target","googleId":"SHKIxxCSTKMJ","googleLink":"https://www.nature.com/articles/leu201752","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.52","elsevierAuthor":"Etxabe A.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"9","altmetricAuthors":["A Etxabe","M C Lara-Castillo","J M Cornet-Masana","A Banús-Mulet","M Nomdedeu","M A Torrente","M Pratcorona","M Díaz-Beyá","J Esteve","R M Risueño"],"twitterCount":6,"altmetricId":16378595,"statusesArray":["946599098257412096","946566454056554497","855352939963142144","843722306753101824","843715002552979457","832385360080621570","831498484427718656"]},{"title":"Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia","googleId":"blN5PPkhco4J","googleLink":"https://www.nature.com/articles/leu201734","googleCitationCount":17,"googleAuthor":"EJ Murphy","doi":"10.1038/leu.2017.34","elsevierAuthor":"Murphy E.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14","altmetricAuthors":["E J Murphy","D S Neuberg","L Z Rassenti","G Hayes","R Redd","C Emson","K Li","J R Brown","W G Wierda","S Turner","A W Greaves","C S Zent","J C Byrd","C McConnel","J Barrientos","N Kay","M K Hellerstein","N Chiorazzi","T J Kipps","K R Rai"],"twitterCount":1,"altmetricId":20871714,"statusesArray":["872410873561837568","872410604132339712"]},{"title":"Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy","googleId":"IDyMM-U184EJ","googleLink":"https://www.nature.com/articles/leu2017178","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.178","elsevierAuthor":"Martínez-Cuadrón D.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"12","altmetricAuthors":["D Martínez-Cuadrón","P Montesinos","E Vellenga","T Bernal","O Salamero","A Holowiecka","S Brunet","C Gil","C Benavente","J M Ribera","M Pérez-Encinas","J De la Serna","J Esteve","V Rubio","J González-Campos","L Escoda","M E Amutio","M Arnan","J Arias","S Negri","B Lowënberg","M A Sanz"],"twitterCount":8,"altmetricId":20871899,"statusesArray":["885189505325596675","885183774207692802","885171853052063746","885170645176332288","879973700497526784","879970471743291398","879969115175354368","872412035623079936"]},{"title":"Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL","googleId":"uNyYKNqORAMJ","googleLink":"https://www.nature.com/articles/leu201765","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.65","elsevierAuthor":"Munir T.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"16","altmetricAuthors":["T Munir","D R Howard","L McParland","C Pocock","A C Rawstron","A Hockaday","A Varghese","M Hamblin","A Bloor","A Pettitt","C Fegan","J Blundell","J G Gribben","D Phillips","P Hillmen"],"twitterCount":2,"altmetricId":17162332,"statusesArray":["860456663442214912","860093147526946816"]},{"title":"Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia","googleId":"TNmoXkRdx9sJ","googleLink":"https://www.nature.com/articles/leu2016181","googleCitationCount":21,"googleAuthor":"LM Saleh","doi":"10.1038/leu.2016.181","elsevierAuthor":"Saleh L.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"17","altmetricAuthors":["L M Saleh","W Wang","S E M Herman","N S Saba","V Anastas","E Barber","M Corrigan-Cummins","M Farooqui","C Sun","S M Sarasua","Z Zhao","N K Abousamra","O Elbaz","H A Abdelghaffar","A Wiestner","K R Calvo"],"twitterCount":7,"altmetricId":9242762,"statusesArray":["830007451177070592","826815285965492229","756088856378650624","756064961395167234","750300713255919616","750300228197187585","750291947626135552"]},{"title":"Extended time-lapse in vivo imaging of tibia bone marrow to visualize dynamic hematopoietic stem cell engraftment","googleId":"Q_83eTd957UJ","googleLink":"https://www.nature.com/articles/leu2016354","googleCitationCount":19,"googleAuthor":"S Kim","doi":"10.1038/leu.2016.354","elsevierAuthor":"Kim S.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"11","altmetricAuthors":["S Kim","L Lin","G A J Brown","K Hosaka","E W Scott"],"twitterCount":2,"altmetricId":14228205,"statusesArray":["804672222736609281","804475432456376320"]},{"title":"Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo","googleId":"JcO9bU9epHIJ","googleLink":"https://www.nature.com/articles/s41375-018-0126-9","googleCitationCount":11,"googleAuthor":"Y Guo","doi":"10.1038/s41375-018-0126-9","elsevierAuthor":"Guo Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells","googleId":"s9XjuepzfL8J","googleLink":"https://www.nature.com/articles/leu2017338","googleCitationCount":11,"googleAuthor":"B Wingelhofer","doi":"10.1038/leu.2017.338","elsevierAuthor":"Peter B.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"9","altmetricAuthors":["B Peter","S Bibi","G Eisenwort","B Wingelhofer","D Berger","G Stefanzl","K Blatt","H Herrmann","E Hadzijusufovic","G Hoermann","T Hoffmann","J Schwaab","M Jawhar","M Willmann","W R Sperr","J Zuber","K Sotlar","H-P Horny","R Moriggl","A Reiter","M Arock","P Valent"],"twitterCount":1,"altmetricId":30651028,"statusesArray":["943054382404456455"]},{"title":"Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL","googleId":"FoWA9budcAgJ","googleLink":"https://www.nature.com/articles/leu201796","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.96","elsevierAuthor":"Howard D.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"15","altmetricAuthors":["D R Howard","T Munir","L McParland","A C Rawstron","D Milligan","A Schuh","A Hockaday","D J Allsup","S Marshall","A S Duncombe","J L O'Dwyer","A F Smith","R Longo","A Varghese","P Hillmen"],"twitterCount":8,"altmetricId":18239374,"statusesArray":["860456663442214912","860093147526946816","848583191539720195","848492746918813697","847630857518972928","847550168627105796","847335608125079555","847114287424385024"]},{"title":"HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation","googleId":"jDwmPQpy670J","googleLink":"https://www.nature.com/articles/leu2016210","googleCitationCount":18,"googleAuthor":"","doi":"10.1038/leu.2016.210","elsevierAuthor":"Herr W.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"14","altmetricAuthors":["W Herr","Y Eichinger","J Beshay","A Bloetz","S Vatter","C Mirbeth","E Distler","U F Hartwig","S Thomas"],"twitterCount":3,"altmetricId":10225010,"statusesArray":["763614520057196544","763550563720171520","760584612577894404"]},{"title":"A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high …","googleId":"sZYcpQU6DjQJ","googleLink":"https://www.nature.com/articles/leu2016255","googleCitationCount":20,"googleAuthor":"H Chen","doi":"10.1038/leu.2016.255","elsevierAuthor":"Reddy N.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"15","altmetricAuthors":["N M Reddy","J P Greer","D S Morgan","H Chen","S I Park","K L Richards"],"twitterCount":1,"altmetricId":12173067,"statusesArray":["779483760177786880"]},{"title":"Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome","googleId":"FiNXp4w8R0oJ","googleLink":"https://www.nature.com/articles/leu201727","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/leu.2017.27","elsevierAuthor":"Li J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"10","altmetricAuthors":["J Li","M-H Duan","C Wang","X-F Huang","W Zhang","X-X Cao","T-N Zhu","J-L Zhuang","B Han","H Cai","H-C Cai","D-B Zhou"],"twitterCount":6,"altmetricId":15988632,"statusesArray":["836088569110401024","836055017677340677","826553521268981764","826461283637661697","826437809263218689","826434872340258816"]},{"title":"Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients","googleId":"3YFb-atpHIEJ","googleLink":"https://www.nature.com/articles/s41375-018-0086-0","googleCitationCount":11,"googleAuthor":"","doi":"10.1038/s41375-018-0086-0","elsevierAuthor":"Höllein A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome","googleId":"MOqPW0qInYsJ","googleLink":"https://www.nature.com/articles/leu201712","googleCitationCount":18,"googleAuthor":"AD Kelly","doi":"10.1038/leu.2017.12","elsevierAuthor":"Kelly A.D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"18","altmetricAuthors":["A D Kelly","H Kroeger","J Yamazaki","R Taby","F Neumann","S Yu","J T Lee","B Patel","Y Li","R He","S Liang","Y Lu","M Cesaroni","S A Pierce","S M Kornblau","C E Bueso-Ramos","F Ravandi","H M Kantarjian","J Jelinek","J-PJ Issa"],"twitterCount":3,"altmetricId":15413634,"statusesArray":["928366327793729536","819552326524485633","819552001138622465"]},{"title":"The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies","googleId":"_fmKvNdJz9gJ","googleLink":"https://www.nature.com/articles/leu2016374","googleCitationCount":17,"googleAuthor":"T Radivoyevitch","doi":"10.1038/leu.2016.374","elsevierAuthor":"Statler A.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"15","altmetricAuthors":["A Statler","T Radivoyevitch","C Siebenaller","A T Gerds","M Kalaycio","E Kodish","S Mukherjee","C Cheng","M A Sekeres"],"twitterCount":22,"altmetricId":14561214,"statusesArray":["1281651132507381761","862843521711181824","856963060933832708","855798010894331906","826118477090004992","819432701342130176","819431710295203840","819279171054608384","819278241575866368","807851881515061249","807550868505718784","807375905244975104","807324616913928192","807285837603934208","807191158149484544","807014800706281472","806960323282530304","806935013262397440","806854305076670465","806844361589870592","806843456505122816","806839854906638336","806839725512413184","806839140113412098","806837467391422464"]},{"title":"Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway","googleId":"DQR7sqbSdL4J","googleLink":"https://www.nature.com/articles/leu2016339","googleCitationCount":16,"googleAuthor":"Y Shen","doi":"10.1038/leu.2016.339","elsevierAuthor":"Shen Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"11","altmetricAuthors":["Y Shen","C S Park","K Suppipat","T-A Mistretta","M Puppi","T M Horton","K Rabin","N S Gray","J P P Meijerink","H D Lacorazza"],"twitterCount":2,"altmetricId":13903469,"statusesArray":["801222520242192384","801222205552009220"]},{"title":"The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia","googleId":"LgvYWILtNE4J","googleLink":"https://www.nature.com/articles/s41375-018-0046-8","googleCitationCount":11,"googleAuthor":"L Ermini","doi":"10.1038/s41375-018-0046-8","elsevierAuthor":"Furness C.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"7","altmetricAuthors":["Caroline L Furness","Marcela B Mansur","Victoria J Weston","Luca Ermini","Frederik W van Delft","Sarah Jenkinson","Rosemary Gale","Christine J Harrison","Maria S Pombo-de-Oliveira","Marta Sanchez-Martin","Adolfo A Ferrando","Pamela Kearns","Ian Titley","Anthony M Ford","Nicola E Potter","Mel Greaves"],"twitterCount":13,"altmetricId":34583276,"statusesArray":["983790633818230790","983649753543176192","983649556264038400","982710042582503424","981919859540922368","981913765603102722","981903849417072640","981894158053990401","981881545400242177","980338218544451584","978985714497994758","976656224061071365","975911321932722176","975903869648691200"]},{"title":"Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis","googleId":"ROSSvb6DGHsJ","googleLink":"https://www.nature.com/articles/leu2017268","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.268","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Enhanced MAPK signaling is essential for CSF3R-induced leukemia","googleId":"pVOp1JdHMjwJ","googleLink":"https://www.nature.com/articles/leu2016376","googleCitationCount":18,"googleAuthor":"","doi":"10.1038/leu.2016.376","elsevierAuthor":"Rohrabaugh S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"16","altmetricAuthors":["S Rohrabaugh","M Kesarwani","Z Kincaid","E Huber","J Leddonne","Z Siddiqui","Y Khalifa","K Komurov","H L Grimes","M Azam"],"twitterCount":1,"altmetricId":35183611,"statusesArray":["1085619802083864577","1085593244522725376","1084875652384391173"]},{"title":"RNA editing signature during myeloid leukemia cell differentiation","googleId":"09EChaVm_m8J","googleLink":"https://www.nature.com/articles/leu2017134","googleCitationCount":14,"googleAuthor":"E Picardi","doi":"10.1038/leu.2017.134","elsevierAuthor":"Riddy D.M.","publicationName":"PLoS ONE","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"8","altmetricAuthors":["C Rossetti","E Picardi","M Ye","G Camilli","A M D'Erchia","L Cucina","F Locatelli","L Fianchi","L Teofili","G Pesole","A Gallo","R Sorrentino"],"twitterCount":2,"altmetricId":20156788,"statusesArray":["941989297128800257","863973480227852288"]},{"title":"Chromothripsis in acute myeloid leukemia: Biological features and impact on survival","googleId":"LD-3lb3BBg4J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892717/","googleCitationCount":12,"googleAuthor":"G Marconi","doi":"10.1038/leu.2017.351","elsevierCitationCount":0,"altmetricAuthors":["M C Fontana","G Marconi","J D M Feenstra","E Fonzi","C Papayannidis","A G L di Rorá","A Padella","V Solli","E Franchini","E Ottaviani","A Ferrari","C Baldazzi","N Testoni","I Iacobucci","S Soverini","T Haferlach","V Guadagnuolo","L Semerad","M Doubek","M Steurer","Z Racil","S Paolini","M Manfrini","M Cavo","G Simonetti","R Kralovics","G Martinelli"],"twitterCount":6,"altmetricId":30638218,"statusesArray":["955048226528382976","943251286463479808","943195182941593600","943149691696377857","942959201151737857","942940212451307520"]},{"title":"EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia","googleId":"yxpAdAM4dAIJ","googleLink":"https://www.nature.com/articles/leu2016371","googleCitationCount":17,"googleAuthor":"S Charmsaz","doi":"10.1038/leu.2016.371","elsevierAuthor":"Charmsaz S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"15","altmetricAuthors":["S Charmsaz","F Al-Ejeh","T M Yeadon","K J Miller","F M Smith","B W Stringer","A S Moore","F-T Lee","L T Cooper","C Stylianou","G T Yarranton","J Woronicz","A M Scott","M Lackmann","A W Boyd"],"twitterCount":1,"altmetricId":14674113,"statusesArray":["808280656375672832"]},{"title":"The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia","googleId":"FRmE-IrGPHYJ","googleLink":"https://www.nature.com/articles/leu2016338","googleCitationCount":16,"googleAuthor":"R Dillon","doi":"10.1038/leu.2016.338","elsevierAuthor":"Jovanovic J.V.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation","googleId":"tny1cnptb7EJ","googleLink":"https://www.nature.com/articles/s41375-018-0208-8","googleCitationCount":8,"googleAuthor":"F Stölzel","doi":"10.1038/s41375-018-0208-8","elsevierAuthor":"Chitre S.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"7","altmetricAuthors":["Sneha Chitre","Friedrich Stölzel","Kirsty Cuthill","Mathew Streetly","Charlotte Graham","Claudia Dill","Azim Mohamedali","Alexander Smith","Johannes Schetelig","Heidi Altmann","Martin Bornhäuser","Ghulam J. Mufti"],"twitterCount":3,"altmetricId":45388495,"statusesArray":["1044906274784194560","1021686771132891136","1020989355131744256"]},{"title":"Influence of IDH on FLT3-ITD status in newly diagnosed AML","googleId":"AAd94Jg0_ckJ","googleLink":"https://www.nature.com/articles/leu2017244","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2017.244","elsevierAuthor":"Boddu P.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"10","altmetricAuthors":["P Boddu","K Takahashi","N Pemmaraju","N Daver","C B Benton","S Pierce","M Konopleva","F Ravandi","J Cortes","H Kantarjian","C D DiNardo"],"twitterCount":5,"altmetricId":22957390,"statusesArray":["892837140740091904","892377243938410496","892368955029028864","892194688870084608","890959775634272257"]},{"title":"Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis","googleId":"HwiGdHByhKAJ","googleLink":"https://www.nature.com/articles/leu2017166","googleCitationCount":11,"googleAuthor":"CG Mullighan","doi":"10.1038/leu.2017.166","elsevierAuthor":"Welsh S.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Epigenetic heterogeneity affects the risk of relapse in children with t (8; 21) RUNX1-RUNX1T1-rearranged AML","googleId":"9o85KkXCTxYJ","googleLink":"https://www.nature.com/articles/s41375-017-0003-y","googleCitationCount":9,"googleAuthor":"M Zampini","doi":"10.1038/s41375-017-0003-y","elsevierAuthor":"Zampini M.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation","googleId":"ZmbykQRJ1I8J","googleLink":"https://www.nature.com/articles/leu2016244","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2016.244","elsevierAuthor":"McCracken A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14","altmetricAuthors":["A N McCracken","R J McMonigle","J Tessier","R Fransson","M S Perryman","B Chen","A Keebaugh","E Selwan","S A Barr","S M Kim","S G Roy","G Liu","D Fallegger","L Sernissi","C Brandt","N Moitessier","A J Snider","S Clare","M Müschen","A Huwiler","M T Kleinman","S Hanessian","A L Edinger"],"twitterCount":0,"altmetricId":12346331,"statusesArray":[]},{"title":"The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell function","googleId":"bX6wKfsmXcAJ","googleLink":"https://www.nature.com/articles/s41375-018-0025-0","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0025-0","elsevierAuthor":"Mohr J.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"8","altmetricAuthors":["Juliane Mohr","Banaja P. Dash","Tina M. Schnoeder","Denise Wolleschak","Carolin Herzog","Nuria Tubio Santamaria","Sönke Weinert","Sonika Godavarthy","Costanza Zanetti","Michael Naumann","Björn Hartleben","Tobias B. Huber","Daniela S. Krause","Thilo Kähne","Lars Bullinger","Florian H. Heidel"],"twitterCount":5,"altmetricId":33621431,"statusesArray":["984419840088858625","984415888005828608","984393545036517376","984382879919722497","967361939784552448","967106100364419072"]},{"title":"Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014","googleId":"odpCjJGcZIMJ","googleLink":"https://www.nature.com/articles/s41375-018-0149-2","googleCitationCount":7,"googleAuthor":"AB de Gonzalez","doi":"10.1038/s41375-018-0149-2","elsevierAuthor":"Teepen J.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"5","altmetricAuthors":["Jop C. Teepen","Rochelle E. Curtis","Graça M. Dores","Amy Berrington de Gonzalez","Marry M. van den Heuvel-Eibrink","Leontien C. M. Kremer","Ethel S. Gilbert","Flora E. van Leeuwen","Cécile M. Ronckers","Lindsay M. Morton"],"twitterCount":0,"altmetricId":42524763,"statusesArray":[]},{"title":"Identification of immune-activated hematopoietic stem cells","googleId":"LsBG47aeWTwJ","googleLink":"https://www.nature.com/articles/s41375-018-0220-z","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-018-0220-z","elsevierAuthor":"Bujanover N.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"6","altmetricAuthors":["Nir Bujanover","Oron Goldstein","Yariv Greenshpan","Hodaya Turgeman","Amit Klainberger","Ye’ela Scharff","Roi Gazit"],"twitterCount":4,"altmetricId":45721355,"statusesArray":["1226193416658149376","1024396573676109825","1023598393325707265","1023590246498422785"]},{"title":"Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis","googleId":"3jikv3EoxjkJ","googleLink":"https://www.nature.com/articles/leu2017112","googleCitationCount":12,"googleAuthor":"T Maekawa","doi":"10.1038/leu.2017.112","elsevierAuthor":"Maekawa T.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0","altmetricAuthors":["T Maekawa","Y Osawa","T Izumi","S Nagao","K Takano","Y Okada","N Tachi","M Teramoto","T Kawamura","T Horiuchi","R Saga","S Kato","T Yamamura","J Watanabe","A Kobayashi","S Kobayashi","K Sato","M Hashimoto","S Suzu","F Kimura"],"twitterCount":1,"altmetricId":19611021,"statusesArray":["857289856036286464"]},{"title":"Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling","googleId":"3UCauPTFppgJ","googleLink":"https://www.nature.com/articles/leu2017168","googleCitationCount":13,"googleAuthor":"JP Bürckert","doi":"10.1038/leu.2017.168","elsevierAuthor":"Hahn M.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group","googleId":"P062YXNy4CsJ","googleLink":"https://www.nature.com/articles/leu2016177","googleCitationCount":17,"googleAuthor":"E Manara","doi":"10.1038/leu.2016.177","elsevierAuthor":"Manara E.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"12","altmetricAuthors":["E Manara","G Basso","M Zampini","B Buldini","C Tregnago","R Rondelli","R Masetti","V Bisio","M Frison","K Polato","G Cazzaniga","G Menna","F Fagioli","P Merli","A Biondi","A Pession","F Locatelli","M Pigazzi"],"twitterCount":6,"altmetricId":9105637,"statusesArray":["755850509483991040","755802013842051072","754311161567338496","748335160463097857","747967148954427392","747925244543909888"]},{"title":"Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T …","googleId":"VdNut9Ki0dgJ","googleLink":"https://www.nature.com/articles/leu2017316","googleCitationCount":12,"googleAuthor":"GL Zhang","doi":"10.1038/leu.2017.316","elsevierAuthor":"Bae J.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"10","altmetricAuthors":["J Bae","T Hideshima","G L Zhang","J Zhou","D B Keskin","N C Munshi","K C Anderson"],"twitterCount":3,"altmetricId":28355453,"statusesArray":["943516582159966209","926447545072717825","926433787763986433"]},{"title":"Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis","googleId":"KAxFg0jE88EJ","googleLink":"https://www.nature.com/articles/leu201742","googleCitationCount":15,"googleAuthor":"HL Wang","doi":"10.1038/leu.2017.42","elsevierAuthor":"Ustun C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14","altmetricAuthors":["C Ustun","F Giannotti","M-J Zhang","H-L Wang","C Brunstein","M Labopin","V Rocha","M de Lima","F Baron","B M Sandmaier","M Eapen","E Gluckman","A Nagler","D J Weisdorf","A Ruggeri"],"twitterCount":10,"altmetricId":15833133,"statusesArray":["829415124477833218","828733177334206468","828678205108281344","828619644093218816","828616862988513280","828591105264451584","828587060369956864","828586594915450881","824955176461225985","824649520579502081"]},{"title":"MicroRNA-155 promotes G-CSF-induced mobilization of murine hematopoietic stem and progenitor cells via propagation of CXCL12 signaling","googleId":"WkDmBZpBkVsJ","googleLink":"https://www.nature.com/articles/leu201750","googleCitationCount":15,"googleAuthor":"T Itkin","doi":"10.1038/leu.2017.50","elsevierAuthor":"Itkin T.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"13","altmetricAuthors":["T Itkin","A Kumari","E Schneider","S Gur-Cohen","C Ludwig","R Brooks","O Kollet","K Golan","E Khatib-Massalha","C M Russo","J D Chisholm","A Rouhi","H Geiger","E Hornstein","W G Kerr","F Kuchenbauer","T Lapidot"],"twitterCount":2,"altmetricId":17257368,"statusesArray":["1007566782926733312","840688072958345217"]},{"title":"HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemia","googleId":"FR_65Ao-P8IJ","googleLink":"https://www.nature.com/articles/leu20173","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/leu.2017.3","elsevierAuthor":"Mehdipour P.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10","altmetricAuthors":["P Mehdipour","F Santoro","O A Botrugno","M Romanenghi","C Pagliuca","G M Matthews","R W Johnstone","S Minucci"],"twitterCount":2,"altmetricId":15729079,"statusesArray":["826047387181391875","823829532360654848"]},{"title":"Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial","googleId":"QPYo94vT8kAJ","googleLink":"https://www.nature.com/articles/leu2017258","googleCitationCount":12,"googleAuthor":"JR Mikhael","doi":"10.1038/leu.2017.258","elsevierAuthor":"Ailawadhi S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"11","altmetricAuthors":["S Ailawadhi","J R Mikhael","B R LaPlant","K M Laumann","S Kumar","V Roy","D Dingli","P L Bergsagel","F K Buadi","S V Rajkumar","R Fonseca","M A Gertz","P Kapoor","T Sher","S R Hayman","A K Stewart","A Dispenzieri","R A Kyle","W I Gonsalves","C B Reeder","Y Lin","R S Go","N Leung","T Kourelis","J A Lust","S J Russell","A A Chanan-Khan","M Q Lacy"],"twitterCount":24,"altmetricId":24611073,"statusesArray":["915245656230461441","912551847289815040","912394445445849088","912384394735837186","912375804285345792","912307540419125248","912305394172690433","912303385948360704","905809638892994560","905751148006662144","905695986290487296","905169058991091713","904495387561652224","904457085143928833","904418718385504256","904406184270192641","904405892883517440","904397876348014593","904366585472790528","904290774866591748","904288753023205376","904286735298908160","904285760597184517","904282731617640448","904120876450418690","903580739484168192"]},{"title":"Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1","googleId":"a90fLshaM08J","googleLink":"https://www.nature.com/articles/leu2016285","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2016.285","elsevierAuthor":"Du C.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"19","altmetricAuthors":["C Du","Y Xu","K Yang","S Chen","X Wang","S Wang","C Wang","M Shen","F Chen","M Chen","D Zeng","F Li","T Wang","F Wang","J Zhao","G Ai","T Cheng","Y Su","J Wang"],"twitterCount":1,"altmetricId":27297457,"statusesArray":["918060875084263424"]},{"title":"Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32","googleId":"PTQvKkJ8f4sJ","googleLink":"https://www.nature.com/articles/s41375-018-0231-9","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/s41375-018-0231-9","elsevierAuthor":"Babushok D.V.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4","altmetricAuthors":["Daria V. Babushok","Natasha L. Stanley","Jennifer J. D. Morrissette","David B. Lieberman","Timothy S. Olson","Stella T. Chou","Elizabeth O. Hexner"],"twitterCount":1,"altmetricId":61604855,"statusesArray":["1136678653520035840"]},{"title":"New drugs in AML: uses and abuses","googleId":"x43znXD8KgwJ","googleLink":"https://www.nature.com/articles/s41375-018-0168-z","googleCitationCount":8,"googleAuthor":"RP Gale","doi":"10.1038/s41375-018-0168-z","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"7","altmetricAuthors":["Elihu H. Estey","Robert Peter Gale","Mikkael A. Sekeres"],"twitterCount":18,"altmetricId":43393342,"statusesArray":["1167671366356733952","1167622331172343809","1167616245161779201","1167615245633953793","1167467585870487552","1007538827228057600","1006869810427383808","1006609616745238534","1006574509829296131","1006564470125146113","1006530581277048832","1006528146307518465","1006422519245672448","1006406710809030656","1006406035249205249","1006367021531975680","1006361558325309440","1006314432836796418","1006278878242000896","1006245994047180802","1004476097348734978"]},{"title":"Irf8 regulates the progression of myeloproliferative neoplasm-like syndrome via Mertk signaling in zebrafish","googleId":"Sx_AHMFWIU0J","googleLink":"https://www.nature.com/articles/leu2017189","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.189","elsevierAuthor":"Zhao F.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"5","altmetricAuthors":["F Zhao","Y Shi","Y Huang","Y Zhan","L Zhou","Y Li","Y Wan","H Li","H Huang","H Ruan","L Luo","L Li"],"twitterCount":3,"altmetricId":21193491,"statusesArray":["879827393736658944","879827347045629952","877111080970891264"]},{"title":"PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma","googleId":"qF2FmPNe114J","googleLink":"https://www.nature.com/articles/leu2016389","googleCitationCount":18,"googleAuthor":"I Schlam","doi":"10.1038/leu.2016.389","elsevierAuthor":"Panchabhai S.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"14","altmetricAuthors":["S Panchabhai","I Schlam","S Sebastian","R Fonseca"],"twitterCount":1,"altmetricId":15553455,"statusesArray":["821497192821223424"]},{"title":"Prognostic impact of IKZF1 deletions in association with vincristine–dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic …","googleId":"DeYiVmvUXdMJ","googleLink":"https://www.nature.com/articles/leu2017154","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.154","elsevierAuthor":"Hinze L.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML","googleId":"Du0PMCAeoiIJ","googleLink":"https://www.nature.com/articles/leu2017217","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2017.217","elsevierAuthor":"Herold S.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A novel AHI-1–BCR-ABL–DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated …","googleId":"Z6jkZ6gDnUYJ","googleLink":"https://www.nature.com/articles/leu2017108","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2017.108","elsevierAuthor":"Liu X.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"10","altmetricAuthors":["X Liu","K Rothe","R Yen","C Fruhstorfer","T Maetzig","M Chen","D L Forrest","R K Humphries","X Jiang"],"twitterCount":3,"altmetricId":18481487,"statusesArray":["852739455601360897","850849521399721984","849205858802163712"]},{"title":"A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewal","googleId":"kLp_VpNfdG0J","googleLink":"https://www.nature.com/articles/leu2016201","googleCitationCount":16,"googleAuthor":"Z Zhang","doi":"10.1038/leu.2016.201","elsevierAuthor":"Zhang Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"13","altmetricAuthors":["Z Zhang","P Zhu","Y Zhou","Y Sheng","Y Hong","D Xiang","Z Qian","J Mosenson","W-S Wu"],"twitterCount":1,"altmetricId":10250030,"statusesArray":["760895580197490688"]},{"title":"Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm—a comparison of 756 cases","googleId":"u5ElUAN6AkQJ","googleLink":"https://www.nature.com/articles/s41375-018-0119-8","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/s41375-018-0119-8","elsevierAuthor":"Baer C.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Trends in pre-and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004 …","googleId":"Uc2LcOgvLq0J","googleLink":"https://www.nature.com/articles/leu2017185","googleCitationCount":12,"googleAuthor":"A D'Souza","doi":"10.1038/leu.2017.185","elsevierAuthor":"D'Souza A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"12","altmetricAuthors":["A D'Souza","M-J Zhang","J Huang","M Fei","M Pasquini","M Hamadani","P Hari"],"twitterCount":17,"altmetricId":21130239,"statusesArray":["909461340024180736","886117175609655296","885277069684482048","885212182539100160","882107030403563521","882046299532644352","881993274881437697","881985947407142914","881936246150504449","881910671847415808","881905296066711553","881905293583691776","881894714693361665","881894310362308610","881893749554528256","881844605335076865","881765607993221121","881744511378092032","881713140253306880","881706627623260160","881689191926648833","875888619969490944"]},{"title":"Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses","googleId":"TGu73rzjMUEJ","googleLink":"https://www.nature.com/articles/s41375-018-0080-6","googleCitationCount":9,"googleAuthor":"T Tashi","doi":"10.1038/s41375-018-0080-6","elsevierAuthor":"Hasselbalch H.C.","publicationName":"Seminars in Immunopathology","elsevierCoverDate":"2019-01-11","elsevierCoverDisplayDate":"11 January 2019","elsevierCitationCount":"20","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish","googleId":"fAP5onTjpVUJ","googleLink":"https://www.nature.com/articles/leu2016170","googleCitationCount":16,"googleAuthor":"Z Huang","doi":"10.1038/leu.2016.170","elsevierAuthor":"Liu W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"19","altmetricAuthors":["W Liu","M Wu","Z Huang","J Lian","J Chen","T Wang","A Y H Leung","Y Liao","Z Zhang","Q Liu","K Yen","S Lin","L I Zon","Z Wen","Y Zhang","W Zhang"],"twitterCount":1,"altmetricId":10067866,"statusesArray":["1298202429343895552"]},{"title":"Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis","googleId":"8sN_H0HnSCgJ","googleLink":"https://www.nature.com/articles/s41375-018-0063-7","googleCitationCount":8,"googleAuthor":"S Sidana","doi":"10.1038/s41375-018-0063-7","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"7","altmetricAuthors":["Surbhi Sidana","Nidhi Tandon","Angela Dispenzieri","Morie A. Gertz","David Dingli","Dragan Jevremovic","William G. Morice","Prashant Kapoor","Taxiarchis V. Kourelis","Martha Q. Lacy","Suzanne R. Hayman","Francis K. Buadi","Nelson Leung","Ronald S. Go","Yi Lin","Stephen J. Russell","John A. Lust","Steven R. Zeldenrust","Rahma Warsame","Yi L. Hwa","Miriam Hobbs","Amie Fonder","Robert A. Kyle","S. Vincent Rajkumar","Shaji K. Kumar","Wilson I. Gonsalves"],"twitterCount":25,"altmetricId":33496216,"statusesArray":["1296589331751038976","1296443944021241856","997963519097298944","997830318802591744","997818229501415424","997556481934446593","997508303998607360","997479491168538624","997476286279794689","997467522260766720","997456561118285824","997450097616130049","997448730000396288","997448584948867072","981210838085324801","981177756754038784","981177395599290368","981177126354391040","973124202738921472","973014118583152640","972960631857950720","972942440641581056","972934300097236992","968820598032879616","968809277493100544","967811673271672832","966696355719798784","966538389754339328","966535442823704576","966480167362355200"]},{"title":"Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation","googleId":"POEnwFToc-EJ","googleLink":"https://www.nature.com/articles/leu2017105","googleCitationCount":12,"googleAuthor":"V Vas","doi":"10.1038/leu.2017.105","elsevierAuthor":"Thiel V.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"8","altmetricAuthors":["V N Thiel","B D Giaimo","P Schwarz","K Soller","V Vas","M Bartkuhn","T J Blätte","K Döhner","L Bullinger","T Borggrefe","H Geiger","F Oswald"],"twitterCount":0,"altmetricId":19619739,"statusesArray":[]},{"title":"The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation","googleId":"wHjqVsURC94J","googleLink":"https://www.nature.com/articles/leu2016259","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/leu.2016.259","elsevierAuthor":"Weissinger E.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14","altmetricAuthors":["E M Weissinger","C Human","J Metzger","L Hambach","D Wolf","H T Greinix","A M Dickinson","W Mullen","D Jonigk","Z Kuzmina","H Kreipe","P Schweier","O Böhm","I Türüchanow","D Ihlenburg-Schwarz","J Raad","A Durban","M Schiemann","C Könecke","H Diedrich","E Holler","G Beutel","J Krauter","A Ganser","M Stadler"],"twitterCount":0,"altmetricId":12440213,"statusesArray":[]},{"title":"IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus","googleId":"IR3Arbiy-cMJ","googleLink":"https://www.nature.com/articles/leu2016356","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2016.356","elsevierAuthor":"Drennan S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"12","altmetricAuthors":["S Drennan","A D'Avola","Y Gao","C Weigel","E Chrysostomou","A J Steele","T Zenz","C Plass","P W Johnson","A P Williams","G Packham","F K Stevenson","C C Oakes","F Forconi"],"twitterCount":5,"altmetricId":14535859,"statusesArray":["806994204685692928","806626892556206081","806622773116358656","806598017621094401","806487283935379457"]},{"title":"Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma","googleId":"G_mMy0lMfD8J","googleLink":"https://www.nature.com/articles/s41375-018-0066-4","googleCitationCount":6,"googleAuthor":"J Bertran","doi":"10.1038/s41375-018-0066-4","elsevierAuthor":"Gallardo F.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"5","altmetricAuthors":["Fernando Gallardo","Joan Bertran","Erika López-Arribillaga","Jéssica González","Silvia Menéndez","Ignacio Sánchez","Luis Colomo","Mar Iglesias","Marta Garrido","Luis Francisco Santamaría-Babí","Ferran Torres","Ramon M Pujol","Anna Bigas","Lluís Espinosa"],"twitterCount":1,"altmetricId":33828990,"statusesArray":["969328947514232834"]},{"title":"Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target","googleId":"Pd-_lywXtukJ","googleLink":"https://www.nature.com/articles/leu2016302","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/leu.2016.302","elsevierAuthor":"Barabé F.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11","altmetricAuthors":["F Barabé","L Gil","M Celton","A Bergeron","V Lamontagne","É Roques","K Lagacé","A Forest","R Johnson","L Pécheux","J Simard","J Pelloux","A Bellemare-Pelletier","E Gagnon","J Hébert","S Cellot","B T Wilhelm"],"twitterCount":1,"altmetricId":13398895,"statusesArray":["795485973547286528"]},{"title":"Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia","googleId":"BjqHC5MiFQsJ","googleLink":"https://www.nature.com/articles/leu201772","googleCitationCount":13,"googleAuthor":"SH Kim","doi":"10.1038/leu.2017.72","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0","altmetricAuthors":["S H Han","S-H Kim","H-J Kim","Y Lee","S-Y Choi","G Park","D-H Kim","A Lee","J Kim","J-M Choi","Y Kim","K Myung","H Kim","D-W Kim"],"twitterCount":1,"altmetricId":16986769,"statusesArray":["838090475340976130"]},{"title":"Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency","googleId":"2JuxvHbRgdEJ","googleLink":"https://www.nature.com/articles/leu2016256","googleCitationCount":15,"googleAuthor":"LW Ding","doi":"10.1038/leu.2016.256","elsevierAuthor":"Ding L.W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"11","altmetricAuthors":["L-W Ding","T Ikezoe","K-T Tan","M Mori","A Mayakonda","W Chien","D-C Lin","Y-Y Jiang","M Lill","H Yang","Q-Y Sun","H P Koeffler"],"twitterCount":0,"altmetricId":12554292,"statusesArray":[]},{"title":"Rare germline variants in ATM are associated with chronic lymphocytic leukemia","googleId":"5UybE7OlEPcJ","googleLink":"https://www.nature.com/articles/leu2017201","googleCitationCount":13,"googleAuthor":"W Poh","doi":"10.1038/leu.2017.201","elsevierAuthor":"Tiao G.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"8","altmetricAuthors":["G Tiao","M R Improgo","S Kasar","W Poh","A Kamburov","D-A Landau","E Tausch","A Taylor-Weiner","C Cibulskis","S Bahl","S M Fernandes","K Hoang","E Rheinbay","H T Kim","J Bahlo","S Robrecht","K Fischer","M Hallek","S Gabriel","E S Lander","S Stilgenbauer","C J Wu","A Kiezun","G Getz","J R Brown"],"twitterCount":2,"altmetricId":21388318,"statusesArray":["1049028067098877952","1002858823713865731","880007392313827328"]},{"title":"Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t (8; 21)(q22; q22): a study of the German-Austrian AML Study …","googleId":"0OF5Infv03IJ","googleLink":"https://www.nature.com/articles/leu201718","googleCitationCount":14,"googleAuthor":"M Agrawal","doi":"10.1038/leu.2017.18","elsevierAuthor":"Jahn N.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Identification and characterization of activating ABL1 1b kinase mutations: impact on sensitivity to ATP-competitive and allosteric ABL1 inhibitors","googleId":"0nJWrTECTpkJ","googleLink":"https://www.nature.com/articles/leu2016353","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/leu.2016.353","elsevierAuthor":"Lee B.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"13","altmetricAuthors":["B J Lee","N P Shah"],"twitterCount":5,"altmetricId":15385338,"statusesArray":["819307654522802176","819163536966426624","819151629945552896","819145885959520256","819144830173532160"]},{"title":"Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia","googleId":"SoDTlMUVbJgJ","googleLink":"https://www.nature.com/articles/s41375-018-0225-7","googleCitationCount":7,"googleAuthor":"CE Tognon","doi":"10.1038/s41375-018-0225-7","elsevierAuthor":"Kurtz S.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A novel t (3; 13)(q13; q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?","googleId":"eRdtEa_0JjgJ","googleLink":"https://www.nature.com/articles/leu2016304","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/leu.2016.304","elsevierAuthor":"Troadec E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia","googleId":"zvcFIowimY8J","googleLink":"https://www.nature.com/articles/leu201799","googleCitationCount":12,"googleAuthor":"C Moutinho","doi":"10.1038/leu.2017.99","elsevierAuthor":"Anadón C.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"8","altmetricAuthors":["C Anadón","G van Tetering","H J Ferreira","C Moutinho","A Martínez-Cardús","A Villanueva","M Soler","H Heyn","S Moran","M Castro de Moura","F Setien","A Vidal","E Genescà","J M Ribera","J F Nomdedeu","S Guil","M Esteller"],"twitterCount":7,"altmetricId":18193167,"statusesArray":["847590985353891841","847445871608250368","847429696325246976","847428902112739328","847427576142340096","847427093210189825","847122842848145408","846749937773666305"]},{"title":"DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells","googleId":"jXSAsl-WfncJ","googleLink":"https://www.nature.com/articles/leu2016284","googleCitationCount":15,"googleAuthor":"M Wu","doi":"10.1038/leu.2016.284","elsevierAuthor":"Wu M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Do we need to distinguish exosomes from microvesicles in hematological malignancies?","googleId":"l0Td6X5aYZUJ","googleLink":"https://www.nature.com/articles/leu2017205","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2017.205","elsevierAuthor":"Caivano A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"10","altmetricAuthors":["A Caivano","L Del Vecchio","P Musto"],"twitterCount":1,"altmetricId":21408775,"statusesArray":["880370055812325379"]},{"title":"Diagnostic algorithm for lower-risk myelodysplastic syndromes","googleId":"EgRuybOsukoJ","googleLink":"https://www.nature.com/articles/s41375-018-0173-2","googleCitationCount":5,"googleAuthor":"GJ Mufti","doi":"10.1038/s41375-018-0173-2","elsevierAuthor":"Mufti G.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"2","altmetricAuthors":["Ghulam J. Mufti","Donal P. McLornan","Arjan A. van de Loosdrecht","Ulrich Germing","Robert P. Hasserjian"],"twitterCount":21,"altmetricId":44154411,"statusesArray":["1034304420614496256","1031634870458613761","1031555291056361472","1031526423020888066","1031452903335190528","1031452724490121216","1031435041619042305","1031339289441906688","1031332964779679744","1031271715832311809","1031216472448745472","1031152118995009536","1030661839439454208","1030566482248445953","1030552587102285825","1030531716933410817","1030527346074443776","1030523213745405953","1030523087358492675","1030517129374777344","1029700191518113793","1028939020913573888","1012302604573872128","1011575441625190401"]},{"title":"A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia","googleId":"7nV6Q-v2DLQJ","googleLink":"https://www.nature.com/articles/leu2016225","googleCitationCount":17,"googleAuthor":"NH Russell","doi":"10.1038/leu.2016.225","elsevierAuthor":"Burnett A.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"13","altmetricAuthors":["A K Burnett","N H Russell","R K Hills","J Kell","O J Nielsen","M Dennis","P Cahalin","C Pocock","S Ali","S Burns","S Freeman","D Milligan","R E Clark"],"twitterCount":10,"altmetricId":11570452,"statusesArray":["1002467421028958208","826795120070639616","826795068799479808","826795050159972352","826795039661531142","809729014235537410","809039961399947264","784190318073745408","783963762847944704","772441272342556674","772435504595959808","771903904779042817","771888504620056576"]},{"title":"Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL","googleId":"eUMr5WvZv-4J","googleLink":"https://www.nature.com/articles/leu2017274","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/leu.2017.274","elsevierAuthor":"Brazdilova K.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma","googleId":"dNuoPeu5A84J","googleLink":"https://www.nature.com/articles/leu2017309","googleCitationCount":11,"googleAuthor":"G Hu","doi":"10.1038/leu.2017.309","elsevierAuthor":"Hu G.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset","googleId":"Qs70BWd8CB0J","googleLink":"https://www.nature.com/articles/s41375-018-0099-8","googleCitationCount":10,"googleAuthor":"G Goyal","doi":"10.1038/s41375-018-0099-8","elsevierAuthor":"Goyal G.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"7","altmetricAuthors":["Gaurav Goyal","Adam C. Bartley","Shealeigh Funni","Jonathan Inselman","Nilay D. Shah","Ariela L. Marshall","Aneel A. Ashrani","Prashant Kapoor","Urshila Durani","Shahrukh K. Hashmi","Mustaqeem A. Siddiqui","Francis K. Buadi","Ronald S. Go","Robert A. Kyle","Shaji Kumar","Wilson I. Gonsalves"],"twitterCount":6,"altmetricId":37392758,"statusesArray":["1016877037297061888","1016844168021315584","1016786815817220103","1016763525610405888","1016758962690117632","985720508732854273","985720428483276800","985473810383101952"]},{"title":"NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group","googleId":"4FNkWjiGTLsJ","googleLink":"https://www.nature.com/articles/leu2016361","googleCitationCount":15,"googleAuthor":"M Zampini","doi":"10.1038/leu.2016.361","elsevierAuthor":"Bisio V.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis","googleId":"plznjgF_yOEJ","googleLink":"https://www.nature.com/articles/leu2017183","googleCitationCount":11,"googleAuthor":"G Martinelli","doi":"10.1038/leu.2017.183","elsevierAuthor":"Martinelli G.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"11","altmetricAuthors":["G Martinelli","M Mancini","C De Benedittis","M Rondoni","C Papayannidis","M Manfrini","M Meggendorfer","R Calogero","V Guadagnuolo","M C Fontana","L Bavaro","A Padella","E Zago","L Pagano","R Zanotti","L Scaffidi","G Specchia","F Albano","S Merante","C Elena","P Savini","D Gangemi","P Tosi","F Ciceri","G Poletti","L Riccioni","F Morigi","M Delledonne","T Haferlach","M Cavo","P Valent","S Soverini"],"twitterCount":2,"altmetricId":52229285,"statusesArray":["1071120335150440449","1070353508690386944"]},{"title":"Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used","googleId":"B4UT7rCHFqIJ","googleLink":"https://www.nature.com/articles/s41375-018-0041-0","googleCitationCount":9,"googleAuthor":"M Delforge","doi":"10.1038/s41375-018-0041-0","elsevierAuthor":"Bossuyt X.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR","googleId":"nOYgGRx0ui8J","googleLink":"https://www.nature.com/articles/s41375-018-0052-x","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-018-0052-x","elsevierAuthor":"Notario L.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"5","altmetricAuthors":["Laura Notario","Elisenda Alari-Pahissa","Almudena Albentosa","Magdalena Leiva","Guadalupe Sabio","Pilar Lauzurica"],"twitterCount":3,"altmetricId":33788580,"statusesArray":["969088630684872704","969085204039192576","968995524442558466"]},{"title":"14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors","googleId":"WUGSdpqonk4J","googleLink":"https://www.nature.com/articles/leu2017288","googleCitationCount":9,"googleAuthor":"BG Barwick","doi":"10.1038/leu.2017.288","elsevierAuthor":"Gu Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"8","altmetricAuthors":["Y Gu","K Xu","C Torre","M Samur","B G Barwick","M Rupji","J Arora","P Neri","J Kaufman","A Nooka","L Bernal-Mizrachi","P Vertino","S-Y Sun","J Chen","N Munshi","H Fu","J Kowalski","L H Boise","S Lonial"],"twitterCount":13,"altmetricId":26404068,"statusesArray":["1087767216169332736","1087740426747035653","1087617925320630273","1087432938873122816","1087430916870496256","1051877925652484097","1046053626337271809","1046045988434182152","1016667743855276033","1016663325910986754","1012633816886849536","1012402881465634817","960907255439872000","954075978380300288","943550945526460416","941695503057739777","941690619478659073","939844579150483458","936594128858738689","936256207018393600","935981209460625408","935980898608087040","935970070844641285","935917439782719488","935914445041291269","935913907650220032","935913060887343105","935912815902195713","935886369255247872","935523990159929344","930844787007160322","930083535754547201","928676256903847937","926118061333270528","915751424742580224","915733773081292802","915693719965364224","915630265044754433","915612020757663744","915598743923302401","915598592760532992","915532368353644544","915309151340855296","915285278461501440","915284418771775488","915283938330935296","915283533031145472","910851122633392130"]},{"title":"Saracatinib impairs maintenance of human T-ALL by targeting the LCK tyrosine kinase in cells displaying high level of lipid rafts","googleId":"JCYF5v9XMuMJ","googleLink":"https://www.nature.com/articles/s41375-018-0081-5","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0081-5","elsevierAuthor":"Buffière A.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"3","altmetricAuthors":["Anne Buffière","Théo Accogli","Laetitia Saint-Paul","Géraldine Lucchi","Benjamin Uzan","Paola Ballerini","Jean-Noël Bastie","Laurent Delva","Françoise Pflumio","Ronan Quéré"],"twitterCount":1,"altmetricId":37621705,"statusesArray":["985848935985176577"]},{"title":"Novel PDGFRB fusions in childhood B-and T-acute lymphoblastic leukemia","googleId":"ITXPZlaoVg4J","googleLink":"https://www.nature.com/articles/leu2017161","googleCitationCount":10,"googleAuthor":"AB Schrock","doi":"10.1038/leu.2017.161","elsevierAuthor":"Heilmann A.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"10","altmetricAuthors":["A M Heilmann","A B Schrock","J He","M Nahas","K Curran","N Shukla","S Cramer","L Draper","A Verma","R Erlich","J Ross","P Stephens","V A Miller","S M Ali","J-A Verglio","M S Tallman","T I Mughal"],"twitterCount":4,"altmetricId":20687762,"statusesArray":["869547269481267200","869522117066444803","869498805686747136","869298936619597824"]},{"title":"A critical role of periostin in B-cell acute lymphoblastic leukemia","googleId":"mL6s1eZy8d4J","googleLink":"https://www.nature.com/articles/leu2017149","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.149","elsevierAuthor":"Ma Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy","googleId":"QuoK_ZUWAdgJ","googleLink":"https://www.nature.com/articles/s41375-018-0101-5","googleCitationCount":6,"googleAuthor":"LN Eadie","doi":"10.1038/s41375-018-0101-5","elsevierAuthor":"Eadie L.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"6","altmetricAuthors":["Laura N Eadie","Timothy P Hughes","Deborah L White"],"twitterCount":1,"altmetricId":34847411,"statusesArray":["978147123001638912"]},{"title":"IDH1 R132, IDH2 R140 and IDH2 R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies","googleId":"7dHGBA6IXz4J","googleLink":"https://www.nature.com/articles/s41375-018-0026-z","googleCitationCount":7,"googleAuthor":"W Walter","doi":"10.1038/s41375-018-0026-z","elsevierAuthor":"Meggendorfer M.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS","googleId":"HY89xWGJ8n4J","googleLink":"https://www.nature.com/articles/leu2016264","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2016.264","elsevierAuthor":"Müller E.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10","altmetricAuthors":["E Müller","S Bauer","T Stühmer","A Mottok","C-J Scholz","T Steinbrunn","D Brünnert","A Brandl","H Schraud","S Kreßmann","A Beilhack","A Rosenwald","R C Bargou","M Chatterjee"],"twitterCount":2,"altmetricId":12362586,"statusesArray":["785106290368315392","782203633668456448"]},{"title":"PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis","googleId":"PMSDXGxA5d8J","googleLink":"https://www.nature.com/articles/leu2016333","googleCitationCount":14,"googleAuthor":"MJ Carter","doi":"10.1038/leu.2016.333","elsevierAuthor":"Carter M.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"9","altmetricAuthors":["M J Carter","K L Cox","S J Blakemore","A H Turaj","R J Oldham","L N Dahal","S Tannheimer","F Forconi","G Packham","M S Cragg"],"twitterCount":5,"altmetricId":13926304,"statusesArray":["872492651614007297","872411449980833792","804258007886548993","803911121157681152","801445316146950145"]},{"title":"Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients","googleId":"Lemp3CE8SRIJ","googleLink":"https://www.nature.com/articles/leu2017220","googleCitationCount":10,"googleAuthor":"P Guglielmelli","doi":"10.1038/leu.2017.220","elsevierAuthor":"Ruberti S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"9","altmetricAuthors":["S Ruberti","E Bianchi","P Guglielmelli","S Rontauroli","G Barbieri","L Tavernari","T Fanelli","R Norfo","V Pennucci","G Corbizi Fattori","C Mannarelli","N Bartalucci","B Mora","L Elli","M A Avanzini","C Rossi","S Salmoiraghi","R Zini","S Salati","Z Prudente","V Rosti","F Passamonti","A Rambaldi","S Ferrari","E Tagliafico","A M Vannucchi","R Manfredini"],"twitterCount":2,"altmetricId":25183563,"statusesArray":["907893406688530432","907892880026595328"]},{"title":"Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations","googleId":"QiuhxlL88BcJ","googleLink":"https://www.nature.com/articles/s41375-018-0056-6","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0056-6","elsevierAuthor":"Willekens C.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"7","altmetricAuthors":["Christophe Willekens","Aline Renneville","Sophie Broutin","Véronique Saada","Jean-Baptiste Micol","Julia Delahousse","Vianney Poinsignon","Claire Bories","Céline Berthon","Raphael Itzykson","Nicolas Boissel","Cyril Quivoron","Marie Terroir-Cassou-Mounat","Jacques Bosq","Claude Preudhomme","Angelo Paci","Virginie Penard-Lacronique","Stéphane De Botton"],"twitterCount":1,"altmetricId":33708193,"statusesArray":["968274907506372613"]},{"title":"Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target","googleId":"BMuFmJrb5qIJ","googleLink":"https://www.nature.com/articles/leu2016249","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2016.249","elsevierAuthor":"Alatrash G.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"8","altmetricAuthors":["G Alatrash","H R Garber","M Zhang","P Sukhumalchandra","Y Qiu","H Jakher","A A Perakis","L Becker","S Y Yoo","K C Dwyer","K Coombes","A H Talukder","L S St John","V Senyukov","D A Lee","A Sergeeva","H He","Q Ma","P M Armistead","J Roszik","E A Mittendorf","J J Molldrem","D Hawke","G Lizee","S M Kornblau"],"twitterCount":3,"altmetricId":11886593,"statusesArray":["773666177977425921","773655750220521474","773638183066083328"]},{"title":"Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma","googleId":"E_oUnAVAlvcJ","googleLink":"https://www.nature.com/articles/leu2016253","googleCitationCount":16,"googleAuthor":"JD Shaughnessy Jr","doi":"10.1038/leu.2016.253","elsevierAuthor":"Sawyer J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"15","altmetricAuthors":["J R Sawyer","E Tian","J D Shaughnessy Jr","J Epstein","C M Swanson","C Stangeby","C L Hale","L Parr","M Lynn","G Sammartino","J L Lukacs","C Stein","C Bailey","M Zangari","F E Davies","F Van Rhee","B Barlogie","G J Morgan"],"twitterCount":9,"altmetricId":12420960,"statusesArray":["903968098126090241","903951534765072385","903924979506470913","783718892434759680","783683036244275200","783677423791419393","783319894817443840","783295908347650048","783289746088865793"]},{"title":"Lamin B1 regulates somatic mutations and progression of B-cell malignancies","googleId":"TJiA6Aqt26oJ","googleLink":"https://www.nature.com/articles/leu2017255","googleCitationCount":9,"googleAuthor":"T Klymenko","doi":"10.1038/leu.2017.255","elsevierAuthor":"Klymenko T.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"6","altmetricAuthors":["T Klymenko","J Bloehdorn","J Bahlo","S Robrecht","G Akylzhanova","K Cox","S Estenfelder","J Wang","J Edelmann","J C Strefford","T K Wojdacz","K Fischer","M Hallek","S Stilgenbauer","M Cragg","J Gribben","A Braun"],"twitterCount":3,"altmetricId":23845148,"statusesArray":["955492219770802176","899638871524331520","897411322534428673"]},{"title":"Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway","googleId":"Chzpx8IokEkJ","googleLink":"https://www.nature.com/articles/s41375-018-0114-0","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0114-0","elsevierAuthor":"Busch L.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"10","altmetricAuthors":["Leonhard Busch","Dimitrios Mougiakakos","Maike Büttner-Herold","Miriam J. Müller","Dietrich A. Volmer","Christian Bach","Mario Fabri","Jörg T. Bittenbring","Frank Neumann","Rainer Boxhammer","Jens Nolting","Savita Bisht","Martin Böttcher","Simon Jitschin","Markus H. Hoffmann","Heidi Balzer","Fabian Beier","Deniz Gezer","Diana Dudziak","Kolja Gelse","Friedrich F. Hennig","Christian P. Pallasch","Bernd Spriewald","Andreas Mackensen","Heiko Bruns"],"twitterCount":5,"altmetricId":35724166,"statusesArray":["985467782996242432","982177465056374786","981942739033051136","981839326572175360","981839083075981312"]},{"title":"Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma","googleId":"DqsZhxEXIr0J","googleLink":"https://www.nature.com/articles/leu2016379","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2016.379","elsevierAuthor":"Nair J.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"10","altmetricAuthors":["J R Nair","J Caserta","K Belko","T Howell","G Fetterly","C Baldino","K P Lee"],"twitterCount":2,"altmetricId":15248513,"statusesArray":["817170915117199361","817011524749430784"]},{"title":"Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone …","googleId":"7Ovgiv3WTMkJ","googleLink":"https://www.nature.com/articles/leu201773","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.73","elsevierAuthor":"Hussein K.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Nuclear FOXM1 drives chemoresistance in AML","googleId":"FeqoVGilTXwJ","googleLink":"https://www.nature.com/articles/leu2016270","googleCitationCount":12,"googleAuthor":"P Gann","doi":"10.1038/leu.2016.270","elsevierAuthor":"Khan I.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"10","altmetricAuthors":["I Khan","M Halasi","M F Zia","P Gann","S Gaitonde","N Mahmud","A L Gartel"],"twitterCount":3,"altmetricId":12573360,"statusesArray":["800714369470492672","786570578501050369","786017484918841344"]},{"title":"A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD","googleId":"R_NRMOQG7igJ","googleLink":"https://www.nature.com/articles/s41375-018-0183-0","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-018-0183-0","elsevierAuthor":"Sauer S.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4","altmetricAuthors":["Sandra Sauer","Johannes Hüsing","Jacek Hajda","Frank Neumann","Aleksandar Radujkovic","Anthony D. Ho","Peter Dreger","Thomas Luft"],"twitterCount":2,"altmetricId":44207110,"statusesArray":["1119257039824355329","1118894653674225664","1012018237553463298"]},{"title":"An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS","googleId":"Y4sk8owKtTEJ","googleLink":"https://www.nature.com/articles/s41375-018-0189-7","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0189-7","elsevierAuthor":"Kida J.i.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"3","altmetricAuthors":["Jun-ichiro Kida","Takayuki Tsujioka","Shin-ichiro Suemori","Shuichiro Okamoto","Kanae Sakakibara","Takayuki Takahata","Takahiro Yamauchi","Akira Kitanaka","Yumi Tohyama","Kaoru Tohyama"],"twitterCount":1,"altmetricId":54231623,"statusesArray":["1087361689706684417"]},{"title":"Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group","googleId":"SGAQMqrrSQwJ","googleLink":"https://www.nature.com/articles/leu2017221","googleCitationCount":8,"googleAuthor":"O Al-Sawaf","doi":"10.1038/leu.2017.221","elsevierAuthor":"Al-Sawaf O.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"3","altmetricAuthors":["O Al-Sawaf","S Robrecht","J Bahlo","A M Fink","P Cramer","J von Tresckow","C Maurer","M Bergmann","T Seiler","E Lange","M Kneba","S Stilgenbauer","H Döhner","M G Kiehl","U Jäger","C M Wendtner","K Fischer","V Goede","M Hallek","B Eichhorst","G Hopfinger"],"twitterCount":2,"altmetricId":21790308,"statusesArray":["1002856570718482433","1002854105373728768","890516940019703808"]},{"title":"Mutation, methylation, and gene expression profiles in dup (1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia","googleId":"P0TEvWThJfcJ","googleLink":"https://www.nature.com/articles/s41375-018-0092-2","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-018-0092-2","elsevierAuthor":"Gunnarsson R.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4","altmetricAuthors":["Rebeqa Gunnarsson","Sebastian Dilorenzo","Kristina B Lundin-Ström","Linda Olsson","Andrea Biloglav","Henrik Lilljebjörn","Marianne Rissler","Per Wahlberg","Anders Lundmark","Anders Castor","Mikael Behrendtz","Thoas Fioretos","Kajsa Paulsson","Anders Isaksson","Bertil Johansson"],"twitterCount":4,"altmetricId":34264142,"statusesArray":["982991624408936449","979039687204638720","973384274454999046","973372493833687041"]},{"title":"Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex","googleId":"TbeOYzgUJ3kJ","googleLink":"https://www.nature.com/articles/leu2016331","googleCitationCount":12,"googleAuthor":"TI Shaw","doi":"10.1038/leu.2016.331","elsevierAuthor":"Palacios G.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma","googleId":"9lA9b9ndPMsJ","googleLink":"https://www.nature.com/articles/leu2017115","googleCitationCount":11,"googleAuthor":"J Shaughnessy","doi":"10.1038/leu.2017.115","elsevierAuthor":"Hao M.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"11","altmetricAuthors":["M Hao","R Franqui-Machin","H Xu","J Shaughnessy","B Barlogie","D Roodman","D E Quelle","S Janz","M H Tomasson","R D Sanderson","L Qiu","I Frech","G Tricot","F Zhan"],"twitterCount":1,"altmetricId":18989446,"statusesArray":["854318597933379584"]},{"title":"Frequent evolution of copy number alterations in CLL following first-line treatment with FC (R) is enriched with TP53 alterations: results from the CLL8 trial","googleId":"deqpenSpGxYJ","googleLink":"https://www.nature.com/articles/leu2016317","googleCitationCount":13,"googleAuthor":"DA Landau","doi":"10.1038/leu.2016.317","elsevierAuthor":"Edelmann J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"7","altmetricAuthors":["J Edelmann","E Tausch","D A Landau","S Robrecht","J Bahlo","K Fischer","A M Fink","J Bloehdorn","K Holzmann","S Böttcher","L Werner","M Kneba","J G Gribben","D S Neuberg","C J Wu","M Hallek","H Döhner","S Stilgenbauer"],"twitterCount":0,"altmetricId":14549627,"statusesArray":[]},{"title":"Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1","googleId":"_Zf-3Q3hCE4J","googleLink":"https://www.nature.com/articles/s41375-018-0091-3","googleCitationCount":7,"googleAuthor":"M Cavo","doi":"10.1038/s41375-018-0091-3","elsevierAuthor":"Garderet L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo","googleId":"YFfpP0B1PAcJ","googleLink":"https://www.nature.com/articles/leu2017269","googleCitationCount":10,"googleAuthor":"N Jyotsana","doi":"10.1038/leu.2017.269","elsevierAuthor":"Jyotsana N.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8","altmetricAuthors":["N Jyotsana","A Sharma","A Chaturvedi","M Scherr","F Kuchenbauer","L Sajti","A Barchanski","R Lindner","F Noyan","K-W Sühs","D Grote-Koska","K Brand","H-P Vornlocher","M Stanulla","B Bornhauser","J-P Bourquin","M Eder","F Thol","A Ganser","R K Humphries","E Ramsay","P Cullis","M Heuser"],"twitterCount":2,"altmetricId":24202795,"statusesArray":["900305145509986304","900297675706388481"]},{"title":"Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia","googleId":"ebNBho1dNoMJ","googleLink":"https://www.nature.com/articles/s41375-018-0164-3","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0164-3","elsevierAuthor":"Criado I.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations","googleId":"eaVlxJIfZVEJ","googleLink":"https://www.nature.com/articles/leu2017126","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.126","elsevierAuthor":"Zhang H.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Nucleolin promotes execution of the hematopoietic stem cell gene expression program","googleId":"wzlWBB3kjmMJ","googleLink":"https://www.nature.com/articles/s41375-018-0090-4","googleCitationCount":6,"googleAuthor":"S Bhatia","doi":"10.1038/s41375-018-0090-4","elsevierAuthor":"Mahotka C.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"5","altmetricAuthors":["Csaba Mahotka","Sanil Bhatia","Jutta Kollet","Edgar Grinstein"],"twitterCount":1,"altmetricId":70362634,"statusesArray":["977851483826765824"]},{"title":"How good are we at predicting the fate of someone with acute myeloid leukaemia?","googleId":"DBJW7IESnR0J","googleLink":"https://www.nature.com/articles/leu201756","googleCitationCount":19,"googleAuthor":"RP Gale","doi":"10.1038/leu.2017.56","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"17","altmetricAuthors":["E Estey","R P Gale"],"twitterCount":3,"altmetricId":17598062,"statusesArray":["843928838686101504","843828477824569345","842673390779473920"]},{"title":"The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion","googleId":"cxGbr6y5dbIJ","googleLink":"https://www.nature.com/articles/leu2016242","googleCitationCount":11,"googleAuthor":"S Amarachintha","doi":"10.1038/leu.2016.242","elsevierAuthor":"Du W.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"7","altmetricAuthors":["W Du","S Amarachintha","A Wilson","Q Pang"],"twitterCount":1,"altmetricId":11903034,"statusesArray":["785336694207897600","783869420917690369","774025834944495616"]},{"title":"Epistasis between TIFAB and miR-146a: neighboring genes in del (5q) myelodysplastic syndrome","googleId":"vgKTv5WnTykJ","googleLink":"https://www.nature.com/articles/leu2016276","googleCitationCount":11,"googleAuthor":"ME Varney","doi":"10.1038/leu.2016.276","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impact of treatment site on disparities in outcome among adolescent and young adults with Hodgkin lymphoma","googleId":"2TrwS3jcvcoJ","googleLink":"https://www.nature.com/articles/leu201766","googleCitationCount":9,"googleAuthor":"S Bhatia","doi":"10.1038/leu.2017.66","elsevierAuthor":"Wolfson J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"6","altmetricAuthors":["J Wolfson","C-L Sun","L Wyatt","W Stock","S Bhatia"],"twitterCount":2,"altmetricId":20871850,"statusesArray":["872441439917092864","872411788163379200"]},{"title":"Constitutive activation of nuclear factor kappa B-inducing kinase counteracts apoptosis in cells with rearranged mixed lineage leukemia gene","googleId":"WwLkayTCs_QJ","googleLink":"https://www.nature.com/articles/s41375-018-0128-7","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-018-0128-7","elsevierAuthor":"Studencka-Turski M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Transforming growth factor-β1 regulates the nascent hematopoietic stem cell niche by promoting gluconeogenesis","googleId":"9AsVBcvGwJUJ","googleLink":"https://www.nature.com/articles/leu2017198","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/leu.2017.198","elsevierAuthor":"Zhang C.Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"7","altmetricAuthors":["C-Y Zhang","H-M Yin","H Wang","D Su","Y Xia","L-F Yan","B Fang","W Liu","Y-M Wang","A-H Gu","Y Zhou"],"twitterCount":1,"altmetricId":21493534,"statusesArray":["881913099250536449"]},{"title":"Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis","googleId":"cryWBBjFtWgJ","googleLink":"https://www.nature.com/articles/leu2016299","googleCitationCount":12,"googleAuthor":"RF Schlenk","doi":"10.1038/leu.2016.299","elsevierAuthor":"Schlenk R.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10","altmetricAuthors":["R F Schlenk","F Stegelmann","A Reiter","E Jost","N Gattermann","H Hebart","C Waller","A Hochhaus","U Platzbecker","P Schafhausen","I W Blau","W Verbeek","F H Heidel","M Werner","H Kreipe","V Teleanu","A Benner","H Döhner","M Grießhammer","K Döhner"],"twitterCount":7,"altmetricId":12973841,"statusesArray":["855156538905853953","854992874013945856","842197665085546500","840994758952665089","840575892606857219","790921723591823360","790720279047581696"]},{"title":"Myelodysplastic syndromes and bone loss in mice and men","googleId":"b7IS3O1JVvUJ","googleLink":"https://www.nature.com/articles/leu20177","googleCitationCount":12,"googleAuthor":"J Schmitt","doi":"10.1038/leu.2017.7","elsevierAuthor":"Weidner H.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"7","altmetricAuthors":["H Weidner","M Rauner","F Trautmann","J Schmitt","E Balaian","A Mies","S Helas","U Baschant","C Khandanpour","M Bornhäuser","L C Hofbauer","U Platzbecker"],"twitterCount":1,"altmetricId":15521541,"statusesArray":["821001657253298176"]},{"title":"Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL","googleId":"TdiUwYq5XaUJ","googleLink":"https://www.nature.com/articles/leu201713","googleCitationCount":11,"googleAuthor":"","doi":"10.1038/leu.2017.13","elsevierAuthor":"Serafin V.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms","googleId":"vTA9kNtruZUJ","googleLink":"https://www.nature.com/articles/leu201798","googleCitationCount":9,"googleAuthor":"HA O'Leary","doi":"10.1038/leu.2017.98","elsevierAuthor":"O'Leary H.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"10","altmetricAuthors":["H A O’Leary","M Capitano","S Cooper","C Mantel","H S Boswell","R Kapur","B Ramdas","R Chan","L Deng","C-K Qu","H E Broxmeyer"],"twitterCount":3,"altmetricId":18186957,"statusesArray":["847105416257404928","847105339518435330","846670222383734785"]},{"title":"Casein kinase 2 controls the survival of normal thymic and leukemic γδ T cells via promotion of AKT signaling","googleId":"GeKB79hJlRQJ","googleLink":"https://www.nature.com/articles/leu2016363","googleCitationCount":12,"googleAuthor":"ST Ribeiro","doi":"10.1038/leu.2016.363","elsevierAuthor":"Ribeiro S.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"9","altmetricAuthors":["S T Ribeiro","M Tesio","J C Ribot","E Macintyre","J T Barata","B Silva-Santos"],"twitterCount":1,"altmetricId":14422047,"statusesArray":["805127682472157184"]},{"title":"PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells","googleId":"zUqZ9nI4SyEJ","googleLink":"https://www.nature.com/articles/leu2017162","googleCitationCount":9,"googleAuthor":"SE Dunn","doi":"10.1038/leu.2017.162","elsevierAuthor":"Sun L.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"6","altmetricAuthors":["L Sun","Y Shi","G Wang","X Wang","S Zeng","S E Dunn","G D Fairn","Y-J Li","D E Spaner"],"twitterCount":2,"altmetricId":20721756,"statusesArray":["870016821235036160","869861947553980416"]},{"title":"A human bone marrow mesodermal-derived cell population with hemogenic potential","googleId":"LktpJE_lwGEJ","googleLink":"https://www.nature.com/articles/s41375-018-0016-1","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0016-1","elsevierAuthor":"Mokhtari S.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"0","altmetricAuthors":["Saloomeh Mokhtari","Evan Colletti","Weihong Yin","Chad Sanada","Zanetta Lamar","Paul J. Simmons","Steven Walker","Colin Bishop","Anthony Atala","Esmail D. Zanjani","Christopher D. Porada","Graça Almeida-Porada"],"twitterCount":1,"altmetricId":37040330,"statusesArray":["967057230368354304"]},{"title":"Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity","googleId":"zDH2IdbRr2IJ","googleLink":"https://www.nature.com/articles/leu2017343","googleCitationCount":8,"googleAuthor":"H Khiabanian","doi":"10.1038/leu.2017.343","elsevierAuthor":"Marsilio S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"6","altmetricAuthors":["S Marsilio","H Khiabanian","G Fabbri","S Vergani","C Scuoppo","E Montserrat","E J Shpall","M Hadigol","P Marin","K R Rai","R Rabadan","S Devereux","L Pasqualucci","N Chiorazzi"],"twitterCount":6,"altmetricId":30035376,"statusesArray":["941406308254838785","938415152633974786","938236003373940736","938171221686046720","938161478666018816","938104025714741248"]},{"title":"Validation of a prognostic score for patients with POEMS syndrome: a mayo clinic cohort","googleId":"ywLZPslrICcJ","googleLink":"https://www.nature.com/articles/leu201768","googleCitationCount":9,"googleAuthor":"TV Kourelis","doi":"10.1038/leu.2017.68","elsevierAuthor":"Kourelis T.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"5","altmetricAuthors":["T V Kourelis","A Dispenzieri"],"twitterCount":4,"altmetricId":17191684,"statusesArray":["841758814835752963","840900341361188865","840884347955761153","840136181845180417"]},{"title":"Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia","googleId":"96R9dw_vPXcJ","googleLink":"https://www.nature.com/articles/leu2016286","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2016.286","elsevierAuthor":"Ojamies P.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"6","altmetricAuthors":["P N Ojamies","M Kontro","H Edgren","P Ellonen","S Lagström","H Almusa","T Miettinen","S Eldfors","D Tamborero","K Wennerberg","C Heckman","K Porkka","M Wolf","O Kallioniemi"],"twitterCount":2,"altmetricId":13276985,"statusesArray":["796390389179621377","795950794839379968","793788159234600960"]},{"title":"A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies","googleId":"WYQSPx0oMY8J","googleLink":"https://www.nature.com/articles/leu2017293","googleCitationCount":7,"googleAuthor":"S Bournazos","doi":"10.1038/leu.2017.293","elsevierAuthor":"Casey E.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4","altmetricAuthors":["E Casey","S Bournazos","G Mo","P Mondello","K S Tan","J V Ravetch","D A Scheinberg"],"twitterCount":5,"altmetricId":26318851,"statusesArray":["1110283565814763523","1082361467129774080","962042363085377539","921095818731577345","921020367149391872","921014495379632128"]},{"title":"Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role","googleId":"I4dP78rU754J","googleLink":"https://www.nature.com/articles/s41375-018-0072-6","googleCitationCount":5,"googleAuthor":"MV Mateos","doi":"10.1038/s41375-018-0072-6","elsevierAuthor":"Rodríguez-Otero P.","publicationName":"Leukemia","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"1 April 2019","elsevierCitationCount":"0","altmetricAuthors":["Paula Rodríguez-Otero","María Victoria Mateos","Joaquín Martínez-López","Nerea Martín-Calvo","Miguel-Teodoro Hernández","Enrique M. Ocio","Laura Rosiñol","Rafael Martínez","Ana-Isabel Teruel","Norma C. Gutiérrez","Joan Bargay","Enrique Bengoechea","Yolanda González","Jaime Pérez de Oteyza","Mercedes Gironella","Cristina Encinas","Jesús Martín","Carmen Cabrera","Luis Palomera","Felipe de Arriba","María Teresa Cedena","Bruno Paiva","Noemí Puig","Albert Oriol","Joan Bladé","Juan José Lahuerta","Jesús F. San Miguel"],"twitterCount":3,"altmetricId":34241315,"statusesArray":["1064597572440993792","1061366213924798464","973227327000858635","973183216797528066"]},{"title":"Response kinetics and factors predicting survival in core-binding factor leukemia","googleId":"pu818wUrypsJ","googleLink":"https://www.nature.com/articles/s41375-018-0158-1","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0158-1","elsevierAuthor":"Boddu P.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"5","altmetricAuthors":["Prajwal Boddu","Christopher Gurguis","David Sanford","Jorge Cortes","Mary Akosile","Farhad Ravandi","Guillermo Garcia-Manero","Keyur P Patel","Tapan Kadia","Mark Brandt","Rita Maduike","Hagop Kantarjian","Gautam Borthakur"],"twitterCount":3,"altmetricId":44177874,"statusesArray":["1011812588404035591","1011794354095214594","1011794121684602880"]},{"title":"Demethylator phenotypes in acute myeloid leukemia","googleId":"6dvQnCgUvWkJ","googleLink":"https://www.nature.com/articles/s41375-018-0084-2","googleCitationCount":5,"googleAuthor":"AD Kelly","doi":"10.1038/s41375-018-0084-2","elsevierAuthor":"Kelly A.D.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4","altmetricAuthors":["Andrew D. Kelly","Jozef Madzo","Priyanka Madireddi","Patricia Kropf","Charly R. Good","Jaroslav Jelinek","Jean-Pierre J. Issa"],"twitterCount":3,"altmetricId":34030402,"statusesArray":["1053301794586222592","977204971325321217","971567167656390656","971312638675300354"]},{"title":"Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?","googleId":"tkdZOZo75QQJ","googleLink":"https://www.nature.com/articles/leu2017263","googleCitationCount":9,"googleAuthor":"PS Becker","doi":"10.1038/leu.2017.263","elsevierAuthor":"Zhou Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"9","altmetricAuthors":["Y Zhou","B L Wood","R B Walter","P S Becker","M-E Percival","M Bar","C Shaw","K Gardner","P Hendrie","J Abkowitz","F R Appelbaum","E Estey"],"twitterCount":1,"altmetricId":24021025,"statusesArray":["898689599387652097"]},{"title":"Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma","googleId":"Vooai9__TXcJ","googleLink":"https://www.nature.com/articles/leu2017146","googleCitationCount":17,"googleAuthor":"E Menu","doi":"10.1038/leu.2017.146","elsevierAuthor":"Favreau M.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"13","altmetricAuthors":["M Favreau","E Menu","D Gaublomme","K Vanderkerken","S Faict","K Maes","E De Bruyne","S Govindarajan","M Drennan","S Van Calenbergh","X Leleu","L Zabeau","J Tavernier","K Venken","D Elewaut"],"twitterCount":8,"altmetricId":20066113,"statusesArray":["942377102526914560","942033762115874816","942005583674187779","870800461586198529","870344414488666113","863489445919588352","863382446011813888","863380811919179776","863103267810689025","862983718968807427","862971410406420481"]},{"title":"Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster","googleId":"vndPZHz8BoUJ","googleLink":"https://www.nature.com/articles/leu2017127","googleCitationCount":8,"googleAuthor":"G Cazzaniga","doi":"10.1038/leu.2017.127","elsevierAuthor":"Cazzaniga G.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"4","altmetricAuthors":["G Cazzaniga","L Bisanti","G Randi","S Deandrea","S Bungaro","F Pregliasco","D Perotti","F Spreafico","G Masera","M G Valsecchi","A Biondi","M Greaves"],"twitterCount":2,"altmetricId":20301386,"statusesArray":["1240936156868591616","926842161995362304"]},{"title":"Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance","googleId":"g87505vxWFoJ","googleLink":"https://www.nature.com/articles/s41375-018-0202-1","googleCitationCount":4,"googleAuthor":"M Merz","doi":"10.1038/s41375-018-0202-1","elsevierAuthor":"Merz M.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1","altmetricAuthors":["Maximilian Merz","Thomas Hielscher","Korbinian Hoffmann","Anja Seckinger","Dirk Hose","Marc S. Raab","Jens Hillengass","Anna Jauch","Hartmut Goldschmidt"],"twitterCount":5,"altmetricId":45054650,"statusesArray":["1018694973271740416","1018620428531757056","1018617511099666435","1018564923801194496","1018541769468805121","1018540697056493568"]},{"title":"Establishment of a congenital amegakaryocytic thrombocytopenia model and a thrombocyte–specific reporter line in zebrafish","googleId":"gk4cp8K1_YMJ","googleLink":"https://www.nature.com/articles/leu2016320","googleCitationCount":11,"googleAuthor":"Y Zhang","doi":"10.1038/leu.2016.320","elsevierAuthor":"Lin Q.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"7","altmetricAuthors":["Q Lin","Y Zhang","R Zhou","Y Zheng","L Zhao","M Huang","X Zhang","A Y H Leung","W Zhang","Y Zhang"],"twitterCount":1,"altmetricId":13473577,"statusesArray":["796420905698263040"]},{"title":"JAK2-V617F activates β1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1","googleId":"vpgZqlWpr5EJ","googleLink":"https://www.nature.com/articles/leu201726","googleCitationCount":11,"googleAuthor":"N Gupta","doi":"10.1038/leu.2017.26","elsevierAuthor":"Gupta N.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"7","altmetricAuthors":["N Gupta","B Edelmann","T M Schnoeder","F C Saalfeld","D Wolleschak","S Kliche","B Schraven","F H Heidel","T Fischer"],"twitterCount":0,"altmetricId":16462428,"statusesArray":[]},{"title":"No evidence for microsatellite instability in acute myeloid leukemia","googleId":"Pw8nPI1skIcJ","googleLink":"https://www.nature.com/articles/leu201797","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.97","elsevierAuthor":"Walker C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches","googleId":"aoRGJq9Ko4AJ","googleLink":"https://www.nature.com/articles/leu2017143","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.143","elsevierAuthor":"Pearson S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia","googleId":"4bbXaG3WPnoJ","googleLink":"https://www.nature.com/articles/leu2017284","googleCitationCount":6,"googleAuthor":"A Jacquel","doi":"10.1038/leu.2017.284","elsevierAuthor":"Hospital M.A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"10","altmetricAuthors":["M-A Hospital","A Jacquel","F Mazed","E Saland","C Larrue","J Mondesir","R Birsen","A S Green","M Lambert","P Sujobert","E-F Gautier","V Salnot","M Le Gall","J Decroocq","L Poulain","N Jacque","M Fontenay","O Kosmider","C Récher","P Auberger","P Mayeux","D Bouscary","J-E Sarry","J Tamburini"],"twitterCount":1,"altmetricId":25442140,"statusesArray":["909018580057858048"]},{"title":"The-2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and …","googleId":"zhLf8f9A2xEJ","googleLink":"https://www.nature.com/articles/s41375-018-0088-y","googleCitationCount":5,"googleAuthor":"G Gobbi","doi":"10.1038/s41375-018-0088-y","elsevierAuthor":"Masselli E.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90 Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499","googleId":"tOYsMFEIQpYJ","googleLink":"https://www.nature.com/articles/leu2016305","googleCitationCount":11,"googleAuthor":"F Hong","doi":"10.1038/leu.2016.305","elsevierAuthor":"Smith M.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines?","googleId":"8cu1LajWnIwJ","googleLink":"https://www.nature.com/articles/s41375-018-0247-1","googleCitationCount":4,"googleAuthor":"N Aghel","doi":"10.1038/s41375-018-0247-1","elsevierAuthor":"Aghel N.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"2","altmetricAuthors":["Nazanin Aghel","Diego Hernan Delgado","Jeffrey Howard Lipton"],"twitterCount":9,"altmetricId":48073483,"statusesArray":["1057056534197231617","1056964077124284416","1054313100906807297","1054304978964221954","1039946416079233024","1039946276039811073","1039894206922280960","1039867086963654658","1039856087225303042","1039854648176332800","1039271692311425025","1039201925093367813"]},{"title":"Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms","googleId":"WCeMC2t2ggYJ","googleLink":"https://www.nature.com/articles/leu2017295","googleCitationCount":6,"googleAuthor":"SK Balasubramanian","doi":"10.1038/leu.2017.295","elsevierAuthor":"Balasubramanian S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"5","altmetricAuthors":["S K Balasubramanian","M Aly","Y Nagata","T Bat","B P Przychodzen","C M Hirsch","V Adema","V Visconte","T Kuzmanovic","T Radivoyevitch","A Nazha","S Mukherjee","M A Sekeres","J P Maciejewski"],"twitterCount":2,"altmetricId":26451894,"statusesArray":["911356290017955840","911332480237568000"]},{"title":"Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia","googleId":"Az9cdw8tvdsJ","googleLink":"https://www.nature.com/articles/s41375-018-0187-9","googleCitationCount":4,"googleAuthor":"J Bond","doi":"10.1038/s41375-018-0187-9","elsevierAuthor":"Bond J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"2","altmetricAuthors":["Jonathan Bond","Elise Labis","Alice Marceau-Renaut","Nicolas Duployez","Myriam Labopin","Guillaume Hypolite","Gérard Michel","Stéphane Ducassou","Hélène Boutroux","Brigitte Nelken","Yves Bertrand","André Baruchel","Arnaud Petit","Vahid Asnafi","Guy Leverger","Claude Preudhomme","Elizabeth Macintyre","Hélène Lapillonne"],"twitterCount":8,"altmetricId":44315954,"statusesArray":["1133476055250034688","1133461401131986945","1133450617207382018","1133434308222509056","1133257951983144960","1019579402349314048","1019550243430522880","1014444780925915136","1014444247372660736","1012809445687025664"]},{"title":"Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma","googleId":"wNWKZFihpPcJ","googleLink":"https://www.nature.com/articles/leu2016238","googleCitationCount":9,"googleAuthor":"J Richter","doi":"10.1038/leu.2016.238","elsevierAuthor":"Wurster K.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"7","altmetricAuthors":["K D Wurster","F Hummel","J Richter","M Giefing","S Hartmann","M-L Hansmann","S Kreher","K Köchert","D Krappmann","W Klapper","M Hummel","S-S Wenzel","G Lenz","M Janz","B Dörken","R Siebert","S Mathas"],"twitterCount":1,"altmetricId":10729664,"statusesArray":["767160320020193280"]},{"title":"Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma","googleId":"AYNx4epSm-IJ","googleLink":"https://www.nature.com/articles/leu2017124","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.124","elsevierAuthor":"Knop S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"6","altmetricAuthors":["S Knop","C Langer","M Engelhardt","L-O Mügge","A Reichle","W Rösler","F Bassermann","B Hertenstein","A Kunitz","C Röllig","H Ostermann","K Schäfer-Eckart","M Ringhoffer","A Günther","C Junghanss","H Biersack","M Schreder","A Liebert","S Held","H Einsele","R C Bargou"],"twitterCount":2,"altmetricId":19639294,"statusesArray":["857715788093956096","857613641394397186","857582608259198977"]},{"title":"Recurrent cyclin D2 mutations in myeloid neoplasms","googleId":"byRm2jRMdJ0J","googleLink":"https://www.nature.com/articles/leu2017195","googleCitationCount":7,"googleAuthor":"V Khanna","doi":"10.1038/leu.2017.195","elsevierAuthor":"Khanna V.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"4","altmetricAuthors":["V Khanna","C A Eide","C E Tognon","J E Maxson","B Wilmot","D Bottomly","S McWeeney","D K Edwards V","B J Druker","J W Tyner"],"twitterCount":1,"altmetricId":21201673,"statusesArray":["877204638788931585"]},{"title":"Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity","googleId":"td-EB3rz_KkJ","googleLink":"https://www.nature.com/articles/leu2016167","googleCitationCount":10,"googleAuthor":"S Weng","doi":"10.1038/leu.2016.167","elsevierAuthor":"Weng S.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"9","altmetricAuthors":["S Weng","S Matsuura","C T Mowery","S A Stoner","K Lam","D Ran","A G Davis","M-C Lo","D-E Zhang"],"twitterCount":2,"altmetricId":9535123,"statusesArray":["753439016901545984","751737201600278529"]},{"title":"A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial","googleId":"LqgxMR-miDEJ","googleLink":"https://www.nature.com/articles/s41375-018-0148-3","googleCitationCount":5,"googleAuthor":"RK Hills","doi":"10.1038/s41375-018-0148-3","elsevierAuthor":"Burnett A.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib","googleId":"QIb66V5xGZwJ","googleLink":"https://www.nature.com/articles/leu2016174","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2016.174","elsevierAuthor":"Ishiyama K.I.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"7","altmetricAuthors":["K-i Ishiyama","T Kitawaki","N Sugimoto","T Sozu","N Anzai","M Okada","M Nohgawa","K Hatanaka","N Arima","T Ishikawa","S Tabata","T Onaka","S Oka","Y Nakabo","R Amakawa","M Matsui","T Moriguchi","A Takaori-Kondo","N Kadowaki"],"twitterCount":2,"altmetricId":9106660,"statusesArray":["748283185310556160","748272438635552770"]},{"title":"Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?","googleId":"5xx5-PmN8IIJ","googleLink":"https://www.nature.com/articles/leu2017238","googleCitationCount":7,"googleAuthor":"MA Sekeres","doi":"10.1038/leu.2017.238","elsevierAuthor":"Zeidan A.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Mutant NRAS Q61K is responsible for MAPK pathway activation in the MARIMO cell line and renders these cells independent of the CALR–MPL–JAK2–STAT5 …","googleId":"6abA-jm9pT4J","googleLink":"https://www.nature.com/articles/s41375-018-0234-6","googleCitationCount":3,"googleAuthor":"TH Brümmendorf","doi":"10.1038/s41375-018-0234-6","elsevierAuthor":"Han L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Perspective on Diamond–Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome","googleId":"58RWXOMXi7UJ","googleLink":"https://www.nature.com/articles/leu2017314","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2017.314","elsevierAuthor":"Sakamoto K.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN/AKT/RCOR2/RUNX1 pathways","googleId":"lLHAo8KBNnMJ","googleLink":"https://www.nature.com/articles/leu2017232","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2017.232","elsevierAuthor":"Xia F.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias","googleId":"JyRgx8HVOfMJ","googleLink":"https://www.nature.com/articles/leu2016386","googleCitationCount":9,"googleAuthor":"L Riva","doi":"10.1038/leu.2016.386","elsevierAuthor":"Ronchini C.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study","googleId":"XMe390H57e8J","googleLink":"https://www.nature.com/articles/s41375-018-0268-9","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0268-9","elsevierAuthor":"Braess J.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4","altmetricAuthors":["Jan Braess","Susanne Amler","Karl-Anton Kreuzer","Karsten Spiekermann","Hans Walter Lindemann","Eva Lengfelder","Ullrich Graeven","Peter Staib","Wolf-Dieter Ludwig","Harald Biersack","Yon-Dschun Ko","Michael J. Uppenkamp","Maike De Wit","Stefan Korsten","Rudolf Peceny","Tobias Gaska","Xaver Schiel","Dirk M. Behringer","Michael G. Kiehl","Bettina Zinngrebe","Gerald Meckenstock","Eva Roemer","Dirk Medgenberg","Ernst Spaeth-Schwalbe","Gero Massenkeil","Heidrun Hindahl","Rainer Schwerdtfeger","Guido Trenn","Cristina Sauerland","Raphael Koch","Martin Lablans","Andreas Faldum","Dennis Görlich","Stefan K. Bohlander","Stephanie Schneider","Annika Dufour","Christian Buske","Michael Fiegl","Marion Subklewe","Birgit Braess","Michael Unterhalt","Anja Baumgartner","Bernhard Wörmann","Dietrich Beelen","Wolfgang Hiddemann"],"twitterCount":10,"altmetricId":49080910,"statusesArray":["1139542103636287488","1076453332036866048","1075958364713160705","1074510025622720512","1074398656239931394","1074384898331430915","1074211142950641665","1074205644205494272","1074040213889040384","1074027182568157189","1046681255192883200"]},{"title":"MZH29 is a novel potent inhibitor that overcomes drug resistance FLT3 mutations in acute myeloid leukemia","googleId":"5Y8_cBE4x00J","googleLink":"https://www.nature.com/articles/leu2016297","googleCitationCount":9,"googleAuthor":"B Xu","doi":"10.1038/leu.2016.297","elsevierAuthor":"Xu B.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"8","altmetricAuthors":["B Xu","Y Zhao","X Wang","P Gong","W Ge"],"twitterCount":2,"altmetricId":18534259,"statusesArray":["849680075129708544","849679597532659712"]},{"title":"Discriminating a common somatic ASXL1 mutation (c. 1934dup; p. G646Wfs* 12) from artifact in myeloid malignancies using NGS","googleId":"RsBuX4dvQgEJ","googleLink":"https://www.nature.com/articles/s41375-018-0193-y","googleCitationCount":3,"googleAuthor":"MO Alberti","doi":"10.1038/s41375-018-0193-y","elsevierAuthor":"Alberti M.O.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"3","altmetricAuthors":["Michael O. Alberti","Sridhar Nonavinkere Srivatsan","Jin Shao","Samantha N. McNulty","Gue Su Chang","Christopher A. Miller","Jennifer B. Dunlap","Fei Yang","Richard D. Press","Qingsong Gao","Li Ding","Jonathan W. Heusel","Eric J. Duncavage","Matthew J. Walter"],"twitterCount":2,"altmetricId":44364726,"statusesArray":["1013436836117483520","1013368768561491968"]},{"title":"Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis","googleId":"_4EzKgV9rGwJ","googleLink":"https://www.nature.com/articles/leu2017267","googleCitationCount":5,"googleAuthor":"FC Baltanas","doi":"10.1038/leu.2017.267","elsevierAuthor":"Gerboth S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions","googleId":"hOJ-2gdoQQ0J","googleLink":"https://www.nature.com/articles/s41375-018-0214-x","googleCitationCount":4,"googleAuthor":"FH Heidel","doi":"10.1038/s41375-018-0214-x","elsevierAuthor":"Heidel F.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"3","altmetricAuthors":["Florian H. Heidel","Haifa-Kathrin Al-Ali","Carsten Hirt","Dietrich Kämpfe","Kathleen Jentsch-Ullrich","Christian Junghanss","Ralf Nowak","Andreas Schwarzer","Claudia Spohn","Vladan Vucinic","Andreas Hochhaus","Thoralf Lange"],"twitterCount":1,"altmetricId":45475141,"statusesArray":["1021764961624715265"]},{"title":"Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia","googleId":"VHcm9kuA0msJ","googleLink":"https://www.nature.com/articles/s41375-017-0001-0","googleCitationCount":6,"googleAuthor":"JA Hixon","doi":"10.1038/s41375-017-0001-0","elsevierAuthor":"Cramer S.D.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"5","altmetricAuthors":["Sarah D. Cramer","Julie A. Hixon","Caroline Andrews","Ross J. Porter","Gisele O. L. Rodrigues","Xiaolin Wu","Tim Back","Kelli Czarra","Helen Michael","Maggie Cam","Jack Chen","Dominic Esposito","Emilee Senkevitch","Vijay Negi","Peter D. Aplan","Wenqing Li","Scott K. Durum"],"twitterCount":1,"altmetricId":60817592,"statusesArray":["1131169848128561158"]},{"title":"Plastic CD34 and CD38 expression in adult B–cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations","googleId":"dSSOcBUAlWoJ","googleLink":"https://www.nature.com/articles/leu2016315","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/leu.2016.315","elsevierAuthor":"Lang F.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Lenalidomide-mediated erythroid improvement in non-del (5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling","googleId":"-Dyb9GAJupcJ","googleLink":"https://www.nature.com/articles/leu2017305","googleCitationCount":6,"googleAuthor":"E Becht","doi":"10.1038/leu.2017.305","elsevierAuthor":"Kerdivel G.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4","altmetricAuthors":["G Kerdivel","V Chesnais","E Becht","A Toma","N Cagnard","F Dumont","A Rousseau","P Fenaux","S Chevret","N Chapuis","V Boeva","W H Fridman","M Fontenay","O Kosmider"],"twitterCount":3,"altmetricId":26963261,"statusesArray":["1080883582409809922","1080869966268764161","1080864132855808000","915543165792223233"]},{"title":"C-terminal BRE overexpression in 11q23-rearranged and t (8; 16) acute myeloid leukemia is caused by intragenic transcription initiation","googleId":"QGGsGJdWLR8J","googleLink":"https://www.nature.com/articles/leu2017280","googleCitationCount":5,"googleAuthor":"KHM Prange","doi":"10.1038/leu.2017.280","elsevierAuthor":"Marneth A.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Acute myeloid leukemia therapy and the chosen people","googleId":"NAogqIXtT9gJ","googleLink":"https://www.nature.com/articles/leu2016306","googleCitationCount":10,"googleAuthor":"RP Gale","doi":"10.1038/leu.2016.306","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM","googleId":"MomFs8b8vykJ","googleLink":"https://www.nature.com/articles/leu2017271","googleCitationCount":5,"googleAuthor":"D Townsley","doi":"10.1038/leu.2017.271","elsevierAuthor":"Albitar A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"2","altmetricAuthors":["A Albitar","D Townsley","W Ma","I De Dios","V Funari","N S Young","M Albitar"],"twitterCount":3,"altmetricId":24237577,"statusesArray":["925364970518282242","924999440288509954","900470076163457025"]},{"title":"Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective","googleId":"lUCB3TsWs9MJ","googleLink":"https://www.nature.com/articles/s41375-018-0050-z","googleCitationCount":3,"googleAuthor":"D Yan","doi":"10.1038/s41375-018-0050-z","elsevierAuthor":"Than H.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2","altmetricAuthors":["Hein Than","Yi Qiao","Xiaomeng Huang","Dongqing Yan","Jamshid S. Khorashad","Anthony D. Pomicter","Tibor J. Kovacsovics","Gabor T. Marth","Thomas O’Hare","Michael W. Deininger"],"twitterCount":1,"altmetricId":60444047,"statusesArray":["1128347930555863040"]},{"title":"Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia","googleId":"i-BlhJrtHL0J","googleLink":"https://www.nature.com/articles/s41375-018-0059-3","googleCitationCount":4,"googleAuthor":"P Strati","doi":"10.1038/s41375-018-0059-3","elsevierAuthor":"Strati P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"3","altmetricAuthors":["Paolo Strati","Alessandra Ferrajoli","William G. Wierda","Nitin Jain","Philip A. Thompson","Susan M. O’Brien","Katy Rezvani","Hagop M. Kantarjian","Jan A. Burger","Christina O. Hinojosa","Michael J. Keating","Zeev Estrov"],"twitterCount":2,"altmetricId":34729542,"statusesArray":["1056021993596702720","1050831043434045440"]},{"title":"Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria","googleId":"UFpvzDHuik0J","googleLink":"https://www.nature.com/articles/s41375-018-0138-5","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0138-5","elsevierAuthor":"Clemente M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"4","altmetricAuthors":["Michael J. Clemente","Bartlomiej Przychodzen","Cassandra M. Hirsch","Yasunobu Nagata","Taha Bat","Marcin W. Wlodarski","Tomas Radivoyevitch","Hideki Makishima","Jaroslaw P. Maciejewski"],"twitterCount":1,"altmetricId":39314809,"statusesArray":["989298751503290369"]},{"title":"E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia","googleId":"CLhoDJfu1iwJ","googleLink":"https://www.nature.com/articles/leu2016293","googleCitationCount":8,"googleAuthor":"SD Baker","doi":"10.1038/leu.2016.293","elsevierAuthor":"Park I.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells","googleId":"DfEJAKD6e4AJ","googleLink":"https://www.nature.com/articles/s41375-018-0200-3","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-018-0200-3","elsevierAuthor":"Du W.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2","altmetricAuthors":["Wei Du","Wei Liu","Benjamin Mizukawa","Xun Shang","Jared Sipple","Mark Wunderlich","Hartmut Geiger","Stella Davies","James Mulloy","Qishen Pang","Yi Zheng"],"twitterCount":7,"altmetricId":44364727,"statusesArray":["1045165479533449216","1045112573346148352","1044616214612496385","1044602352869756928","1044586605619466241","1044572021500399617","1013368771883364353"]},{"title":"Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells","googleId":"HABob9asBD0J","googleLink":"https://www.nature.com/articles/leu201777","googleCitationCount":8,"googleAuthor":"S Sharma","doi":"10.1038/leu.2017.77","elsevierAuthor":"Fiskus W.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia","googleId":"EgLY337jmhQJ","googleLink":"https://www.nature.com/articles/leu2016330","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/leu.2016.330","elsevierAuthor":"Baer C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"7","altmetricAuthors":["C Baer","F Dicker","W Kern","T Haferlach","C Haferlach"],"twitterCount":2,"altmetricId":15609800,"statusesArray":["872411105007722496","822447342272020482"]},{"title":"P2X7 polymorphisms and stem cell mobilisation","googleId":"vS9ENcNl1pkJ","googleLink":"https://www.nature.com/articles/s41375-018-0232-8","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-018-0232-8","elsevierAuthor":"Koldej R.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma","googleId":"4P2MJNx1Ew8J","googleLink":"https://www.nature.com/articles/leu2016292","googleCitationCount":7,"googleAuthor":"E Pomari","doi":"10.1038/leu.2016.292","elsevierAuthor":"Pomari E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD","googleId":"GoRIHWj92AYJ","googleLink":"https://www.nature.com/articles/leu2016343","googleCitationCount":7,"googleAuthor":"QY Sun","doi":"10.1038/leu.2016.343","elsevierAuthor":"Chien W.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Inhibition of reactive oxygen species limits expansion of chronic lymphocytic leukemia cells","googleId":"OR5bvsFpXEkJ","googleLink":"https://www.nature.com/articles/leu2017241","googleCitationCount":5,"googleAuthor":"B Yigit","doi":"10.1038/leu.2017.241","elsevierAuthor":"Yigit B.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors","googleId":"xxQ8FTjnO-wJ","googleLink":"https://www.nature.com/articles/leu2016250","googleCitationCount":8,"googleAuthor":"K Byrgazov","doi":"10.1038/leu.2016.250","elsevierAuthor":"Byrgazov K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"8","altmetricAuthors":["K Byrgazov","R Kastner","M Gorna","G Hoermann","M Koenig","C B Lucini","R Ulreich","M Benesch","V Strenger","H Lackner","W Schwinger","P Sovinz","O A Haas","M van den Heuvel-Eibrink","C M Niemeyer","O Hantschel","P Valent","G Superti-Furga","C Urban","M N Dworzak","T Lion"],"twitterCount":0,"altmetricId":12494784,"statusesArray":[]},{"title":"Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia","googleId":"anRD_4jT9BAJ","googleLink":"https://www.nature.com/articles/leu2016294","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2016.294","elsevierAuthor":"Lohmann G.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"5","altmetricAuthors":["G Lohmann","E Vasyutina","J Bloehdorn","N Reinart","J I Schneider","V Babu","G Knittel","G Crispatzu","P Mayer","C Prinz","J K Muenzner","B Biersack","D G Efremov","L Chessa","C D Herling","S Stilgenbauer","M Hallek","R Schobert","H C Reinhardt","B Schumacher","M Herling"],"twitterCount":1,"altmetricId":13086850,"statusesArray":["792325165610835968"]},{"title":"Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma","googleId":"IPYKE9gdaDsJ","googleLink":"https://www.nature.com/articles/leu2016311","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2016.311","elsevierAuthor":"Piao W.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Base excision repair proteins couple activation-induced cytidine deaminase and endonuclease G during replication stress-induced MLL destabilization","googleId":"vH64iK7uTtwJ","googleLink":"https://www.nature.com/articles/leu2017191","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.191","elsevierAuthor":"Gole B.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"1","altmetricAuthors":["B Gole","E Mian","M Rall","L Wiesmüller"],"twitterCount":1,"altmetricId":21279790,"statusesArray":["879293398859075586","878042453995130880"]},{"title":"High frequency of RUNX1 mutation in myelodysplastic syndrome patients with whole-arm translocation of der (1; 7)(q10; p10)","googleId":"z7nJoe2W0QcJ","googleLink":"https://www.nature.com/articles/leu2017228","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/leu.2017.228","elsevierAuthor":"Zhang T.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"5","altmetricAuthors":["T Zhang","Y Xu","J Pan","H Li","Q Wang","L Wen","D Wu","A Sun","S Chen"],"twitterCount":1,"altmetricId":22199375,"statusesArray":["887948433897771009"]},{"title":"Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice","googleId":"APYPByKBCXUJ","googleLink":"https://www.nature.com/articles/leu201769","googleCitationCount":6,"googleAuthor":"Y Fløisand","doi":"10.1038/leu.2017.69","elsevierAuthor":"Wang D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"4","altmetricAuthors":["D Wang","Y Fløisand","C V Myklebust","S Bürgler","A Parente-Ribes","P O Hofgaard","B Bogen","K Taskén","G E Tjønnfjord","F Schjesvold","J Dalgaard","A Tveita","L A Munthe"],"twitterCount":2,"altmetricId":16893490,"statusesArray":["923160254262673408","836940342117056512"]},{"title":"Towards 'off-the-shelf'genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells","googleId":"7aSG3GMsgSYJ","googleLink":"https://www.nature.com/articles/leu2017332","googleCitationCount":4,"googleAuthor":"N Or-Geva","doi":"10.1038/leu.2017.332","elsevierAuthor":"Or-Geva N.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia","googleId":"YTNkN_eBbrQJ","googleLink":"https://www.nature.com/articles/s41375-018-0137-6","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0137-6","elsevierAuthor":"Renneville A.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients","googleId":"r5l8NUdJqS4J","googleLink":"https://www.nature.com/articles/leu2017315","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/leu.2017.315","elsevierAuthor":"Bera T.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4","altmetricAuthors":["T K Bera","Y Abe","T Ise","A Oberle","D Gallardo","X-f Liu","S Nagata","M Binder","I Pastan"],"twitterCount":3,"altmetricId":28410177,"statusesArray":["931916185511198721","931842460833030144","931544000988790784"]},{"title":"Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML","googleId":"Jr4OR956He0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29381150/","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.9.","elsevierAuthor":"Schütz C.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004","googleId":"mjeOHdvXzuUJ","googleLink":"https://www.nature.com/articles/leu2017121","googleCitationCount":4,"googleAuthor":"M Dworzak","doi":"10.1038/leu.2017.121","elsevierAuthor":"Rasche M.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"2","altmetricAuthors":["M Rasche","C von Neuhoff","M Dworzak","J-P Bourquin","J Bradtke","G Göhring","G Escherich","G Fleischhack","N Graf","B Gruhn","O A Haas","T Klingebiel","B Kremens","T Lehrnbecher","A von Stackelberg","J Tchinda","Z Zemanova","C Thiede","N von Neuhoff","M Zimmermann","U Creutzig","D Reinhardt"],"twitterCount":1,"altmetricId":19573821,"statusesArray":["857035285779152897"]},{"title":"Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia","googleId":"P4WWAZXOUEkJ","googleLink":"https://www.nature.com/articles/s41375-018-0076-2","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0076-2","elsevierAuthor":"Ali A.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"1","altmetricAuthors":["Ashfaq Ali","Justine Penneroux","Reinaldo Dal Bello","Aline Massé","Samuel Quentin","Ashwin Unnikrishnan","Lucie Hernandez","Emmanuel Raffoux","Raouf Ben Abdelali","Aline Renneville","Claude Preudhomme","John Pimanda","Hervé Dombret","Jean Soulier","Pierre Fenaux","Emmanuelle Clappier","Lionel Adès","Alexandre Puissant","Raphael Itzykson"],"twitterCount":5,"altmetricId":33719518,"statusesArray":["969081294343888896","968949653147283456","968894249310806018","968796879969509376","968384936532115459"]},{"title":"Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia","googleId":"fknZKPO3E9gJ","googleLink":"https://www.nature.com/articles/s41375-018-0191-0","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0191-0","elsevierAuthor":"Lundin-Ström K.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia","googleId":"r6M6kAcMWrsJ","googleLink":"https://www.nature.com/articles/leu2017208","googleCitationCount":5,"googleAuthor":"D Kentrup","doi":"10.1038/leu.2017.208","elsevierAuthor":"Angenendt L.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"5","altmetricAuthors":["L Angenendt","S Reuter","D Kentrup","A S Benk","F Neumann","J Hüve","A C Martens","C Schwöppe","T Kessler","L H Schmidt","T Sauer","C Brand","J-H Mikesch","G Lenz","R M Mesters","C Müller-Tidow","W Hartmann","E Wardelmann","D Neri","W E Berdel","C Roesli","C Schliemann"],"twitterCount":9,"altmetricId":22720153,"statusesArray":["893173554681958400","891037192218390529","890726388189155328","890663375088173056","890647657743384576","890643447702409216","890598065396232192","890587160537178114","890574858811170816"]},{"title":"CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC","googleId":"HU8A1V6A0nUJ","googleLink":"https://www.nature.com/articles/leu2017346","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.346","elsevierAuthor":"Tirado-Gonzalez I.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0","altmetricAuthors":["I Tirado-Gonzalez","E Czlonka","A Nevmerzhitskaya","D Soetopo","E Bergonzani","A Mahmoud","A Contreras","I Jeremias","U Platzbecker","J P Bourquin","U Kloz","F Van der Hoeven","H Medyouf"],"twitterCount":6,"altmetricId":30133918,"statusesArray":["984858467356815360","984585062510465026","984461330970099712","984223965756444672","984188987047788546","938886818556141568"]},{"title":"Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia","googleId":"sEnhMGOWrsUJ","googleLink":"https://www.nature.com/articles/leu2017324","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/leu.2017.324","elsevierAuthor":"Nimmagadda S.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia","googleId":"g6eRaR22DKcJ","googleLink":"https://www.nature.com/articles/leu2016340","googleCitationCount":7,"googleAuthor":"Y Bai","doi":"10.1038/leu.2016.340","elsevierAuthor":"Kobayashi M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A revisionist history of adult marrow stem cell biology or 'they forgot about the discard'","googleId":"pc_T_aK94pUJ","googleLink":"https://www.nature.com/articles/leu2017155","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.155","elsevierAuthor":"Quesenberry P.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"4","altmetricAuthors":["P Quesenberry","L Goldberg"],"twitterCount":0,"altmetricId":23928731,"statusesArray":[]},{"title":"Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma","googleId":"r-Uc9E25ShoJ","googleLink":"https://www.nature.com/articles/leu2016346","googleCitationCount":7,"googleAuthor":"J Bordini","doi":"10.1038/leu.2016.346","elsevierAuthor":"Bordini J.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"5","altmetricAuthors":["J Bordini","S Galvan","M Ponzoni","M T S Bertilaccio","M Chesi","P L Bergsagel","C Camaschella","A Campanella"],"twitterCount":1,"altmetricId":14132798,"statusesArray":["823537088171741184","803252304057135105"]},{"title":"Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia","googleId":"b6JBXhQnZigJ","googleLink":"https://www.nature.com/articles/leu2016223","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2016.223","elsevierAuthor":"Fang Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"6","altmetricAuthors":["Y Fang","Y Yang","C Hua","S Xu","M Zhou","H Guo","N Wang","X Zhao","L Huang","F Yu","H Cheng","M L Wang","L Meng","T Cheng","W Yuan","D Ma","J Zhou"],"twitterCount":3,"altmetricId":10400109,"statusesArray":["763788095552651268","763782975276347392","763702827063578626"]},{"title":"Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells","googleId":"0F-RclkiSwMJ","googleLink":"https://www.nature.com/articles/leu2016154","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2016.154","elsevierAuthor":"Charaf L.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"4","altmetricAuthors":["L Charaf","F-X Mahon","I Lamrissi-Garcia","I Moranvillier","F Beliveau","B Cardinaud","S Dabernat","H de Verneuil","F Moreau-Gaudry","A Bedel"],"twitterCount":2,"altmetricId":8432121,"statusesArray":["738239192602447872","738238764150083584"]},{"title":"Response commentary: exosomes vs microvesicles in hematological malignancies","googleId":"rAzeD-zsELEJ","googleLink":"https://www.nature.com/articles/leu2017248","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.248","elsevierAuthor":"Whiteside T.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?","googleId":"tXE2iWWkH1kJ","googleLink":"https://www.nature.com/articles/leu2016266","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2016.266","elsevierAuthor":"Némethová V.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia","googleId":"YHm593d-4IoJ","googleLink":"https://www.nature.com/articles/leu2017319","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.319","elsevierAuthor":"Sakai H.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"3","altmetricAuthors":["H Sakai","N Hosono","H Nakazawa","B Przychodzen","C Polprasert","H E Carraway","M A Sekeres","T Radivoyevitch","K Yoshida","M Sanada","T Yoshizato","K Kataoka","M M Nakagawa","H Ueno","Y Nannya","A Kon","Y Shiozawa","J Takeda","Y Shiraishi","K Chiba","S Miyano","J Singh","R A Padgett","S Ogawa","J P Maciejewski","H Makishima"],"twitterCount":3,"altmetricId":28420654,"statusesArray":["933600615661420544","933600283510239232","927264183372181504","926781116039577600"]},{"title":"Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid …","googleId":"jA95sV7IJFEJ","googleLink":"https://www.nature.com/articles/leu2017118","googleCitationCount":5,"googleAuthor":"P Kongtim","doi":"10.1038/leu.2017.118","elsevierAuthor":"Kongtim P.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Treatment-free remission in chronic myeloid leukemia: floating between expectation and evidence","googleId":"uf364V5PQYAJ","googleLink":"https://www.nature.com/articles/leu201720","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2017.20","elsevierAuthor":"Baccarani M.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"6","altmetricAuthors":["M Baccarani"],"twitterCount":1,"altmetricId":16071217,"statusesArray":["827452351346679808"]},{"title":"CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS","googleId":"Qc2FvLwrKKwJ","googleLink":"https://www.nature.com/articles/leu2016272","googleCitationCount":5,"googleAuthor":"SR Oruganti","doi":"10.1038/leu.2016.272","elsevierAuthor":"Oruganti S.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"5","altmetricAuthors":["S R Oruganti","D J Torres","S Krebsbach","F Asperti-Boursin","J Winters","K Matlawska-Wasowska","S S Winter","C Halsey","J L Cannon"],"twitterCount":0,"altmetricId":12575223,"statusesArray":[]},{"title":"Managing myeloproliferative neoplasms evidence based on the ELN treatment recommendations 2018","googleId":"2L50e1cVYDMJ","googleLink":"https://www.nature.com/articles/s41375-018-0079-z","googleCitationCount":2,"googleAuthor":"FH Heidel","doi":"10.1038/s41375-018-0079-z","elsevierAuthor":"Heidel F.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"0","altmetricAuthors":["Florian H. Heidel","Robert Peter Gale","Andreas Hochhaus"],"twitterCount":1,"altmetricId":33755994,"statusesArray":["968710955877175297"]},{"title":"Revisiting thrombocytopenia in acute promyelocytic leukemia","googleId":"DLqLgP_dijIJ","googleLink":"https://www.nature.com/articles/s41375-018-0105-1","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0105-1","elsevierAuthor":"Kuchenbauer F.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Deletion of Ptpn1 induces myeloproliferative neoplasm","googleId":"dGuPGcogP44J","googleLink":"https://www.nature.com/articles/leu201731","googleCitationCount":5,"googleAuthor":"Y Yang","doi":"10.1038/leu.2017.31","elsevierAuthor":"Jobe F.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"3","altmetricAuthors":["F Jobe","B Patel","T Kuzmanovic","H Makishima","Y Yang","B Przychodzen","R E Hutchison","K K Bence","J P Maciejewski","G Mohi"],"twitterCount":0,"altmetricId":31721576,"statusesArray":[]},{"title":"Equivalence of BCSH and WHO diagnostic criteria for ET","googleId":"HC_3Son7daIJ","googleLink":"https://www.nature.com/articles/leu2016318","googleCitationCount":5,"googleAuthor":"MF McMullin","doi":"10.1038/leu.2016.318","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation","googleId":"jVcW7YjY50YJ","googleLink":"https://www.nature.com/articles/s41375-018-0145-6","googleCitationCount":1,"googleAuthor":"W Xiao","doi":"10.1038/s41375-018-0145-6","elsevierAuthor":"Xiao W.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"0","altmetricAuthors":["Wenbin Xiao","Raajit Rampal","Yanming Zhang","Robert Cimera","Achim A. Jungbluth","Maria Arcila","Mikhail Roshal","David C. Park"],"twitterCount":1,"altmetricId":45479281,"statusesArray":["1021790209925623808"]},{"title":"Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low-and very-low-risk genetic profile","googleId":"DDUYOh-k59oJ","googleLink":"https://www.nature.com/articles/leu2017292","googleCitationCount":4,"googleAuthor":"GM Rigolin","doi":"10.1038/leu.2017.292","elsevierAuthor":"Del Giudice I.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"3","altmetricAuthors":["I Del Giudice","G M Rigolin","S Raponi","L Cafforio","C Ilari","J Wang","M Bordyuh","A Piciocchi","M Marinelli","M Nanni","S Tavolaro","M Filetti","A Bardi","E Tammiso","E Volta","M Negrini","E Saccenti","F R Mauro","D Rossi","G Gaidano","A Guarini","R Rabadan","A Cuneo","R Foà"],"twitterCount":1,"altmetricId":26309796,"statusesArray":["910118658990645253"]},{"title":"Gain of function in Jak2 V617F-positive T-cells","googleId":"WXJ6luudrbMJ","googleLink":"https://www.nature.com/articles/leu20176","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.6","elsevierAuthor":"Nishanth G.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"3","altmetricAuthors":["G Nishanth","D Wolleschak","C Fahldieck","T Fischer","A Mullally","F Perner","T M Schnöder","S Just","F H Heidel","D Schlüter"],"twitterCount":2,"altmetricId":16462429,"statusesArray":["849629191377235969","849617164516675584"]},{"title":"Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3","googleId":"ocgAT4hQTckJ","googleLink":"https://www.nature.com/articles/leu2016289","googleCitationCount":6,"googleAuthor":"M Clarke","doi":"10.1038/leu.2016.289","elsevierAuthor":"Clarke M.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic implication of appendicular skeleton bone marrow abnormalities detected using low-dose multidetector computed tomography in patients with …","googleId":"TMorQueLJ0cJ","googleLink":"https://www.nature.com/articles/s41375-018-0048-6","googleCitationCount":2,"googleAuthor":"M Fujisawa","doi":"10.1038/s41375-018-0048-6","elsevierAuthor":"Abe Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?","googleId":"EdTCmauPY-oJ","googleLink":"https://www.nature.com/articles/leu2017237","googleCitationCount":3,"googleAuthor":"X Calvo","doi":"10.1038/leu.2017.237","elsevierAuthor":"Calvo X.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"2","altmetricAuthors":["X Calvo","L Florensa","L Arenillas"],"twitterCount":6,"altmetricId":23321464,"statusesArray":["916189721214246912","902683724919267328","902435544742989824","902257363335475200","902241015154618368","900515011310870529","898863410871283714","898497153735290880","898497139797524484","898496038172078081","898494264237330432"]},{"title":"Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and …","googleId":"qMPGSe3CpMwJ","googleLink":"https://www.nature.com/articles/leu2017289","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.289","elsevierAuthor":"Piette C.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells","googleId":"Wn8X8G48zYYJ","googleLink":"https://www.nature.com/articles/leu2016372","googleCitationCount":4,"googleAuthor":"FL Cosset","doi":"10.1038/leu.2016.372","elsevierAuthor":"Costa C.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"4","altmetricAuthors":["C Costa","G Hypolite","O Bernadin","C Lévy","F-L Cosset","V Asnafi","E Macintyre","E Verhoeyen","M Tesio"],"twitterCount":1,"altmetricId":43166320,"statusesArray":["1002855156927479809"]},{"title":"Response to'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'","googleId":"Lh83vhg8wCYJ","googleLink":"https://www.nature.com/articles/s41375-018-0155-4","googleCitationCount":1,"googleAuthor":"A Lakshman","doi":"10.1038/s41375-018-0155-4","elsevierAuthor":"Lakshman A.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1","altmetricAuthors":["Arjun Lakshman","Praful Ravi","S. Vincent Rajkumar","Shaji K. Kumar"],"twitterCount":3,"altmetricId":42985728,"statusesArray":["1001819048257212416","1001810178545737730","1001805104276819970"]},{"title":"Do hematopoietic stem cells get old?","googleId":"Qc40_5YJVu8J","googleLink":"https://www.nature.com/articles/leu2016301","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2016.301","elsevierAuthor":"Jung J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"4","altmetricAuthors":["J J Jung","S C Buisman","G de Haan"],"twitterCount":1,"altmetricId":15251088,"statusesArray":["817055650677223424"]},{"title":"Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences","googleId":"CbJVG-HeMkEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608236/","googleCitationCount":2,"googleAuthor":"I Cifola","doi":"10.1038/s41375-018-0177-y","elsevierAuthor":"L’Abbate A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes","googleId":"cwWG-aV_Uw8J","googleLink":"https://www.nature.com/articles/leu2017223","googleCitationCount":4,"googleAuthor":"KS Tan","doi":"10.1038/leu.2017.223","elsevierAuthor":"Mathias M.D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"4","altmetricAuthors":["M D Mathias","J T Sockolosky","A Y Chang","K S Tan","C Liu","K C Garcia","D A Scheinberg"],"twitterCount":0,"altmetricId":21790307,"statusesArray":[]},{"title":"Blast-phase chronic myelomonocytic leukemia: more than just semantics","googleId":"u7Eaup8gDsQJ","googleLink":"https://www.nature.com/articles/s41375-018-0228-4","googleCitationCount":1,"googleAuthor":"MM Patnaik","doi":"10.1038/s41375-018-0228-4","elsevierAuthor":"Patnaik M.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia","googleId":"rKkLBR5YqE0J","googleLink":"https://www.nature.com/articles/leu201737","googleCitationCount":3,"googleAuthor":"L Chilton","doi":"10.1038/leu.2017.37","elsevierAuthor":"Chilton L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014","googleId":"IyX162k9D3kJ","googleLink":"https://www.nature.com/articles/s41375-018-0057-5","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0057-5","elsevierAuthor":"Helm-Petersen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1","altmetricAuthors":["Sissel Helm-Petersen","Rasmus Sørrig","Tobias W. Klausen","Birgitte Preiss","Ulf Christian Frølund","Carsten Helleberg","Marie Breinholt","Mette Klarskov Andersen","Niels Abildgaard","Peter Gimsing","Annette J. Vangsted"],"twitterCount":1,"altmetricId":51407702,"statusesArray":["970260538704850944"]},{"title":"CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis","googleId":"metMaKN9qp4J","googleLink":"https://www.nature.com/articles/leu201753","googleCitationCount":3,"googleAuthor":"A Mandoli","doi":"10.1038/leu.2017.53","elsevierAuthor":"Cordonnier G.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Mtss1 (CSC156) mutant mice fail to display efficient Mtss1 protein depletion","googleId":"IAAciMlcaFEJ","googleLink":"https://www.nature.com/articles/leu201719","googleCitationCount":3,"googleAuthor":"S Koschmieder","doi":"10.1038/leu.2017.19","elsevierAuthor":"Fahrenkamp D.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study","googleId":"5ls0ix4FF8MJ","googleLink":"https://www.nature.com/articles/s41375-018-0054-8","googleCitationCount":1,"googleAuthor":"JL Biccler","doi":"10.1038/s41375-018-0054-8","elsevierAuthor":"Biccler J.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"1","altmetricAuthors":["Jorne Lionel Biccler","Lene Sofie Granfeldt Østgård","Marianne Tang Severinsen","Claus Werenberg Marcher","Peter Møller","Claudia Schöllkopf","Lone Smidstrup Friis","Martin Bøgsted","Lasse Hjort Jakobsen","Tarec Christoffer El-Galaly","Jan Maxwell Nørgaard"],"twitterCount":1,"altmetricId":49589674,"statusesArray":["1050830759630647306"]},{"title":"Spotlight on pomalidomide: could less be more?","googleId":"qeGmCaCoM6YJ","googleLink":"https://www.nature.com/articles/leu2017156","googleCitationCount":3,"googleAuthor":"T Zander","doi":"10.1038/leu.2017.156","elsevierAuthor":"Zander T.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"3","altmetricAuthors":["T Zander","S Aebi","T Pabst","C Renner","C Driessen"],"twitterCount":24,"altmetricId":20409455,"statusesArray":["1142337128241569792","1142327363042205696","979404569280155648","979397730387812354","979397572547706883","979394037907120128","975248099378696192","975108460693086209","974906733297651712","957890780303183872","953253238605844480","952984178622124036","905699959961518082","905405024519340032","905397242739040256","905394952791703552","905385470397267968","904457085143928833","904450517354598400","904409789027016704","904406184270192641","904405892883517440","873270043508957184","873169855138213889","873019517512929284","872960885538660352","872958021575507968","872951775535517696","872948418460692481","871367127659421696","867320176433352708","867069301492264963","867060686245040128","866997477752352775","866995085774344192"]},{"title":"Comment on structural basis of DUX4/IGH-driven transactivation","googleId":"d5Cxw3gK-F8J","googleLink":"https://www.nature.com/articles/s41375-018-0217-7","googleCitationCount":1,"googleAuthor":"H Aihara","doi":"10.1038/s41375-018-0217-7","elsevierAuthor":"Aihara H.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1","altmetricAuthors":["Hideki Aihara","Ke Shi","John K. Lee","Darko Bosnakovski","Michael Kyba"],"twitterCount":3,"altmetricId":45753208,"statusesArray":["1089076646186008576","1023825350826967040","1023510982146940928"]},{"title":"The NF1 hotspot in acute myeloid leukemia: what's in a name?","googleId":"wo9h0WZ8RNoJ","googleLink":"https://www.nature.com/articles/s41375-018-0266-y","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-018-0266-y","elsevierAuthor":"Vandepoele K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia","googleId":"Juo6Ye1bduEJ","googleLink":"https://www.nature.com/articles/leu201767","googleCitationCount":4,"googleAuthor":"S Chen","doi":"10.1038/leu.2017.67","elsevierAuthor":"Kobayashi M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations","googleId":"AWnIgNh9lBEJ","googleLink":"https://www.nature.com/articles/leu2017180","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.180","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"2","altmetricAuthors":["A Stengel","W Kern","M Meggendorfer","T Haferlach","C Haferlach"],"twitterCount":1,"altmetricId":20918729,"statusesArray":["872952951270146049"]},{"title":"An unusual, activating insertion/deletion MPL mutant in primary myelofibrosis","googleId":"Bx2CaSENAlgJ","googleLink":"https://www.nature.com/articles/leu2017153","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/leu.2017.153","elsevierAuthor":"Defour J.P.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"3","altmetricAuthors":["J-P Defour","Y Hoade","A-M Reuther","A Callaway","D Ward","F Chen","S N Constantinescu","N C P Cross"],"twitterCount":1,"altmetricId":23377008,"statusesArray":["892856850034470912"]},{"title":"The C-terminal multimerization domain is essential for leukemia development by CBFβ-SMMHC in a mouse knockin model","googleId":"iVie0ClkFKIJ","googleLink":"https://www.nature.com/articles/leu2017262","googleCitationCount":2,"googleAuthor":"H Alkadi","doi":"10.1038/leu.2017.262","elsevierAuthor":"Zhao L.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis","googleId":"23OLack7RUUJ","googleLink":"https://www.nature.com/articles/leu2017227","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/leu.2017.227","elsevierAuthor":"Kawabata K.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia","googleId":"jRvtCuMcaS4J","googleLink":"https://www.nature.com/articles/leu2017290","googleCitationCount":2,"googleAuthor":"P van den Elzen","doi":"10.1038/leu.2017.290","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"New drugs in myeloma: beware of phase I trial results, beware of cost and demand for new trials","googleId":"MOQtwsitM0cJ","googleLink":"https://www.nature.com/articles/leu2017188","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/leu.2017.188","elsevierAuthor":"Moreau P.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"0","altmetricAuthors":["P Moreau"],"twitterCount":5,"altmetricId":21434961,"statusesArray":["905702058808008704","905582226858942464","905582067987206148","905548241269293056","880708761979150336"]},{"title":"Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin","googleId":"ui_c0Lcv_2MJ","googleLink":"https://www.nature.com/articles/leu2016313","googleCitationCount":3,"googleAuthor":"TH Liu","doi":"10.1038/leu.2016.313","elsevierAuthor":"Liu T.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"1","altmetricAuthors":["T-H Liu","Y-J Tang","Y Huang","L Wang","X-L Guo","J-Q Mi","L-G Liu","H Zhu","Y Zhang","L Chen","X Liu","L-H Zhang","Q-J Ye","B-S Li","J-Y Tang","A Ford","T Enver","F Liu","G-Q Chen","D-L Hong"],"twitterCount":2,"altmetricId":13374830,"statusesArray":["798137263351697409","794997567084003333"]},{"title":"Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2","googleId":"SCLnqsfYFD0J","googleLink":"https://www.nature.com/articles/s41375-018-0171-4","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-018-0171-4","elsevierAuthor":"Holmqvist A.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Cardiologist's perspective to the European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid …","googleId":"Utc_nIczNGsJ","googleLink":"https://www.nature.com/articles/leu2016336","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2016.336","elsevierAuthor":"Constance C.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling","googleId":"y-r7YOCba-EJ","googleLink":"https://www.nature.com/articles/s41375-018-0053-9","googleCitationCount":0,"googleAuthor":"F Pagano","doi":"10.1038/s41375-018-0053-9","elsevierAuthor":"Pagano F.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"0","altmetricAuthors":["Francesca Pagano","Federico Comoglio","Jacob Grinfeld","Juan Li","Anna Godfrey","Joanna Baxter","Yvonne Silber","Anthony R Green"],"twitterCount":1,"altmetricId":33732781,"statusesArray":["968488402533453824","968486998725091328"]},{"title":"No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden","googleId":"e_kMNbN67NgJ","googleLink":"https://www.nature.com/articles/leu2017131","googleCitationCount":1,"googleAuthor":"M Höglund","doi":"10.1038/leu.2017.131","elsevierAuthor":"Gunnarsson N.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"1","altmetricAuthors":["N Gunnarsson","M Höglund","L Stenke","F Sandin","M Björkholm","A Dreimane","M Lambe","B Markevärn","U Olsson-Strömberg","H Wadenvik","J Richter","A Själander"],"twitterCount":7,"altmetricId":23369167,"statusesArray":["893078830419648512","892803805703688192","892801382452838400","892751330606850048","892741170249388032","892740884395024384","892740164568571904"]},{"title":"Application of the Filter approach and the Clustering algorithm on Cancer datasets","googleId":"IbBRGaHeknAJ","googleLink":"https://www.researchgate.net/profile/Sara_Haddou_Bouazza/publication/347447334_Application_of_the_Filter_approach_and_the_Clustering_algorithm_on_Cancer_datasets/links/5fdc8aaa299bf140881d1852/Application-of-the-Filter-approach-and-the-Clustering-algorithm-on-Cancer-datasets.pdf","googleCitationCount":1,"googleAuthor":"A ZEROUAL","statusesArray":[]},{"title":"Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia","googleId":"vLQnEVVyyvkJ","googleLink":"https://www.nature.com/articles/leu2016159","googleCitationCount":3,"googleAuthor":"T Velasco-Hernandez","doi":"10.1038/leu.2016.159","elsevierAuthor":"Jaako P.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"2","altmetricAuthors":["P Jaako","A Ugale","M Wahlestedt","T Velasco-Hernandez","J Cammenga","M S Lindström","D Bryder"],"twitterCount":1,"altmetricId":8477016,"statusesArray":["739038571726655488"]},{"title":"Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria","googleId":"bIQ855IoswEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608183/","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2016.291","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"(In) convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes","googleId":"O_4ZZMCflIkJ","googleLink":"https://www.nature.com/articles/s41375-018-0064-6","googleCitationCount":0,"googleAuthor":"X Calvo","doi":"10.1038/s41375-018-0064-6","elsevierAuthor":"Calvo X.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"0","altmetricAuthors":["Xavier Calvo","Lourdes Florensa","Leonor Arenillas"],"twitterCount":7,"altmetricId":33769365,"statusesArray":["969694634933981185","969337578959843329","969332525129699328","969208135251628032","968844126866288640","968834222646611968","968828904063594496"]},{"title":"Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL","googleId":"UPnzP04udpMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608364/","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0236-4","elsevierAuthor":"Prieto C.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"2","altmetricAuthors":["C. Prieto","B. López-Millán","H. Roca-Ho","R. W. Stam","D. Romero-Moya","F. J. Rodríguez-Baena","A. Sanjuan-Pla","V. Ayllón","M. Ramírez","M. Bardini","P. De Lorenzo","M. G. Valsecchi","M. Stanulla","M. Iglesias","P. Ballerini","Á. M. Carcaboso","J. Mora","F. Locatelli","A. Bertaina","L. Padilla","Juan Carlos Rodríguez-Manzaneque","C. Bueno","P. Menéndez"],"twitterCount":2,"altmetricId":48498170,"statusesArray":["1043435784781606912","1041414691942162432"]},{"title":"The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor","googleId":"sLh0VBBz9f0J","googleLink":"https://www.nature.com/articles/s41375-018-0156-3","googleCitationCount":1,"googleAuthor":"CF de Larrea","doi":"10.1038/s41375-018-0156-3","elsevierAuthor":"Fernández de Larrea C.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1","altmetricAuthors":["Carlos Fernández de Larrea","Ignacio Isola","Arturo Pereira","Ma Teresa Cibeira","Joan Bladé","Laura Rosiñol"],"twitterCount":1,"altmetricId":42928045,"statusesArray":["1128263825831018496","1001525143758192641"]},{"title":"Response to “Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions” by …","googleId":"kV1OaXuq3dIJ","googleLink":"https://www.nature.com/articles/s41375-018-0259-x","googleCitationCount":0,"googleAuthor":"F Passamonti","doi":"10.1038/s41375-018-0259-x","elsevierAuthor":"Barosi G.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Response to 'Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?'","googleId":"3owjBUDA55AJ","googleLink":"https://www.nature.com/articles/leu2016335","googleCitationCount":0,"googleAuthor":"LN Eadie","doi":"10.1038/leu.2016.335","elsevierAuthor":"Eadie L.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma","googleId":"mRDkC8duuI8J","googleLink":"https://www.nature.com/articles/s41375-018-0235-5","googleCitationCount":0,"googleAuthor":"CC Hofmeister","doi":"10.1038/s41375-018-0235-5","elsevierAuthor":"Richardson P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0","altmetricAuthors":["P. G. Richardson","C. C. Hofmeister","N. S. Raje","D. S. Siegel","S. Lonial","J. Laubach","Y. A. Efebera","D. H. Vesole","A. K. Nooka","J. Rosenblatt","D. Doss","M. H. Zaki","A. Bensmaine","J. Herring","Y. Li","L. Watkins","M. S. Chen","K. C. Anderson"],"twitterCount":1,"altmetricId":48498169,"statusesArray":["1041414684753055745"]},{"title":"The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib","googleId":"drqFKNc52LIJ","googleLink":"https://www.nature.com/articles/leu2016269","googleCitationCount":1,"googleAuthor":"CT Quang","doi":"10.1038/leu.2016.269","elsevierAuthor":"Rocchetti F.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"1","altmetricAuthors":["F Rocchetti","C Tran Quang","A L Maragno","J Nguyen","C Lasgi","J Ghysdael"],"twitterCount":0,"altmetricId":12897809,"statusesArray":[]},{"title":"Reply to Goel et al.'TP53 mutation allele-burden and disease outcome in MDS/AML'","googleId":"HYR0NgpxyjYJ","googleLink":"https://www.nature.com/articles/leu2016257","googleCitationCount":2,"googleAuthor":"E Padron","doi":"10.1038/leu.2016.257","elsevierAuthor":"Sallman D.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1","altmetricAuthors":["D A Sallman","R Komrokji","A List","E Padron"],"twitterCount":3,"altmetricId":12623657,"statusesArray":["837742560525312001","837722596535848960","837689274552111104"]},{"title":"Bone Marrow Study is Still Gold Standard In Evaluation Of Peripheral Pancytopenia","googleId":"dFi8OP_O4AoJ","googleLink":"https://www.academia.edu/download/56845654/F1701083342.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Reply to Constance et al.","googleId":"1czXTJI7bkcJ","googleLink":"https://www.nature.com/articles/leu2016337","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/leu.2016.337","elsevierAuthor":"Steegmann J.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"So-called “blast phase” of chronic myelomonocytic leukemia: a plea for uniform terminology","googleId":"TF6oTmReRZoJ","googleLink":"https://www.nature.com/articles/s41375-018-0186-x","googleCitationCount":0,"googleAuthor":"E Margolskee","doi":"10.1038/s41375-018-0186-x","elsevierAuthor":"Margolskee E.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1","altmetricAuthors":["Elizabeth Margolskee"],"twitterCount":3,"altmetricId":44252063,"statusesArray":["1012409803572903937","1012367602579058688","1012348154123960320"]},{"title":"NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib","googleId":"h8cCUzYYPNoJ","googleLink":"https://www.nature.com/articles/leu2017235","googleCitationCount":1,"googleAuthor":"S Mustjoki","doi":"10.1038/leu.2017.235","elsevierAuthor":"Sopper S.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"2","altmetricAuthors":["S Sopper","S Mustjoki","B T Gjertsen","F Giles","A Hochhaus","J J W M Janssen","K Porkka","D Wolf"],"twitterCount":3,"altmetricId":22304770,"statusesArray":["892704159262265345","890528714328387584","890512332887134209"]},{"title":"Role of absolute reticulocyte count (ARC) in assessment of pancytopenia in patients undergoing bone marrow biopsy","googleId":"zgQ-VUmJSmEJ","googleLink":"https://www.researchgate.net/profile/Shahzad_Ali_Jiskani/publication/342550543_Role_of_Absolute_Reticulocyte_Count_in_Pancytopenia_in_Patients_Undergoing_Bone_Marrow_Biopsy/links/5efafa42a6fdcc4ca43d9fcd/Role-of-Absolute-Reticulocyte-Count-in-Pancytopenia-in-Patients-Undergoing-Bone-Marrow-Biopsy.pdf","googleCitationCount":0,"googleAuthor":"SA Jiskani","statusesArray":[]},{"title":"The expression of P2Y14, a purinergic G-protein coupled receptor, defines functionally distinct subpopulations in placenta-derived hematopoietic stem progenitor cells","googleId":"LmAmWazIRlUJ","googleLink":"https://www.nature.com/articles/leu2017254","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/leu.2017.254","elsevierAuthor":"Kook S.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"1","altmetricAuthors":["S-H Kook","H-J Sim","J-C Lee","B-C Lee"],"twitterCount":1,"altmetricId":23780658,"statusesArray":["1003940951729946626"]},{"title":"Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemia","googleId":"BvhdZZrMpb8J","googleLink":"https://www.nature.com/articles/leu2017184","googleCitationCount":0,"googleAuthor":"Q Zhang","doi":"10.1038/leu.2017.184","elsevierAuthor":"Zhang Q.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A Pilot study of different doses of Ibrutinib in patients with Chronic Lymphocytic Leukemia 2016-0226","googleId":"tWuZckf-yMkJ","googleLink":"https://www.clinicaltrials.gov/ProvidedDocs/78/NCT02801578/Prot_SAP_000.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Correction: Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis","googleId":"KmhtdK93IqUJ","googleLink":"https://www.nature.com/articles/s41375-018-0237-3","googleCitationCount":0,"googleAuthor":"T Maekawa","doi":"10.1038/s41375-018-0237-3","elsevierAuthor":"Maekawa T.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo","googleId":"hfbJfE2HbYkJ","googleLink":"https://www.nature.com/articles/leu2017114","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.114","elsevierAuthor":"Yokota A.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"3","altmetricAuthors":["A Yokota","H Hirai","T Shoji","T Maekawa","K Okuda"],"twitterCount":1,"altmetricId":18914840,"statusesArray":["854114894148513802"]},{"title":"Response to Harrison et al.'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'","googleId":"ZzCDgsy0Hn4J","googleLink":"https://www.nature.com/articles/leu2016319","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/leu.2016.319","elsevierAuthor":"Gisslinger H.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used (epub ahead of print)","googleId":"IyKlhdZYDEgJ","googleLink":"https://lirias.kuleuven.be/retrieve/485462","googleCitationCount":1,"googleAuthor":"M Delforge","doi":"10.1038/leu.2017.335","elsevierCitationCount":0,"altmetricAuthors":["X Bossuyt","M Delforge","M Reynders","D Dillaerts","B Sprangers","K Fostier","K Poesen","M Vercammen"],"twitterCount":2,"altmetricId":34367606,"statusesArray":["933403769714421761","933092666132258816"]},{"title":"Package 'plsgenomics'","googleId":"B3LjmTBKScwJ","googleLink":"https://pbil.univ-lyon1.fr/CRAN/web/packages/plsgenomics/plsgenomics.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"The assembly competence domain is essential for inv (16)-associated acute myeloid leukemia","googleId":"9gaEtVAxO6kJ","googleLink":"https://www.nature.com/articles/leu2017236","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/leu.2017.236","elsevierAuthor":"Kim H.G.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Microbiology of Acute Rhinosinusitis in Immunosuppressed Patients","googleId":"La3KvcQA6EAJ","googleLink":"https://www.researchgate.net/profile/John_Greene7/publication/317933996_Microbiology_of_Acute_Rhinosinusitis_in_Immunosuppressed_Patients/links/599ec363aca272dff134dc16/Microbiology-of-Acute-Rhinosinusitis-in-Immunosuppressed-Patients.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Practice Corner","googleId":"_WJpvrdOMgUJ","googleLink":"https://aphon.org/UPLOADS/Education/APHON_Counts/counts_ref_summer18.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION: EBMT DATA MANAGEMENT GROUP—POSTER SESSION (P739–P749)","googleId":"e3RXwdxjjj8J","googleLink":"https://www.nature.com/bmt/journal/v52/n1s/pdf/bmt2017137a.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Gender differences in disease characteristics and biologic treatment outcomes in 1750","googleId":"Mcc-wnpoMVgJ","googleLink":"http://www.parkerinst.dk/sites/default/files/gender_differences_in_tnfi_outcomes_among_patients_with_psoriatic_arthritis_a_registry_study_protocol.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic …","googleId":"ZbrfzWkoSK0J","googleLink":"https://biblio.ugent.be/publication/8664266/file/8664268","googleCitationCount":0,"googleAuthor":"S Demeyer","statusesArray":[]},{"title":"International Journal of Medical and Health Sciences","googleId":"93s51WJd3zAJ","googleLink":"https://www.academia.edu/download/51985864/paper.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Nudges for Privacy and Security: Understanding and Assisting Users' Choices Online ACM Reference Format","googleId":"jMoK1yuvZOQJ","googleLink":"https://pennstate.pure.elsevier.com/en/publications/nudges-for-privacy-and-security-understanding-and-assisting-users","googleCitationCount":0,"googleAuthor":"A Acquisti","doi":"10.1145/3054926","elsevierAuthor":"Acquisti A.","publicationName":"ACM Computing Surveys","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"102","altmetricAuthors":["Alessandro Acquisti","Idris Adjerid","Rebecca Balebako","Laura Brandimarte","Lorrie Faith Cranor","Saranga Komanduri","Pedro Giovanni Leon","Norman Sadeh","Florian Schaub","Manya Sleeper","Yang Wang","Shomir Wilson"],"twitterCount":14,"altmetricId":23520929,"statusesArray":["1304848214277971968","1130829486084239360","927867031084568577","903934300340486145","899684156967452672","899664479625105408","899664449203777536","895361540735545345","895306121585602560","895303034749812736","895105782966091778","895104659521765376","895047686621147136","895041069527597056","895026302771703808","895026155782377474","895025891310354432","895025226974609408"]},{"title":"Quantum Chemical Insight into the Adsorption Mechanisms of Troxacitabine onto Functionalized Carbon Nanotubes","googleId":"Kms92TiK5FgJ","googleLink":"https://www.researchgate.net/profile/Ali_Morsali2/publication/328267941_Quantum_chemical_insight_into_the_adsorption_mechanisms_of_troxacitabine_onto_functionalized_carbon_nanotubes/links/5c3522c0458515a4c71771ff/Quantum-chemical-insight-into-the-adsorption-mechanisms-of-troxacitabine-onto-functionalized-carbon-nanotubes.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Johannes Joseph van Rood Pioneer in immuno-genetics (7 April 1926–21 July 2017)","googleId":"5oG74d9FtOsJ","googleLink":"https://www.nature.com/articles/leu2017278","googleCitationCount":0,"googleAuthor":"RP Gale","doi":"10.1038/leu.2017.278","elsevierAuthor":"Fibbe W.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"0","altmetricAuthors":["W Fibbe","R P Gale"],"twitterCount":1,"altmetricId":24608819,"statusesArray":["911234677981057024"]},{"title":"Correction: A human bone marrow mesodermal-derived cell population with hemogenic potential","googleId":"Jp2X5Yyj6yQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29891936/","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-018-0172-3,","elsevierAuthor":"Mokhtari S.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Responses to pomalidomide and placebo in myelofibrosis-related anaemia","googleId":"0Azn7oe634oJ","googleLink":"https://www.nature.com/articles/leu2016348","googleCitationCount":1,"googleAuthor":"DM Ross","doi":"10.1038/leu.2016.348","elsevierAuthor":"Ross D.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1","altmetricAuthors":["D M Ross"],"twitterCount":4,"altmetricId":15648844,"statusesArray":["842197676162744322","840994774479953920","840575701371752449","837310713488113664"]},{"title":"The role of bone marrow morphology in the diagnosis of relapsed acute myeloid leukemia","googleId":"KegB8W6POe8J","googleLink":"https://www.nature.com/articles/leu2017308","googleCitationCount":0,"googleAuthor":"B Said","doi":"10.1038/leu.2017.308","elsevierAuthor":"Said B.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"0","altmetricAuthors":["B Said","S Gilles","D Weisdorf","A Rashidi"],"twitterCount":2,"altmetricId":28178292,"statusesArray":["925472756111675399","925382414959906817"]},{"title":"Expansion of Th 1-like Vγ 9 Vδ 2 T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid","googleId":"ZGwx8dHB7IkJ","googleLink":"https://www.nature.com/articles/leu2016273","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/leu.2016.273","elsevierAuthor":"Harada T.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Recently approved therapies in acute myeloid leukemia: a complex treatment landscape","googleId":"m6aDAPti3SgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302078","googleCitationCount":39,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.001","elsevierAuthor":"Talati C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"28","altmetricAuthors":["Chetasi Talati","Kendra Sweet"],"twitterCount":5,"altmetricId":48584114,"statusesArray":["1059601582759833600","1059593319808991233","1053229207168401408","1042300695033139203","1042033029898756096"]},{"title":"Current approach to the treatment of chronic myeloid leukaemia","googleId":"_jfdROuauEoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730005X","googleCitationCount":55,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.005","elsevierAuthor":"Pasic I.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"32","altmetricAuthors":["Ivan Pasic","Jeffrey H. Lipton"],"twitterCount":5,"altmetricId":15910264,"statusesArray":["837416978226819072","837346786880675845","825370009656504323","825366589910478848","825366588790603776","825366026955141122","825365957946261506"]},{"title":"The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia","googleId":"m8eJUv3QUsQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306185","googleCitationCount":34,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.009","elsevierAuthor":"Zhao H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"29","altmetricAuthors":["Huihui Zhao","Huayuan Zhu","Jiayu Huang","Yu Zhu","Ming Hong","Han Zhu","Jingjing Zhang","Shan Li","Lijia Yang","Yun Lian","Shuai Wang","Jianping Mao","Yaoyu Chen","Jianyong Li","Sixuan Qian"],"twitterCount":7,"altmetricId":31504583,"statusesArray":["956142318943375360","956126515393019904","952859567142051841","951153263218446336","951149546142404609","951127921808347136","951109878067662848"]},{"title":"Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo","googleId":"19-1xp6IRw8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305222","googleCitationCount":36,"googleAuthor":"J Laloy","doi":"10.1016/j.leukres.2017.09.014","elsevierAuthor":"Bouvy C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"22","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML","googleId":"nr3qCi7FQjwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304228","googleCitationCount":40,"googleAuthor":"E Hadzijusufovic","doi":"10.1016/j.leukres.2017.05.008","elsevierAuthor":"Valent P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"28","altmetricAuthors":["Peter Valent","Emir Hadzijusufovic","Gregor Hoermann","Wolfgang Füreder","Gerit-Holger Schernthaner","Wolfgang R. Sperr","Rudolf Kirchmair","Dominik Wolf"],"twitterCount":3,"altmetricId":20646422,"statusesArray":["901405090262724609","901405076178251776","868412985672220672","868407824543383552"]},{"title":"Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years","googleId":"RS6sZXgSulsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300462","googleCitationCount":38,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.033","elsevierAuthor":"Lyons R.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"22","altmetricAuthors":["Roger M. Lyons","Billie J. Marek","Carole Paley","Jason Esposito","Katie McNamara","Paul D. Richards","Nicholas DiBella","Guillermo Garcia-Manero"],"twitterCount":2,"altmetricId":18394603,"statusesArray":["848642030750322688","848317074472673280"]},{"title":"Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia","googleId":"_DEcXrnG4McJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300383","googleCitationCount":37,"googleAuthor":"JL Patel","doi":"10.1016/j.leukres.2017.01.027","elsevierAuthor":"Patel J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"31","altmetricAuthors":["Jay L. Patel","Jonathan A. Schumacher","Kimberly Frizzell","Shelly Sorrells","Wei Shen","Adam Clayton","Rakhi Jattani","Todd W. Kelley"],"twitterCount":1,"altmetricId":16103266,"statusesArray":["827706203203440640"]},{"title":"8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms","googleId":"XvIyFSXJheEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300195","googleCitationCount":25,"googleAuthor":"Z Tang","doi":"10.1016/j.leukres.2018.01.013","elsevierAuthor":"Boddu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"22","altmetricAuthors":["Prajwal C. Boddu","Sa A. Wang","Naveen Pemmaraju","Zhenya Tang","Shimin Hu","Shaoying Li","Jie Xu","L. Jeffrey Medeiros","Guilin Tang"],"twitterCount":10,"altmetricId":32803892,"statusesArray":["1155305337702047744","1149786150812319744","1149330288742457344","1149168859741659136","1149113766375776257","1149110517165899777","1149109495097896965","1076221229001031682","1076206440573009921","964325774953205760","962538045156286464","961806970121408513","961367603934502912"]},{"title":"Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group …","googleId":"sbPZIT5_IBAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300067","googleCitationCount":26,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.008","elsevierAuthor":"Harada Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"21","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis","googleId":"FSsQTcjr6IAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304460","googleCitationCount":33,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.001","elsevierAuthor":"Masarova L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"27","altmetricAuthors":["Lucia Masarova","Prithviraj Bose","Naval Daver","Naveen Pemmaraju","Kate J. Newberry","Taghi Manshouri","Jorge Cortes","Hagop M. Kantarjian","Srdan Verstovsek"],"twitterCount":9,"altmetricId":20990997,"statusesArray":["925793674700709889","925487124224323586","925487048227729408","905781520589348865","905701462478434306","905626537810173952","883816606610182145","883805058957266947","874657074139066370","874412244339224576","874353774541893633","874353773770133505","874350713022885888","874326092907069440"]},{"title":"Extracellular vesicles in leukemia","googleId":"FxLhYVtkwGEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305970","googleCitationCount":23,"googleAuthor":"JL Reagan","doi":"10.1016/j.leukres.2017.11.011","elsevierAuthor":"Pando A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"17","altmetricAuthors":["Alejandro Pando","John L. Reagan","Peter Quesenberry","Loren D. Fast"],"twitterCount":1,"altmetricId":29763362,"statusesArray":["936562291616579585"]},{"title":"Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome","googleId":"gFtHxRbiCa8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305684","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.015","elsevierAuthor":"Shirahata-Adachi M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"15","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia","googleId":"AnDbsidSQpIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305209","googleCitationCount":22,"googleAuthor":"P Bhatia","doi":"10.1016/j.leukres.2017.09.012","elsevierAuthor":"Singh M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"15","altmetricAuthors":["Minu Singh","Prateek Bhatia","Sanjeev Khera","Amita Trehan"],"twitterCount":1,"altmetricId":26871935,"statusesArray":["914798675838111744","914435994044133376"]},{"title":"Bortezomib in plasmablastic lymphoma: a glimpse of hope for a hard-to-treat disease","googleId":"hEOiH5_IqpAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305283","googleCitationCount":23,"googleAuthor":"JJ Castillo","doi":"10.1016/j.leukres.2017.09.020","elsevierAuthor":"Guerrero-Garcia T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"17","altmetricAuthors":["Thomas A. Guerrero-Garcia","Renzo J. Mogollon","Jorge J. Castillo"],"twitterCount":1,"altmetricId":89810987,"statusesArray":["1304111853103128577"]},{"title":"A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease","googleId":"Y9-LBHLJw5AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302480","googleCitationCount":16,"googleAuthor":"L Hazlehurst","doi":"10.1016/j.leukres.2018.10.002","elsevierAuthor":"Sweet K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"15","altmetricAuthors":["Kendra Sweet","Lori Hazlehurst","Eva Sahakian","John Powers","Lisa Nodzon","Fadi Kayali","Kelly Hyland","Ashley Nelson","Javier Pinilla-Ibarz"],"twitterCount":2,"altmetricId":49524028,"statusesArray":["1050447709684097026","1050400882536407043"]},{"title":"PD-1/PD-L1 checkpoint in hematological malignancies","googleId":"1OZ9xp2cyRMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300201","googleCitationCount":21,"googleAuthor":"O Annibali","doi":"10.1016/j.leukres.2018.01.014","elsevierAuthor":"Annibali O.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"14","altmetricAuthors":["O. Annibali","A. Crescenzi","V. Tomarchio","A. Pagano","A. Bianchi","A. Grifoni","G. Avvisati"],"twitterCount":4,"altmetricId":34011869,"statusesArray":["1106136943933431808","991554984209629184","991279682753613824","990999254645780480"]},{"title":"Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events","googleId":"gvVKbxKgX90J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302121","googleCitationCount":15,"googleAuthor":"Z Tang","doi":"10.1016/j.leukres.2018.09.006","elsevierAuthor":"Tang Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"13","altmetricAuthors":["Zhenya Tang","Yan Li","Wei Wang","C. Cameron Yin","Guilin Tang","Phyu P. Aung","Shimin Hu","Xinyan Lu","Gokce A. Toruner","L. Jeffrey Medeiros","Joseph D. Khoury"],"twitterCount":10,"altmetricId":48878446,"statusesArray":["1146129672650010630","1119131578821533696","1119055118064812032","1119015143092965376","1118972871576047617","1118903700662235137","1118890605994807296","1118887724642119680","1118886456959934466","1044592507336552450"]},{"title":"Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic …","googleId":"ZPRpClES9jgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301000","googleCitationCount":21,"googleAuthor":"CK Kontos","doi":"10.1016/j.leukres.2018.04.014","elsevierAuthor":"Papageorgiou S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"14","altmetricAuthors":["Sotirios G. Papageorgiou","Christos K. Kontos","Panagiotis Tsiakanikas","Georgia Stavroulaki","Anthi Bouchla","Diamantina Vasilatou","Efthymia Bazani","Afroditi Lazarakou","Andreas Scorilas","Vasiliki Pappa"],"twitterCount":3,"altmetricId":40608730,"statusesArray":["992061035489189890","992060966190833664","991728384454479872"]},{"title":"Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic …","googleId":"FbJ80Qbod_wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301498","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.005","elsevierAuthor":"Sommer S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"12","altmetricAuthors":["Sebastian Sommer","Marjan Cruijsen","Rainer Claus","Hartmut Bertz","Ralph Wäsch","Reinhard Marks","Robert Zeiser","Lioudmila Bogatyreva","Nicole M.A. Blijlevens","Annette May","Justus Duyster","Gerwin Huls","Walter J.F.M. van der Velden","Jürgen Finke","Michael Lübbert"],"twitterCount":3,"altmetricId":44920698,"statusesArray":["1024629349255864320","1024600664100364288","1017363187904069633"]},{"title":"High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features …","googleId":"YDMCy-BTfSwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304344","googleCitationCount":22,"googleAuthor":"L Magnano","doi":"10.1016/j.leukres.2017.05.014","elsevierAuthor":"Dlouhy I.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"19","altmetricAuthors":["Ivan Dlouhy","Xavier Filella","Jordina Rovira","Laura Magnano","Alfredo Rivas-Delgado","Tycho Baumann","Alejandra Martínez-Trillos","Olga Balagué","Antonio Martínez","Blanca González-Farre","Kennosuke Karube","Eva Gine","Julio Delgado","Elías Campo","Armando López-Guillermo"],"twitterCount":1,"altmetricId":20579101,"statusesArray":["915517969991704577","868044406405963777"]},{"title":"Subcellular localization of the FLT3-ITD oncogene plays a significant role in the production of NOX-and p22phox-derived reactive oxygen species in acute myeloid …","googleId":"jse4zQT-ybcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302466","googleCitationCount":27,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.006","elsevierAuthor":"Moloney J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation","googleId":"9URnf4Z9aJIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301024","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.016","elsevierAuthor":"Iovino L.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"17","altmetricAuthors":["Lorenzo Iovino","Francesco Mazziotta","Giovanni Carulli","Francesca Guerrini","Riccardo Morganti","Valentina Mazzotti","Fabrizio Maggi","Lisa Macera","Enrico Orciuolo","Gabriele Buda","Edoardo Benedetti","Francesco Caracciolo","Sara Galimberti","Mauro Pistello","Mario Petrini"],"twitterCount":23,"altmetricId":40926975,"statusesArray":["1026649053235490816","1026551559469948928","1026551136512225280","1026548773877506049","1026543431886098432","1014915923592077312","995948537870417920","995413222537691136","995408199745335296","995317712946593793","994884641265012737","994799189174509568","994780424202326018","994765259947814913","994620402830856194","994585450118512642","994579316808867841","994562104878284801","994560311897280512","994545678104907776","994542066934996992","994541495410622464","994533138247376897","994513877864857600"]},{"title":"Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey","googleId":"fMXWO6ssmRgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302661","googleCitationCount":26,"googleAuthor":"A Candoni","doi":"10.1016/j.leukres.2016.12.003","elsevierAuthor":"Lazzarotto D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"22","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia","googleId":"G0SmM0PT7nEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306148","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.010","elsevierAuthor":"Millan N.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"15","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Pegylated interferon alpha–2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial","googleId":"kuVbZT8DrhcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300085","googleCitationCount":24,"googleAuthor":"T Jain","doi":"10.1016/j.leukres.2017.01.006","elsevierAuthor":"Gowin K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14","altmetricAuthors":["K. Gowin","T. Jain","H. Kosiorek","R. Tibes","J. Camoriano","J. Palmer","R. Mesa"],"twitterCount":3,"altmetricId":15268329,"statusesArray":["818345448444309504","817542120198311936","817389397893120001"]},{"title":"Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy","googleId":"7h19MUaZIjAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304964","googleCitationCount":20,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.015","elsevierAuthor":"Comont T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma","googleId":"hnhYJKvU58IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301607","googleCitationCount":16,"googleAuthor":"T Radivoyevitch","doi":"10.1016/j.leukres.2018.07.016","elsevierAuthor":"Radivoyevitch T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"9","altmetricAuthors":["Tomas Radivoyevitch","Robert M. Dean","Bronwen E. Shaw","Ruta Brazauskas","Heather R. Tecca","Remco J. Molenaar","Minoo Battiwalla","Bipin N. Savani","Mary E.D. Flowers","Kenneth R. Cooke","Betty K. Hamilton","Matt Kalaycio","Jaroslaw P. Maciejewski","Ibrahim Ahmed","Görgün Akpek","Ashish Bajel","David Buchbinder","Jean-Yves Cahn","Anita D’Souza","Andrew Daly","Zachariah DeFilipp","Siddhartha Ganguly","Mehdi Hamadani","Robert J. Hayashi","Peiman Hematti","Yoshihiro Inamoto","Nandita Khera","Tamila Kindwall-Keller","Heather Landau","Hillard Lazarus","Navneet S. Majhail","David I. Marks","Richard F. Olsson","Sachiko Seo","Amir Steinberg","Basem M. William","Baldeep Wirk","Jean A. Yared","Mahmoud Aljurf","Muneer H. Abidi","Heather Allewelt","Amer Beitinjaneh","Rachel Cook","Robert F. Cornell","Joseph W. Fay","Gregory Hale","Jennifer Holter Chakrabarty","Sonata Jodele","Kimberly A. Kasow","Anuj Mahindra","Adriana K. Malone","Uday Popat","J. Douglas Rizzo","Harry C. Schouten","Anne B. Warwick","William A. Wood","Mikkael A. Sekeres","Mark R. Litzow","Robert P. Gale","Shahrukh K. Hashmi"],"twitterCount":21,"altmetricId":45575972,"statusesArray":["1128601302919938049","1063192429766090755","1062846424960978944","1062506430975168512","1025048005857222656","1024953456820412416","1024848973289467909","1024671102625177600","1023900272664371200","1023897036679200768","1023894999685980160","1023892242488950785","1023884183326711809","1023874007211290624","1022714333195907072","1022567233606897666","1022551478756679681","1022550136461946880","1022538295190925317","1022522365719322625","1022521978316615681","1022521962776748032","1022516964034584576","1022516627324264449","1022516142433288192"]},{"title":"Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts","googleId":"Z7jERiOXn4cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301541","googleCitationCount":16,"googleAuthor":"AA Mangaonkar","doi":"10.1016/j.leukres.2018.07.010","elsevierAuthor":"Mangaonkar A.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8","altmetricAuthors":["Abhishek A. Mangaonkar","Naseema Gangat","Aref Al-Kali","Michelle A. Elliott","Kebede H. Begna","Curtis A. Hanson","Rhett P. Ketterling","Alexandra P. Wolanskyj-Spinner","William J. Hogan","Mark R. Litzow","Mrinal M. Patnaik"],"twitterCount":3,"altmetricId":44858337,"statusesArray":["1017748871005573124","1017033006245171201","1016867779520147456"]},{"title":"A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)","googleId":"oBV04NTlxRkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302612","googleCitationCount":25,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.015","elsevierAuthor":"Mascarenhas J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"22","altmetricAuthors":["John Mascarenhas","Lonette Sandy","Min Lu","James Yoon","Bruce Petersen","David Zhang","Fei Ye","Carrie Newsom","Vesna Najfeld","Tsivia Hochman","Judith D. Goldberg","Ronald Hoffman"],"twitterCount":0,"altmetricId":31551597,"statusesArray":[]},{"title":"Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia","googleId":"JKWvtg6oiRgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305131","googleCitationCount":22,"googleAuthor":"JA Webster","doi":"10.1016/j.leukres.2017.09.005","elsevierAuthor":"Webster J.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"18","altmetricAuthors":["Jonathan A. Webster","Raoul Tibes","Larry Morris","Amanda L. Blackford","Mark Litzow","Mrinal Patnaik","Gary L. Rosner","Ivana Gojo","Robert Kinders","Lihua Wang","L. Austin Doyle","Catherine J. Huntoon","Larry M. Karnitz","Scott H. Kaufmann","Judith E. Karp","B. Douglas Smith"],"twitterCount":1,"altmetricId":27837960,"statusesArray":["922530972398211072"]},{"title":"Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study","googleId":"U0v2224EeCgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830016X","googleCitationCount":18,"googleAuthor":"Y Najima","doi":"10.1016/j.leukres.2018.01.010","elsevierAuthor":"Najima Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"12","altmetricAuthors":["Yuho Najima","Chikashi Yoshida","Noriyoshi Iriyama","Shin Fujisawa","Hisashi Wakita","Shigeru Chiba","Shinichiro Okamoto","Kimihiro Kawakami","Naoki Takezako","Takashi Kumagai","Kazuma Ohyashiki","Jun Taguchi","Shingo Yano","Tadahiko Igarashi","Yasuji Kouzai","Satoshi Morita","Junichi Sakamoto","Hisashi Sakamaki","Koiti Inokuchi"],"twitterCount":2,"altmetricId":32780918,"statusesArray":["961215881442336769","961193914161037314"]},{"title":"Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms","googleId":"ZDXZ0GqCEmQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301371","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.leukres.2018.06.014","elsevierAuthor":"Berdeja J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"17","altmetricAuthors":["J. Berdeja","F. Palandri","M.R. Baer","D. Quick","J.J. Kiladjian","G. Martinelli","A. Verma","O. Hamid","R. Walgren","C. Pitou","P.L. Li","A.T. Gerds"],"twitterCount":6,"altmetricId":44531455,"statusesArray":["1015024885901529088","1014908366278123527","1014899482855723008","1014886790002405376","1014886714697973762","1014886367694708737"]},{"title":"A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia","googleId":"4v7hWvaNVLEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305842","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.006","elsevierAuthor":"Navada S.C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"14","altmetricAuthors":["Shyamala C. Navada","Steven M. Fruchtman","Rosalie Odchimar-Reissig","Erin P. Demakos","Michael E. Petrone","Patrick S. Zbyszewski","James F. Holland","Lewis R. Silverman"],"twitterCount":2,"altmetricId":28957348,"statusesArray":["931422714748956672","931204970711568384"]},{"title":"Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7+ 3) in newly …","googleId":"k6n3E-wkibAJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7169946/","googleCitationCount":14,"googleAuthor":"JF Zeidner","statusesArray":[]},{"title":"A phase 1 study of the Janus kinase 2 (JAK2) V617F inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential …","googleId":"MNs2Sk5_0BwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304915","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.010","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"16","altmetricAuthors":["Srdan Verstovsek","Ruben A. Mesa","Mohamed E. Salama","Li","Celine Pitou","Fabio P. Nunes","Gregory L. Price","Jennifer L. Giles","Deborah N. D’Souza","Richard A. Walgren","Josef T. Prchal"],"twitterCount":0,"altmetricId":27371192,"statusesArray":[]},{"title":"Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study","googleId":"AZVRqVmgfIYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305866","googleCitationCount":29,"googleAuthor":"D Azzam","doi":"10.1016/j.leukres.2017.11.008","elsevierAuthor":"Swords R.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"23","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Immunotherapy in adult acute leukemia","googleId":"oAG0_z5PzHgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304642","googleCitationCount":18,"googleAuthor":"S Blum","doi":"10.1016/j.leukres.2017.06.011","elsevierAuthor":"Blum S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"14","altmetricAuthors":["Sabine Blum","Filipe Martins","Michael Lübbert"],"twitterCount":0,"altmetricId":22191025,"statusesArray":[]},{"title":"Iron overload in myelodysplastic syndromes: evidence based guidelines from the Canadian consortium on MDS","googleId":"P_yCbEB3QvgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830211X","googleCitationCount":10,"googleAuthor":"R Buckstein","doi":"10.1016/j.leukres.2018.09.005","elsevierAuthor":"Leitch H.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"8","altmetricAuthors":["Heather A. Leitch","Rena Buckstein","Nancy Zhu","Thomas J. Nevill","Karen W.L. Yee","Brian Leber","Mary-Margaret Keating","Eve St. Hilaire","Rajat Kumar","Robert Delage","Michelle Geddes","John M. Storring","April Shamy","Mohamed Elemary","Richard A. Wells"],"twitterCount":8,"altmetricId":49259294,"statusesArray":["1063190751591481344","1062857088827822080","1062832429889740807","1062796623393275906","1062796091823964162","1062721133458403328","1062709130182512641","1062506707027456000","1048153659127681026"]},{"title":"An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function","googleId":"8Xhq4yKjXBEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302248","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.017","elsevierAuthor":"Maimaitili Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7","altmetricAuthors":["Yimamu Maimaitili","Aki Inase","Yoshiharu Miyata","Akihito Kitao","Yu Mizutani","Seiji Kakiuchi","Yohei Shimono","Yasuyuki Saito","Takashi Sonoki","Hironobu Minami","Hiroshi Matsuoka"],"twitterCount":2,"altmetricId":49368661,"statusesArray":["1128606712494153728","1049297803900571649"]},{"title":"Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders–A consensus project of the Italian Society of Hematology","googleId":"Hspu98DLGEkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730111X","googleCitationCount":18,"googleAuthor":"P Guglielmelli","doi":"10.1016/j.leukres.2017.04.006","elsevierAuthor":"Guglielmelli P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"10","altmetricAuthors":["Paola Guglielmelli","Daniela Pietra","Fabrizio Pane","Alessandro Pancrazzi","Mario Cazzola","Alessandro M. Vannucchi","Sante Tura","Giovanni Barosi"],"twitterCount":4,"altmetricId":21647103,"statusesArray":["890706324039794688","890557424201060352","883648806394507264","883641838414049280"]},{"title":"Telomerase and telomere biology in hematological diseases: A new therapeutic target","googleId":"fZD-VOncqGQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300486","googleCitationCount":18,"googleAuthor":"V Innao","doi":"10.1016/j.leukres.2017.02.002","elsevierAuthor":"Allegra A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11","altmetricAuthors":["Alessandro Allegra","Vanessa Innao","Giuseppa Penna","Demetrio Gerace","Andrea G. Allegra","Caterina Musolino"],"twitterCount":1,"altmetricId":21595072,"statusesArray":["883264365872521217"]},{"title":"Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections …","googleId":"N37qZMkQRLsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830033X","googleCitationCount":16,"googleAuthor":"CAC Wong","doi":"10.1016/j.leukres.2018.02.005","elsevierAuthor":"Wong C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Interpretation of clinical endpoints in trials of acute myeloid leukemia","googleId":"OMnYbUDQdr8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300304","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.002","elsevierAuthor":"Medeiros B.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"10","altmetricAuthors":["Bruno C. Medeiros"],"twitterCount":3,"altmetricId":41826766,"statusesArray":["1340312674366877702","997136451757314048","997129654166327297"]},{"title":"Living with the burden of relapse in multiple myeloma from the patient and physician perspective","googleId":"5JgBHFgQ01YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304411","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.019","elsevierAuthor":"Hulin C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"9","altmetricAuthors":["Cyrille Hulin","Timon Hansen","Louise Heron","Rachel Pughe","Matthew Streetly","Ananda Plate","Sue Perkins","Kate Morgan","Antoine Tinel","Filipe Rodrigues","Karthik Ramasamy"],"twitterCount":8,"altmetricId":20857914,"statusesArray":["1251281825248546816","1251259995238420481","917320898386059264","880717484638314498","875496910689316864","875496521260830720","875342130499252224","872148100709613568"]},{"title":"Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy","googleId":"VVhNRwfvAuQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302236","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.018","elsevierAuthor":"Bonifacio M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"5","altmetricAuthors":["Massimiliano Bonifacio","Luigi Scaffidi","Gianni Binotto","Maria Cristina Miggiano","Marco Danini","Claudia Minotto","Davide Griguolo","Luciana Marin","Luca Frison","Fabio D’Amore","Marco Basso","Roberto Sartori","Martina Tinelli","Manuela Stulle","Stefania Fortuna","Angela Bonalumi","Giovanni Bertoldero","Ercole De Biasi","Marco Ruggeri","Gianpietro Semenzato","Renato Fanin","Giovanni Pizzolo","Mauro Krampera","Mario Tiribelli"],"twitterCount":4,"altmetricId":50300218,"statusesArray":["1063191818416910338","1063072960708263936","1062709400111067141","1062506117413122048","1055667474375467008"]},{"title":"The rising prevalence of chronic myeloid leukemia in France","googleId":"hhaPUlAtBnEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300948","googleCitationCount":15,"googleAuthor":"M Delord","doi":"10.1016/j.leukres.2018.04.008","elsevierAuthor":"Delord M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma","googleId":"eKB6hbOycQsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301085","googleCitationCount":18,"googleAuthor":"M Ahmadvand","doi":"10.1016/j.leukres.2018.05.006","elsevierAuthor":"Ahmadvand M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"16","altmetricAuthors":["Mohammad Ahmadvand","Mahsa Eskandari","Hossein Pashaiefar","Marjan Yaghmaie","Saba Manoochehrabadi","Golnaz Khakpour","Fatemeh Sheikhsaran","Mostafa Montazer Zohour"],"twitterCount":3,"altmetricId":42561775,"statusesArray":["1000119181482786816","1000016923495628800","999941895190171648"]},{"title":"A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia","googleId":"bSjTMuPw-hsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304162","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.002","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): characteristics of refined MDS types","googleId":"Z17P_goDpLQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300644","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.008","elsevierAuthor":"Strupp C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"15","altmetricAuthors":["Corinna Strupp","Kathrin Nachtkamp","Barbara Hildebrandt","Aristoteles Giagounidis","Rainer Haas","Norbert Gattermann","John M. Bennett","Carlo Aul","Ulrich Germing"],"twitterCount":2,"altmetricId":21304322,"statusesArray":["878386979125305344","878339309274898432"]},{"title":"Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome","googleId":"a3uN3BfsW6QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617301108","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.04.005","elsevierAuthor":"Zheng Q.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"17","altmetricAuthors":["Qing-qing Zheng","You-shan Zhao","Juan Guo","Si-da Zhao","Lu-xi Song","Cheng-ming Fei","Zheng Zhang","Xiao Li","Chun-kang Chang"],"twitterCount":6,"altmetricId":19778626,"statusesArray":["892607847036473346","891685460359036928","891374628735770625","891283310147772416","891282184719527938","859353674904199168"]},{"title":"Donor age matters in T-cell depleted haploidentical hematopoietic stem cell transplantation in pediatric patients: faster immune reconstitution using younger donors","googleId":"oFsz3G5YIgwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730070X","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.03.001","elsevierAuthor":"González-Vicent M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14","altmetricAuthors":["Marta González-Vicent","Blanca Molina","Natalia Deltoro","Julián Sevilla","José Luis Vicario","Ana Castillo","Manuel Ramirez","Miguel Ángel Díaz"],"twitterCount":2,"altmetricId":17400421,"statusesArray":["842336445025136640","842327353556631552"]},{"title":"Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia","googleId":"Iz3QkUsdxVUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306173","googleCitationCount":13,"googleAuthor":"M Byrne","doi":"10.1016/j.leukres.2017.12.012","elsevierAuthor":"Strickland S.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Incorporating newer agents in the treatment of acute myeloid leukemia","googleId":"6K4Dm5ifWLcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304429","googleCitationCount":8,"googleAuthor":"RV Raj","doi":"10.1016/j.leukres.2018.10.008","elsevierAuthor":"Raj R.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6","altmetricAuthors":["Renju V. Raj","Sameem M. Abedin","Ehab Atallah"],"twitterCount":3,"altmetricId":51152884,"statusesArray":["1063192638805995520","1063160020408455169","1062709419400675328","1062506828255387648"]},{"title":"Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway","googleId":"yPtR8g_EZREJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300742","googleCitationCount":13,"googleAuthor":"CF Lam","doi":"10.1016/j.leukres.2018.03.012","elsevierAuthor":"Lam C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"5′-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid …","googleId":"7rO0ZzBX8wIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300863","googleCitationCount":19,"googleAuthor":"RP Gale","doi":"10.1016/j.leukres.2017.03.010","elsevierAuthor":"Li D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"16","altmetricAuthors":["Dengzhe Li","Robert Peter Gale","Yanfeng Liu","Baoxia Lei","Yuan Wang","Dongmei Diao","Mei Zhang"],"twitterCount":1,"altmetricId":18550750,"statusesArray":["849933204777652224"]},{"title":"Effect of BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells","googleId":"VKNyVeP9AGAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305234","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.015","elsevierAuthor":"Huang Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"12","altmetricAuthors":["Yiqun Huang","Yong Zou","Luhui Lin","Xudong Ma","Xiaohong Huang"],"twitterCount":1,"altmetricId":27087751,"statusesArray":["916268208516222976","916245589364563968"]},{"title":"The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3p","googleId":"tlvAFXo4r5EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304198","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.005","elsevierAuthor":"Sukegawa M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"11","altmetricAuthors":["Masumi Sukegawa","Xiangmin Wang","Chie Nishioka","Bin Pan","Kailin Xu","Hiroshi Ohkawara","Yoichi Hamasaki","Masayuki Mita","Kenichi Nakamura","Masatoshi Okamoto","Hiromi Shimura","Masatsugu Ohta","Takayuki Ikezoe"],"twitterCount":2,"altmetricId":20169662,"statusesArray":["864222249712099328","864176432762699776"]},{"title":"Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view","googleId":"wLqqWjusOJkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300316","googleCitationCount":13,"googleAuthor":"F Kouhkan","doi":"10.1016/j.leukres.2018.02.003","elsevierAuthor":"Shokri G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"11","altmetricAuthors":["Gelareh Shokri","Shaghayegh Doudi","Mehrnoosh Fathi-Roudsari","Fatemeh Kouhkan","Mohammad-Hossein Sanati"],"twitterCount":2,"altmetricId":35060661,"statusesArray":["980094084751806464","980030698395348993"]},{"title":"Towards repositioning of quinacrine for treatment of acute myeloid leukemia–Promising synergies and in vivo effects","googleId":"2onQvm9PRx4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305659","googleCitationCount":13,"googleAuthor":"J Gullbo","doi":"10.1016/j.leukres.2017.10.012","elsevierAuthor":"Eriksson A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells","googleId":"-b72QG0RzisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305374","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.022","elsevierAuthor":"Tan M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia","googleId":"xeVYNP1PeoEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300298","googleCitationCount":12,"googleAuthor":"N Tosic","doi":"10.1016/j.leukres.2018.02.001","elsevierAuthor":"Tosic N.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"8","altmetricAuthors":["Natasa Tosic","Isidora Petrovic","Natasa Kovacevic Grujicic","Slobodan Davidovic","Marijana Virijevic","Nada Suvajdzic Vukovic","Sonja Pavlovic","Milena Stevanovic"],"twitterCount":2,"altmetricId":33281664,"statusesArray":["964459137315811335","964457076259893249"]},{"title":"Autophagy is an important event for low-dose cytarabine treatment in acute myeloid leukemia cells","googleId":"H0lh1G7Ih4EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304605","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.007","elsevierAuthor":"Chen L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"15","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes","googleId":"R_kfM5otdm0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305386","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.001","elsevierAuthor":"Angelucci E.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"9","altmetricAuthors":["Emanuele Angelucci","Paolo Cianciulli","Carlo Finelli","Cristina Mecucci","Maria Teresa Voso","Sante Tura"],"twitterCount":1,"altmetricId":27741296,"statusesArray":["921685519729246209"]},{"title":"Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: a …","googleId":"1yb9uMLvPGsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304648","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2018.11.003","elsevierAuthor":"Itonaga H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway","googleId":"JFh_0f3jlQ8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300821","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.004","elsevierAuthor":"Grohmann T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"8","altmetricAuthors":["Theresa Grohmann","Melanie Penke","Stefanie Petzold-Quinque","Susanne Schuster","Sandy Richter","Wieland Kiess","Antje Garten"],"twitterCount":3,"altmetricId":36722373,"statusesArray":["984395598005702661","984394972605632513","984394700231602176"]},{"title":"Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary …","googleId":"v85h5vjnb_QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300371","googleCitationCount":16,"googleAuthor":"G Zhang","doi":"10.1016/j.leukres.2017.01.026","elsevierAuthor":"Yao J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia","googleId":"ap67V_da1H0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301784","googleCitationCount":12,"googleAuthor":"G Garcia-Manero","doi":"10.1016/j.leukres.2018.08.001","elsevierAuthor":"Garcia-Manero G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8","altmetricAuthors":["Guillermo Garcia-Manero","Bart L. Scott","Christopher R. Cogle","Thomas E. Boyd","Suman Kambhampati","Joel Hetzer","Qian Dong","Keshava Kumar","Stacey M. Ukrainskyj","CL Beach","Barry S. Skikne"],"twitterCount":12,"altmetricId":46305107,"statusesArray":["1063610849271664641","1056033011962015745","1043603166401638403","1033049641565212673","1033018647013416965","1032829189123174401","1032819140304752640","1032776950488563712","1032721511231172609","1032710177366130688","1032678052671700992","1032665799989886978","1027475822343385088"]},{"title":"Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study","googleId":"-Luuz8Vk_ukJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304314","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.10.006","elsevierAuthor":"Birgegård G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6","altmetricAuthors":["Gunnar Birgegård","Folke Folkvaljon","Hans Garmo","Lars Holmberg","Carlos Besses","Martin Griesshammer","Luigi Gugliotta","Jingyang Wu","Heinrich Achenbach","Jean-Jacques Kiladjian","Claire N. Harrison"],"twitterCount":0,"altmetricId":51012770,"statusesArray":[]},{"title":"Management of melanoma in patients with chronic lymphocytic leukemia","googleId":"044hmuSwqwAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301474","googleCitationCount":11,"googleAuthor":"WJ Archibald","doi":"10.1016/j.leukres.2018.07.003","elsevierAuthor":"Archibald W.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"9","altmetricAuthors":["William J. Archibald","Philip J. Meacham","AnnaLynn M. Williams","Andrea M. Baran","Adrienne I. Victor","Paul M. Barr","Deepak M. Sahasrahbudhe","Clive S. Zent"],"twitterCount":9,"altmetricId":44887510,"statusesArray":["1168997125113503744","1110483828257292288","1030543947851022336","1030371807059161088","1030099282450309120","1030098625278369792","1018684191867850752","1018101065667891200","1018086218284744704","1018074955798499333","1017200325571342337"]},{"title":"The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma","googleId":"y7JsFV0nc8QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300061","googleCitationCount":18,"googleAuthor":"N Burwick","doi":"10.1016/j.leukres.2017.01.007","elsevierAuthor":"Burwick N.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"12","altmetricAuthors":["Nicholas Burwick","Michael Y. Zhang","Pilar de la Puente","Abdel Kareem Azab","Teresa S. Hyun","Melisa Ruiz-Gutierrez","Marilyn Sanchez-Bonilla","Tomoka Nakamura","Jeffrey J. Delrow","Vivian L. MacKay","Akiko Shimamura"],"twitterCount":1,"altmetricId":15865509,"statusesArray":["824985320215175168"]},{"title":"Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia","googleId":"V2i9k1GoTggJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301899","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.009","elsevierAuthor":"Chen X.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"7","altmetricAuthors":["Xue Chen","Fang Wang","Yang Zhang","Mangju Wang","Wenjun Tian","Wen Teng","Xiaoli Ma","Lei Guo","Jiancheng Fang","Ying Zhang","Ping Zhu","Hongxing Liu"],"twitterCount":5,"altmetricId":46796448,"statusesArray":["1033739124921040896","1032884328001351685","1032787148670296064","1032658724001697792","1031972900490768384"]},{"title":"Prognostic importance of Aurora Kinases and mitotic spindle genes transcript levels in Myelodysplastic syndrome","googleId":"kjNxK2VgXwYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305994","googleCitationCount":13,"googleAuthor":"CRK Paier","doi":"10.1016/j.leukres.2017.11.013","elsevierAuthor":"Borges D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7","altmetricAuthors":["Daniela de Paula Borges","Antônio Wesley Araújo dos Santos","Carlos Roberto Koscky Paier","Howard Lopes Ribeiro","Marília Braga Costa","Izabelle Rocha Farias","Roberta Taiane Germano de Oliveira","Ivo Gabriel da Frota França","Gabrielle Melo Cavalcante","Sílvia Maria Meira Magalhães","Ronald Feitosa Pinheiro"],"twitterCount":1,"altmetricId":30210917,"statusesArray":["939478531037212673"]},{"title":"The FOSSIL Study: FLAG or standard 7+ 3 induction therapy in secondary acute myeloid leukemia","googleId":"JlYPCLmD7OoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301139","googleCitationCount":13,"googleAuthor":"AJ Perissinotti","doi":"10.1016/j.leukres.2018.05.011","elsevierAuthor":"Vulaj V.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"9","altmetricAuthors":["Vera Vulaj","Anthony J. Perissinotti","James R. Uebel","Victoria R. Nachar","Gianni B. Scappaticci","Ashley Crouch","Dale L. Bixby","Patrick W. Burke","Ivan Maillard","Moshe Talpaz","Bernard L. Marini"],"twitterCount":20,"altmetricId":43146590,"statusesArray":["1216778525694406657","1184240814647627777","1184232335358808065","1137046238178603008","1135642679356923905","1135612236125204480","1134826412496629760","1103698942599069698","1069682331806355457","1068960783403339778","1025158612396605440","1025100815432916993","1024978134939119616","1024960058252247041","1024954423481655296","1004532553490067456","1004521503759699968","1003401216058150912","1003045264649850880","1002993685917728768","1002989425184342016","1002974760836456449","1002971923389779968","1002969091102117889","1002912931611381761","1002900869686419456","1002898729421164545","1002688406025932800","1002688301596397568","1002682964118040579"]},{"title":"Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis","googleId":"smtwrOwJ-dgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304587","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.005","elsevierAuthor":"Gowin K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"18","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia","googleId":"buc9DOODh3sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300225","googleCitationCount":11,"googleAuthor":"J Petiti","doi":"10.1016/j.leukres.2018.01.016","elsevierAuthor":"Petiti J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6","altmetricAuthors":["Jessica Petiti","Valentina Rosso","Marco Lo Iacono","Chiara Calabrese","Elisabetta Signorino","Valentina Gaidano","Massimo Berger","Giuseppe Saglio","Daniela Cilloni"],"twitterCount":1,"altmetricId":40673573,"statusesArray":["992086412991250433"]},{"title":"Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML","googleId":"Ml8_pEJYfb0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730601X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.002","elsevierAuthor":"Schuler E.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"7","altmetricAuthors":["E. Schuler","F. Frank","B. Hildebrandt","B. Betz","C. Strupp","M. Rudelius","C. Aul","T. Schroeder","N. Gattermann","R. Haas","U. Germing"],"twitterCount":1,"altmetricId":30166997,"statusesArray":["939130718042472449"]},{"title":"Independent prognostic significance of monosomy 17 and impact of karyotype complexity in monosomal karyotype/complex karyotype acute myeloid leukemia: results …","googleId":"UgIMSNwBe8sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304241","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.010","elsevierAuthor":"Strickland S.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"IRF4 in multiple myeloma—biology, disease and therapeutic target","googleId":"WgIUJh6QHOgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301772","googleCitationCount":11,"googleAuthor":"EJ Mancini","doi":"10.1016/j.leukres.2018.07.025","elsevierAuthor":"Agnarelli A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8","altmetricAuthors":["Alessandro Agnarelli","Tim Chevassut","Erika J. Mancini"],"twitterCount":6,"altmetricId":46472534,"statusesArray":["1038909534260092928","1037387760309551107","1037014928014667780","1036968249727037441","1029153677943103489","1029061290822488064"]},{"title":"Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in myeloma","googleId":"9Mf0N2zwMdIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301590","googleCitationCount":11,"googleAuthor":"DA Salem","doi":"10.1016/j.leukres.2018.07.015","elsevierAuthor":"Salem D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"11","altmetricAuthors":["Dalia A. Salem","Irina Maric","Constance M. Yuan","David J. Liewehr","David J. Venzon","James Kochenderfer","Maryalice Stetler-Stevenson"],"twitterCount":4,"altmetricId":45782249,"statusesArray":["1106394491856941058","1024100605277679616","1024078207581126658","1024006719829991425","1023152103743602688"]},{"title":"DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia","googleId":"FXYGmTmzz6EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304976","googleCitationCount":12,"googleAuthor":"S Younesian","doi":"10.1016/j.leukres.2017.08.016","elsevierAuthor":"Younesian S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"8","altmetricAuthors":["Samareh Younesian","Sepideh Shahkarami","Parisa Ghaffari","Shaban Alizadeh","Roya Mehrasa","Ardeshir Ghavamzadeh","Seyed H. Ghaffari"],"twitterCount":2,"altmetricId":24796911,"statusesArray":["905024259918929920","905014935050043394"]},{"title":"Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: a retrospective cohort study","googleId":"-8cJgnwwSHMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304897","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.008","elsevierAuthor":"Frairia C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"10","altmetricAuthors":["Chiara Frairia","Semra Aydin","Ernesta Audisio","Ludovica Riera","Sabrina Aliberti","Bernardino Allione","Alessandro Busca","Stefano D'Ardia","Chiara Maria Dellacasa","Anna Demurtas","Andrea Evangelista","Giovannino Ciccone","Paola Francia di Celle","Barbara Nicolino","Alessandra Stacchini","Filippo Marmont","Umberto Vitolo"],"twitterCount":2,"altmetricId":24475856,"statusesArray":["909195442545676289","902483536120131585"]},{"title":"Pediatric acute lymphoblastic leukemia—Conquering the CNS across the choroid plexus","googleId":"iHgCFh_i_MMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301450","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.001","elsevierAuthor":"März M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma","googleId":"HorG2W9kupgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730526X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.018","elsevierAuthor":"Guidetti A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"8","altmetricAuthors":["A. Guidetti","A. Mazzocchi","R. Miceli","E. Paterno’","F. Taverna","F. Spina","F. Crippa","L. Farina","P. Corradini","A.M. Gianni","S. Viviani"],"twitterCount":5,"altmetricId":26696555,"statusesArray":["913517988036280321","913515707542966274","913402211379576834","913383125459378178","913380521631154176"]},{"title":"Recent advances in the genomics and therapy of BCR/ABL1-positive and-negative chronic myeloproliferative neoplasms","googleId":"KbvPTJDHvAkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300432","googleCitationCount":10,"googleAuthor":"S Koschmieder","doi":"10.1016/j.leukres.2018.02.008","elsevierAuthor":"Mughal T.I.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Outcomes and predictors of survival in blast phase myeloproliferative neoplasms","googleId":"4VoTxDaCjxUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301061","googleCitationCount":13,"googleAuthor":"A Brunner","doi":"10.1016/j.leukres.2018.05.004","elsevierAuthor":"Lancman G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia","googleId":"sEytDrjLXQ4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304216","googleCitationCount":15,"googleAuthor":"B Kumar","doi":"10.1016/j.leukres.2017.05.007","elsevierAuthor":"Kumar B.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Global methylation patterns in primary plasma cell leukemia","googleId":"dukP8YkAI1oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302133","googleCitationCount":7,"googleAuthor":"V Simeon","doi":"10.1016/j.leukres.2018.09.007","elsevierAuthor":"Todoerti K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"6","altmetricAuthors":["Katia Todoerti","Giovanni Calice","Stefania Trino","Vittorio Simeon","Marta Lionetti","Martina Manzoni","Sonia Fabris","Marzia Barbieri","Alessandra Pompa","Luca Baldini","Valentina Bollati","Pietro Zoppoli","Antonino Neri","Pellegrino Musto"],"twitterCount":2,"altmetricId":48933041,"statusesArray":["1045719788897673216","1045251966144634880"]},{"title":"Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-κB signaling","googleId":"MTQXCFIL8HUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304678","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.002","elsevierAuthor":"Yang H.L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"12","altmetricAuthors":["HongLiang Yang","YingChun Zheng","YiZhuo Zhang","Zeng Cao","Yingzhe Jiang"],"twitterCount":2,"altmetricId":23449322,"statusesArray":["893519368105197568","893516893964955648"]},{"title":"Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias","googleId":"0M9QIZnLDuUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300942","googleCitationCount":16,"googleAuthor":"C Weiss","doi":"10.1016/j.leukres.2017.03.011","elsevierAuthor":"Popp H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia","googleId":"2cgcg2wAk7oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302600","googleCitationCount":16,"googleAuthor":"CK Kontos","doi":"10.1016/j.leukres.2016.11.014","elsevierAuthor":"Kontos C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"11","altmetricAuthors":["Christos K. Kontos","Sotirios G. Papageorgiou","Marios A. Diamantopoulos","Andreas Scorilas","Efthimia Bazani","Diamantina Vasilatou","Konstantinos Gkontopoulos","Eirini Glezou","Georgia Stavroulaki","George Dimitriadis","Vasiliki Pappa"],"twitterCount":5,"altmetricId":14535305,"statusesArray":["835444297335963648","835444242168283136","830416367606231041","806492488177483777","806491631138537472"]},{"title":"Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years","googleId":"My3v_CscrtYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302636","googleCitationCount":17,"googleAuthor":"","doi":"10.1016/j.leukres.2016.12.001","elsevierAuthor":"Heini A.D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"11","altmetricAuthors":["Alexander D. Heini","Martin D. Berger","Katja Seipel","Behrouz Mansouri Taleghani","Gabriela M. Baerlocher","Kurt Leibundgut","Yara Banz","Urban Novak","Thomas Pabst"],"twitterCount":2,"altmetricId":14742155,"statusesArray":["809232497011671040","809012567033024512"]},{"title":"Incidence and survival of therapy related myeloid neoplasm in United States","googleId":"B6WVANX_ZrkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301577","googleCitationCount":12,"googleAuthor":"GSG Murthy","doi":"10.1016/j.leukres.2018.07.013","elsevierAuthor":"Guru Murthy G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"9","altmetricAuthors":["Guru Subramanian Guru Murthy","Mehdi Hamadani","Binod Dhakal","Parameswaran Hari","Ehab Atallah"],"twitterCount":1,"altmetricId":46874967,"statusesArray":["1032673874763243520"]},{"title":"Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell …","googleId":"6DJNsu1FedwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300262","googleCitationCount":12,"googleAuthor":"Y Imai","doi":"10.1016/j.leukres.2018.01.020","elsevierAuthor":"Wang Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"8","altmetricAuthors":["Yan-Hua Wang","Yoichi Imai","Masayuki Shiseki","Junji Tanaka","Toshiko Motoji"],"twitterCount":1,"altmetricId":33727896,"statusesArray":["968452057060356096"]},{"title":"Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia","googleId":"AXKWsf8NwFwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617301005","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.04.003","elsevierAuthor":"Medinger M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"10","altmetricAuthors":["Michael Medinger","Deborah Zeiter","Dominik Heim","Jörg Halter","Sabine Gerull","André Tichelli","Jakob Passweg","Nicole Nigro"],"twitterCount":1,"altmetricId":19510690,"statusesArray":["856449069325078528"]},{"title":"Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia","googleId":"tDOWCIk-2xMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304691","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.004","elsevierAuthor":"Mpakou V.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"7","altmetricAuthors":["Vassiliki E. Mpakou","Heleni-Dikaia Ioannidou","Eugene Konsta","Myrofora Vikentiou","Aris Spathis","Frieda Kontsioti","Christos K. Kontos","Athanassios D. Velentzas","Sotiris Papageorgiou","Diamantina Vasilatou","Konstantinos Gkontopoulos","Irene Glezou","Georgia Stavroulaki","Efthimia Mpazani","Stella Kokkori","Elias Kyriakou","Petros Karakitsos","George Dimitriadis","Vasiliki Pappa"],"twitterCount":4,"altmetricId":23552445,"statusesArray":["895680557408935937","895553673811677185","895535272536006656","895533949094690817"]},{"title":"Aneuploidy identification in pre-B acute lymphoblastic leukemia patients at diagnosis by Multiplex Ligation-dependent Probe Amplification (MLPA)","googleId":"7OanHp8U3J8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304447","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.022","elsevierAuthor":"Vázquez-Reyes A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"8","altmetricAuthors":["A. Vázquez-Reyes","L. Bobadilla-Morales","C. Barba-Barba","G. Macías-Salcedo","G. Serafín-Saucedo","M.E. Velázquez-Rivera","M.C. Almodóvar-Cuevas","A. Márquez-Mora","H.J. Pimentel-Gutiérrez","C. Ortega-de-la-Torre","R.M. Cruz-Osorio","S. Nava-Gervasio","J. Rivera-Vargas","F. Sánchez-Zubieta","J.R. Corona-Rivera","A. Corona-Rivera"],"twitterCount":1,"altmetricId":21168985,"statusesArray":["876743482399797248"]},{"title":"CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation","googleId":"RvH5zrNQbecJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302648","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.leukres.2016.12.002","elsevierAuthor":"Gordon M.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"16","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Association between health literacy, communication and psychological distress among myelodysplastic syndromes patients","googleId":"Ug8xvJG29nYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301875","googleCitationCount":7,"googleAuthor":"PN Butow","doi":"10.1016/j.leukres.2018.08.020","elsevierAuthor":"Ousseine Y.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":["Youssoufa M. Ousseine","Phyllis N. Butow","Pierre Fenaux","Rebecca Dring","Patrick Festy","Léa Restivo","Norbert Vey","Julien Mancini"],"twitterCount":9,"altmetricId":47684006,"statusesArray":["1118846144279224320","1118838470279974914","1041967052486057984","1041798197293789184","1041767842763481094","1041686182797697024","1040995375878946816","1040994541195603968","1039797855592964096","1037270276332036097"]},{"title":"Targeting autophagy in multiple myeloma","googleId":"jSUBvcDN03MJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304472","googleCitationCount":17,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.002","elsevierAuthor":"Yun Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"11","altmetricAuthors":["Zhuang Yun","Jin Zhichao","Yao Hao","Ji Ou","Yang Ran","Dong Wen","Shen Qun"],"twitterCount":2,"altmetricId":20943085,"statusesArray":["876429290589495296","873484054695260160"]},{"title":"Genomic analysis of adult B-ALL identifies potential markers of shorter survival","googleId":"m7yGv-Ypp2sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300450","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.034","elsevierAuthor":"Patel S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia","googleId":"NM6UETkymFEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301930","googleCitationCount":7,"googleAuthor":"CA Hudson","doi":"10.1016/j.leukres.2018.08.015","elsevierAuthor":"Hudson C.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Therapeutic drug monitoring of ponatinib using a simple high-performance liquid chromatography method in Japanese patients","googleId":"2X3fXy9JUsEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305982","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.012","elsevierAuthor":"Abumiya M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia","googleId":"7c63yzLiQRgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305362","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.021","elsevierAuthor":"Henkenius K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"8","altmetricAuthors":["Katharina Henkenius","Brandon H Greene","Christina Barckhausen","Raimo Hartmann","Melanie Märken","Tom Kaiser","Miriam Rehberger","Stephan K Metzelder","Wolfgang J Parak","Andreas Neubauer","Cornelia Brendel","Elisabeth Mack"],"twitterCount":1,"altmetricId":27722776,"statusesArray":["960867358507175937"]},{"title":"Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms","googleId":"m_Rb-IiyVWMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306100","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.005","elsevierAuthor":"Gángó A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous …","googleId":"fqcldGcroyIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300274","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.021","elsevierAuthor":"Advani A.S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6","altmetricAuthors":["Anjali S. Advani","Hongli Li","Laura C. Michaelis","Bruno C. Medeiros","Michaela Liedtke","Alan F. List","Kristen O’Dwyer","Megan Othus","Harry P. Erba","Frederick R. Appelbaum"],"twitterCount":0,"altmetricId":34331025,"statusesArray":[]},{"title":"Tetraploidy/near-tetraploidy acute myeloid leukemia","googleId":"tl1Cs33MopAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302624","googleCitationCount":14,"googleAuthor":"S Li","doi":"10.1016/j.leukres.2016.11.016","elsevierAuthor":"Huang L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"8","altmetricAuthors":["Lanshan Huang","Sa A. Wang","Courtney DiNardo","Shaoying Li","Shimin Hu","Jie Xu","Wenli Zhou","Maitrayee Goswami","L. Jeffrey Medeiros","Guilin Tang"],"twitterCount":1,"altmetricId":16847018,"statusesArray":["836531403961565187"]},{"title":"Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia","googleId":"O_MDs9amzRwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300997","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.013","elsevierAuthor":"Tan Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: a single-center experience","googleId":"cPJfhgN8sK4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300158","googleCitationCount":11,"googleAuthor":"BR Dholaria","doi":"10.1016/j.leukres.2018.01.009","elsevierAuthor":"Dholaria B.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells","googleId":"4HkG_nbhdSUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302224","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.016","elsevierAuthor":"Hishiki K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6","altmetricAuthors":["Kotaro Hishiki","Masaharu Akiyama","Yumi Kanegae","Koji Ozaki","Miyuki Ohta","Emi Tsuchitani","Ken Kaito","Hisashi Yamada"],"twitterCount":3,"altmetricId":49453854,"statusesArray":["1050545358701510656","1050121559476563969","1049964920958148608"]},{"title":"The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia","googleId":"RRBLaUGYbgUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305878","googleCitationCount":10,"googleAuthor":"H Jiang","doi":"10.1016/j.leukres.2017.11.009","elsevierAuthor":"Zhu H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by …","googleId":"rsudcKEBT1EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304721","googleCitationCount":12,"googleAuthor":"K Tarte","doi":"10.1016/j.leukres.2017.07.007","elsevierAuthor":"Aggoune D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"8","altmetricAuthors":["Djamel Aggoune","Nathalie Sorel","Marie-Laure Bonnet","Jean-Michel Goujon","Karin Tarte","Olivier Hérault","Jorge Domenech","Delphine Réa","Laurence Legros","Hyacinthe Johnson-Ansa","Philippe Rousselot","Emilie Cayssials","Agnès Guerci-Bresler","Annelise Bennaceur-Griscelli","Jean-Claude Chomel","Ali G. Turhan"],"twitterCount":1,"altmetricId":31171725,"statusesArray":["948218857965129728"]},{"title":"Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia","googleId":"JKO6sUR0P0oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730067X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.011","elsevierAuthor":"Mauro F.R.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with …","googleId":"f4uGYzGuBKoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730615X","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.013","elsevierAuthor":"Burke P.W.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute …","googleId":"R4-XAujtnq4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300043","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.004","elsevierAuthor":"Wang S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"9","altmetricAuthors":["Shu-mei Wang","Wei-xin Zeng","Wan-shui Wu","Lu-lu Sun","Dan Yan"],"twitterCount":1,"altmetricId":31445790,"statusesArray":["950663965893259264"]},{"title":"Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia","googleId":"84IMtgDdkssJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300663","googleCitationCount":10,"googleAuthor":"EJ Choi","doi":"10.1016/j.leukres.2018.03.006","elsevierAuthor":"Choi E.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"8","altmetricAuthors":["Eun-Ji Choi","Je-Hwan Lee","Jung-Hee Lee","Han-Seung Park","Sun-Hye Ko","Eun-Hye Hur","Juhyun Moon","Bon-Kwan Goo","Yeonhee Kim","Miee Seol","Young-Shin Lee","Young-Ah Kang","Mijin Jeon","Ji Min Woo","Kyoo-Hyung Lee"],"twitterCount":19,"altmetricId":34407157,"statusesArray":["989296144831234048","988212449986916352","987634291340390400","987599725477154816","987586503873351681","987443651671478273","975414954961534976","975142040978776065","974909706899730433","974906416975810560","974906361040572416","974902195622735872","974840027195813888","974817236526313472","974793885024161792","974790527223762944","974785191226019840","974636877390188545","974603872412020737","974584048126451712","974582797082882048"]},{"title":"Primary plasma cell leukemia in the era of novel agents for myeloma–a multicenter retrospective analysis of outcome","googleId":"9qrPplk3Js8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300456","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.010","elsevierAuthor":"Ganzel C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"6","altmetricAuthors":["Chezi Ganzel","Ory Rouvio","Irit Avivi","Hila Magen","Osnat Jarchowsky","Katrin Herzog","Yossi Cohen","Tamar Tadmor","Netanel A. Horwitz","Merav Leiba","Arnon Nagler","Yael Cohen","Shlomo Bulvik","Aaron Polliack","Jacob M. Rowe","Moshe E. Gatt"],"twitterCount":1,"altmetricId":33946092,"statusesArray":["970615795473465345"]},{"title":"Comparative study of porcine anti-human lymphocyte immunoglobulin and rabbit anti-human thymocyte immunoglobulin as a first-line treatment of acquired severe …","googleId":"Z_3KcUlus7oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300018","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.001","elsevierAuthor":"Chen M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients","googleId":"zN2qI13wvdkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300991","googleCitationCount":13,"googleAuthor":"M Tiribelli","doi":"10.1016/j.leukres.2017.04.001","elsevierAuthor":"Tiribelli M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"7","altmetricAuthors":["Mario Tiribelli","Donatella Raspadori","Antonella Geromin","Margherita Cavallin","Santina Sirianni","Erica Simeone","Monica Bocchia","Renato Fanin","Daniela Damiani"],"twitterCount":4,"altmetricId":18554914,"statusesArray":["852828112102412289","850140725438169088","849980522482864129","849971453516668928"]},{"title":"Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line","googleId":"jYXEoDT7ZdMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302157","googleCitationCount":5,"googleAuthor":"K Podshivalova","doi":"10.1016/j.leukres.2018.09.009","elsevierAuthor":"Podshivalova K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4","altmetricAuthors":["Katie Podshivalova","Eileen A. Wang","Traver Hart","Daniel R. Salomon"],"twitterCount":3,"altmetricId":49085247,"statusesArray":["1128601320074690560","1046765200467156994","1046710865213382656"]},{"title":"Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy","googleId":"pwt4d6bPUUgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300449","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.032","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11","altmetricAuthors":["Srdan Verstovsek","Claire N. Harrison","Jean-Jacques Kiladjian","Carole Miller","Ahmad B. Naim","Dilan C. Paranagama","Dany Habr","Alessandro M. Vannucchi"],"twitterCount":0,"altmetricId":17884483,"statusesArray":[]},{"title":"A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual …","googleId":"1kPqwtumtt8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730423X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.009","elsevierAuthor":"Duan M.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"8","altmetricAuthors":["M.-H. Duan","H. Li","H. Cai"],"twitterCount":2,"altmetricId":20364096,"statusesArray":["915520033907908608","866476104013434880","866234706106368003"]},{"title":"Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group","googleId":"aNS2CArliTMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300036","googleCitationCount":13,"googleAuthor":"M Ishikawa","doi":"10.1016/j.leukres.2017.01.003","elsevierAuthor":"Iriyama N.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"8","altmetricAuthors":["Noriyoshi Iriyama","Michihide Tokuhira","Tomoiku Takaku","Eriko Sato","Maho Ishikawa","Tomonori Nakazato","Kei-Ji Sugimoto","Hiroyuki Fujita","Isao Fujioka","Yoshihiro Hatta","Masahiro Kizaki","Norio Komatsu","Norio Asou","Tatsuya Kawaguchi"],"twitterCount":1,"altmetricId":15389187,"statusesArray":["819196167409913856"]},{"title":"Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of …","googleId":"k8efu4bMqgQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304563","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.004","elsevierAuthor":"Barosi G.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine","googleId":"n3xXI_TPWWoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305829","googleCitationCount":9,"googleAuthor":"CC Porter","doi":"10.1016/j.leukres.2017.11.004","elsevierAuthor":"Garcia T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8","altmetricAuthors":["Tamara B. Garcia","Susan P. Fosmire","Christopher C. Porter"],"twitterCount":1,"altmetricId":29060372,"statusesArray":["931546506645172226"]},{"title":"Synergistic antitumor effect of histone deacetylase inhibitor and Doxorubicin in peripheral T-cell lymphoma","googleId":"nczUR3nVOwsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730036X","googleCitationCount":12,"googleAuthor":"H Zhang","doi":"10.1016/j.leukres.2017.01.025","elsevierAuthor":"Zhang H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"10","altmetricAuthors":["Huilai Zhang","Ling Dong","Qingqing Chen","Lingzhe Kong","Bin Meng","Huaqing Wang","Kai Fu","Xi Wang","Qiang Pan-Hammarström","Ping Wang","Xianhuo Wang"],"twitterCount":4,"altmetricId":16052025,"statusesArray":["827887067367514113","827143447656144896","827137505078177792","827135734603616256"]},{"title":"Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk","googleId":"vmDrl9-Mc5AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300651","googleCitationCount":9,"googleAuthor":"MW Schoen","doi":"10.1016/j.leukres.2018.03.005","elsevierAuthor":"Schoen M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5","altmetricAuthors":["Martin W. Schoen","Susan K. Woelich","James T. Braun","Dhinesh V. Reddy","Mark J. Fesler","Paul J. Petruska","Carl E. Freter","Jack M. Lionberger"],"twitterCount":4,"altmetricId":34758504,"statusesArray":["978647838362972162","977266208897732608","977173939725234181","977171534841249792"]},{"title":"High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones","googleId":"F7nd0tonkvIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302491","googleCitationCount":14,"googleAuthor":"M Giraud","doi":"10.1016/j.leukres.2016.11.009","elsevierAuthor":"Salson M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"9","altmetricAuthors":["Mikaël Salson","Mathieu Giraud","Aurélie Caillault","Nathalie Grardel","Nicolas Duployez","Yann Ferret","Marc Duez","Ryan Herbert","Tatiana Rocher","Shéhérazade Sebda","Sabine Quief","Céline Villenet","Martin Figeac","Claude Preudhomme"],"twitterCount":2,"altmetricId":14562755,"statusesArray":["891238398295506944","806860936174772225"]},{"title":"Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis","googleId":"wG3wwnMBelYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300966","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.leukres.2017.03.013","elsevierAuthor":"Guo Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"7","altmetricAuthors":["Zhen Guo","Shao-kai Zhang","Zhe Zou","Rui-hua Fan","Xiao-dong Lyu"],"twitterCount":1,"altmetricId":20298028,"statusesArray":["865534700403646466"]},{"title":"Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical …","googleId":"0HUXAI-bhisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302442","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.004","elsevierAuthor":"Drusbosky L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"12","altmetricAuthors":["Leylah Drusbosky","Cindy Medina","Regina Martuscello","Kimberly E. Hawkins","Myron Chang","Jatinder K. Lamba","Shireen Vali","Ansu Kumar","Neeraj Kumar Singh","Taher Abbasi","Mikkael A. Sekeres","Mar Mallo","Francesc Sole","Rafael Bejar","Christopher R. Cogle"],"twitterCount":9,"altmetricId":16354568,"statusesArray":["1052940110445064193","989912131687669766","989705321026236416","986781286067994624","986741671076524033","831168537532182528","831119700889329664","831108999206428672","831065411970093057","831065402067259392"]},{"title":"Survival outcomes in iron chelated and non-chelated patients with lower-risk myelodysplastic syndromes: review and pooled analysis of observational studies","googleId":"Ms5QW61B1oUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28343141/","googleCitationCount":13,"googleAuthor":"M Al Yami","doi":"10.1016/j.leukres.2017.03.007,","elsevierAuthor":"Abraham I.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Expression of autophagy related genes in chronic lymphocytic leukemia is associated with disease course","googleId":"l84wFWKBQbUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306136","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.007","elsevierAuthor":"Kong Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an …","googleId":"U4yNZdamYk8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302091","googleCitationCount":8,"googleAuthor":"AMR Dos Santos","doi":"10.1016/j.leukres.2018.09.003","elsevierAuthor":"de Carvalho D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7","altmetricAuthors":["Darlen Cardoso de Carvalho","Alayde Vieira Wanderley","André Mauricio Ribeiro dos Santos","Marianne Rodrigues Fernandes","Amanda de Nazaré Cohen Lima de Castro","Luciana Pereira Colares Leitão","João Augusto Nunes de Carvalho","Tatiane Piedade de Souza","André Salim Khayat","Sidney Emanuel Batista dos Santos","Paulo Pimentel de Assumpção","Ney Pereira Carneiro dos Santos"],"twitterCount":2,"altmetricId":49085248,"statusesArray":["1128601323216211969","1046710868912746498"]},{"title":"High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction","googleId":"DfSvg_GPkTQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300183","googleCitationCount":9,"googleAuthor":"P Bhatia","doi":"10.1016/j.leukres.2018.01.012","elsevierAuthor":"Singh M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway","googleId":"As_92CNcaRQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300577","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.005","elsevierAuthor":"Zhao P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"8","altmetricAuthors":["Pan Zhao","Yafang Chen","Zhijie Yue","Ying Yuan","Xiaofang Wang"],"twitterCount":1,"altmetricId":18010838,"statusesArray":["844534139672018944"]},{"title":"MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sezary syndrome patients","googleId":"r7WCALSaxZcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302508","googleCitationCount":21,"googleAuthor":"KM Kodigepalli","doi":"10.1016/j.leukres.2016.11.010","elsevierAuthor":"Kohnken R.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"13","altmetricAuthors":["Rebecca Kohnken","Karthik M. Kodigepalli","Anjali Mishra","Pierluigi Porcu","Li Wu"],"twitterCount":1,"altmetricId":14255170,"statusesArray":["809035422466764800"]},{"title":"Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia","googleId":"2fBycH8qaFAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304319","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.011","elsevierAuthor":"Tan J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"7","altmetricAuthors":["Jie Tan","Ya Wang","Si-Jian Yu","Yong-Yong Ma","Hu-Yi Lei","Qi-Fa Liu"],"twitterCount":1,"altmetricId":20251308,"statusesArray":["866234701425426432"]},{"title":"Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic …","googleId":"V4Rqo61dfLoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305180","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.010","elsevierAuthor":"Xu M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"7","altmetricAuthors":["Ming Xu","Jian-ye Ren","Yuan-cheng Guo","Bai-xue Xu","Qing Zeng","Qi Hu","Yong-ming Zhou","Jia-hui Lu"],"twitterCount":2,"altmetricId":26872606,"statusesArray":["935869472212054018","914442293234376704"]},{"title":"Enhanced perforin expression associated with dasatinib therapy in natural killer cells","googleId":"xzvyfVWjwGYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300493","googleCitationCount":7,"googleAuthor":"K Miura","doi":"10.1016/j.leukres.2018.02.014","elsevierAuthor":"Iriyama N.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"7","altmetricAuthors":["Noriyoshi Iriyama","Hiromichi Takahashi","Katsuhiro Miura","Yoshihito Uchino","Masaru Nakagawa","Yoshihiro Hatta","Masami Takei"],"twitterCount":5,"altmetricId":33844553,"statusesArray":["971052818265145344","969596831041753088","969535107076825088","969532028822564865","969528598372773888"]},{"title":"Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia","googleId":"p-_dESqgEVIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306008","googleCitationCount":9,"googleAuthor":"D Zhan","doi":"10.1016/j.leukres.2017.12.001","elsevierAuthor":"Zhan D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"8","altmetricAuthors":["Di Zhan","Yingchi Zhang","Peifang Xiao","Xinchang Zheng","Min Ruan","Jingliao Zhang","Aili Chen","Yao Zou","Yumei Chen","Gang Huang","Shaoyan Hu","Qian-fei Wang","Xiaofan Zhu"],"twitterCount":4,"altmetricId":30513784,"statusesArray":["943507225473056768","943481142904262656","943414690121576448","941901265231122432"]},{"title":"Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia","googleId":"6Pz3y1BCYLgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301796","googleCitationCount":6,"googleAuthor":"WJ Geldenhuys","doi":"10.1016/j.leukres.2018.08.002","elsevierAuthor":"Nair R.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Therapeutic options for leukemic transformation in patients with myeloproliferative neoplasms","googleId":"7bMn5MP5RmEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305623","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.009","elsevierAuthor":"Khan M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"8","altmetricAuthors":["Maliha Khan","Rabbia Siddiqi","Naseema Gangat"],"twitterCount":1,"altmetricId":31412477,"statusesArray":["950396699788369922"]},{"title":"Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome","googleId":"dhP1E61TdH0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830081X","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.003","elsevierAuthor":"Sasada K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7","altmetricAuthors":["Keiko Sasada","Noriko Yamamoto","Hiroki Masuda","Yoko Tanaka","Ayako Ishihara","Yasushi Takamatsu","Yutaka Yatomi","Waichiro Katsuda","Issei Sato","Hirotaka Matsui"],"twitterCount":22,"altmetricId":39633497,"statusesArray":["1353344622668333056","1353328012775723008","990699788327964672","990699046120570881","990627713936310272","990564916682637312","990562299697025024","990545143559159808","990534246111395840","990511882778767360","990470065509154816","990462249419530241","990365099545182209","990364486048530432","990255038701318145","990241965311606784","990232953610358784","990231133882269697","990230163148308480","990224641045155841","990223078612393984","990218517591965696","990216883373682688"]},{"title":"miR-137 downregulates c-kit expression in acute myeloid leukemia","googleId":"wXWLmpB_9mwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300395","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.028","elsevierAuthor":"Hu Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature","googleId":"dTctN_hGZ_QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304903","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.009","elsevierAuthor":"Norsworthy K.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"6","altmetricAuthors":["Kelly J. Norsworthy","Amy E. DeZern","Hua-Ling Tsai","Wesley A. Hand","Ravi Varadhan","Steven D. Gore","Ivana Gojo","Keith Pratz","Hetty E. Carraway","Margaret Showel","Michael A. McDevitt","Douglas Gladstone","Gabriel Ghiaur","Gabrielle Prince","Amy H. Seung","Dina Benani","Mark J. Levis","Judith E. Karp","B. Douglas Smith"],"twitterCount":1,"altmetricId":24798480,"statusesArray":["905024254667776003"]},{"title":"Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS","googleId":"JPrT2IpQZeIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300699","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.03.007","elsevierAuthor":"Boch T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5","altmetricAuthors":["Tobias Boch","Thomas Luft","Georgia Metzgeroth","Maximilian Mossner","Johann-Christoph Jann","Daniel Nowak","Franziska La Meir","Christiane Schumann","Jennifer Klemmer","Susanne Brendel","Harald Fricke","Claudia Kunz","Christel Weiß","Wolf-Karsten Hofmann","Florian Nolte"],"twitterCount":1,"altmetricId":34481678,"statusesArray":["975371268882124801"]},{"title":"Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55–65 years with Philadelphia chromosome-negative acute …","googleId":"KKTesrZwHD8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300729","googleCitationCount":8,"googleAuthor":"JM Ribera","doi":"10.1016/j.leukres.2018.03.010","elsevierAuthor":"Ribera J.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5","altmetricAuthors":["Josep-Maria Ribera","Olga García","Cristina Gil","Santiago Mercadal","Irene García-Cadenas","Pau Montesinos","Pere Barba","Susana Vives","José González-Campos","Mar Tormo","Jordi Esteve","Aurelio López","María José Moreno","Jordi Ribera","Natalia Alonso","Arancha Bermúdez","María Luz Amigo","Eulàlia Genescà","Daniel García","Ferran Vall-Llovera","Juan Miguel Bergua","Ramon Guàrdia","María Carmen Monteserín","Teresa Bernal","María Calbacho","María Pilar Martínez","Evarist Feliu"],"twitterCount":4,"altmetricId":34618866,"statusesArray":["1115273109492371457","979266994569654272","978990364525776897","978937334371635200","976040003217354752"]},{"title":"The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review","googleId":"Thx2sw2ptewJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730084X","googleCitationCount":16,"googleAuthor":"L Falchi","doi":"10.1016/j.leukres.2017.03.008","elsevierAuthor":"Boddu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"9","altmetricAuthors":["Prajwal Boddu","Lorenzo Falchi","Chitra Hosing","Kate Newberry","Prithviraj Bose","Srdan Verstovsek"],"twitterCount":3,"altmetricId":18550727,"statusesArray":["1093935472219443206","885166921892732930","849933196284141569"]},{"title":"Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy","googleId":"w_5JFkDIaiMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305532","googleCitationCount":9,"googleAuthor":"M Rahmati","doi":"10.1016/j.leukres.2017.10.007","elsevierAuthor":"Fakhimahmadi A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low-and middle-income …","googleId":"2Md5hRLX1KAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304708","googleCitationCount":11,"googleAuthor":"AFT Ribeiro","doi":"10.1016/j.leukres.2017.07.005","elsevierAuthor":"Benicio M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia","googleId":"xDTU-zeeTf0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306021","googleCitationCount":7,"googleAuthor":"B Snetsinger","doi":"10.1016/j.leukres.2017.12.003","elsevierAuthor":"Cull A.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"4","altmetricAuthors":["A.H. Cull","D. Mahendru","B. Snetsinger","D. Good","K. Tyryshkin","A. Chesney","Z. Ghorab","M. Reis","R. Buckstein","R.A. Wells","M.J. Rauh"],"twitterCount":8,"altmetricId":30191216,"statusesArray":["947526141086224384","947208590154223616","947184518003412998","947124455079280640","947113471384186880","947105019765186561","940580341349093377","939294305231032320"]},{"title":"HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia","googleId":"qOiNCG38qvQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304861","googleCitationCount":8,"googleAuthor":"R Cusano","doi":"10.1016/j.leukres.2017.08.005","elsevierAuthor":"Caocci G.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"7","altmetricAuthors":["Giovanni Caocci","Marianna Greco","Marcella Arras","Roberto Cusano","Sandro Orrù","Bruno Martino","Elisabetta Abruzzese","Sara Galimberti","Olga Mulas","Marcello Trucas","Roberto Littera","Sara Lai","Carlo Carcassi","Giorgio La Nasa"],"twitterCount":2,"altmetricId":28648713,"statusesArray":["928672047378714625","928607798933385216"]},{"title":"TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome","googleId":"xRyYbLcFvsgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304296","googleCitationCount":5,"googleAuthor":"SH Jung","doi":"10.1016/j.leukres.2018.10.004","elsevierAuthor":"Kim Y.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2","altmetricAuthors":["Yoo-Jin Kim","Seung-Hyun Jung","Eun-Hye Hur","Eun-Ji Choi","Kyoo-Hyung Lee","Seon-Hee Yim","Hye-Jung Kim","Yong-Rim Kwon","Young-Woo Jeon","Sug Hyung Lee","Yeun-Jun Chung","Je-Hwan Lee"],"twitterCount":7,"altmetricId":49890769,"statusesArray":["1301890227573751808","1248980334118670338","1215392182724710402","1133814313876115456","1126489539986567168","1053972409047375872","1053677205614743553","1053677091714154496","1052940834994315264","1052931147800268800","1052930232112558080","1052929855183044609","1052929798069211139"]},{"title":"Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute …","googleId":"BCf11r2IGeQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304332","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.013","elsevierAuthor":"Gu B.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"7","altmetricAuthors":["Bin Gu","Xiaojin Wu","Guanghua Chen","Xiao Ma","Zhengming Jin","Xiaowen Tang","Yue Han","Chengcheng Fu","Huiying Qiu","Aining Sun","Depei Wu"],"twitterCount":1,"altmetricId":20647098,"statusesArray":["868412776976232448"]},{"title":"TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia","googleId":"eM0Pw4Rd_QwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302169","googleCitationCount":5,"googleAuthor":"MS Brassesco","doi":"10.1016/j.leukres.2018.09.010","elsevierAuthor":"Brassesco M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"5","altmetricAuthors":["María Sol Brassesco","Julia Alejandra Pezuk","Maria Angelica Cortez","Karina Bezerra Salomão","Carlos Alberto Scrideli","Luiz Gonzaga Tone"],"twitterCount":1,"altmetricId":51242517,"statusesArray":["1128601327632814080"]},{"title":"Reduced ADAMTS-13 level negatively correlates with inflammation factors in plasma of acute myeloid leukemia patients","googleId":"96FNcSwgJh8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302673","googleCitationCount":12,"googleAuthor":"C Liu","doi":"10.1016/j.leukres.2016.12.004","elsevierAuthor":"Liu C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"12","altmetricAuthors":["Chen Liu","Lei Zhao","Jingzhong Zhao","Qinzhu Xu","Ying Song","Hui Wang"],"twitterCount":3,"altmetricId":15227057,"statusesArray":["830778749977255936","816711930836615172","816632024601497600"]},{"title":"DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia","googleId":"kUApXid4K2IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730543X","googleCitationCount":16,"googleAuthor":"BG Dedeoglu","doi":"10.1016/j.leukres.2017.10.006","elsevierAuthor":"Ozdogan H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"14","altmetricAuthors":["Hakan Ozdogan","Bala Gur Dedeoglu","Yasemin Oztemur Islakoglu","Alp Aydos","Sevil Kose","Arzu Atalay","Zeynep Arzu Yegin","Ferit Avcu","Duygu Uckan Cetinkaya","Osman Ilhan"],"twitterCount":2,"altmetricId":28493707,"statusesArray":["927564503151026176","927498329507770368"]},{"title":"Circular RNA expression profiles are significantly altered in mice bone marrow stromal cells after total body irradiation","googleId":"ndSNAR4I5XIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301127","googleCitationCount":9,"googleAuthor":"R Huang","doi":"10.1016/j.leukres.2018.05.010","elsevierAuthor":"Zhang J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Therapy of older persons with acute myeloid leukaemia","googleId":"qfO_h-nabmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304423","googleCitationCount":12,"googleAuthor":"RP Gale","doi":"10.1016/j.leukres.2017.05.020","elsevierAuthor":"Krug U.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy","googleId":"jOVUWT4hClUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304629","googleCitationCount":16,"googleAuthor":"TH Kim","doi":"10.1016/j.leukres.2017.06.009","elsevierAuthor":"Kim T.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"9","altmetricAuthors":["TaeHyung Kim","Marc S. Tyndel","Zhaolei Zhang","Jaesook Ahn","Seunghyun Choi","Michael Szardenings","Jeffrey H. Lipton","Hyeoung-Joon Kim","Dennis Kim Dong Hwan"],"twitterCount":11,"altmetricId":21221509,"statusesArray":["901405698449428480","881610626870718465","881523054450552832","881521694996877314","881462727792746500","878085269479538688","877560453513084928","877525165051138049","877524865468833793","877521572873084928","877513686713212929"]},{"title":"High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic …","googleId":"FGwVO66E9lwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305635","googleCitationCount":16,"googleAuthor":"A Candoni","doi":"10.1016/j.leukres.2017.10.010","elsevierAuthor":"Candoni A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Epigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia","googleId":"rmb7gNC7eFsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304186","googleCitationCount":10,"googleAuthor":"A Gopalakrishnapillai","doi":"10.1016/j.leukres.2017.05.004","elsevierAuthor":"Gopalakrishnapillai A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"4","altmetricAuthors":["Anilkumar Gopalakrishnapillai","E. Anders Kolb","Suzanne M. McCahan","Sonali P. Barwe"],"twitterCount":2,"altmetricId":20183985,"statusesArray":["864427825993990144","864422734847025152"]},{"title":"Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation","googleId":"eUrjFXsrxHoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300620","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.006","elsevierAuthor":"Gao L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study","googleId":"5Xe6qLNipsoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730485X","googleCitationCount":9,"googleAuthor":"YJ Kim","doi":"10.1016/j.leukres.2017.08.004","elsevierAuthor":"Lee J.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma","googleId":"goR6tB-3J3cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305714","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.001","elsevierAuthor":"Liu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"3","altmetricAuthors":["Pingyi Liu","Lingling Chen"],"twitterCount":3,"altmetricId":28898609,"statusesArray":["938770123208511488","930391674961797120","930391390160412672"]},{"title":"Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma–proliferation centres are characterized by high miR-92a and miR-155 and …","googleId":"AKH7zv1trYoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730098X","googleCitationCount":9,"googleAuthor":"A Matolcsy","doi":"10.1016/j.leukres.2017.04.002","elsevierAuthor":"Szurián K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"9","altmetricAuthors":["Kinga Szurián","Irén Csala","Violetta Piurkó","Linda Deák","András Matolcsy","Lilla Reiniger"],"twitterCount":1,"altmetricId":18812578,"statusesArray":["852828117047558146"]},{"title":"Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?","googleId":"I0aVseyB64YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301802","googleCitationCount":6,"googleAuthor":"RP Gale","doi":"10.1016/j.leukres.2018.08.011","elsevierAuthor":"Yang S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP","googleId":"LOE6AwiZAiEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301589","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.014","elsevierAuthor":"Kim S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"6","altmetricAuthors":["Seok-Hyun Kim","Se-Il Go","Jangho Seo","Myoung Hee Kang","Sung Woo Park","Hoon-Gu Kim","Gyeong-Won Lee"],"twitterCount":1,"altmetricId":45517685,"statusesArray":["1022107952549834752"]},{"title":"Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit","googleId":"Rd9kJBgcmlIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305258","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.017","elsevierAuthor":"Ahmed T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified","googleId":"d5g5XKv6UawJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301644","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.020","elsevierAuthor":"Li Q.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":["Qian Li","Shuang Gao","Jing Ma","Su Liu","Yuanfang Yue","Lin Chen","Han Li","Xue Wang","Dongying Li","Zeng Cao","Zhigang Zhao","Xiaofang Wang","Yong Yu","Yizhuo Zhang","Yafei Wang"],"twitterCount":3,"altmetricId":45947669,"statusesArray":["1038005742597365762","1036555435208318976","1024956723453485056"]},{"title":"CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation","googleId":"RgOUdaJIZBUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30401521/","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.10.007,","elsevierAuthor":"Unnikrishnan A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study","googleId":"zCk5TRrhuOcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305271","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.019","elsevierAuthor":"Visani G.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"12","altmetricAuthors":["Giuseppe Visani","Felicetto Ferrara","Francesco Di Raimondo","Federica Loscocco","Fabio Fuligni","Stefania Paolini","Valentina Zammit","Eleonora Spina","Marco Rocchi","Axel Visani","Pier Paolo Piccaluga","Alessandro Isidori"],"twitterCount":4,"altmetricId":27835901,"statusesArray":["935865705689358337","931904991899672576","922520851811008513","922511080026529792"]},{"title":"Secreted Wnt antagonists in leukemia: A road yet to be paved","googleId":"WO620v870EgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300730","googleCitationCount":5,"googleAuthor":"M Pehlivan","doi":"10.1016/j.leukres.2018.03.011","elsevierAuthor":"Pehlivan M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"2","altmetricAuthors":["Melek Pehlivan","Ceyda Çalışkan","Zeynep Yüce","Hakki Ogun Sercan"],"twitterCount":2,"altmetricId":35811193,"statusesArray":["982628181805969408","982570942080606208"]},{"title":"Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcome","googleId":"6t33cae37zEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730440X","googleCitationCount":8,"googleAuthor":"P Jain","doi":"10.1016/j.leukres.2017.05.018","elsevierAuthor":"Jain P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"7","altmetricAuthors":["Preetesh Jain","Sa Wang","Keyur P. Patel","Nawid Sarwari","Jorge Cortes","Hagop Kantarjian","Srdan Verstovsek"],"twitterCount":1,"altmetricId":20946665,"statusesArray":["873600063087427584"]},{"title":"Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish …","googleId":"ymVZ-ocoelIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305647","googleCitationCount":8,"googleAuthor":"X Calvo","doi":"10.1016/j.leukres.2017.10.011","elsevierAuthor":"Nomdedeu M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"2","altmetricAuthors":["Meritxell Nomdedeu","Arturo Pereira","Xavier Calvo","Joan Colomer","Francesc Sole","Amparo Arias","Candida Gomez","Elisa Luño","Jose Cervera","Montserrat Arnan","Helena Pomares","Fernando Ramos","Itziar Oiartzabal","Blanca Espinet","Carme Pedro","Beatriz Arrizabalaga","María Laura Blanco","Mar Tormo","Jesus Maria Hernandez-Rivas","María Díez-Campelo","Margarita Ortega","David Valcárcel","Maria-Teresa Cedena","Rosa Collado","Javier Grau","Isabel Granada","Guillermo Sanz","Elias Campo","Jordi Esteve","Dolors Costa"],"twitterCount":4,"altmetricId":28716356,"statusesArray":["952242637918035968","952189757571743744","928957689237065728","928942079786360832"]},{"title":"Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA","googleId":"xYk9rkJkdecJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300250","googleCitationCount":8,"googleAuthor":"M Yaghmaie","doi":"10.1016/j.leukres.2018.01.019","elsevierAuthor":"Ghavamzadeh A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: a case-control study","googleId":"j6iBjPethGcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300766","googleCitationCount":6,"googleAuthor":"KT Soh","doi":"10.1016/j.leukres.2018.03.014","elsevierAuthor":"Etter J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4","altmetricAuthors":["John Lewis Etter","Rikki Cannioto","Kah Teong Soh","Emad Alquassim","Hani Almohanna","Zachary Dunbar","Janine M. Joseph","Sophia Balderman","Francisco Hernandez-Ilizaliturri","Kirsten B. Moysich"],"twitterCount":4,"altmetricId":35721051,"statusesArray":["1027516284605538304","1027509970143793154","986320170175074305","981811680807215104"]},{"title":"Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence","googleId":"qzZJiZQtFZgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304812","googleCitationCount":9,"googleAuthor":"CR Cogle","doi":"10.1016/j.leukres.2017.07.008","elsevierAuthor":"Cogle C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"4","altmetricAuthors":["Christopher R. Cogle","Sheila R. Reddy","Eunice Chang","Elya Papoyan","Michael S. Broder","Michael McGuire","Gary Binder"],"twitterCount":1,"altmetricId":24068617,"statusesArray":["898850554599714816"]},{"title":"Anti-proliferative activity of CGK012 against multiple myeloma cells via Wnt/β-catenin signaling attenuation","googleId":"IFCEPvkzBBAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304666","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.001","elsevierAuthor":"Choi P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"6","altmetricAuthors":["Pyung jun Choi","Yuseok O","Jin-Hyuk Her","Eunju Yun","Gyu Yong Song","Sangtaek Oh"],"twitterCount":2,"altmetricId":23320006,"statusesArray":["894936240448872451","892030115521196032"]},{"title":"A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia","googleId":"ikfGF73UvQIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304612","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2018.10.018","elsevierAuthor":"Fries C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"3","altmetricAuthors":["Carol Fries","W. Richard Burack"],"twitterCount":1,"altmetricId":61926534,"statusesArray":["1137298473798291457"]},{"title":"Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: introducing a parameter quantifying CD33 expression on CD34+ cells","googleId":"bpeOpDdvcesJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830153X","googleCitationCount":7,"googleAuthor":"MG Della Porta","doi":"10.1016/j.leukres.2018.07.009","elsevierAuthor":"Ogata K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"6","altmetricAuthors":["Kiyoyuki Ogata","Kazuma Sei","Leonie Saft","Naoya Kawahara","Matteo G. Della Porta","Nicolas Chapuis","Yumi Yamamoto"],"twitterCount":1,"altmetricId":70454255,"statusesArray":["1110490864093220866"]},{"title":"The impact of the neutrophil: lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma","googleId":"V9-NCR-QhpsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300468","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.011","elsevierAuthor":"Beltrán B.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6","altmetricAuthors":["Brady E. Beltrán","Sally Paredes","Esther Cotrina","Eduardo M. Sotomayor","Jorge J. Castillo"],"twitterCount":4,"altmetricId":33549410,"statusesArray":["968061778780450816","967117396640260097","966811015131250688","966806557634674689"]},{"title":"ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation","googleId":"BunkWzO3MlQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300523","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.017","elsevierAuthor":"Liu J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"3","altmetricAuthors":["Jia Liu","Wenting Lu","Shuang Liu","Ying Wang","Saisai Li","Yingxi Xu","Haiyan Xing","Kejing Tang","Zheng Tian","Qing Rao","Min Wang","Jianxiang Wang"],"twitterCount":1,"altmetricId":34631619,"statusesArray":["976112370727743488"]},{"title":"Helios expression in regulatory T cells promotes immunosuppression, angiogenesis and the growth of leukemia cells in pediatric acute lymphoblastic leukemia","googleId":"0X6PipREWisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300420","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.007","elsevierAuthor":"Li X.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day+ 30 after allo-HSCT","googleId":"QxVwgq_le4kJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300140","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.014","elsevierAuthor":"Drokov M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia","googleId":"drjZYYOofOcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305726","googleCitationCount":6,"googleAuthor":"P Collin","doi":"10.1016/j.leukres.2017.11.002","elsevierAuthor":"Sajwani F.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis","googleId":"AiNcAFLFOeAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306094","googleCitationCount":6,"googleAuthor":"Z Hu","doi":"10.1016/j.leukres.2017.12.004","elsevierAuthor":"Hu Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"4","altmetricAuthors":["Zhihong Hu","Shimin Hu","Changsheng Ji","Zhenya Tang","Beenu Thakral","Sanam Loghavi","L.Jeffrey Medeiros","Wei Wang"],"twitterCount":1,"altmetricId":31104661,"statusesArray":["947466029533339649"]},{"title":"Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines","googleId":"_LqmfqjbFxUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305672","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.014","elsevierAuthor":"Zhao W.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy","googleId":"WmTu4OIRVKgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302454","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.005","elsevierAuthor":"Zhang Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells","googleId":"sVMPMUKovdUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301255","googleCitationCount":6,"googleAuthor":"S Das","doi":"10.1016/j.leukres.2018.06.005","elsevierAuthor":"Das S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML","googleId":"TYS9MoWHDmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301152","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2018.05.013","elsevierAuthor":"Janiszewska H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"3","altmetricAuthors":["Hanna Janiszewska","Aneta Bąk","Katarzyna Skonieczka","Anna Jaśkowiec","Marek Kiełbiński","Anna Jachalska","Maria Czyżewska","Bożena Jaźwiec","Małgorzata Kuliszkiewicz-Janus","Jarosław Czyż","Kazimierz Kuliczkowski","Olga Haus"],"twitterCount":1,"altmetricId":70376899,"statusesArray":["1007569445357694977"]},{"title":"p53 deletion promotes myeloma cells invasion by upregulating miR19a/CXCR5","googleId":"C-aNe9kNyh8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730468X","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.003","elsevierAuthor":"Yue Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"4","altmetricAuthors":["Zhijie Yue","Yongxia Zhou","Pan Zhao","Yafang Chen","Ying Yuan","Yaoyao Jing","Xiaofang Wang"],"twitterCount":1,"altmetricId":23510596,"statusesArray":["895328834492354561"]},{"title":"Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase …","googleId":"BnDFIirRMzYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300481","googleCitationCount":7,"googleAuthor":"D Hiwase","doi":"10.1016/j.leukres.2018.02.013","elsevierAuthor":"Hiwase D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"5","altmetricAuthors":["Devendra Hiwase","Peter Tan","James D’Rozario","John Taper","Anthony Powell","Ian Irving","Matthew Wright","Susan Branford","David T. Yeung","Luke Anderson","Othon Gervasio","Carly Levetan","Will Roberts","Ann Solterbeck","Robert Traficante","Timothy Hughes"],"twitterCount":8,"altmetricId":33803326,"statusesArray":["984574318716772354","970302589496647682","970183080601423872","970124521238859776","970092736350126080","969935450562494464","969535113800200192","969137416270331904"]},{"title":"A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia","googleId":"1yWt9P6sTMgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301279","googleCitationCount":5,"googleAuthor":"AL Bryant","doi":"10.1016/j.leukres.2018.06.006","elsevierAuthor":"Bryant A.L.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States","googleId":"ih1_km84eScJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301310","googleCitationCount":6,"googleAuthor":"S Murty","doi":"10.1016/j.leukres.2018.06.010","elsevierAuthor":"Bell J.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"AML refractory to primary induction with Ida-FLAG has a poor clinical outcome","googleId":"tvhMiph-rqYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830047X","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.012","elsevierAuthor":"Kavanagh S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5","altmetricAuthors":["Simon Kavanagh","Emily Heath","Rose Hurren","Marcela Gronda","Samir H. Barghout","Sanduni U. Liyanage","Thirushi P. Siriwardena","Jaime Claudio","Tong Zhang","Mahadeo Sukhai","Tracy L. Stockley","Suzanne Kamel-Reid","Amr Rostom","Andrzej Lutynski","Dina Khalaf","Anna Rydlewski","Steven M. Chan","Vikas Gupta","Dawn Maze","Hassan Sibai","Andre C. Schuh","Karen Yee","Mark D. Minden","Aaron D. Schimmer"],"twitterCount":0,"altmetricId":70458535,"statusesArray":[]},{"title":"NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells","googleId":"UF6blnmV20IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300031","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.003","elsevierAuthor":"Okabe-Kado J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells","googleId":"QKZLca93HAkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305854","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.007","elsevierAuthor":"Lei H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML","googleId":"-JgEp3bydZwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301851","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.007","elsevierAuthor":"Anderson E.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2","altmetricAuthors":["Elizabeth Anderson","Priyanka Mehta","Jonathan Heywood","Barbara Rees","Heather Bone","Gareth Robinson","Darren Reynolds","Vyv Salisbury","Lawrence Mayer"],"twitterCount":2,"altmetricId":46702679,"statusesArray":["1031167757176303617","1031130160219611136"]},{"title":"Anti-angiogenic and anti-multiple myeloma effects of oprozomib (OPZ) alone and in combination with pomalidomide (Pom) and/or dexamethasone (Dex)","googleId":"0yrBc-vmF3EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300711","googleCitationCount":9,"googleAuthor":"CS Wang","doi":"10.1016/j.leukres.2017.03.002","elsevierAuthor":"Sanchez E.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"6","altmetricAuthors":["Eric Sanchez","Mingjie Li","Cathy S. Wang","George Tang","Abigail Gillespie","Haiming Chen","James R. Berenson"],"twitterCount":1,"altmetricId":22456461,"statusesArray":["900915519150272516"]},{"title":"Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data","googleId":"M0vnar0XF5gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301760","googleCitationCount":4,"googleAuthor":"F Ferraro","doi":"10.1016/j.leukres.2018.07.024","elsevierAuthor":"Ferraro F.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: portrait of a rare clinical entity","googleId":"tquHbmDNlSsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301292","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2018.06.008","elsevierAuthor":"Barzilai M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center.(Positive effect of erythropoietin±prednisone …","googleId":"ewCKHeOgZ0AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300778","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.03.015","elsevierAuthor":"Jonasova A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: from the Japanese central review study","googleId":"FnaaIJY4cOQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301243","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.06.003","elsevierAuthor":"Matsuda A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia","googleId":"ofVVJyP-tRIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830184X","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.006","elsevierAuthor":"Manukyan G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era","googleId":"cZVc3F6vi3sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304435","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.021","elsevierAuthor":"Chen H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine","googleId":"-u2SzWWON-wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305660","googleCitationCount":6,"googleAuthor":"MA Sekeres","doi":"10.1016/j.leukres.2017.10.013","elsevierAuthor":"Sébert M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech …","googleId":"fI-zR-42NZIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302029","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.019","elsevierAuthor":"Belada D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":["David Belada","Vit Prochazka","Andrea Janikova","Vit Campr","Petra Blahovcova","Robert Pytlik","Alice Sykorova","Pavel Klener","Katerina Benesova","Jan Pirnos","Juraj Duras","Heidi Mocikova","Marek Trneny"],"twitterCount":18,"altmetricId":47924015,"statusesArray":["1055908886270500864","1055822238144839681","1038953970943717376","1038729834501943296","1038556340946460673","1038552276418396160","1038191935972933633","1038140231340490753","1038107086293532672","1038106666993168384","1038076075690143745","1038072765750947841","1038068774493188096","1038068128683646976","1038066190772563969","1038064986051039232","1038064858841997313","1038062177066921985","1038057854547124224","1038056288171831296"]},{"title":"The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma","googleId":"_uBcNJiM8zkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300012","googleCitationCount":8,"googleAuthor":"X Hu","doi":"10.1016/j.leukres.2017.01.001","elsevierAuthor":"Hu X.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia","googleId":"Qr6AfPkgSKQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305192","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.011","elsevierAuthor":"Sahai T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"3","altmetricAuthors":["Tanmay Sahai","Kelly Henrichs","Majed Refaai","Joanna M. Heal","Scott A. Kirkley","Amy E. Schmidt","Jason H. Mendler","Debra Masel","Jane Liesveld","Christopher Aquina","Neil Blumberg"],"twitterCount":6,"altmetricId":26641682,"statusesArray":["917546208159195136","914798667915132928","913368416479698944","913129402455793666","912995473593643008","912993219448758272"]},{"title":"Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing","googleId":"2c03jLbauvUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305167","googleCitationCount":9,"googleAuthor":"T Umezu","doi":"10.1016/j.leukres.2017.09.008","elsevierAuthor":"Azuma K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"8","altmetricAuthors":["Kenko Azuma","Tomohiro Umezu","Satoshi Imanishi","Michiyo Asano","Seiichiro Yoshizawa","Seiichiro Katagiri","Kazuma Ohyashiki","Junko H. Ohyashiki"],"twitterCount":1,"altmetricId":26909715,"statusesArray":["914821531296870405"]},{"title":"The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians","googleId":"YT14u0huAlYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730509X","googleCitationCount":6,"googleAuthor":"K Kim","doi":"10.1016/j.leukres.2017.09.001","elsevierAuthor":"Kim S.Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"6","altmetricAuthors":["Seon Young Kim","Kwantae Kim","Byungjin Hwang","Kyongok Im","Si Nae Park","Jung-Ah Kim","Sang Mee Hwang","Duhee Bang","Dong Soon Lee"],"twitterCount":1,"altmetricId":26476492,"statusesArray":["911560596830564353"]},{"title":"In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome","googleId":"OHUHdEwe8VsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305404","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.003","elsevierAuthor":"Kojima S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"3","altmetricAuthors":["Shinsuke Kojima","Chie Nishioka","SungGi Chi","Akihito Yokoyama","Takayuki Ikezoe"],"twitterCount":1,"altmetricId":27826921,"statusesArray":["922445275175596032"]},{"title":"Preclinical activity of FF-10501-01, a novel inosine-5′-monophosphate dehydrogenase inhibitor, in acute myeloid leukemia","googleId":"yrrp4bH9pacJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304381","googleCitationCount":6,"googleAuthor":"ZS Bohannan","doi":"10.1016/j.leukres.2017.05.016","elsevierAuthor":"Yang H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"5","altmetricAuthors":["Hui Yang","Zhihong Fang","Yue Wei","Zachary S. Bohannan","Irene Gañán-Gómez","Ana Alfonso Pierola","Linda J. Paradiso","Hiroyuki Iwamura","Guillermo Garcia-Manero"],"twitterCount":5,"altmetricId":20943207,"statusesArray":["873600067185262592","873519290682667009","873511612572999680","873505654278848514","873487074229399553"]},{"title":"Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia","googleId":"IZUDaUshlH8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300851","googleCitationCount":6,"googleAuthor":"I Dyagil","doi":"10.1016/j.leukres.2017.03.009","elsevierAuthor":"Bilous N.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"4","altmetricAuthors":["Nadiia Bilous","Iryna Abramenko","Vladimir Saenko","Anatoliy Chumak","Iryna Dyagil","Zoya Martina","Iryna Kryachok"],"twitterCount":1,"altmetricId":18428946,"statusesArray":["848481184292130816"]},{"title":"Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland …","googleId":"Op7d5RqIVfIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304873","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.006","elsevierAuthor":"Sakihama S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"7","altmetricAuthors":["Shugo Sakihama","Mineki Saito","Megumi Kuba-Miyara","Takeaki Tomoyose","Naoya Taira","Takashi Miyagi","Masaki Hayashi","Shigeko Kinjo","Sawako Nakachi","Iori Tedokon","Yukiko Nishi","Keita Tamaki","Kazuho Morichika","Jun-nosuke Uchihara","Satoko Morishima","Ken-nosuke Karube","Yuetsu Tanaka","Hiroaki Masuzaki","Takuya Fukushima"],"twitterCount":2,"altmetricId":24750369,"statusesArray":["920955035521028096","904661228114518016","904647004416086016"]},{"title":"Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes","googleId":"g3E4JDS675UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305969","googleCitationCount":4,"googleAuthor":"H Wang","doi":"10.1016/j.leukres.2017.11.010","elsevierAuthor":"Liu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A","googleId":"RT603xVgr90J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301097","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2018.05.007","elsevierAuthor":"Kelaidi C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"3","altmetricAuthors":["C. Kelaidi","T. Braun","R. Arana","A. Marceau-Renaut","G. Lazarian","J. Soret","S. Cereja","R. Letestu","V. Eclache","D. Lusina","F. Baran-Marszak","L. Ades","C. Preudhomme","A. Martin","P. Fenaux","C. Gardin"],"twitterCount":0,"altmetricId":48638975,"statusesArray":[]},{"title":"Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia","googleId":"SEni_AauXnsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300437","googleCitationCount":7,"googleAuthor":"A Gopalakrishnapillai","doi":"10.1016/j.leukres.2017.01.030","elsevierAuthor":"Quagliano A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"4","altmetricAuthors":["Anthony Quagliano","Anilkumar Gopalakrishnapillai","Sonali P. Barwe"],"twitterCount":1,"altmetricId":16028168,"statusesArray":["826826697131520000"]},{"title":"Iron chelation therapy in lower IPSS risk myelodysplastic syndromes; which subtypes benefit?","googleId":"mQocQbVX88EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305830","googleCitationCount":6,"googleAuthor":"SA Wong","doi":"10.1016/j.leukres.2017.11.005","elsevierAuthor":"Wong S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for …","googleId":"96k2hQz-g44J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302066","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.022","elsevierAuthor":"Miyazaki Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"5","altmetricAuthors":["Yasushi Miyazaki","Heinz Tuechler","Guillermo Sanz","Julie Schanz","Guillermo Garcia-Manero","Francesc Solé","John M. Bennett","David Bowen","Pierre Fenaux","Francois Dreyfus","Hagop Kantarjian","Andrea Kuendgen","Luca Malcovati","Mario Cazzola","Jaroslav Cermak","Christa Fonatsch","Michelle M. Le Beau","Marilyn L. Slovak","Valeria Santini","Michael Lübbert","Jaroslaw Maciejewski","Sigrid Machherndl-Spandl","Silvia M.M. Magalhaes","Michael Pfeilstöcker","Mikkael A. Sekeres","Wolfgang R. Sperr","Reinhard Stauder","Sudhir Tauro","Peter Valent","Teresa Vallespi","Arjan A. van de Loosdrecht","Ulrich Germing","Detlef Haase","Peter L. Greenberg"],"twitterCount":5,"altmetricId":48219334,"statusesArray":["1041967482947493889","1041777847679897600","1040558213987528705","1040534795187613696","1040230210006917120"]},{"title":"TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.","googleId":"8frtu7xSRtMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304940","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.013","elsevierAuthor":"Tamai M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation","googleId":"gpuwsYaLkLIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302108","googleCitationCount":4,"googleAuthor":"Y Abaza","doi":"10.1016/j.leukres.2018.09.004","elsevierAuthor":"Abaza Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":["Yasmin Abaza","Juliana E. Hidalgo-Lopez","Srdan Verstovsek","Elias Jabbour","Farhad Ravandi","Gautam Borthakur","Zeev Estrov","Yesid Alvarado","Jan Burger","Heather Schneider","Kelly A. Soltysiak","Yue Wei","Hagop M. Kantarjian","Carlos E. Bueso-Ramos","Guillermo Garcia-Manero"],"twitterCount":1,"altmetricId":48921944,"statusesArray":["1047481308996427776","1045044936419266560"]}]